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1. CHAPTER 1 
GENERAL INTRODUCTION 
 
1.1 Mortality, morbidity and costs associated with respiratory 
disease 
Whilst cardiovascular diseases are the leading cause of death in the world (causing 
almost 32% of all deaths in women and 27% in men in 2004), respiratory disease is 
also a major cause of mortality and morbidity (WHO, 2008). Indeed, as stated in the 
World Health Organisation (WHO) consultation on the development of a 
comprehensive approach for the prevention and control of chronic respiratory 
diseases (January 2001, Geneva), almost one-fifth of all deaths are attributable to 
respiratory illness, and both communicable respiratory diseases (tuberculosis, acute 
respiratory infection, pertussis, diphtheria, measles) and non communicable diseases 
(asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, cystic 
fibrosis, obliterative bronchiolitis, sarcoidosis) represent about 20% of the global 
burden of disease measured in disability-adjusted life years (DALYS) (WHO, 2001).  
 
1.2 Global Health Challenges 
Projections indicate that the four leading causes of death globally in 2030 will be 
ischaemic heart disease, cerebrovascular disease (stroke), chronic obstructive 
pulmonary disease and lower respiratory infections (mainly pneumonia) (WHO, 
2008). Amongst all diseases, those of chronic process are of particular concern for 
future generations as a chronic disease epidemic is anticipated over the next two 
decades (Wang L et al., 2005, Srinath Reddy K et al., 2005).  
 
In relation to current perspectives on chronic respiratory disease it is estimated that in 
the world today over 300 million people suffer from asthma, over 210 million from 
COPD and over 450 million from allergic rhinitis and other chronic respiratory 




These global observations and predictions are mirrored to a large extent in statistics 
pertaining to the United Kingdom. According to the report “The Burden of Lung 
Disease” produced by the British Thoracic Society in 2006 (BTS, 2006), 117,456 
people died of respiratory disease in 2004 (compared to 106,081 dying of ischaemic 
heart disease). Respiratory disease kills one in five people in the UK. The financial 
burden associated with respiratory diseases is significant and increasing year on year. 
It cost the NHS £6.6 billion in 2004 (£3.0 billion in NHS primary care, secondary 
care and drugs), £1.9 billion in mortality costs and £1.7 billion in morbidity costs, as 
compared to £2,576 million in 2000 (BTS, 2001 , BTS, 2006).  
 
Against this backdrop of impending epidemics and crippling cost forecasts, the 
WHO have launched, the Global Alliance against Chronic Respiratory Diseases. 
(GARD) - an organization dedicated to bringing together the combined knowledge of 
national and international organizations, institutions and agencies to improve the 
lives of millions of people affected by chronic respiratory diseases. Amongst the key 
objectives of the WHO strategy for prevention and control of chronic respiratory 
diseases are the need to improve secondary and tertiary prevention by identifying 
cost-effective interventions and optimised pharmacologic treatments.  
 
1.3 Asthma and COPD: waves of inflammation, and a failure to 
repair 
A common feature of both chronic asthma and COPD, the commonest chronic 
airway diseases, is the airway wall remodelling that occurs in association with 
cellular and structural changes and which, in both cases, leads to thickening, airway 
narrowing and airflow limitation. Whilst different cell types contribute to the 
pathology (asthma is characterized by an increase in CD4+ T cells and eosinophils 
whilst COPD is characterised by increased numbers of neutrophils and CD8+ T 
cells), it is recognised that repetitive bouts of inflammation and airway epithelial 
injury is a feature of both conditions. 
 
In COPD, the repeated bouts of inflammation develop as a consequence of chronic 
inhalation of irritants. The inhaled irritant is usually tobacco smoke, but occupational 
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dust and environmental pollution are also invariably implicated. In asthma, 
inflammatory exacerbations are predominantly linked to viral infections, particularly 
rhinoviruses, whilst other causes including bacterial infection and exposure to 
allergens are also implicated. The structural and inflammatory features of COPD and 
asthma are described by (Jeffery PK, 2000, Jeffery PK, 2001). In asthma the 
epithelium appears to be more fragile than that of COPD, the epithelial reticular 
basement membrane (RBM) is significantly thicker and there is marked enlargement 
of the mass of bronchial smooth muscle. In COPD, there is epithelial mucous 
metaplasia, airway wall fibrosis, and inflammation associated with loss of 
surrounding alveolar attachments to the outer wall of small airways as well as an 
increase in bronchiolar smooth muscle (Jeffery PK, 2001, Szilasi M et al., 2006).  
 
Whilst it is well accepted that a link exists between chronic repetitive bouts of 
inflammation and the development of airway wall remodelling in both conditions, 
questions do arise as to why there should be an apparent failure in airway epithelial 
repair in these settings? Answering these and other questions relating to the 
pathophysiology of chronic respiratory disease, demands an appreciation of the 
dynamic cellular and molecular events that normally operate to repair the airway 
epithelium following injury, and indeed, it is only through such appreciation that the 
abnormal process will be understood and candidate therapeutics potentially 
identified. It is likely that such approaches will increasingly revolve around ‘omic’ 
pathway and network analyses such that identification of candidate hub points as 
putative drug targets likely to influence the course of disease can be identified.  
 
1.4 Developmental ontogeny and tissue repair 
It is apparent that many of the pathways and molecules invoked as a consequence of 
tissue injury have their origins in developmental biology. Indeed, in bone and kidney, 
tissues with only limited repair potential, developmental pathways are co-opted 
during the healing process subsequent to injury (Imgrund M et al., 1999, Vortkamp 
A et al., 1998). Similarly in the skin, liver, pancreas, muscle, and vasculature, 
developmentally important genes have been linked to cellular repair (Beer HD et al., 
2005, Steiling H and Werner S, 2003, Zhao P, 2004).  
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For the lung, although less information is available concerning the molecular 
regulation of cellular responses to injury and mechanisms of tissue repair, there is 
substantial literature available with respect to the developmental ontogeny of this 
organ (Cardoso WV and Lü J, 2006, Kimura J and Deutsch GH, 2007, Shannon MJ 
and Hyatt BA, 2004, Warburton D et al., 2005, Copland I and Post M, 2004). The 
development of the human lung is a complex process involving different stages and 
steps from the embryonic to post-natal periods. Shi et al., (2009) descibes the stages 
of respiratory system development from the formation of the lung and tracheal 
primodia from the primitive foregut, a formation of bronchial tree from lung 
epithelial tubules which then accompanied by development of the vascular structures 
(Shi W et al., 2009). Activation of specific developmental programs leads epithelial 
progenitor cells to differentiate into a variety of cell types such as secretory, ciliated, 
neuroendocrine, and basal cells (Shi W et al., 2009). Later, distal epithelial tubules 
undergo sacculation to form the primitive gas exchange region of the lung as well as 
differentiate to epithelial cell types I and II. Alveolar developed by the sub-division 
of primitive saccules by a process of septation called ‘alveolization’ (Shi W et al., 
2009). This complex morphogenesis is controlled by the coordinated expression of 
transcription factors, growth factors, extracellular matrix molecules, integrins and 
intracellular adhesion molecules in local regulatory networks extending along the 
proximal to distal axis (Copland I and Post M, 2004, Demayo F et al., 2002, 
Warburton D et al., 2005). The formation of each component of the lung is regulated 
by the complex mixture of transcription factors. Transcription factors (such as 
GATA-binding protein 6 (GATA-6)) have the ability to influence lung epithelial 
specification whilst mesenchyme transcription factors (such as Gli2 and Gli3) exert 
influence over direct epithelial patterning (Copland I and Post M, 2004). The 
epithelial-mesenchymal interactions control the expression of signalling molecules 
during lung development and repair, and this control occurs in a temporal, spatial and 
cell-specific manner (Demayo F et al., 2002).  
 
The mechanisms of cellular response and the control of transcription factors during 
early lung development and growth are gradually being revealed, as advantage is 
taken of mice with specific gene mutations, in order to question the specific role of 
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the respective gene products. Overall, the programmed regulation of the 
developmental process is undeniably complex in an organ that contains cells of at 
least 40 distinct lineages (Warburton D et al., 1998).  
 
There is increasing interest, fuelled by genome-wide association studies, microarray 
profiling and animal disease models, in the role of developmentally regulated genes 
in complex chronic disease pathogenesis (Hedgehog, Secreted modular calcium-
binding protein 2 (SMOC2), Notch, retinoic acid, transforming growth factor beta 
(TGF-b), SMAD) (Shi W et al., 2009). Clearly there is some merit to the concept that 
mechanisms of repair recapitulate elements of the developmental process (Demayo F 
et al., 2002, Warburton D et al., 2005). In relation to this concept, the disruption of 
any of these developmental pathways (Sonic Hedgehog, Notch, Retinoid, and TGF-
beta) has also been found to influence the development of the post-natal lung, disease 
(Stick S, 2000) and COPD (Shi W et al., 2009, Shi W et al., 2007).   
 
1.5 Models of airway injury and repair in the lung  
In the context of characterising the processes occurring during healing subsequent to 
injury of the airway epithelium, advantage has been taken of a number of animal 
model systems which are broadly divided into those systems reliant on physical 
injury (Erjefält JS et al., 1995, Gordon RE and Lane BP, 1976, Hilding AC, 1965, 
Keenan KP et al., 1982a, Keenan KP et al., 1982b, Keenan KP et al., 1982c, Keenan 
KP et al., 1983, Lane BP and Gordon R, 1974, McDowell EM et al., 1979, Shimizu 
T et al., 1994, Wilhelm DL, 1953, Kim JS et al., 1997a) and those reliant on 
chemically induced injury – whether administered by inhalation or systemic means 
(Barrow RE et al., 1992, Barrow RE et al., 1993, Cox RA et al., 2005, Cox RA et al., 
2009, Hoffman A et al., 2003, Hong KU et al., 2001, Hong KU et al., 2004b, Kim JS 
et al., 1997a, Kim JS et al., 1997b, Tuck SA et al., 2008). The nature and extent of 
injury varies widely between such model systems.  
 
In this regard, Barrow RE et al., (1992) described four general categories of injury to 
the airway epithelium. The first is described as being reversible – healing occurs 
after the irritant is removed and the cells return to normal (Barrow RE et al., 1992). 
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The second involves exfoliation of individual cells but leaves the majority of the 
nonciliated columnar and basal cells intact (Barrow RE et al., 1992). The third 
involves desquamation of the group of cells, but leaves the basal cell layer intact 
(Barrow RE et al., 1992). The fourth category involves desquamation of cells, 
including the basal cells and after injury the repair process involves proliferation and 
migration of surviving nonciliated cells and differentiation to the normal phenotype, 
with the degree of proliferation reflecting the amount of injury that occurred (Barrow 
RE et al., 1992).  
 
1.5.1 Chemical induction 
Chemically-induced lung injury is well established as a means of achieving airway 
epithelial perturbation. Such techniques include exposing the lung to high 
concentrations of oxygen (O2) or oxidant gases such as nitrogen dioxide (NO2) or 
ozone (O3). Cell death from hyperoxic injury may occur through either apoptotic or 
non-apoptotic pathways, possibly via free oxygen radicals (Liu X et al., 2006). It is 
appreciated that the different types of cell present at the air interface in the lung 
exhibit a range of sensitivity to the effects of chemical exposure. For instance, the 
alveolar epithelial cell type I (AEC I) is particularly sensitive to bleomycin and the 
first to be injured in the context of exposure to this chemical whereas alveolar 
epithelial cell type II (AEC II) have a more variable sensitivity (Izbicki G et al., 
2002).  Subsets of Clara cells in the conducting airway epithelium are recognised to 
be differentially sensitive to naphthalene (Giangreco A et al., 2002, Hong KU et al., 
2001). These susceptibilities should be borne in mind when interpreting the response 
to injury mediated by these chemicals.  
 
Whilst the general utility of chemically-induced lung injury in small animal models 
is reflected in their popularity it is important to reflect upon their comparative 
relevance. Indeed, naphthalene is a cytochrome P-450-activated Clara cell 
cytotoxicant that, in mice, causes swelling and vacuolation of Clara cells in terminal 
bronchioles leading to exfoliation and necrosis of the majority of cells in the airways 
of the deep lung (Plopper CG et al., 1992). Mice appear to be much more susceptible 
to this toxicant than other species, including nonhuman primates, rats and hamsters 
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(Plopper CG and Hyde DM, 2008) and this fact, coupled with the predominance of 
this cell type in the proximal conducting airway in mice relative to humans suggests 
that potential exists for mechanisms of repair evoked as a consequence of such injury 
to vary between species. Indeed, the cellular composition of the tracheal and 
tracheobrochial tree of the airway does differ between species – with Clara cells in 
mice representing 49% of the total epithelial cells in tracheal epithelium whilst at the 
same site in monkeys or humans less than 1% of the cells are Clara cells (Plopper 
CG and Hyde DM, 2008). Further, sub mucosal glands are important secretory 
glands that are present in the major airways and bronchioles of humans and whilst in 
mice the structure, cellular composition, and density of tracheal submucosal gland 
(SMG) are similar to those seen in humans, this is in fact the only site where they are 
seen in this species (Innes BA and Dorin JR, 2001). Lastly, there are obvious 
differences between large and small animals in the thickness of the epithelium with 
the former being characterised by a thicker epithelium. These differences raise the 
possibility that mechanisms of repair evoked as a consequence of injury may also 
vary between species (Plopper CG and Hyde DM, 2008).  
 
Chemically-induced lung injury normally causes relatively mild injury involving 
shedding of the epithelium whilst leaving attenuated squamous basal cell layer and 
underlying tissue architecture (Park KS et al., 2006). Any remaining or lesion-
bordering epithelial cells have the capacity to quickly regenerate a pseudostratified 
epithelium and both basal and/or nonciliated columnar epithelial cells have the 
potential to serve as primary progenitor cells in this regard (Rock JR et al., 2009, 
Rawlins EL et al., 2008). Although this technique allows for perturbation of the 
airway epithelial morphology, the extent and location of the epithelial damage is 
non-uniform throughout the exposed areas.  
 
Such animal models coupled with transgenic and cell type-specific knockout 
strategies have been used to probe the importance of beta-catenin regulated gene 
expression in bronchiolar regeneration and repair on this species (Zemke AC et al., 
2009). Manipulation of gene-specific cell types also promises the ability to trace the 
roles of each epithelial cell (i.e Clara and alveolar type I and II) in airway epithelial 
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proliferation and differentiation during lung development. This includes studies 
directed towards determining the role(s) of GATA-6 in regulating bronchioalveolar 
stem cells (BASCs) during development and airway regeneration (Zhang Y et al., 
2008). 
 
Such chemically-induced models of lung injury are not confined to the domain of 
small animal models. For instance a model of smoke-induced lung injury in sheep is 
widely considered of appropriate comparative relevance to the human (Alpard SK et 
al., 2000, Wang CZ et al., 1990). With similarities in terms of the immediate 
response to direct lung injury, the subsequent inflammatory response syndrome and 
similar therapeutic opportunities and application including mechanical ventilation 
(with associated risk of baro/volutrauma) the model continues to inform. In addition, 
the use of the goat as a model for smoke induced lung injury was reported as reliable 
and of comparative relevance particularly in the context of histopathological changes 
in the tracheobronchial tree (Walker HL et al., 1981). One such study demonstrated 
that within 1 day of exposure to toxic smoke the columnar epithelium sloughed intact 
from the trachea with a concomitant reduction of nearly 35% in the basal cell 
population. Complete repair occurred within 18-22 days following injury (Barrow 
RE et al., 1992) 
 
It is however difficult to align such studies across species wherein the extent of the 
injury itself, and presumably the evoked mechanisms of repair are a prima facie 
reflection of fundamental differences in anatomy, dosimetry and xenobiotic 
metabolism. 
 
1.5.2 Physical methods: mechanical trauma 
Whilst not immune from the effects of species differences in the anatomy of the 
tracheobronchial tree, methods that use physical means to perturb the airway 
epithelium have provided an alternative strategy to study the mechanisms involved in 
successful repair and regeneration following injury. Table 1.1 shows a summary of 
the mechanical injury techniques used in small animal models systems. The extent of 
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the injury varied - in some models no epithelial cells remained on the denuded 
epithelium, whilst in others the basal cell layer was left intact.  
 
Wilhelm DL (1953) was the first to apply a mechanical injury, induced by curettage, 
to the tracheal airway mucosa in a small animal (rat) model system. The induced 
injury was relatively severe – involving the complete removal of the intact mucosa 
(Wilhelm DL, 1953). A subsequent study carried out by Hilding AC (1965) 
demonstrated the use of cotton swabs to mechanically injure the trachea of calves. In 
this study, the lesion was produced by passing a weighted cotton swab over the 
tracheal epithelium and caused only the exfoliation and loss of mature columnar 
cells, leaving the basal layer intact (Hilding AC, 1965).  
 
A series of studies carried out by Keenan KP and colleagues studied the process of 
repair and regeneration following mechanical injury applied to the tracheae of 
hamsters. In these experiments, the ventral surface of the trachea was exposed 
surgically and incised at the intercartilaginous portion immediately posterior to the 
larynx. A mechanical injury was induced by a single stroke of a small stainless steel 
probe along the ventral quadrant of the tracheal mucosa from the carina to the larynx. 
The basal layer was left intact (Keenan KP et al., 1982a, Keenan KP et al., 1982b, 
Keenan KP et al., 1982c). These studies were similar in principle to a study carried 
out by Lane BP and Gordon R (1974), in which the dorsal surface of the trachea was 
lightly stroked by a blunt probe. In this latter study, there was loss of most of the 
damaged cells in the area of injury leaving a single discontinuous layer of basal cells 
with occasional residual ciliated or goblet cells (Lane BP and Gordon R, 1974).  
 
In a study of tracheal epithelial regeneration following a mechanical injury in 
hamsters (McDowell EM et al., 1979), a severe injury was induced by scraping with 
a blunt probe. This method lethally damaged all the epithelial cells in focal areas in 
order to maximise the extent of the regenerative response and to induce the 
involvement of all cell types during airway epithelial regeneration and repair 
(McDowell EM et al., 1979). De-differentiation and migration of the epithelial cells 
bordering the lesion were clearly described in this study. 
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Similar processes were studied in rats following a mechanical injury (Shimizu T et 
al., 1994). The epithelium was lethally injured by exposing the ventral surface of the 
tracheal by surgical incision at the intracartilaginous portion below the larynx. A 
stainless steel probe was inserted through the surgical incision and stroked the 
ventral surface of the trachea from carina to larynx (Shimizu T et al., 1994). No 
viable cells were present at the area of damage. The transition area between damaged 
and undamaged epithelium was abrupt with normal and viable epithelial cells seen at 
the margins of the wounded area. Those cells from the wound margins appeared to 
flatten and migrate across the wound site to cover the damaged epithelium. 
Thereafter the migrated cells contributed towards the formation of an initially poorly 
differentiated multilayered epithelium (Shimizu T et al., 1994).  
 
In a study carried out by Erjefalt JS et al., (1995) involving in vivo restitution of 
guinea-pig airway epithelium, the epithelium was removed along the dorsal aspect of 
the trachea by a steel-probe. This technique did not cause damage to the underlying, 
denuded basement membrane. Basal cells remained attached to the basement 
membrane. It was reported in this study that the epithelial cells at the wound edge 
flattened and migrated over the denuded basement membrane within 15 minutes. 
Cells underwent dedifferentiation with ciliated cells losing their cilia and secretory 

















Rat Tracheae Curettage Complete removal of intact mucosa Severe (Wilhelm DL, 1953) 











(Keenan KP et al., 1982a, Keenan KP 
et al., 1982b, Keenan KP et al., 1982c, 
Keenan KP et al., 1983) 
Rat Tracheae Blunt probe Basal layer retained Mild (Lane BP and Gordon R, 1974) 
Hamster Tracheae Blunt probe complete removal of intact mucosa Severe (McDowell EM et al., 1979)  








Scattered basal cells remained 
attached to the BM 
Mild 
 
(Erjefält JS et al., 1995) 
 
Guinea-pig Tracheae Flattened scrapper Complete removal of intact mucosa Severe (Kim JS et al., 1997a)  
 
Table 1.1: Small animal models involving mechanical injury to the trachea 







1.6 Patterns of repair in the airways 
1.6.1 Dedifferentiation, migration, proliferation and re-
differentiation 
The process of airway epithelial repair subsequent to severe injury appears to follow 
well-defined stages. At an early juncture, unaffected epithelial cells bordering the 
lesion migrate to cover the damaged area. These migrated cells appear to form a 
multilayered epithelium, a hyperplastic epidermoid metaplasia. Lastly, these cells re-
differentiate to re-establish a normal pseudostratified epithelium (McDowell EM et 
al., 1979). Subsequent to mild injury in which viable basal cells are left at the surface 
of the damaged area, regeneration is completed by epithelial hyperplasia and 
epidermoid metaplasia, followed by differentiation (Lane BP and Gordon R, 1974, 
Hilding AC, 1965). In this latter instance, basal cells were reported to be the primary 
progenitor cells contributing to the cellular migration and proliferation in response to 
injury, whereas in the case of more severe injury (with no basal cells left intact), the 
secretory and nonciliated cells (goblet cell in particular) were thought to be the 
primary progenitor cells involved in the cellular de-differentiation, migration and re-
differentiation.  
 
It is therefore concluded that the common features that seem to characterize airway 
epithelial repair following physical injury induced by mechanical means involve the 
dedifferentiation of cells bordering the lesion, migration of the flattened cells over 
the wound area, proliferation and re-differentiation. In particular, various cell types, 
including basal, ciliated and secretory cells, appear to possess the capacity to 
dedifferentiate, to migrate, and to either re-differentiate, or trans-differentiate to give 
rise to other types of cells. Indeed secretory cells have been shown to dedifferentiate 
and become flattened epithelial cells when seeded in normal tracheal epithelial cell 
culture and thereafter re-differentiate to normal morphology whilst basal cells were 
less frequently observed in a similar process (McDowell EM et al., 1987). These 
observations further suggest that potential may exist to manipulate conditions 
following injury or even in the context of airway disease such that the airway 






1.6.2 The role of stem/progenitor cells 
As previously expressed, many of the mechanisms that normally operate to engineer 
tissue repair and which are overwhelmed in the prelude to lung pathology are 
believed to have their foundation in lung development. A further aspect of this 
corollary is that during development, self-renewing tissues are imbued with resident, 
tissue-specific stem cells, so-called adult somatic stem cells (Neuringer IP and 
Randell SH, 2004). These stem cells are a subset of undifferentiated cells with the 
capacity to maintain multipotency in the context of the physiologic domain in which 
they reside. In this context, adult lung stem cells are capable of abundant self-
renewal and regeneration, and should act as stem/progenitor cells in response to 
injury and effect local repair (Emura, 2002, Engelhardt JF, 2001, Liu X et al., 2006, 
Otto, 2002, Stripp and Shapiro, 2006). As such, these cells may serve as a viable 
target to manipulate this process in the context of the abnormal repair patterns that 
threaten normal lung physiology. Several cell types of the lung capable of 
functioning as stem/progenitor cells in response to injury have been identified; these 
cells are thought to localize to proximal airway sub mucosal gland ducts, 
intercartilagenous ring regions, neuroepithelial bodies, and terminal 
bronchioles/bronchoalveolar duct junctions (Adam Giangreco et al., 2002, Carla F. 
Bender Kim et al., 2005, Duncan W. Borthwick et al., 2001, Hong KU et al., 2001). 
The cells identified as progenitor or stem cells in the lung appear to vary according to 
the lung compartment (Berns A, 2005, Bishop AE, 2004, Emura M, 2002, 
Engelhardt JF, 2001, Neuringer IP and Randell SH, 2004, Otto WR, 2002). Equally 
these observations potentially imply that the specific repair mechanisms evoked in 
response to lung injury will draw upon several sources of stem/progenitor cells 
according to the nature and extent of the damage. In this regard it has been suggested 
that slight or moderate injury will result in resident progenitor cell activation to 
restore tissue homeostasis whereas severe injury and extensive epithelial cell loss 
will promote stem-mediated repair (Giangreco A et al., 2009).  
 
Proliferative potential is often taken as a defining characteristic for stem cells 
(Stewart, 2006). The normally slow rate of lung epithelial turnover is easily 





stem/progenitor cells (Raiser DM et al., 2008). Stripp BR and Reynolds SD (2008) 
have described the terminology for the progenitor cells as any cell that has the 
capacity to proliferate and this terminology is commonly used to indicate a cell that 
is in the process of cell division or has the potential to enter the cell cycle (Stripp BR 
and Reynolds SD, 2008). In contrast to other tissues such as the gut and skin where 
the epithelium renews on a frequent basis, murine lung epithelium has little or no 
turnover in the absence of exogenous stimuli (Raiser DM et al., 2008). Therefore, 
under such conditions, it is difficult to capture the nature of the specific events 
involved in renewal, and it is only when normal tissue homeostasis is stressed by the 
need to engineer widespread tissue repair that the relative importance of different cell 
types within the tissue can be ascertained. It is possible that lung stem cell 
populations may be a subset of the same cells that function daily as contributors to 
the gas-exchange machinery, and their stem cell characteristics may only be realised 
in times when injury of more specialized, or more differentiated, cells occurs (Raiser 
DM et al., 2008). For this reason, several lung injury models have been developed to 
probe the mechanisms involved in tissue inflammation and repair, and will likely 
continue as the most useful approaches to identifying stem cell populations and 
understanding the regulation of stem cell fates in the lung (Liu X et al., 2006). These 
include radiation (Theise ND et al., 2002), sulphur dioxide (SO2), polidocanol 
(Duncan W. Borthwick et al., 2001), bleomycin (Izbicki G et al., 2002) and 
naphthalene (Carla F. Bender Kim et al., 2005) as well as the previously discussed 
mechanically-induced lung injury (Keenan KP et al., 1982a, Keenan KP et al., 
1982b, Keenan KP et al., 1982c, Keenan KP et al., 1983, Kennedy AR et al., 1978, 
Lane BP and Gordon R, 1974, Lane BP and Gordon RE, 1979, McDowell EM et al., 
1979, Shimizu T et al., 1994, Wilhelm DL, 1953).      
 
The maintenance and fate of the stem cells populations are regulated by their local 
anatomical and chemical microenvironment, or niche. In order to maintain stem cell 
phenotypes and thus promoting appropriate cell fate and migration activities, niches 
discrete microenvironments of specialized cell types, matrix, and diffusible factors 
such as cytokines and growth factors (Liu X et al., 2006, Watt FM and Hogan BL, 





labelling techniques with detectable nucleotide analogues have been employed to 
track stem cells in situ. BrdU (5-bromo-2-deoxyuridine) is one such common 
nucleotide analogue that is classically used to track label-retaining cells (LRCs) after 
a prolonged “washout” period that dilutes the label within the more rapidly cycling 
transient-amplifying (TA) cells – committed progenitors derived from stem cells 
whose propensity for rapid cycling has a defined capacity. 
 
1.7 Chronic airway disease – cellular mechanisms 
One frequently observed pulmonary response to injury (such as acute lung injury 
(ALI) and acute respiratory distress syndrome (ARDS)) is the activation of 
endothelial cells and macrophages (alveolar and interstitial), up regulation of 
adhesion molecules, and the production of cytokines and chemokines. The activation 
of these activities induces a massive sequestration of neutrophils within the 
pulmonary microvasculature. Transmigration of these cells into the alveolar space 
which then release a variety of cytotoxic and proinflammatory compounds including 
proteolytic enzymes, reactive oxygen species (ROS) and nitrogen species, cationic 
proteins, lipid mediators, and additional inflammatory cytokines (Chow CW et al., 
2003).  
 
Persistent activation and chronic secretion of a variety of proinflammatory epithelial 
factors resulted from a chronic injury or defective repair of the surface epithelium 
which include epithelial-derived growth factor and granulocyte-macrophage colony 
stimulating factor which act to induce alterations to the epithelial reticular basement 
membrane, via activation of adjacent fibroblasts and myofibroblasts (Jeffery PK, 
2004). Injury to the superficial epithelium is normally accompanied by mitotic 
activity in the remaining cells and rapid restoration of the denuded surface (Jeffery 
PK, 2001). However, whilst it is still unclear as to exactly how these mechanisms 
and factors fail to ensure continuous repair in the context of the disease state the 
assumption does arise that the repeated injury scenario eventually leads to defects in 






As previously stated, the normal response of the airway surface epithelium to injury 
includes a succession of cellular events, varying from the loss of the surface 
epithelium integrity to partial shedding of the epithelium, or even complete 
denudation of the basement membrane (Puchelle E et al., 2006). The repair of the 
epithelium includes spreading and migration of basal and secretory cells, followed by 
proliferation and differentiation of epithelial cells (Puchelle E et al., 2006). In the 
event that these processes fail to adequately repair the airway then pathology and 
remodelling may ensue with subsequent pathophysiological impact. Indeed, the 
development of squamous metaplasia and mucous hyperplasia in COPD as part of 
remodelling process are considered to disturb the innate immune functions of the 
airway epithelium (Puchelle E et al., 2006). The airway epithelial remodelling in 
COPD may induce an abnormal localization and expression of ion channel proteins 
such as cystic fibrosis transmembrane conductance regulator (CFTR), which may 
cause abnormal epithelial functions, such as periciliary epithelial dehydration, as 
observed in cystic fibrosis (CF) due to the defective CFTR protein (Puchelle E et al., 
2006). A hyposecretion of mucus in the submucosal gland could also be responsible 
for a decreased release in the airway lumen of glycoproteins, proteins, and peptides 
which normally represent the biochemical barrier against microorganisms (Puchelle 
E et al., 2006).  
 
1.8 Tools and resources to study airway epithelial repair 
The complexity of the airway wall tissue architecture, the multiple cell lineages 
involved and their physical, autocrine and paracrine interactions has contributed to 
difficulties and delay in understanding the mechanisms involved during airway 
regeneration and repair. Accepting the likelihood that cells, genes and regulatory 
pathways involved during lung morphogenesis and development may also play a 
crucial role during lung injury and repair it is conceivable that key default pathways 
do indeed exist and that these pathways are evoked in response to acute injury. 
Further, it is only when such pathways are perturbed or overwhelmed that the 
sequences of events result in pathology. To get a wider perspective of the genes 
involved during airway repair, global gene expression profiling has emerged as the 





of several thousands of genes in each individual sample. Such screening raises the 
potential that individual genes or gene regulatory pathways with key roles in the 
repair process can be identified and, in future, that such identification will lead to 
more informed therapeutic targeting in the context of complex chronic lung diseases. 
Whilst the past decade has seen the development of such high throughput methods to 
collect proteomic, genomic and transcriptomic data, and the increasing application of 
systems biology approaches to understand biological processes there has, to our 
knowledge, been limited attempts to marry these resources to the well characterized 
process of airway epithelial repair following physical injury.  
 
The use of this high-throughput technology has been fundamental to identifying 
genes with key roles in the progression of diseases such as asthma (Aoki T et al., 
2009, Tölgyesi G et al., 2009), lung cancer (Rohrbeck A et al., 2008) and COPD 
(Bhattacharya S and Mariani TJ, 2009) and the promise remains that new biomarkers 
will be detected and diseases better understood through sub-classification according 
to their underlying mechanisms (Bhattacharya S and Mariani TJ, 2009) – in turn 
adding leverage to genome-wide disease association studies.  
 
Gene expression profiling continues to play a vital role in the context of 
understanding the response of animal model systems to experimental manipulation. 
Such studies have encompassed the response of the lung to injury. As a recent 
example, in a study of gene expression profiling in the lungs of wild-type mice 
exposed to naphthalene at various time points, 3,552 genes were significantly up-
regulated and 1,199 genes significantly down-regulated following injury (Snyder JC 
et al., 2009 ). Analysis of gene expression in the repairing lung revealed prominent 
clusters of up-regulated genes with putative roles in regulation of the extracellular 
matrix and cellular proliferation (Snyder JC et al., 2009 ). It was also suggested that 
the extracellular matrix (ECM) is dynamically remodelled in response to selective 
epithelial cell injury and that this process is activated without resolution in the setting 
of defective airway epithelial repair (Snyder JC et al., 2009 ). Other examples of such 
expression profiling in the context of airway epithelial injury in small animals relate 





model of acute lung injury (ALI) induced by E. coli lipopolysaccharide (LPS) 
(Jeyaseelan S et al., 2004), acute respiratory allergen exposure of transgenic BALB/c 
mice by a single intratracheal aspiration exposure to Metarhizium anisopliae crude 
antigen (MACA) (Pucheu-Haston CM et al., 2010), the gene expression profile of 
mice exposed to cigarette smoke (Cavarra E et al., 2009) and co-exposure of mice to 
cigarette smoke, lipopolysaccharide, or smoke plus lipopolysaccharide by inhalation 
(Meng QR et al., 2006). 
 
In a clinical study, using fiberoptic bronchoscopy and brushing to sample the human 
bronchial epithelium, Harvey et al., (2007) investigated the modification of gene 
expression in response to cigarette smoking. Such transcriptomic screening revealed 
that in comparing between phenotypically-normal smokers (no symptoms, normal 
lung function, normal imaging) and non-smokers, microarray analysis of gene 
expression of the small airway epithelium demonstrated up- and down-regulation of 
genes in multiple categories relevant to the pathogenesis of COPD, including genes 
coding for cytokines/innate immunity, apoptosis, mucin, response to oxidants and 
xenobiotics, and general cellular processes (Harvey BG et al., 2007). Such studies 
highlight the depth of information that can exist behind the screen of apparently 
similar phenotypes and augers well for the future application of such technology in 
predicting disease onset and hence directing appropriate prophylactic and/or 
therapeutic strategies.  
 
Another clinical study that relates to our interest in understanding the molecular 
regulation of gene expression during airway regeneration and repair is a study carried 
out by Heguy A et al., (2007) to identify genes participating in the airway epithelial 
repair of healthy volunteers after exposure to mechanical injury induced by bronchial 
brushing via fiberoptic bronchoscopy. This study revealed that 1,196 genes were 
significantly differentially expressed at day 7 post injury when compared with day 0 
(un-injured) (Heguy A et al., 2007). Among these genes, 60% were associated with 
the G2 and M phases of the cell cycle, and it was suggested that this reflected the fact 






1.9 Large animal models 
The aforementioned clinical studies in particular emphasise the value of being able to 
accord gene expression profiles with some experimental state – whether by virtue of 
exposure to cigarette smoke, or bronchial brushing injury – and equally suggest the 
value of being able to measure and adjust for the influence of between- and within-
subject variability in gene expression in analysing experimental effects. Naturally 
there are limits to the nature and extent of intervention possible in a clinical research 
setting and to yield information pertinent to more severe pathology it is necessary to 
either collect data from relatively poorly controlled clinical case material and/or from 
relevant animal model systems. In the latter regard it is important that the system 
selected is indeed of comparative relevance, offers the same facility to study 
expression profiles in selected cells over time in the same subject and is backed up 
by the necessary reagents and tools to allow a complete characterisation of the 
process in question. 
 
The issue of comparative relevance is hotly debated by every proponent of every 
animal model system (Abraham WM, 2008, Bates JH et al., 2009 , Canning BJ and 
Wright JL, 2008, Chapman RW, 2008, Keir S and Page C, 2008, Kumar RK and 
Foster PS, 2001) and suffice is to say that no particular system is ideal for all 
situations and that each system generally has meritable comparative aspects, whether 
in the context of normal lung structure or function, or in relation to response to 
injury. In relation to the second requirement, that of following expression profiles in 
selected cell populations (available for harvesting during routine bronchoscopic 
procedures) in the same individual animals over time it is clear that such facility is 
only really provided by larger animals. Whilst it is the last requirement that has 
largely fuelled the popularity of the mouse as a model system for investigating the 
pathogenesis of airway disease – it is inevitable that, with the inexorable progress 
underway in relation to genome characterisation across species, the nature and extent 
of tools and technologies available for larger animals will similarly increase. 
Whilst some large animals have been employed to study the dynamics of repair in 
the tracheal epithelium, notably in the context of either very mild trauma (in calves 





et al., 1998) and rabbits (Hardillo J et al., 2001)), no studies have, to our knowledge, 
sought to define the patterns of repair that follow injury to the bronchial epithelium 
in large animals. Previous studies within our group have indicated the utility and 
comparative relevance of the sheep as an appropriate large animal model system to 
study lung disease pathogenesis and follow the response to lung-directed gene 
delivery (McLachlan G et al., 2007). However, to the best of our knowledge, there 
have been no previous studies directed towards the transcriptomic profiling of sheep 
airway epithelial gene expression following lung injury. Such studies would 
supplement the recently published transcriptional data in relation to repair following 
bronchial brush biopsy in human subjects (Heguy A et al., 2007) and serve as a 
useful comparison of the respective processes underlying repair in a relevant model 
system. 
 
1.10 The case for the sheep as a model of comparative relevance 
In considering the most appropriate model system to bring together the time-
dependency, the injury itself, the requirement for directly sampling the injured sites 
themselves and the potential wider relevance to human disease we elected to use the 
sheep as our system of choice. Sheep are docile, easily handled animals that are 
readily purchased from commercial stock markets. Housing and maintenance costs 
obviously depend on the specific research requirements, however these certainly 
compare favourably with other species frequently used as respiratory models, such as 
dogs or primates. Sheep tolerate routine procedures such as blood sampling very well 
and do not constitute a particular anaesthetic risk. For these and other reasons the 
sheep is favoured as an experimental animal in surgical science (Borrie J and 
Mitchell RM, 1960). With specific respect to the respiratory system, sheep lungs are 
anatomically closer to those of man than are dog, cat or monkey lungs (McLaughlin 
RF et al., 1994) and when compared to dogs, sheep appear to be better suited as 
models for human gas exchange (Werlen C et al., 1984). The size of sheep lungs 
facilitates the application of various techniques available for the analysis of human 
cardiorespiratory function. Further in sheep, time sequential analysis of the 
respiratory tract, including physiological, biopsy and lavage procedures, is well 





effects (Bégin R et al., 1981). Thus, dynamic events following natural or 
experimental respiratory intervention can be followed in this species.  
 
Prior to the study of Halmagyi DF and Colebatch HJ, (1961b) negligible data existed 
in the literature regarding cardiorespiratory function in sheep. The data reported by 
these authors included tidal volume, gas exchange, pulmonary mechanics and blood 
gas and acid-base values for normal anaesthetized sheep (Halmagyi DF and 
Colebatch HJ, 1961b). These authors subsequently went on to utilize their experience 
of lung function assessment in sheep to examine cardiopulmonary dysfunction in 
sheep in response to various interventions of both physiological and applied interest 
(Colebatch HJ and Halmagyi DF, 1961, Colebatch HJ and Halmagyi DF, 1963, 
Halmagyi DF and Colebatch HJ, 1961a). This approach, whereby measurement 
protocols and techniques for lung function analysis are developed and refined prior 
to their use in the study of respiratory disease, has also been followed by Bégin and 
colleagues in an evaluation of asbestosis in sheep (Bégin R et al., 1983a, Bégin R et 
al., 1983b). Other groups have developed and used lung function analysis techniques 
in the sheep to examine the airway (Abraham WM et al., 1983, Abraham WM et al., 
1981, Ahmed T et al., 1980, Hutchison AA et al., 1984, Hutchison AA et al., 1982, 
Wagner EM and Mitzner WA, 1990, Wanner A et al., 1979, Wanner A and Reinhart 
ME, 1978), lung inflammatory responses (Wheeler AP et al., 1990a, Wheeler AP et 
al., 1992, Wheeler AP et al., 1990b), lung function during anaesthesia (Coulson NM 
et al., 1989, Coulson NM et al., 1991), gas exchange of the lung (McNeil JS et al., 
1991, Werlen C et al., 1984) and physiological responses to exercise (Mundie TG et 
al., 1991). Further, and beyond the experience of our own group, the sheep is 
favoured as a comparative model in respiratory research with examples of 
applications ranging from smoke inhalation injury (Barrow RE et al., 1992, Barrow 
RE et al., 1993, Cox RA et al., 2005, Cox RA et al., 2009), to the adult respiratory 
distress syndrome (Meyrick B, 1986), asthma (Kirschvink N and Reinhold P, 2008) 
and emphysema (Hoffman A et al., 2003). The sheep and hamster have a large 
number of airway epithelial cell types which secrete acid glycoprotein in the 
proximal airways and the sheep has glands in abundance (Mariassy AT and Plopper 





epithelium of the sheep is 4-5 times the thickness of that reported for hamsters and 
rats (8.6 microns in the hamster to 56.8 microns in the sheep) (Evans MJ et al., 1989) 
and  relatively similar to the height of the epithelium reported in human (40 - 50 
microns) (Plopper CG and Hyde DM, 2008).  
 
As our model of injury we elected to employ the clinical technique of bronchial 
brushing to selectively damage small areas of epithelium and thereby stimulate repair 
processes in those areas. This technique is routinely used within our group to 
selectively harvest small populations of airway epithelial cells from sheep and prior 
experience (D Collie, personal communication) indicates that the technique is both 
























1.11 AIMS OF THE THESIS  
Airway epithelial damage is a prominent feature of chronic airway disease in the 
lung. Whilst a number of classical studies have elegantly characterised the response 
of the airway epithelium to mechanical trauma at the cellular and tissue structural 
levels a gap currently exists in relation to characterising and describing the 
transcriptional features that parallel the repair process. The recent description of 
transcriptional events associated with the repair process following bronchial brush 
biopsy in human subjects provided an opportunity to quantify the effects of similarly 
induced injury in a large animal model of proven comparative relevance for 
respiratory research.  
 
The objectives that this thesis sets out to achieve are stated thus:  
 
1. To develop a bronchial brushing technique as a model system of lung injury 
and repair in sheep. 
2. To investigate the time course-effect of the histopathological changes of the 
airways in response to physical injury  
3. To study the effect of the bronchial brushing at cellular and molecular levels 
using histopathological techniques and large scale transcriptional analysis 













2. CHAPTER 2 
 
A PRELIMINARY ANALYSIS OF TIME DEPENDENT CHANGES 
































The lung is a relatively stable organ with low rates of cell turnover, particularly in 
the airways. Indeed, with less than 1% of epithelial cells proliferating at any given 
point in time (Demoly P et al., 1994, Boers JE et al., 1996 ), there appears to be little 
need for local self-renewal under normal circumstances. However, following airway 
epithelial injury it is clear that the epithelium has great capacity to repair and that the 
mechanisms involved normally allow for the total restitution of the original complex 
structure (Erjefält JS et al., 1995, Erjefält JS and Persson CG, 1997). Understanding 
the mechanisms underlying the process of regeneration and repair of airway 
epithelial structures demands close characterisation of the associated cellular and 
molecular events. In the presence of acute epithelial injury, it is recognised that cell 
proliferation is a feature of repair responses that lead to resolution of the injury. 
Indeed, evidence suggests that there is rapid repair and resolution following physical 
injury, at least in small animal models (Keenan KP et al., 1982a, Keenan KP et al., 
1982b, Keenan KP et al., 1982c, Shimizu T et al., 1994, Kim JS et al., 1997a, 
McDowell EM et al., 1987, Wilhelm DL, 1953). As detailed in the introductory 
chapter to this thesis (Chapter 1; Sections 1.5.1 and 1.5.2) such models indicate that 
an initial key event is the propensity of the cells bordering the lesion to 
dedifferentiate and flatten. These flattened cells then appear to migrate inwards and 
over the denuded area to restore the barrier function of the epithelium. Proliferation 
is also a key feature of complex and chronic lung disease. For example, in asthma, 
airway epithelial cell proliferation varies directly with disease severity (Cohen L et 
al., 2007) whereas the same relationship does not appear to hold for COPD (Miller 
YE et al., 2007). 
 
In many disease conditions, such as asthma and COPD, where the pathogenesis is 
believed to involve chronic repetitive airway epithelial injury and inflammation, the 
damage fails to fully resolve and instead results in tissue remodelling and pathology 
which may interfere with function (Jeffery PK, 2001). Key to understanding the 
factors that divert repair away from resolution and towards remodelling is a close 






Whilst virtually all in vivo physical injury models of airway epithelial repair are 
small animal based, it is at least debatable whether these systems offer valid 
comparison with similar injury experienced in the human lung as such models have 
not been widely studied in that context. Indeed, it would appear that only one such 
model has been examined in any detail (Heguy A et al., 2007) and, whilst apparent 
opportunity exists for comparison, it is notable that the time points examined in this 
study (days 7 and 14 after injury) extend beyond the timing of the majority of 
changes in architecture and cellular dynamics that are well characterised in small 
animal systems ie by day seven the epithelium has regained a normal appearance. In 
contrast, in the study of (Heguy A et al., 2007) in human subjects, the morphological 
abnormality of the injured epithelium 7 days after injury was associated with 
significant changes in gene expression profile – indicating that healing was still 
underway and normality, in both senses, was achieved by 14 days after injury.  
 
This contrast may reflect underlying species differences in the temporal dynamics of 
the repair process or in the underlying structure and composition of the airway 
epithelium however inherent differences in the extent of injury may also contribute. 
This is unlikely to be resolved until some of these variables can be aligned between 
studies and questions probed at a deeper mechanistic level.  
 
To this end one useful contribution would be to develop model systems with closer 
relevance to the human lung – both in the context of providing a closer analogue of 
human airway wall architecture, but also in the context of potentially aligning 
perturbation and assay techniques.  
 
As far as structural considerations are concerned the human airway epithelium is 
characterised as pseudostratified columnar and includes ciliated, secretory and 
parabasal cells that are linked to a foundation of basal cells that anchors the 
epithelium to the lamina reticularis (Harkema JR et al., 1991). The proximal airways 
of small mammals, on the other hand, typically are only one or two cells thick and 
those cells rest on only a very sparse network of basal cells (Evans MJ et al., 1990, 





quantified eight major cell groups in sheep airway based on their differences in cell 
morphology, staining properties, and distribution. These cells were mucous cell 
categories (M1, M2, M3, and M4), ciliated, basal, Clara cells, and serous cells, with 
the latter being restricted to only the submucosal gland areas (Mariassy AT and 
Plopper CG, 1983). At the level of the distal airways Clara and ciliated cells 
predominated in the lining epithelium whereas more proximally mucous (M1, M2, 
M3, and M4), basal, and Clara cells shared the epithelial lining (Mariassy AT and 
Plopper CG, 1983). Whilst it is likely that the range of cell types present in the intact 
epithelium and their properties will have a role in determining the response to injury, 
there have been limited studies to date that have attempted to accurately define such 
responses in the context of a large mammalian lung in vivo (Barrow RE et al., 1992, 
Barrow RE et al., 1993, Hilding AC, 1965). 
 
In terms of aligning protocols, since bronchoscopic procedures form the basis of 
clinical respiratory research, a significant advantage could be gained from animal 
model systems that can offer the same facility of access, together with the potential 
of repeated assessment within the same individual.  
 
In identifying the potential of a novel large animal model system to study the 
dynamics of airway epithelial repair following physical injury induced by 
mechanical means we sought to develop the sheep as the animal in question. The 
advantages of using sheep as our animal model system for lung injury and repair 
have previously been described (Chapter 1; Section 1.10). 
 
In deference to the human literature available at the time, induction of injury through 
equivalent employment of a bronchial brushing technique was selected – a routine 
and safe method for cell sampling in clinical and veterinary clinical respiratory 
medicine. In addition to standard means of morphological assessment and 
recognising the key role that proliferation plays during repair and resolution 
following injury we sought to characterise this aspect of the response by BrdU 
labelling. In addition, we also sought to determine the influence of injury on mucus-





2.2 OBJECTIVES  
The objectives of the studies contributing to this chapter are: 
1. To develop a bronchial brushing technique as a model system of lung injury 
and repair in sheep. Such a technique should allow for reproducible epithelial 
damage which can be subsequently precisely localized and assessed. 
2. To study the histopathological changes of the airways in response to physical 
injury 
3. To investigate the time course of proliferation and repair activities following 
physical lung injury in different lung segments of the sheep at different time 
points. 
4. To investigate the effect of bronchial brushing on the differentiation status of 
the airways using a combined AB -PAS technique 
5. To develop a simple and reproducible morphometric technique for 
quantification of structural morphology and proliferation in the airways in 



















2.3 MATERIALS AND METHODS 
2.3.1 Animals 
All experimental procedures were subjected to ethical review at the University of 
Edinburgh and were performed under licence, as specified by the Animals (Scientific 
Procedures) Act 1986. Nine (n=9) commercially sourced crossbred sheep (Appendix 
2.1) aged between 14 and 16 months were used in this study (bodyweight 59.4 
±8.8kg). 
 
2.3.2 Experimental design 
Sheep were anaesthetised (Section 2.3.3 in this chapter) in order to facilitate the 
process of mediating physical injury by application of the bronchial brushing 
technique. The brushing protocol (Section 2.3.4 in this chapter) was similar to that 
previously described (Heguy A et al., 2007), consistent, and employed in such a 
manner as to selectively damage only a small area of epithelium (approximately 
15mm x 4mm) located on the ventral aspect of each airway.  
 
Initial discussions in relation to balancing the potential return from individual 
experiments against the ethical cost of using adequate group sizes necessary to 
adequately power comparisons between time points after injury, centred on the 
capability of following changes within the same animals over time. An additional 
advantage is the facility to study ongoing airway repair responses at several 
individual spatially disparate sites within the same lung – a refinement that has 
obvious value in reducing animal numbers. However, the basis of such an approach 
demands knowledge that changes, in response to separate treatment regimes, 
occurring at different sites and examined at the same point in time are independent of 
each other and are largely consistent with changes that would be seen, should all 
airways be subjected to the same treatment regime. To satisfy this requirement a 
preliminary study was implemented comparing two protocols that would reflect this 
comparison. 
 
In Protocol A (n=4), a bronchial brushing was obtained from a single predefined site 





several subsequent occasions, using separate individual sites each time. As a 
consequence, at the time of necropsy, sites within each lung could be identified that 
would presumably reflect the continuum of repair in response to injury. 
 
The assumption in this progressive injury protocol is that different brushing sites are 
independent of one another and that prior injury in one area of the lung would not 
impact on the lung as a whole. In order to address the possible influence of the nature 
of the repair process in individual segments, a second protocol was designed - 
protocol B. 
 
In Protocol B (n=5), several different sites were brushed within the same lung during 
one anaesthetic period, and no further lung interventions made until the sheep was 
killed for necropsy examination. As a consequence several brushing sites at the same 
stage of healing could be identified within the same lung at necropsy examination - 
single time point per sheep.  
 
Figure 2.1 depicts the essential features of each protocol. In both protocols, the 
brushing technique was consistent and employed in such a manner as to damage only 
a defined portion of each airway. In this manner it was possible to obtain, at post 
mortem examination, airways at various stages of repair subsequent to physical 
injury. In protocol A, the repair process was studied at 6 hours, and 1, 3, 7, 14, 21, 28 
and 35 days after injury whilst in protocol B, the repair process was studied only 
from 6 hours up to 14 days post injury.  
 
Details with respect to which sheep were assigned to each protocol and the sampling 









Figure 2.1: Brushing procedures performed according to the protocols 
In protocol A, each sheep was anaesthetised on eight separate occasions and on each occasion a 
separate airway was subjected to bronchial brushing. At the point of necropsy examination airway 
areas representing the different periods of repair could be identified and sampled. In protocol B, each 
sheep was anaesthetised on only one occasion with six separate bronchial brushings being performed 
at six different airways at one single time point. In each sheep for both protocols, samples were also 
obtained from an unbrushed airway (naïve control). In both protocols, BrdU was administered one 
hour before the sheep were killed. Different colours in Protocol A indicate the brushing was 
performed at different time points prior to post mortem whilst in Protocol B, six segments been 






Anaesthesia was induced by intravenous injection of Thiopentone sodium (20mg/kg 
bodyweight, Thiovet, Novartis, UK) and thereafter maintained by 2% Isofane in 
Nitrogen oxide (NO) and oxygen (O2) (50:50) for the duration of the brushing 
protocol (15-30 sec/brushing). Sheep were ventilated by positive pressure ventilation 
(Harvard Apparatus Model 708 (Massachusetts, US)) with tidal volume set at 
10ml/kg bodyweight.  
 
2.3.4 Brushing procedure 
The bronchoscope was advanced through the endotracheal tube, down the trachea 
and mainstem bronchi and then into each selected segmental bronchus until the 
predefined areas selected for induced physical injury was identified. The bronchial 
brush was then advanced, the sheath retracted and the brush applied to the epithelial 
mucosal surface. By advancing and retracting the brush in contact with the mucosa, 
the epithelial surface could be mechanically perturbed by the brush bristles. By 
changing the position of the tip of the bronchoscope the area of brushing could be 
precisely controlled. The selected ventral aspect of the airway was injured in this 
manner. A consequence of repeatedly passing the brush over the mucosal surface 
was the development of mucosal hyperaemia which served as a visual indication of 
the area exposed to injury. The brushing procedure was terminated if any noticeable 
mucosal bleeding occurred. 
 
One hour before the sheep were killed, BrdU was infused via the jugular vein at a 
dose of 10mg/kg body weight diluted to 10mg/mL in sterile phosphate buffered 
saline (PBS) solution.  
 
2.3.5 Necropsy 
Each sheep was euthanized 1 hour after BrdU infusion by intravenous injection of 
sodium pentobarbital (Euthatal, Merial Animal Health Ltd, Essex, UK). Following 
removal of the heart and lungs the pulmonary circulation was flushed with 3 litres of 





The trachea and both right and left main bronchi were incised along their dorsal 
margins to facilitate identification of the brushed sites on the airway walls of each 
selected segmental bronchus. The whole circumference of the airway comprising the 
longitudinal extent of each brushed site was initially carefully dissected free from the 
surrounding parenchyma. The airway was then separated along the longitudinal plane 
into two equal trough-shaped proportions, with one portion containing the damaged 
epithelium along its most ventral aspect and the other opposite portion being naïve to 
direct injury. 
 
2.3.6 Immunohistochemistry (IHC) 
2.3.6.1 Tissues and slides preparation  
Both brushed and non-brushed (opposite to the brushed area, and naïve control) sites 
were carefully identified and dissected away from the surrounding lung tissue. Small 
intestine and skin samples were also taken as positive controls for BrdU 
immunostaining. Tissues were fixed with 10% neutral buffered formalin for at least 
24 hours before being dehydrated in alcohol and embedded in paraffin. Cut tissue 
sections (5 µm) were fixed on adhesive slides (X-TraTM, Surgipath, Peterborough, 
UK) glass slides, and incubated overnight at 37oC. Tissue sections were then 
deparaffinized with xylene, rinsed with progressively reducing concentrations of 
ethanol and immersed in tap water for 5 minutes. Tissue sections were subjected to 
standard haematoxylin and eosin (HE) and Alcian blue-periodic acid (AB-PAS) 
histochemical stains, and immunohistochemical staining procedures were directed 
towards detecting the presence of BrdU and leukocyte common antigen (CD45) 
(Figure 2.2).  
 
2.3.6.2 IHC for BrdU incorporation  
Following deparaffinization, the tissue sections were immersed in 1x PBS for 5 
minutes before being acid denatured with 2M hydrochloride acid (HCl) for 8 minutes 
in a 60oC water bath and rinsed with 1x PBS for 5 minutes. Thereafter the sections 
were digested with trypsin (pH 7.8) for 30 minutes at 37oC before being washed 
twice with 1x PBS for 5 minutes and then incubated with pre-diluted normal 





sections were incubated overnight with mouse anti-BrdU (1:500 dilutions) antibody 
at 4oC. To minimize endogenous peroxidase activity, the tissue sections were 
incubated with 3% hydrogen peroxide (H2O2) for 10 minutes after the 24-hour 
incubation with anti-BrdU. Visualisation protocols were as specified by the 
manufacturer (RTU Vectastain Universal Elite® ABC commercial kit, Vector 
Laboratories, Peterborough, UK). Sections were counterstained with haematoxylin, 
rehydrated and mounted with DPX. Negative control sections, processed and stained 
as described, were either derived from an animal not exposed to BrdU or from BrdU-
treated animals, but with the primary antibody step omitted. 
 
2.3.6.3 IHC for leukocyte common antigen (CD45) 
After deparaffinization, the tissue sections were immersed in 1x PBS for 5 minutes 
before being heated for 30 minutes in a pressure cooker at high-power in an 800W 
microwave oven. A high pH retrieval solution was used (pH 9.0) [consisting of 1.21g 
of TRIS base (Sigma, UK), 0.37g of EDTA (Life Technologies, UK), pH adjusted to 
9.0, and 0.5ml of Tween-80 (Sigma, UK), made up to 1L with distilled water]. After 
antigen retrieval treatment, the slides were allowed to cool down for 10 minutes at 
room temperature before being immersed in distilled water and washed with 1x PBS 
for 5 minutes. The tissue sections were then incubated with pre-diluted normal 
blocking serum (normal horse serum) for 20 minutes before being incubated for one 
hour with mouse anti-ovine CD45 (Serotec, UK) monoclonal antibody (1:500 
dilutions) diluted in 1x PBS at 37oC. After the primary antibody incubation, the 
sections were handled as previously specified for detecting BrdU incorporation, 
including incubation with 3% hydrogen peroxide, incubation with secondary 
antibody, incubation with ABC Reagent, diaminobenzidine (DAB) and 
counterstaining. Negative control slides were prepared as described above, but with 
the primary CD45 antibody step omitted. 
 
2.3.7 AB-PAS staining 
After deparaffinization, the tissue sections were immersed in distilled water for 5 
minutes; before being incubated in Alcian blue (Sigma, UK) solution (pH 2.5) for 5 





water respectively, followed by incubation in 1% periodic acid (Molecular Probes, 
UK) for 10 minutes. The sections were rinsed well for one minute each, in tap and 
distilled water respectively, and then incubated for 20 minutes in Schiff’s reagent 
(Sigma, UK). The sections were washed in running tap water for 10 minutes, 
counterstained with haematoxylin for 35 seconds, rinsed with Scott’s tap water for 10 
seconds, washed with running tap water for 5 minutes, dehydrated with serial 
degraded alcohol, cleared with xylene and mounted with DPX. Scott’s tap water, in 
acting as a blueing reagent, rapidly and precisely stains the nuclear chromatin and 







                
       
Figure 2.2: A flowchart of the procedures undertaken in this study involving the sheep in Protocol A 
(Left - right) The structure of the sheep lung and the segments brushed at different time points i.e up to 14 days of injury (* (-) prior to post mortem). BrdU was 
administered 1 hour before the sheep was killed and the brushed airway wall areas were identified. The lung segments were carefully mapped and dissected out 
during the post mortem and fixed with 10% buffered-formalin. After processing, thin (5µM) sections were cut and fixed on coated glass slides. Within each airway 
cross section prepared in this way, damaged, transitional and undamaged areas were easily identified for further appraisal and quantification. Each section was 






2.3.8 Morphometric analysis 
In addition to quantifying the extent of cellular proliferative activity using BrdU 
staining in airway wall sections, preliminary evaluation was directed towards 
assessing whether airways selected from different lung segments shared similar 
structural morphology – a necessary prerequisite to interpreting time-dependent 
changes amongst different lung segments. 
 
The initial analysis of HE-stained sections focussed on the proportion of tissue 
components in unbrushed sections of airways from the separate sample sites. The 
components of interest and their definition and locations were as specified by 
(Anthony B et al., 1994). These components included tissue categories (cartilage, 
smooth muscle, epithelium, blood vessels) and compartments (mucosal and 
submucosal regions). Such data collection can be used to ascertain whether, at 
steady-state, any differences exist between airways from different segments of the 
lung.  
 
2.3.8.1 Morphometric procedures 
The initial aim was to assess the influence of sample site on the structural 
morphology of the airway wall in different segments of the lung. Subsequent aims 
involved both a primary appraisal of the nature and extent of any time-dependent 
changes in cell proliferation in the airway wall and an analysis of the influence of the 
choice of protocol on the repair response following physical injury. A similar 
technique for morphometric analysis for HE and BrdU-incorporated cells was 
applied on the airway sections for both protocols.  
 
In order to facilitate comparisons within and between airway samples, considerable 
care was taken to identify and dissect the appropriate sections of the relevant 
airways. Following fixation, these sections were precisely trimmed and arranged 
within the tissue processing/embedding cassettes in order to maximise the likelihood 
that airways would be embedded in such a way that tissue sections would 






Morphometric measurements for HE-stained sections were performed at a lower 
magnification of 100X (10x objective) using a multipurpose test grid composed of a 
combined line and point system (20.4mm square 10 x 10 grid, Olympus UK Ltd, 
Essex, UK). For estimating the proportion of each of the airway structures and 
tissues within the airway walls a set of grid points was placed on the section. By 
counting the number of points falling on each component structure (i.e epithelium, 
smooth muscle, blood vessel, cartilage, mucosa and submucosal) the volume 
composition of the structure could be directly estimated.  
 
Whilst BrdU positive staining was generally easily identified at a magnification of 
200X (20x objective) as dark-black nuclei on the proliferating cells, where any 
difficulty was experienced in precisely identifying individual cells increased 
magnification was utilised to confirm identity. The slides used in the analysis 
involved only those stained with anti-BrdU antibody. In order to provide a basis for 
comparison, airways from both treated and untreated (naïve) segments were 
examined.  
 
Whilst our interest was centred on the area of airway wall directly exposed to injury, 
further measurements were made on undamaged areas of the airway wall opposite 
the area of injury within the treated segments and areas lying in the transition regions 
between these opposite zones. These main areas of interest were thus defined as 
damaged, transitional and undamaged (Figure 2.2 and Figure 2.3). 
  
Whilst damaged areas were easily identified in the first few days after injury, 
preliminary studies indicated that, at later time points (days 7 and 14), difficulty 
could be experienced in reliably identifying these areas at a gross level. However, 
histologically, by days 7 and 14, those areas previously denuded by the cytology 
brush were covered by squamous airway epithelial cells, and as a consequence the 
normal complement of mucus secreting cells was absent. Following physical 
marking of the slides using lines etched on the surface of the coverslips to delineate 






Two compartments of interest, mucosa and submucosa, within the airway wall were 
defined according to the aforementioned criteria proposed by Anthony B et al., 
(1994). Thus, the mucosal region consisted of the epithelium, basement membrane, 
and lamina propria, whilst the submucosal region began at the outer border of the 
lamina propria and included the smooth muscle layer (Anthony B et al., 1994). 
 
In order to quantify the proportion of different tissue categories within the airway 
wall, a point counting method was used. In this regard, the principle of point 
counting relies on counting the number of points on a multipurpose test grid graticule 
that overlies the area of interest, and relating these points to the total number of 
points in the grid to gain an approximation of the proportion of the area of interest 
within the grid area. The volume densities of tissue categories and the compartments 
of interest (mucosal and submucosal) were calculated by relating the number of 
points landing on each tissue category and compartment to the total number of points 
counted.  
 
By contiguous placement of consecutive grids, the whole of the airway in question or 
subordinate areas of interest were subject to point counting. For the purpose of 
consistency and reproducibility, the counting began with the grid placed on the 
marginal edge of the damaged area and, following counting, this was moved to the 
next contiguous grid area within the damaged area. A similar approach was used for 
both transitional zones flanking the damaged area and the undamaged area opposite 
(Figure 2.3). The point counting data were recorded in written form and transcribed 
into a spreadsheet for analysis. 
 
It may be appreciated that the number of fields studied in each section was 
potentially determined by several factors, but notably the area of initial damage 
induced as a consequence of the brushing procedure and the time subsequent to 
injury. In the latter regard, it was anticipated that the area of apparent damage would 
decrease relative to its initial dimensions, and as a consequence the variance 
associated with data pertaining to later time points would be greater. In point of fact, 





the number of fields measured ranged from 2 - 4. All measurements were conducted 
with the slides independently blinded prior to examination. 
 
 
Figure 2.3: Diagram showing the field selection procedure undertaken for morphometric 
analysis 
For the purpose of consistency and reproducibility, the counting began with the grid placed on the 
marginal edge of the damaged area (number 1) and, following counting, the square grid was moved to 
the next contiguous area within the damaged area (numbers 2, 3 and 4). In this manner the whole area 
of damage was subject to evaluation. The same procedures were applied in relation to the flanking 
transitional areas, and the undamaged area opposite the damaged airway. 
 
2.3.8.2 Statistical analysis  
The experimental design, involving repeated measurements on various tissue 
samples from different segments within the same sheep, facilitated the application of 
a mixed effect model analysis similar to that described by Paterson S and Lello J, 
(2003). The individual samples were derived from different segments, each relating 
to different time points. Material collected from sheep involved in both protocols 
were subjected to the morphometric analysis to measure the effect of the segment on 
the distribution of the airway tissues (HE-stained sections) whilst only data collected 
from sheep involved in protocol A were analysed to assess the extent and distribution 
of the proliferative cell response following injury (BrdU-stained sections). Since only 
one sheep was assigned for each time point, therefore no further statistical analysis 





The model was fitted using a generalized linear mixed effect model, using penalized 
quasi-likelihood (PQL) and, binomial (HE proportion data) and Poisson (BrdU count 
data) errors. In these analyses (HE and BrdU), the sheep’s ID was used as a random 
effect in order to control for any pseudoreplication and to minimise the noise 
associated with variation between observations and/or measurements on the same 
sheep, thereby allowing for the significance of factors such as segment identity and 
sheep to be tested within the fixed component of the model (Crawley, 2007, Paterson 
S and Lello J, 2003). In these models, the total number of grids landing on the areas 
measured (i.e mucosal, submucosal, damaged, transitional and undamaged) was used 
as a covariate in order to control/reduce variation associated with the measuring 
process such as the size of the airways measured or the number of grids placed on the 
measured areas. The data was analysed using the freely available statistical software 
environment R (The R Foundation, Software version 2.9.0, Vienna, Austria). In all 




2.4 RESULTS  
2.4.1 Histopathology of the airways after injury: HE staining 
2.4.1.1 Quantitative morphometric analysis: Is airway structure 
consistent between segments? 
In assessing the similarity of structural morphology of different segments of the 
sheep airway, the proportions of each tissue categories were plotted as box plots 
[(Figure 2.4) and (Figure 2.5)]. Overall, it is clear that in this model, with the Sheep 
ID as a random effect and segments RA (protocol A) and RVD1 (protocol B) as 
reference levels, there was no significant difference (p>0.01) in the proportion of 
each separate tissue component between segments of the lung in these groups. 
However, in Protocol A sheep, for the vast majority of cases there were no 
differences between any of the 8 segments for the 6 tissue categories (p >0.017), 
except for RCD (mean=18.9%) and LC (33.9%) in mucosa (p=0.002) and LVD1 
(9.1%) and RA (mean=3.5%) in blood vessels (p=0.005) (Figure 2.4). The R outputs 





of the mucosal and submucosal compartments did not differ between segments. In 
order to test the validity of the reference level, in protocol A the analysis was 
repeated in order to test the proportion of smooth muscle between different segments 
by choosing LCD or RCD as reference levels. The results revealed findings 































































































Proportion of smooth muscle
 
Figure 2.4: The box plots for the proportions of the tissue categories between segments of the 
lung sections for the group A sheep 
The statistical analysis was carried out using a generalized linear mixed model (family binomial). The 
results revealed that there was no significant difference in the relative proportions of the tissue 
categories between different segments of the lung (using segment RA as the reference level). A 
p<0.01 level was considered statistically significant. Symbols represent proportion data for the 
number of points landing on tissues for each area measured relative to the total number of grid points 
landing on each tissue measured. Upper and lower box plot margins represent the interquartile range; 



































































































Proportion of smooth muscle
 
 
Figure 2.5: The box plots for the proportions of the tissue categories between segments of the 
lung sections for the group B sheep 
The results revealed that there was no significant different of the tissues of interest between difference 
segments of the lung as compared to the segment of the RVD1 as a reference level. A p<0.01 was 
considered statistically significant. Symbols represent proportion data for the number of points 
landing on tissues for each area measured relative to the total number of grid points landing on each 
tissue measured. Upper and lower box plot margins represent the interquartile range; middle bar 







2.4.1.2 Histopathological assessment of airway damage and repair 
Whilst in most instances the brushed sites were easily identifiable during gross 
necropsy examination, in some instances, particularly at later time points, it became 
more difficult to visually distinguish the sites of injury. However, the standardised 
brushing protocol and careful mapping of brushed sites facilitated accurate sampling 
of the appropriate areas. At a histological level, the sites of brushing were readily 
apparent, as were time-dependent changes in histopathological appearance. The 
pathophysiological changes of the airways following a bronchial brushing were 
compared to the normal morphology of the airway (naïve and undamaged sites 
(Figure 2.6)). 
 
At six hours after injury (Figure 2.7) mucosal loss and epithelial attenuation (Figure 
2.7; left panel) were apparent together with submucosal oedema (Figure 2.7; bottom 
right panel). There were small numbers of neutrophils, lymphocytes and plasma cells 
percolating around blood vessels and submucosal glands at the site of injury (Figure 
2.7; top right panel).  
 
Twenty-four hours after injury, within the brushed sites, there was evidence of 
respiratory mucosal loss (Figure 2.8; top left panel) with a superimposed layer of 
fibrin, neutrophils and erythrocytes. At the margins of the brushed sites the 
respiratory epithelium was attenuated, ranging from cuboidal to squamous (Figure 
2.8; top panels). In some areas only a single layer of basal epithelial cells was 
apparent (not depicted). There was oedema in the deep submucosa and mucosa, 
characterised by increased spacing and clearing between collagen bundles in the deep 
mucosa and also between the inflammatory cells in the mucosa (Figure 2.8; bottom 
left panel). Inflammatory cells consisted of small numbers of neutrophils, 
lymphocytes and plasma cells (Figure 2.8; bottom right panel). In some areas there 
were also small numbers of eosinophils (not depicted). One or two submucosal 
glands were surrounded by small numbers of neutrophils (Figure 2.8; bottom right 






Three days post injury (Figure 2.9) the mucosa at the brushed site was segmentally 
lost (ulcerated) with a superimposed layer of fibrin, blood and neutrophils (Figure 
2.9; top panels). The ulceration extended to the superficial aspect of some 
submucosal glands, many of which were lined by attenuated epithelial cells and 
contained a small number of neutrophils (Figure 2.9; bottom left panel). The 
submucosa and the lamina propria were infiltrated by small to moderate numbers of 
neutrophils, eosinophils, lymphocytes and plasma cells (not depicted) and there was 
evidence of mild neovascularisation and fibroplasia within the brushed sites (Figure 
2.9; bottom right panel). At the margins of the brushed site, there was mild epithelial 
hyperplasia with neutrophilic exocytosis (Figure 2.9; bottom right panel).  
 
Seven days post injury (Figure 2.10), the epithelium at the brushing site consisted of 
stratified squamous epithelial cells consistent with squamous metaplasia (Figure 
2.10; top right panel). There was neutrophilic exocytosis across the surface of the 
epithelium and the mucosa was thickened by granulation tissue (Figure 2.10; bottom 
panels), which replaced the normal smooth muscle bundles in this region (Figure 
2.10; left panels). This tissue was infiltrated with lymphocytes and plasma cells (not 
depicted). Squamous epithelium lining some submucosal glands was also identified 
(not depicted in the figure). 
 
Fourteen days (Figure 2.11) after injury, in some areas of the epithelium over the 
brushed areas (Figure 2.11; left panel), there was a slight reduction in the height of 
the mucosal epithelial cells with a mild reduction in goblet cell number relative to the 
unbrushed sites (unbrushed site is not depicted in the figure). Within the lamina 
propria there were small areas of fibrosis present (Figure 2.11; right panel). Mild 
attenuation of submucosal gland lining epithelial cells also remained.  
 
Sections prepared from brushed areas from 21 and 35 days post injury indicated that 
















Figure 2.6: Photomicrograph depicting histology typical of the normal airway structure 
A cross-section of the normal airway structure stained with HE. The airway consists of mucosal and submucosal compartments 


































































































Figure 2.7: A Photomicrograph depicting histopathology typical of the repair process underway 6 hours after injury (HE staining) 
At six-hour post injury, mucosal loss and epithelial attenuation are apparent, together with submucosal oedema (bottom right panel). There is a simple 
layer of  cells remaining at the transitional area, interpreted to be dedifferentiated epithelial cells (left panel). Small numbers of neutrophils (arrow heads), 
plasma cells and lymphocytes infiltrate around blood vessels and submucosal glands at the site of injury (top right panel). (SM= smooth muscle; 
SMG=submucosal gland; BV=blood vessels) 
 
Figure 2.8: Photomicrograph depicting histopathology typical of the repair process underway one day after injury (HE staining) 
Twenty-four hours after injury, there is loss of the respiratory mucosa with a superimposed layer of fibrin, neutrophils and blood confined to the brushed 
areas (top left panel). At the margins of the site the respiratory mucosa is attenuated from cuboidal to squamous (top right panel) and, in some areas, only a 
lining of basal cells is apparent. The mucosa and superficial submucosa are thickened by oedema and infiltrated by moderate numbers of neutrophils and 
eosinophils (bottom left panel) which also tended to surround and infiltrate the lumina of submucosal glands (bottom right panel). Arrows show the 
neutrophilic infiltration.  Arrows head show the neutrophils, thick arrows show plasma cells and thin arrows show lymphocytes. (SM=smooth muscle; 
SMG=submucosal gland; and BV=blood vessels). The marked areas show regenerating smooth muscle tissue.  
 
Figure 2.9: Photomicrograph depicting histopathology typical of the repair process underway three days after injury (HE staining) 
By day 3 of injury, the brushed site is covered by a thick layer of fibrin, blood and neutrophils (top panels) which extends to involve the superficial aspects 
of the submucosal glands, many of which are lined with attenuated epithelial cells and contain a small number of neutrophils (bottom left panel). Within 
the mucosa there is evidence of neovascularisation (bottom right panel, arrows) and mild fibroplasia. The intact mucosa is attenuated but there are also 
areas which are thickened, due to hyperplasia (bottom right panel). The large rectangle in the top left panel is shown at higher magnification in the top 
right panel, whilst the smaller rectangle is shown at higher magnification in the bottom left panel. (SMG=submucosal gland)  
  
 Figure 2.10: Photomicrograph depicting histopathology typical of the repair process underway seven days after injury (HE staining) 
 Seven days post injury, the epithelium at the brushing site consists of stratified squamous epithelium (top right panels; arrows) in which there is also 
neutrophilic exocytosis (top right panel; arrow heads). The submucosa is focally thickened by granulation tissue (bottom panels) which, in the submucosal 
area, appeared to displace and/or replace the normal smooth muscle bundles in this region (left panels) (compare this to the normal smooth muscle 
morphology in Figure 2.6). The areas outlined on the left panel indicate smooth muscle tissue. The small square area outlined in the bottom right panel is 
shown at higher magnification in the upper right panel. This area shows epithelial squamous metaplasia (SMG=submucosal gland) 
 
 Figure 2.11: Photomicrograph depicting histopathology typical of the repair process underway 14 days after injury (HE staining) 
 Figure shows, the damaged site fully covered with an epithelial layer at fourteen days after injury (left panel) although some segmental abnormalities in 
the morphology remain. On occasion the mucosa demonstrated small areas of fibrosis (right panel) with some persistent evidence of submucosal gland 





2.4.2 Analysis of immunohistochemistry (IHC) 
2.4.2.1 BrdU incorporation 
Skin and intestinal tissue samples were examined as positive controls for BrdU 
immunohistochemistry. Cells positive for BrdU were easily identified in sections 
derived from these samples (Figure 2.12). In the small intestine, the large numbers of 
positive cells were confined mainly to the crypts while in skin sections, the positive 
cells were observed in both follicle bulbs and skin epithelium. Negative control 
slides demonstrated no positive signal in skin, gut or airway sections. For the sheep 
not been exposed to BrdU, there was no BrdU antigen present in the sheep airway 
tissue sections. When the slides were stained with BrdU antibody, no positive 
staining was observed in which the IHC staining for this slide was similar to that 
seen in the airway tissue sections with BrdU antibody omitted. Both negative control 
slides are shown (Figure 2.13).  
 
In relation to the airway samples, in both protocols the specific location and number 
of proliferating cells varied with time of injury. There was little evidence of BrdU 
positivity in the undamaged region (Figure 2.14, arrows). In the brushed airway 
sections, BrdU-labelled cells were identified as early as six hours post-injury; 
however these BrdU-labelled cells were few in number and sparsely scattered 
through the mucosa and submucosa, not only in the damaged areas but also in 
transitional and undamaged areas (Figure 2.15, arrows). Figure 2.16 shows the 
distribution of BrdU-positive cells at days 1, 3 and 7 post injury. At day 1, BrdU-
labelled cells were visible within the airway epithelium in clusters flanking either 
side of the injury ie in the transitional regions. BrdU positive cells were also found 
underneath the damaged epithelium in the mucosa and submucosa – particularly in 
the submucosal glands (SMGs). Day 3 distribution patterns of BrdU-labelled cells 
were similar to those seen on day 1 with respect to epithelial and SMG localisation 
(not depicted) but in addition large numbers of labelled cells, including those with 
morphology consistent with fibroblasts and endothelial cells were present in the 
underlying mucosa at this time point. By day 7 fewer BrdU labelled cells were 
observed than day 3. In particular very few BrdU-labelled cells were present in the 





day 14 especially in the sub-epithelial region (Figure 2.17). At later time points (days 
21 to 35 post injury), there was very little evidence of BrdU uptake in the sections 
(data not shown).  
 
In order to compare the distribution pattern of proliferative cells between protocols 
(Protocols A and B), the total number of BrdU-positive cells were plotted for both 
protocols and according to the areas of interest and the time relative to the point of 
brushing injury (Figure 2.18). Although the distribution pattern of BrdU-positive 
cells shared broad similarities between protocols one noticeable quantitative 
difference between these two protocols was that the number of BrdU-positive cells 
peaked at day 3 post injury in the protocol A sheep whilst it peaked earlier (day 1) in 
the protocol B sheep especially at the damaged areas (Figure 2.18). Although there 
was evidence of a proliferative cell response to injury in the undamaged areas for 
both protocols it was noticeably lower for protocol B than for protocol A. When 
analysed according to time point, compartments (mucosa and submucosa) or area of 
interest (damaged, undamaged and transitional), in the protocol A sheep (Figure 
2.19), there were significant differences in the numbers of BrdU-positive cells 
observed between compartments (submucosa (geometric means=18.0270) less than 
mucosa (geometric means=33.401), p=0.000) – (Figure 2.19; left panel), between 
areas of interest (damaged (geometric means=53.637) and transitional (geometric 
means=31.441) greater than undamaged (geometric means=8.536), p=0.001 for both 
–(Figure 2.19); middle panel)) and between time points (day 3 (geometric 
means=55.013) greater than naïve (geometric means=9.277), p=0.008) – (Figure 
2.19; right panel). The details of the R outputs for BrdU data analyses are in the 
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Figure 2.12: A cross section of intestinal and skin tissues stained with BrdU 
Cells positive for BrdU were easily identified in sections derived from intestinal and skin samples. In the small intestine (top panel), the 
positive cells were confined mainly to the crypts while in skin sections, the positive cells were observed in both follicle bulbs  (bottom 






Figure 2.13: Negative control slides  
In this instance the sections were derived from an animal exposed to BrdU but the primary antibody step was omitted from the staining process (panel A) and from 








Figure 2.14: A naive airway tissue section stained with BrdU  
Few BrdU-positive cells were observed in undamaged airway tissue sections. These cells were 
sparsely scattered at the basal area of the epithelium, and in the proximity of submucosal glands and 
blood vessels in both mucosal and submucosal compartments. Arrows show the BrdU-labelled cells. 




Figure 2.15: The airway tissue sections at 6 hours post injury stained with BrdU 
BrdU-labelled cells were sparsely scattered both in the epithelium bordering the lesion and in the 
proximity of blood vessels (mucosal region – left panel, and submucosal region – right panel. Arrows 
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At day 1 post injury, BrdU-labelled cells were clearly visible at the transitional areas bordering either 
side of the lesion (top left panel). These positive cells also accumulated underneath the damaged 
epithelium in the mucosa and submucosa– particularly in the submucosal glands (bottom left panel). 
At day 3, a similar pattern of BrdU-labelled cells was observed in the epithelium and SMGs with day 
1 of injury but additionally large numbers of labelled cells were present in the underlying mucosa (top 
right panel). At day 7, the number of BrdU-positive cells reduced particularly in the SMGs. Very few 
BrdU-labelled cells were present in the squamous epithelium formed over the lesion (bottom right 




















Figure 2.17: Airway tissue sections from airway samples derived 14 days post injury stained with BrdU 
At this time point, although the epithelium at the damaged area consisted of partially differentiated epithelial cells, the number of BrdU 
positive cells was decreased relative to day 7 post injury in both the airway epithelium and in the SMGs. Arrows show the BrdU-labelled 






Figure 2.18: Dynamics of proliferative activity following injury 
Boxplot illustrates the time-course of proliferative activity in terms of number of BrdU positive cells separated by specific areas of interest, representing damaged, 
transitional and undamaged epithelium, for each protocol (A and B).  Upper and lower box plot margins represent the interquartile range; middle bar indicates the 







Figure 2.19: Distribution of BrdU-positive cells  
Boxplot illustrating the numbers of BrdU cells counted in sections from sheep in Protocol A, separated by compartment, area of interest and time points. 
Overall cell count was significantly greater for the mucosal versus submucosal compartment (p<0.001) and for the damaged and transitional areas of interest relative to 
the undamaged areas response (p<0.001) in both compartments. There was a significant increase in the number of BrdU-positive cells at day 3 post injury as compared 
to naïve (timepoint 0) (p=0.008). Upper and lower box plot margins represent the interquartile range; middle bar indicates the median. The points outside the ends of 






2.4.2.2 CD45 expression  
To study the involvement of blood-derived cells in airway regeneration and repair, 
the slides were stained with anti-CD45 antibody. Figure 2.20 to Figure 2.23 show the 
airway sections stained with anti-CD45 antibody for the undamaged epithelium, and 
for days 1, 3 and 7 post injury. In the undamaged airway, the CD45-stained cells 
were seen residing in the blood vessels and underneath the epithelium (Figure 2.20) 
and a few positive cells were seen in the vicinity of the submucosal glands. By 1 day 
post injury, there was a considerable increase in the number of CD45-positive cells 
observed in the damaged areas. Cells were observed at the area of epithelial 
haemorrhage and in the mucosa underneath the damaged epithelium (Figure 2.21) as 
well as around the smooth muscle of the submucosal compartment. Although there 
was evidence of positive cells within the epithelium bordering the lesion they were 
fewer in number than those observed underneath the epithelial basement membrane. 
On days 1 and 3, CD45 positive cells were observed both in the airway wall 
subjected to brushing and in the undamaged wall opposite – however numbers in the 
former greatly exceeded those in the latter. By day 3 (Figure 2.22) post injury CD45-
positive cells were found within the repairing epithelium and in the vicinity of the 
submucosal glands. The number of positive-stained cells within these areas 
decreased from this point onwards and by day 7 the number and distribution of CD45 
positive cells was similar for damaged and undamaged sites within the airways 
(Figure 2.23). Quantification of these CD45-positive cells was not attempted. A 
qualitative impression of the relationship between populations of BrdU- and anti-
CD45 stained cells could be obtained through observing serial- or near-serial sections 
obtained at day 1 (Figure 2.24). Whilst some evidence would suggest that similar 
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Figure 2.20: Normal airway tissue sections stained with anti-CD45 antibody 
In the undamaged airway, the CD45-stained cells were seen residing in the blood vessels, underneath the epithelium and in association 



















   
  Figure 2.21: Airway tissue sections reflecting changes consistently observed at day 1 post injury (stained with anti-CD45 antibody)  
  At 1 day post injury increased numbers of CD45-postive cells were observed, especially at the area of epithelial haemorrhage and in the mucosal 
  compartment underneath the damaged epithelium as well as around the smooth muscle of the submucosal compartment. (SMG=submucosal  
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  Figure 2.22: Location of CD45-positive cells at day 3 post-injury 
  Photomicrocraph showing CD45-positive cells (arrows) at day 3 post injury either in the repairing epithelium (left panel) or surrounding the  











   
    Figure 2.23: Airway tissue sections reflecting changes consistently observed at day 7 post injury 
    Most of the airway sections at these time points showed similar patterns of CD45 staining with the undamaged site.   







Figure 2.24: Serial sections of the airways stained with BrdU and CD45 antibodies 
The circled areas suggest some evidence of co-localized CD45 and BrdU positivity within the 




2.4.2.3 AB-PAS staining  
Slides were stained with AB-PAS as described in methods. Figure 2.25 shows 
images of sections from undamaged sites and brushed sites at days 1, 3 and 7 post 
injury. Sections derived from normal (undamaged) airways demonstrated numerous 
goblet cells interspersed amongst the ciliated cells that comprise the bulk of the 
respiratory epithelium at these locations (Figure 2.25 ; top left panel). This 
morphology changed dramatically following brushing, as expected where epithelial 
denudation occurred in the damaged area, but also within the transitional area at the 
wound margins. In this latter area of interest, at 1 day after brushing, the number of 
PAS-positive cells had markedly decreased, presumably associated with the ongoing 





By day 3, a layer of PAS-positive staining was observed overlying the damaged 
epithelial surface. Closer examination determined that the layer was comprised of a 
dense and compact accumulation of neutrophils held within and below the mucin 
layer (Figure 2.25; bottom left panel). Although an epithelial layer had reformed over 
the lesion at day 7 (Figure 2.25; bottom right panel) post injury, there were still very 
few goblet cells present within the regenerating epithelium. Those PAS-positive cells 
that were present demonstrated apical staining. The morphology of the regenerating 
goblet cells on the surface of the repairing epithelium appeared distinct from those 
observed in the undamaged region. At day 14 post injury, although a complete 
epithelial layer exists, the number of goblet cells remains lower than that observed in 
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In the normal airways (undamaged), goblet cells are clearly stained with AB-PAS staining (top left 
panel). At six to twenty-four hours post-injury, PAS-positive cell is no longer retained the 
characteristic morphology of goblet cells but rather were attenuated in appearance (top right panel; 
thick arrows) which characterised as epithelial dedifferentiation. By day 3 post-injury, a layer of 
positive AB-PAS staining was observed overlying the repairing epithelial surface. Closer examination 
determined that the layer was comprised of a dense and compact accumulation of neutrophils held 
within and below the mucin layer (bottom left panel; thin arrows). By day 7 post-injury regenerating 
goblet cells could be seen incorporated in the epithelium overlying the brushed site (bottom right 




We chose the sheep as our model system to examine the airway epithelial response to 
physical injury for several reasons. Sheep are a well accepted model for lung injury 
and disease (Bischof RJ et al., 2003, Scheerlinck JP et al., 2008). The airway 
epithelial structure of the tracheobronchial tree has been well characterised and 
indicates good homology with the human lung (Becci PJ et al., 1978, Kennedy AR et 
al., 1978), the size of the sheep lung facilitates the application of bronchoscopic 
techniques that are equivalent to those used in human clinical respiratory medicine 
(Romagnoli M et al., 1999) and finally segmental approaches can be adopted 
wherein the response of different lung regions can be compared and contrasted over 
time within the same animal (Collie DD et al., 2001, Emerson M et al., 2003, Collie 
DD et al., 2006). This offers a significant advantage with respect to achieving 
statistical power in experimental design, and reducing the number of animals 
required to test given hypotheses.  
 
Our experimental protocol capitalises on these latter advantages and in addition 
allows for the phased induction of lung injury in order to assess the time-dependent 
changes that occur during the repair process. To our knowledge this is the first time 
such a system has been employed in the context of understanding the response to 
physical lung injury in any mammalian system. In addition, the use of BrdU 
labelling, whilst previously used in sheep to assess cell proliferation in wool follicles 
(Holle and Birtles, 1990) has not been previously used to follow similar phenomena 
in the lung. 
 
Accepting the novelty of the model system and protocol design, constructive critique 
could be directed towards individual aspects. One aspect relates to whether the 
selected injury sites were chosen from roughly equivalent levels in the 
tracheobronchial tree. It is known that proximal and distal airways do not share the 
same cell composition (Plopper CG and Hyde DM, 2008) and are differentially 
affected by pathology in diseases such as asthma and COPD (Jeffery PK, 2001) 
therefore it was considered important to assess whether the major aspects of structure 
were equivalent between airways selected from different lung segments. In this study 
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the results confirmed that the relative proportions of different tissue components did 
not differ significantly between segments. A second aspect relates to the 
reproducibility of the bronchial brushing technique. Whilst every effort was made to 
ensure consistency between sites, such that the same numbers of brush passes were 
employed and equivalent areas exposed to injury, it is impossible to definitively 
ascertain that the injuries were exactly the same. This contrasts to some extent with 
previously reported injury systems in surgically prepared small animals (Kim JS et 
al., 1997a, Wilhelm DL, 1953, Keenan KP et al., 1982a, Keenan KP et al., 1982b, 
Keenan KP et al., 1982c, McDowell EM et al., 1979, Shimizu T et al., 1994), or even 
to in vitro (Zahm JM et al., 1991) systems where the nature of the preparation allows 
for greater precision in the nature and extent of the injury process. 
 
Initial protocols were designed to follow the response over 35 days post injury, 
reflecting uncertainty over the likely duration of the repair process in this species. 
Later time points were subsequently dropped since initial studies indicated that in the 
majority of cases recovery had occurred by 21 days post injury. Since our principal 
interest was in understanding the mechanisms underlying the normal processes of 
repair in the airway and potentially relating those findings to situations where the 
airway is continually faced with insult we felt that the early processes, involving 
significant cell proliferation, would likely yield the most useful information to 
compare against a chronic setting.  
 
Of interest is the observation that the brushed areas were covered by partly 
differentiated epithelial cells as early as day 7 post injury. In the study of (Heguy A 
et al., 2007) involving healthy human subjects, the damaged airways regained their 
normal structure by day 14 post injury – by day 7, the damaged areas were similarly 
covered by undifferentiated epithelial cells. Clearly whilst the model systems are not 
exactly equivalent, it is of some interest that the repair response to similar injury 
appears to follow a similar temporal spread between these two species.  
 
It was clearly demonstrated that the different segments of the lung share similar 
airway composition and structure. This reduces the possibility that any differences 
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between sites might reflect differences in airway structure, related to differences in 
the position in the airway tree. Although this was only a preliminary study with low 
numbers, it appeared that the available data supported the notion that the pattern of 
changes in response to physical injury was similar whether the changes were 
assessed over time within the same animal (protocol A) or were assessed between 
different animals, with only one time point represented per animal (protocol B). 
Although it is often assumed, it should not be concluded that spatial separation 
allows for independence of treatments. Indeed, in previous studies by (Heguy A et 
al., 2003), examining the early transcriptional response to bronchial brushing in the 
lung, it was demonstrated that early changes can be observed in the right lung if 
sampled after a preceding procedure in the left lung and vice versa, depending on the 
sequence and timing of individual samples. 
 
Protocol B was limited in terms of there being only one sheep per time point and the 
possibility remains that an individual sheep effect might have contributed to the 
observed difference in the timing of the peak proliferative response subsequent to 
injury between the two protocols. For this reason interpretation is necessarily limited 
to a qualitative appraisal of the general patterns of response, rather than influenced 
by specific comparisons at certain time points.  
 
In the normal state, stem cells have a slow cell turnover, giving rise to transient 
amplifying (TA) progenitor cells that retain the capacity to replicate and impart most 
of the tissue renewal in the presence of injury. However, in the absence of injury or 
cell renewal, TA cells eventually become incapable of proliferation and become 
terminally differentiated (TD) cells (Borthwick DW et al., 2001). The slow cycling 
feature of stem cells lends itself to the use of DNA labelling techniques followed by 
a “washout” period to track candidate stem cells in situ (Liu X and Engelhardt JF, 
2008, Borthwick DW et al., 2001) as “label-retaining cells”. In this study a single 
dose of BrdU, which incorporates during S-phase of the cell cycle (Yanai T et al., 
1996),with no washout period was used to investigate the presence of cells with 
proliferative activity. The BrdU-labelled cells observed in the small intestine and 
skin sections indicate that the dose of BrdU used in this study was appropriate, as 
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well as validating the efficacy of the BrdU infusion protocol. The choice of these 
tissues as the source of control material was based on the study carried out by (Holle 
and Birtles, 1990) for the skin, and by (Yanai T et al., 1996) for the intestine. The 
patterns of staining observed in these tissues was consistent with that anticipated 
from these publications.  
 
Although a cellular response to physical injury was seen as early as 6 hours post 
injury, this response was apparently not accompanied by a significant increase in 
proliferative activity. The observed cellular response at this time point was believed 
to reflect preliminary morphological changes involving epithelial cells, and would 
not necessarily involve significant proliferative activity. Histopathological evidence 
suggests that the observed epithelial attenuation and cellular migration was devoted 
towards the initial regeneration of a single layer of squamous epithelial cells that 
would cover the denuded surface. It is conceivable that the purpose of this migratory 
process is to provide a foundation for other cell types migrating from either local 
epithelial cell population (Hong KU et al., 2004b, Hong KU et al., 2004a, Rawlins 
EL et al., 2007, Reynolds SD et al., 2000) or from the circulation (Abe S et al., 2004, 
Anderson DJ et al., 2001, Kotton DN et al., 2001) in order to contribute to the repair 
process. This assumption is based on the discussions by Lane BP and Gordon R, 
(1974), and (Rennard SI et al., 1991) which describe early peripheral cell migration 
in order to cover the tracheal epithelial defect induced by mechanical trauma. 
Although there was evidence of neutrophil infiltration at the damaged area, these 
were fewer in number when compared to day 1 post injury. 
 
Whilst based only on scrutiny of one segment, preliminary data indicates that 
secretory or mucus-producing cells are involved in the repair process from early as 6 
hours post injury. The involvement of PAS-stained cells in the early repair process 
was reported by (Shimizu T et al., 1994) who described these cells migrating from 
the undamaged epithelium bordering the lesion following a mechanical injury in rats. 
These cells were characterized as partially differentiated cells due to the loss of the 




The histopathological features of the airways at day 1 differed to those observed at 
day 3 post injury where most of the damaged areas were clearly visible with mucosal 
haemorrhage and most of the BrdU-positive cells were clearly seen at both 
transitional areas and underneath the damaged epithelium. At this time point, the 
epithelium at the transitional area was thickened with multiple layers of 
undifferentiated cells. By day 3 post injury the brushed area was covered mostly by 
intact epithelium with some areas thickened as a consequence of hyperplasia. This 
finding appeared to parallel the observed peak in cell proliferation at the same stage. 
This result somewhat contrasts with findings in a guinea pig tracheal injury model in 
which proliferative activity peaked at 48 hours and began to decrease at 72 hours 
post injury (Kim JS et al., 1997a).  
 
The timing of the peak proliferative response might be associated with the severity of 
the brushing technique and respective size of the lesion. It is likely that the technique 
performed in this study would be classified as severe (fourth category, with no intact 
basal cells left following injury (Barrow RE et al., 1992)) since the cellular 
composition of the airway epithelium was removed completely, and the basement 
membrane and various elements of the mucosal structures were also disturbed or 
destroyed. This contrasts with many of the small animal systems where a layer of 
viable basal cells is left at the wound site, apparently facilitating the migration 
process and promoting early proliferation and repair (Keenan KP et al., 1982a). The 
impact of more severe damage on the delay of the proliferation peak was also 
reported by others (Keenan KP et al., 1982a, Keenan KP et al., 1982b, Keenan KP et 
al., 1982c, Lane BP and Gordon R, 1974, McDowell EM et al., 1979, Wilhelm DL, 
1953). Severe injury is thought likely to disturb cell-to-cell communications during 
the early period of the injury (Keenan KP et al., 1982a) and disrupt the basement 
membranes in the denuded areas (Keenan KP et al., 1982c)  - both believed essential 
to the early process of epithelial cell migration. Indeed the basement membrane 
provides a mechanical support for cells, acts as a semi-permeable barrier between 
tissue compartments and regulates cellular attachment, migration and differentiation 




Tissue sections from day 1 to day 3 post injury demonstrated that the newly 
regenerated epithelial surface contained some positive AB-PAS staining. The AB-
PAS stain also nicely highlighted the dedifferentiation process of cells in the 
transition areas adjacent to the injury sites. Whether mucus-producing and/or ciliated 
cells contribute most to the processes of dedifferentiation and migration is unknown 
in the context of the current study. However, in a study of mice exposed to 
naphthalene it was suggested that re-differentiation of the bronchiolar epithelium 
after naphthalene injury involves spreading and trans-differentiation of ciliated 
epithelial cells with concomitant changes in cell shape and gene expression during 
the process of repair (Park KS et al., 2006). Thus, our finding might support the 
hypothesis that either ciliated and/or mucus-producing cells play a role in 
contributing to the repair of the epithelium exposed to physical injury either through 
dedifferentiation (Erjefält JS et al., 1995) or trans-differentiation (Park KS et al., 
2006) and migration towards the damaged area. The involvement of the cells 
bordering the lesion was concurrent with the peak in proliferative activity. The high 
numbers of BrdU-positive cells observed at the transitional area compared with those 
in the undamaged area indicate that the repair process involves neighbouring cell 
populations not directly overlying the area exposed to the injury. This phenomenon 
was clearly described by (Keenan KP et al., 1982a, Keenan KP et al., 1982b, Keenan 
KP et al., 1982c) in which the early repair events involve cell spreading and 
migration into the denuded area.  
 
It is interesting to note that there was also a significant involvement of the 
submucosal glands underlying the wound, with evidence of proliferation in the gland 
epithelium. The increased number of BrdU-labelled cells in the epithelium and 
submucosal glands of the airways might suggest that differentiation of mucus 
secreting progenitor cells and their subsequent proliferation might be a primary aim 
of the healing process. Indeed, an intact mucus ‘scaffold’ overlying the damaged area 
observed at day 1 to day 3 post injury might be a pre-requisite for successful healing 
– preventing further damage, whilst facilitating the migration, attachment and 
interaction of the cells participating in the healing process. The reason for this 
response in the glands is unclear, but could reflect an increase in gland secretory 
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activity to help in forming a protective barrier over the wound site. There is a 
substantial amount of literature on SMG secretions as a source of significant levels of 
antimicrobial molecules and host defence i.e lactoferrin (Lf), lysozyme (Ly). In a 
study by Raphael GD et al., (1989) to investigate the cellular sources and the 
secretory control of these nasal proteins in vivo adults underwent nasal provocation 
tests with methacholine (MC), histamine (H), and gustatory stimuli, reported that Lf 
and Ly, two antimicrobial proteins previously described in nasal secretions, are 
produced and stored in the nasal submucosal glands, specifically within serous cells, 
and are secreted under the influence of the parasympathetic nervous system (Raphael 
GD et al., 1989). This study demonstrated that these molecules are important 
constituents of nasal secretions (Raphael GD et al., 1989). The secretion of these 
molecules by the submucosal glands support the concept that secreted mucus serves 
as a lubricant (Raphael GD et al., 1989) for the airway epithelium surface as well as 
in agreement with predominant role of submucosal gland in the upper airways to 
provide a first line of defence for the mucosa (Raphael GD et al., 1989). In addition, 
it was also been suggested that lactoperoxidase (LPO) is an important component of 
airway defence against infection and inhibiting the LPO system in sheep impaired 
bacterial clearance from the airway (Gerson C et al., 2000). Thus it was suggested 
that LPO system is a major contributor to airway defences (Gerson C et al., 2000). 
 
Mucus production following airway injury might be relevant to the potential 
protective role, or it could also be the response of the gland to initiate the repair of 
duct structures damaged by the brushing. This hypothesis is supported by the 
observation that production and secretion of the of airway mucus from the mucous 
goblet cells and other secretory cells within the surface and underlying submucosal 
glands are significantly increased in human diseases such as cystic fibrosis, chronic 
bronchitis and asthma (Wang K et al., 2007, Engelhardt JF et al., 1995). It is also 
tempting to speculate that the proliferative activity seen in the submucosal glands 
underneath the damaged mucosa might in some way reflect the fact that a stem cell 
niche exists in this vicinity (Engelhardt JF, 2001) and such proliferation might reflect 




The concordance, in terms of location, between the BrdU staining cells at the 
margins of the lesion, and in the submucosal gland structures, is intriguing and 
suggests that a major focus of the cell proliferation could be directed towards early 
(day 1) migration and regeneration of the epithelium at the lesion. Increased AB-PAS 
staining and BrdU-labelled cells at the submucosal gland region at this time point 
suggest early production of mucus to act as a protective barrier to avoid further 
damage to the epithelium. This assumption is supported by the evident of the layer 
comprised of a dense and compact accumulation of neutrophils held within and 
below the mucin layer. Whilst the specific lineages of the proliferating airway 
epithelial cells and where they originated or migrated from are still unclear the 
literature suggests several possible sources including migration from the areas 
bordering the damaged site, from submucosal glands, or perhaps even involvement 
haematopoietic-derived cells. In the latter regard we sought to assess the contribution 
of blood-derived cells in the repair process through anti-CD45 staining. Given that 
CD45 positive cells can be observed within the airway epithelium bordering the 
lesion, one could hypothesise that these cells might also be proliferating since there 
was an abundance of BrdU-positive cells observed in this location, especially at day 
1 post injury. However, only a few CD45-positive cells were observed within the 
repairing epithelium or within or around the glands in the submucosal region. These 
cells were scattered in both areas of mucosal and submucosal compartment and also 
observed in regenerating smooth muscle (day 1). However, it seems unlikely that 
CD45 positive cells account for all proliferative activity in these areas since the 
numbers of cells stained with anti-BrdU in the transitional epithelium exceed the 
numbers of CD45 stained cells. A dual-labelling technique might be a promising tool 
in order to demonstrate this hypothesis; however the protocols for these antibodies 
are not compatible – both antibodies share a similar IgG group (IgG1). Of related 
interest is the observation that in an experimental sheep model of allergic lung 
inflammation after local challenge with house dust mite, it was revealed that CD45-
positive cells were the most prominent leucocytes found in lung tissue 48 hours after 
allergen challenge (Bischof RJ et al., 2003). Naturally, the perceived roles of such 
cells can extend to a range of influence including the secretion of chemokines and 
cytokines essential for the repair process (Chuang CY et al., 2009).  
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The AB-PAS staining at day 3 post injury was arranged in a thin covering over the 
top of the injured epithelial surface, and this layer was packed with neutrophils 
(Figure 2.25). Whilst it is well recognised that neutrophil products promote mucin 
production (Kim S and Nadel JA, 2004) the observed relationship between such 
induction and the cells held within the layer perhaps hints at some functional benefit 
of having these infiltrating leukocytes constrained in such tight apposition to the 
repairing epithelium. Indeed neutrophils have important phagocytic functions that 
might relate to the need to remove dead or dying cells and cell debris within the 
surface and equally might serve an important additional protective function in 
bolstering innate defence at this site. In such light it is also tempting to speculate that 
the observed neutrophilic influx that often characterises exacerbations in chronic 
airway diseases such as COPD has its origins in repair rather than inflammation per 
se. 
 
In the present study, the number of BrdU-positive cells decreased by day 7 post 
injury. By this time, although the epithelial surface was fully covered, some areas 
still consisted only of partially differentiated epithelial cells. The reduction in BrdU-
incorporating cells at day 7 may indicate that at this time point, the majority of the 
proliferating cells might have entered the late stage of cell cycle, and fail to label 
with BrdU which is only incorporated during the S-phase of the cell cycle. In the 
study by (Heguy A et al., (2007) most of the genes picked up on microarray analysis 
at day 7 post injury were the genes involved in the late stage of the cell cycle.  
 
Re-differentiation of the epithelium in the form of increased AB-PAS-positive 
staining was clearly evident by day 7 after injury. Whilst these cells were clearly 
differentiating towards a mucus-secreting phenotype they were still morphologically 
distinct from the fully differentiated mature goblet cells present in the undamaged 
epithelium.  Some concordance was evident in the location and extent of PAS-
staining and proliferative activity present in the submucosal glands. Whether such 
proliferation contributes to increased airway secretions and/or functions as a stem 
cell niche to promote airway epithelial renewal, remains to be determined (Liu X and 
Engelhardt JF, 2008). 
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Basal cells are thought to make a major contribution to the processes of migration, 
proliferation and differentiation during regeneration of the damaged proximal airway 
epithelium (Hong KU et al., 2004b, Hong KU et al., 2004a). These cells may have 
originated from the area bordering the injured epithelium, by changing their shape 
(Keenan KP et al., 1982a, Keenan KP et al., 1982b, Keenan KP et al., 1982c, Kim JS 
et al., 1997a, Wilhelm DL, 1953, Zahm JM et al., 1991) through a dedifferentiation 
process and becoming intermediate cells which then give rise to other specialized 
epithelial cells (i.e ciliated cells). Contrary evidence suggests that secretory cells are 
the principal progenitor cells in the regenerating tracheal epithelium of hamsters and 
rats (Keenan KP et al., 1982a, Keenan KP et al., 1982b, Keenan KP et al., 1982c, 
Lane BP and Gordon R, 1974, McDowell EM et al., 1979). These latter studies also 
demonstrated that such secretory cells provide the majority of the cells that change 
shape and migrate to cover the wound and divide to produce a multi-layered 
metaplastic epidermoid epithelium. Progeny derived from such cells developed into 
columnar secretory cells (pre-secretory cells) or columnar ciliated cells (pre-ciliated 
cells) in order to generate a pseudostratified mucociliary epithelium (Keenan KP et 
al., 1982a, Keenan KP et al., 1982b, Keenan KP et al., 1982c). The scope of the 
present study was such that it was not possible to ascertain the respective roles of 
either cell type in airway regeneration and repair in the sheep.  
 
Although the preceding discussion has largely focused on the changes observed in 
the damaged and transitional areas it was notable that changes were also observed in 
the undamaged area opposite to the brushed area. The result was similar to the 
finding reported by (Kim JS et al., 1997a) in the guinea pig tracheal epithelium (Kim 
JS et al., 1997a) in which a proliferative response was observed in the undamaged 









2.6 CONCLUSION OF THE CHAPTER  
In conclusion, this study demonstrates the utility of a novel model of airway 
epithelial injury in a large animal model system that can be used to follow the repair 
process. The model demonstrated changes in airway architecture and histopathology 
largely consistent with previous studies in small animal systems and with similar 
studies conducted in man. The processes of dedifferentiation, migration, proliferation 
and re-differentiation were easily characterised and assessed by selectively injuring 
areas of the airway epithelium. The model further substantiates the notion that the 
airway epithelium demonstrates remarkable propensity to repair itself in the event of 
acute injury. Indeed, although the brushing technique used in this study destroyed 
most of the morphology of the mucosal region, the ability of the airway to regenerate 
a new partly differentiated epithelium and other airway components such as smooth 
muscle and glands as early as 3 to 7 days post injury was remarkable. The chapter 
also demonstrates the potential of experimental protocols involving segmental 
challenges to maximise data yield whilst minimising the ethical costs associated with 






3. CHAPTER 3 
 
A CANDIDATE GENE APPROACH TO ANALYSING GENE 
























Understanding the mechanisms involved in the response to injury in the lung is 
fundamental to the process of piecing together the pathways and mechanisms that 
underlie more complex respiratory diseases such as asthma and COPD. Amongst the 
various mechanisms, pathways regulating lung morphogenesis may play an 
important role in shaping the nature and extent of tissue remodelling that 
characterises the pathology associated with these conditions. We are interested in 
determining the default process of repair that is evoked when the airway epithelium 
is exposed to physical injury, and also whether this process has its origins in the 
developmental biology of the lung. Indeed, our working hypothesis is that many of 
the mediators and pathways that are known to play an important role in lung 
development are also involved in the repair and remodelling of the airways in 
response to injury. A number of studies have linked lung development to 
concomitant changes in gene and protein expression (Costa RH et al., 2001, 
Warburton D et al., 2000). Whilst the process of wound healing has been examined 
in the airways grossly and at light and electron microscopy resolution (Shimizu T et 
al., 1994, Erjefält JS et al., 1997, Erjefält JS et al., 1995) there is limited information 
available on the changes in gene expression associated with repair. 
 
Lung development is comprised of a series of interrelated morphogenetic events. 
Kho AT et al., (2009) have identified the molecular signature of the lung during the 
transition towards air breathing – a period they refer to as “time to birth”. Amongst 
the statistically overrepresented genes were those involved in oxygen and gas 
transport activity, as well as host defence function and those concerned with the 
initiation of alveolar formation (Kho AT et al., 2009). In addition some more 
unexpected genes were identified including those connected with nitric oxide 
synthesis, and ribosomal and haemoglobin complex formation. These genes are 
informative in terms of defining the relative state of mouse lung tissue in terms of its 
preparedness for the transition to air breathing, and thus represent a molecular 
signature that effectively describes the distance in age from the day of birth (Kho AT 
et al., 2009). More recently another study by Kho AT et al., (2010) characterized 
global patterns of gene expression occurring during human lung development and 
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similarly indicated the existence of molecular phases of lung development (Kho AT 
et al., 2010 ). In early pseudoglandular development, genes were enriched with 
chromosomal organization processes associated with mitosis, and the late 
pseudoglandular genes were enriched with surfactant function–gas exchange and 
immunological-major histocompatibility complex (MHC) class II attributes (Kho AT 
et al., 2010 ) with surfactant protein genes increased from the early to late 
pseudoglandular phase. The early expression of surfactant proteins may indicate a 
necessity of early molecular programming of the lung for subsequent development 
(Kho AT et al., 2010 ).  
 
These findings concur with opinion expressed in the review of (Warburton D et al., 
2001) in which it was acknowledged that modelling of the lungs during 
morphogenesis, repair, and regeneration is tightly coordinated by conserved 
stimulatory and inhibitory signalling mechanisms, including specific transcriptional 
factors, cytokines, peptide growth factors, proteases, and matrix elements 
(Warburton D et al., 2001). Genes that have emerged from functional screening 
studies as directing fly respiratory organogenesis, including sonic hedgehog, patched, 
smoothened, Gli, fibroblast growth factor (FGF), fibroblast growth factor  receptor 
(FGFR), sprouty, bone morphogenetic protein 4 (BMP4), TGF-beta and SMAD, are 
functionally conserved in mice and humans(Warburton D et al., 2001).  
 
It is clearly important for the process of repair to be highly regulated, given the 
complexity of lung structure and the crucial interplay between structure and function 
in this organ. Therefore, it is likely that default pathways do indeed exist and are 
evoked in response to acute injury, and that it is only when such pathways are 
perturbed or overwhelmed that the sequences of events result in pathology. 
Successful repair will likely involve a series of interlinked and interdependent 
events. Pathology may occur where aspects of sequence and/or interdependence are 
compromised and knowledge of where such abnormalities arise offers the potential 
of modulating repair thus minimising the chance of developing significant lung 
pathology. Although the complexity of airway epithelial cell phenotypes and their 
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involvement during injury and repair is well discussed, there is a lack of evidence 
and detailed explanation of how the repair process is regulated.  
Cell migration and proliferation have been shown to be important in wound healing 
in the airway (Chapter 1 Section 1.6.1) and such activities i.e cellular proliferation, 
migration, and differentiation, also play key roles during branching morphogenesis in 
lung development (Costa RH et al., 2001). However, the factors that elicit and 
control such processes have not been fully determined. Transcription factors, such as 
transcription termination factor 1 (TTF-1), fox family members (including Foxa1, 
Foxa2, and FoxJ1), GATA-6, and the beta-catenin/TCF transcriptional complex, 
influence genetic programmes critical for lung morphogenesis, differentiation, and 
pulmonary homeostasis (Costa RH et al., 2001). These transcription factors control 
the expression of genes that are critical for the differentiation of the distinct subsets 
of cells characteristic of the mature lung and act as mediators for epithelial-
mesenchymal interactions during lung development and lung branching 
morphogenesis (Cardoso WV and Lü J, 2006, Costa RH et al., 2001, Mucenski ML 
et al., 2003, Maeda Y et al., 2007).  
 
Beta-catenin is part of a complex of proteins that constitute adhesion junctions which 
are necessary for the creation and maintenance of epithelial cell layers by regulating 
cell growth and adhesion between cells. Beta-catenin also anchors the actin 
cytoskeleton and may be responsible for transmitting the contact inhibition signal 
that causes cells to stop dividing once the epithelial sheet is complete (Rawlins EL et 
al., 2007). The expression of this gene in respiratory epithelium  of the embryonic 
lung was required for the growth and differentiation  of peripheral epithelial cell 
progenitors (Mucenski ML et al., 2003).  Beta catenin is involved in the canonical 
Wnt pathway and canonical Wnt ligands act extracellularly to promote the 
stabilization of beta-catenin in the cytoplasm (Nusse R et al., 2008). The Wnt  
terminologywas originally derived through a combination of Wg (for wingless) and 
Int (for integration) (Rijsewijk F et al., 1987).  Wg was originally identified as a 
recessive mutation affecting wing and haltere development in Drosophila 
melanogaster (Sharma RP and Chopra VL, 1976) whilst Int genes, the vertebrate 
homologues, were initially recognised as being near several integration sites of 
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mouse mammary tumor virus (MMTV) (Nusse R et al., 1984). It was suggested that 
beta-catenin functions to control the balance between progenitor expansion and 
epithelial differentiation that is required for both lung development and repair after 
injury (Bellusci S, 2008). It was also demonstrated that Wnt signalling is activated 
upon lung epithelial regeneration and increased Wnt signalling expands the numbers 
of bronchioalveolar stem cells (BASCs) (Zhang Y et al., 2008).  
 
In the context of lung development, De Langhe SP and Reynolds SD (2008) 
discussed the involvement of this gene in Wnt signalling during lung organogenesis. 
Wnt/beta-catenin signalling regulates aspects of branching morphogenesis, regional 
specialization of the epithelium and mesenchyme, and establishment of progenitor 
cell pools (De Langhe SP and Reynolds SD, 2008). The beta-catenin and the 
Wnt/beta-catenin signalling pathways contribute to the control of cellular 
proliferation, differentiation and migration (De Langhe SP and Reynolds SD, 2008). 
In contrast, Zemke AC et al., (2009) reported that beta-catenin was not necessary for 
maintenance or efficient repair of the bronchiolar epithelium. In a study of transgenic 
and cell type-specific knockout strategies to determine roles for beta-catenin-
regulated gene expression in normal maintenance and repair of the bronchiolar 
epithelium it was demonstrated that repair of the naphthalene-injured airway 
proceeded with establishment of focal regions of beta-catenin-null epithelium 
(Zemke AC et al., 2009).   
 
A further study demonstrated that beta-catenin, Foxa2, FoxJ1 and Sox family 
members (Sox17 and Sox2), are dynamically regulated during repair and re-
differentiation of the bronchiolar epithelium after naphthalene injury (Park KS et al., 
2006). During murine lung development, Hackett BP et al., (1995) reported that 
transcript for hepatocyte nuclear factor-3/forkhead homologue 4 (HFH-4/FoxJ1) was 
first detected at the start of the late pseudoglandular stage (embryonic day 14.5) and 
then was specifically localized to the proximal pulmonary epithelium (Hackett BP et 
al., 1995). The unique temporal and spatial pattern of HFH-4 gene expression in the 
developing lung defines this protein as a marker for the initiation of bronchial 
epithelial cell differentiation and suggests that it may play an important role in cell 
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fate determination during lung development (Hackett BP et al., 1995). Blatt EN et 
al., (1999) demonstrated that HFH-4/FoxJ1 expression is localized to ciliated 
epithelial cells and was temporally related to ciliogenesis. A role for FoxJ1 in 
ciliogenesis was demonstrated by the temporal relationship of HFH-4 to the 
appearance of cilia in developing lung and flagella during spermiogenesis (Blatt EN 
et al., 1999 ). It was also demonstrated that among epithelial cells expressing FoxJ1 
mRNA, FoxJ1 protein expression is localized specifically to ciliated cells (Blatt EN 
et al., 1999 ). Similar to the FoxJ1 gene, a combination of beta-tubulin and FoxJ1 
markers associates with ciliated cell differentiation (Lazard DS et al., 2009, 
LeSimple P et al., 2007, Rowe RK et al., 2004). 
 
The use of keratins 5 and 14 as markers for basal cell regeneration during wound 
repair has been reported previously (Dakir EL et al., 2008, Patel GK et al., 2006 ) 
and the expression of keratin 14 gene has been reported to be time-dependent, 
decreasing in extent during the process of wound repair (Lazard DS et al., 2009). A 
study by Patel GK et al., (2006) revealed the presence of six new keratinocyte 
subpopulations in the epidermis during acute wound healing (2–8 days), as defined 
by their differing keratin expression, and amongst those keratinocyte genes, keratin 
14 (KRT14) and KRT14 were expressed in basal and immediate suprabasal cells of 
the epidermis adjacent to the wound edge (Patel GK et al., 2006 ). These basal 
keratinocytes are fundamental for epidermal integrity and migrate over the wound 
site. A study by Liu JY et al., (1994) during epithelial regeneration in tracheal grafts 
suggested that keratin 14 appeared before markers of highly differentiated secretory 
or ciliated cells, and were instead associated with cells which were poorly 
differentiated and highly proliferative (Liu JY et al., 1994). In addition, Shimizu T et 
al., (1994) reported that following a focal denuding wound in mechanically injured 
rat trachea, cells from the adjacent non-wounded epithelium flattened and migrated 
into the wounded site. These populations of cells were reported to dedifferentiate to 
become a population of poorly differentiated (PD) cells which expressed keratin 14 
and Griffonia simplicifolia I-isolectin B4 (GSI-B4) lectin binding sites, which are 
specific for basal cells in normal epithelium (Shimizu T et al., 1994). Thus, these 
findings suggest that dedifferentiated cells from adjacent sites adopt a basal cell-like 
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phenotype and play a role in migrating towards and replacing denuded areas in 
response to injury and it is believed that this process is one of the fundamental 
mechanisms of the repair process following injury.  
 
With these literature-based observations and findings to hand, and with the 
overarching objective in place of developing an understanding of the mechanisms 
that underlay the different stages of wound repair in the airway epithelium in sheep, 
it was clear that specific needs could be identified that would be key to achieving this 
goal. Whilst protein markers would provide the means to trace the behaviour of 
individual cell types and their involvement in this process, in the majority of 
instances such markers are not yet available for use in sheep. Molecular 
characterisation of this process, on the other hand, is to some extent a more realisable 
current objective as many of the genes involved have been characterised in the sheep 
and/or are highly conserved between species. As such the opportunity exists to 
identify at least some of the likely key, or candidate, genes involved and generate the 
primers necessary to follow the expression of such in the repair process. With this in 
mind, we designed preliminary experiments in which we elected to study and 
quantify the mRNA expression level for five selected genes, namely beta-catenin, 
beta-tubulin, keratins 5 and 14, and FoxJ1 in the ovine airway in response to 
bronchial brushing by using reverse-transcriptase polymerase chain reaction (RT-
PCR). Our expectation was that findings in this regard would lead to a basic 
understanding of the way in which expression of those genes would relate to the 
different stages of epithelial repair.  
 
3.2 OBJECTIVES 
1. To develop reverse transcription polymerase chain reaction (RT-PCR) assays 
for the ovine beta-catenin, keratins 5 and 14, beta-tubulin and FoxJ1  
2. To generate ovine sequences for beta-catenin, beta-tubulin, keratins 5 and 14 
and FoxJ1 genes  
3. To study and quantify the expression patterns for these genes at various time 




3.3  MATERIALS AND METHODS 
3.3.1 Experimental design 
The bronchial brushing procedure was performed at single predefined sites within the 
major airways of anaesthetised sheep (n = 4), at selected time points  (1, 3, 7, 14, 21 
and 28 days prior to post mortem; Protocol A). However each sheep was sampled on 
only three or four different occasions (Table 3.1 and Figure 3.1): Sheep 2683 (days 1, 
3, 7 and 14), Sheep 2676 (days 1, 3, 21 and 28) and Sheep 8038 and 8039 (days 1, 3 
and 7). Naïve sites from each sheep were assigned as controls. A comparison of gene 
expression in mRNA prepared from brushed and unbrushed regions (Figure 3.1) of 
the same airway was performed by RT-PCR. The protocols involved in anaesthesia 
(Chapter 2; Section 2.3.3), the bronchial brushing (Chapter 2; 2.3.4) and necropsy 

























2683 RCD RVD1 LCD RVD2 LC RC LVD2 RA LVD1 - - 
2676 RCD LCD RVD1 LC RVD2 - - RC LVD2 RA LVD1 
8038 RVD1 RC LC RVD2 - - - 








Table 3.1: The sheep, the location of the subsegmental airways subjected to bronchial brushing and the various time points studied prior to necropsy 
(RA = right apical; RC = right cranial; LC = left cranial; RCD = right cranial diaphragmatic; LCD = left cranial diaphragmatic; RVD = right ventral diaphragmatic; 





Figure 3.1: Schematic of the airway structures and the selected segments subjected to bronchial 
brushing at each specific time point 
The airway segments were brushed at specific time points and during necropsy examination the 
airway segments were identified, dissected away from surrounding parenchyma and cut into two 
separate sites relating to the areas that were brushed, and the opposing areas that were not. These 
dissected pieces were preserved in RNAlater. The negative (-) symbol before each time point in the 




3.3.2 Tissue sampling  
Brushed areas were carefully identified during the necropsy examination and the 
airway segments containing the sites under consideration were removed intact from 
the surrounding parenchyma. Brushed and naïve segments were identified, and for 
brushed segments, the airway was divided into brushed and unbrushed portions 
(Figure 3.1). Samples from both areas were collected into RNAlater (Ambion, UK) 
and stored at -20oC for subsequent RNA extraction.  
 
3.3.3 RNA extraction 
RNA was prepared using the Qiagen Allprep Mini kits (Qiagen, UK). For each 
sample thirty milligrams of lung tissue was weighed into a FastRNA ProGreen 
matrix tube (MP Biomedicals, UK) containing 0.7 ml RLT buffer with β-
mercaptoethanol (1 ml RLT buffer:10 µl β-mercaptoethanol). The matrix tube was 
processed in a FastPrep® Instrument (Bio 101; Thermo Electron Corp., UK) for 40 
seconds at a speed setting of 6.0 (followed the procedures as recommended by the 
FastRNA Pro Green Kit (MP Biomedical): Instruction manual). The upper phase was 
transferred to a Qiashredder column (Qiagen, UK) and was centrifuged at 13,000 
rpm for 2 minutes. The supernatant was transferred into an AllPrep Column and 
centrifuged at 10,000 rpm for 30 seconds at room temperature.  
 
One volume of 70% ethanol was added to the flow-through solution, mixed and 
transferred to an RNeasy spin column then centrifuged at 10,000 rpm for 15 seconds. 
The flow-through was discarded and the column washed with 350 µl of RW1 buffer. 
The column was then centrifuged for 15 seconds (10,000 rpm at room temperature). 
After the second flow-through was discarded, 80 µl DNAse (Qiagen, UK) solution 
(10 µl of DNAse I stock solution: 70 µl buffer RDD) was added directly to the 
RNeasy spin column membrane and incubated at room temperature for 30 minutes. 
After incubation, 350 µl RWI was added to the spin column and centrifuged at 
10,000 rpm for 15 seconds.  
 
The column was transferred into a new collection tube and washed with 450 µl 
RPE/Ethanol buffer (1 RPE: 4 Ethanol). The column was centrifuged at 10,000 rpm 
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for 15 seconds and the flow-through was discarded. The washing step with 
RPE/Ethanol was repeated; the column was centrifuged at 10,000 rpm for 2 minutes 
and again the flow-through was discarded. The column was placed into a 1.5 mL 
eppendorf tube (Axygen Scientific, USA) and 50 µl of nuclease-free water was 
added to the column’s membrane; the column was then centrifuged at 10,000 rpm for 
1 minute to elute the RNA.  
 
A 1:10 dilution of RNA sample was quantified using a Spectrophotometer at 260 nm, 
and purity was assessed by determining the OD ratio 260/280 nm. 
 
3.3.4 Reverse transcription of mRNA into cDNA  
A reverse transcription (RT) of 1 µg total RNA was set up on ice and cDNA copies 
were generated using a Perkin Elmer (Perkin-Elmer, USA) thermocycler. Briefly, 
1µg of total RNA was denatured at 70oC for 10 minutes and immediately chilled in 
ice for 5 minutes. The reaction mixture (Promega, UK) consisted of 4µl of MgCl2 
(25mM), 2µl of 10x Reverse Transcription Buffer, 2 µl of deoxynucleotide 
triphosphate (dNTP) mixture (10mM), 0.5µl Recombinant RNAsin Ribonuclease 
Inhibitor, 0.5µl of 15U avian myeloblastoma virus (AMV) reverse transcriptase, 
0.5µl Oligo(dT)15 primer and 9.5µl of nuclease free water added to give a final 
volume of  20µl. The reaction was incubated for 1 hour at 42oC, followed by 
deactivation of the enzyme at 95oC for 5 minutes. The RT mixture was then chilled 
on ice for 10 minutes and subsequently stored at -20oC for further application. The 
control for RNA was set up by replacing the RNA template with RNA-free water and 
the same protocols were applied.  
 
3.3.5 Oligonucleotide primers  
The human sequences for beta-catenin, beta-tubulin, keratins 5 and 14, and FoxJ1 
formed the basis for searching for available ovine or bovine sequences corresponding 
to those genes in the genomic sequence database (GenBank). The obtained bovine 
and ovine (or ovine EST) sequences for genes of beta-catenin, beta-tubulin, keratins 
5 and 14 and FoxJ1 were aligned against available mammalian gene sequences using 
the BLAST algorithm through NCBI (http://blast.ncbi.nlm.nih.gov/Blast), Ensembl 
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(http://trace.ensembl.org/cgi-bin/tracesearch), European Bioinformatic Institute 
(EMBL-EBI) (http://www.ebi.ac.uk/blast/) and DFCI Sheep Gene Index databases, 
to identify areas of conserved sequence that might prove valuable in the context of 
primer design for the present application.  
 
Primers for beta-tubulin and keratin 5 genes were designed based on the bovine 
sequence following inter-species sequence alignments. For keratin 5, primers were 
designed over conserved regions following alignment of bovine (NM_001008663), 
human (NM_000424) and mouse (NM_027011) sequences to give a 493bp PCR 
product. For the beta-tubulin gene, primers were designed based on conserved 
sequence between bovine (NM_001046549) and human (NM_178014) to amplify 
503bp of PCR product.  
 
A bovine expressed sequence tag (EST) (TC3860) for the keratin 14 gene was 
obtained from the DFCI database. ClustalW2 (EMBL-EBI) sequence alignment 
analysis revealed that the TC3860 bovine EST sequence was 97% similar to the 
bovine keratin 14 gene. This EST sequence was used to design the primers for the 
ovine keratin 14 gene based on conserved sequences identified from an alignment 
with horse, chicken, chimp, human and mouse sequence. Based on the bovine 
mRNA sequence, primers were expected to amplify a 407bp PCR product. 
 
For the FoxJ1 gene, the primers were designed based on sheep genomic DNA 
sequence (DU231961: Ovis aries genomic clone CH243-427C5) identified from the 
EMBL-EBI database by blasting the human forkhead box J1 (FoxJ1) mRNA 
sequence (NM_001454.2). In order to check that this sequence was really coding for 
FoxJ1 gene homologue, the blast analysis was completed with the ovine sequence 
using the NCBI reference mRNA sequence (refseq-rna) database, and the results 
showed that 99% of this sequence is similar to the bovine Forkhead box protein J1 
(Forkhead-related protein FKHL13, FoxJ1) mRNA (XM_582255.3) and 92% similar 
to that of human Forkhead box J1 (FoxJ1) mRNA (NM_001454.2). Since there was 
no available ovine mRNA sequence for FoxJ1 gene, primers were designed based on 
conserved regions identified from sequence alignment analysis between bovine 
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mRNA and ovine genomic DNA. The primers were designed to amplify a predicted 
210bp of ovine FoxJ1 mRNA sequence (Figure 3.2).  
 
 
Figure 3.2: A sequence alignment between bovine mRNA and ovine genomic DNA to find the 
conserved areas appropriate for primer design. The primers were designed to amplify a predicted 
210bp of ovine FoxJ1 mRNA sequence. These two sources of sequences are 99% similar.  
 
 
Primers for the ovine beta-catenin (FE032823) gene were designed based on an 
ovine mRNA sequence obtained from the EMBL-EBI database by blast analysis with 
human beta-catenin. This sequence was aligned with that of bovine 
(NM_001076141), human (NM_001098210) and mouse (NM_007614) beta-catenin 
mRNA sequences, and the primers were designed at conserved regions. The primers 
were predicted to amplify a 407bp PCR product.  
 
Primers were designed by using DNAsis Max v2.0 (Micobio Inc, USA). All designed 
primers were again checked for specificity using BLAST algorithm through NCBI 
http://blast.ncbi.nlm.nih.gov/Blast. Primers were purchased from Eurofin (MWG 
Operon, UK). 
 
ATPase, a constitutively expressed ‘housekeeping’ gene, was used as a control to 
assess the quality of the RT product and also as a reference for quantification of 
 
 108
mRNA (Craig NM et al., 2007). The list of the primers used in this study is shown in 
(Table 3.2) 
 
3.3.6 PCR amplification of sheep cDNA 
Beta-tubulin, keratin 5 and beta-catenin genes were each amplified in a duplex PCR 
with ATPase whilst keratin 14 and FoxJ1 were run individually since the high 
annealing temperature required for their respective primers were incompatible with 
the ATPase.  
 
PCR reactions were set up on ice using GoTaq Flexi DNA polymerase (Promega, 
UK) consisting of a 5x GoTaq Flexi Buffer and 25 mM MgCl2 solution. PCR 
reactions, which were contained within thin-walled 0.2 ml PCR tubes (Axygen 
Scientific, USA), consisted of 2µl cDNA template, 5µl of 5x GoTaq Flexi Buffer, 
4µl dNTPs (10mM) (Bioline, UK), 2µl MgCl2 solution (25mM), 1µl of each forward 
and reverse primers (10pmol) (for duplex PCR, the 1µl of each forward and reverse 
primers for ATPase primer was added), 0.125µl of GoTaq Flexi DNA Polymerase 












































































Fwd: 5'-GCTGACTTGGTCATCTGC-3',         Rev: 5'-CAGGTAGGTTTGAGGGGATAC-3' 
 
Table 3.2: The list of primer sequences and PCR conditions for amplifying the candidate genes in this study 
The expected size of the PCR products is based on the length of both forward (Fwd) and reverse (Rev) primers expected to be annealed on the target regions. (*) the 
annealing temperature and PCR cycles varied according to the methods (using either singleplex or duplex PCR techniques). 
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The Techne Gradient (Techne, USA) and/or Perkin-Elmer GeneAmp PCR system 
2400 (Perkin-Elmer, USA) PCR machines were used to heat the samples at 94oC for 
5 minutes for the initial denaturation. The PCR cycles were initiated with 
denaturation of the cDNA template at 94oC for 30 seconds; the primers were 
annealed at the specific annealing temperatures for each gene (as shown in 
Table 3.2) for 30 seconds followed by the extension step at 72oC for 30 seconds. The 
final extension step was completed at 72oC for 7 minutes to make sure the target 
regions of the genes had been transcribed completely. For a duplex PCR, the PCR 
conditions for the ATPase gene were optimised and compatible with the PCR 
conditions of the genes of interest; however, for a semi-quantitative analysis of the 
FoxJ1 and keratin 14 genes, the ATPase gene was amplified alone at 35 and 28 
cycles respectively using the following PCR conditions: initial denaturation for 2 
minutes at 94oC, followed by denaturation at 94oC for 40 seconds, annealing at 60oC 
for 40 seconds, extension at 72oC for 2 minutes, followed by the final extension at 
72oC for 7 minutes.  
 
A 10 µl aliquot of each PCR product was loaded into the well of a 1.3% TBE-
agarose gel (Invitrogen, UK) for electrophoresis to check product size against 1kb 
DNA ladder (Promega, UK). Gels were stained with GelRed (Biosystem, UK) (10 
µl/100 ml) and photographed using QuantityOne software (Bio-Rad Laboratories, 
USA).  
 
Following purification of the PCR product using a PCR Purification kit (Qiagen, 
UK) according to the manufacturer’s protocols, the identity of the PCR products was 
assessed by DNA sequencing. PCR products were sequenced in both directions 
(using both forward and reverse primers) using di-deoxy chain termination cycle 
sequencing (Applied Biosystem, UK) at DBS Genomics, Durham University, UK. 
 
3.3.7 Densitometry of PCR products 
Following image collection, Kodak 1D Analysis software was used to determine the 
density of the PCR product bands. To compare the mRNA expression for each gene 
across samples, a semi-quantitative analysis was performed by normalising the band 
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density of the PCR product for the specific gene of interest to the corresponding 
ATPase PCR product signal.   
 
3.3.8 Molecular cloning  
3.3.8.1 Preparation of cDNA template 
High fidelity PCR products for all genes were prepared using Pfu Taq polymerase 
(Promega, UK). The PCR reactions, consisting of 5 µl of 10x Pfu buffer, 2 µl of 10 
mM of each primer, 2 µl of 10 mM dNTPs (Bioline, UK), 4 µl of cDNA template, 
0.25 µl of Pfu Taq polymerase and nuclease free water, were prepared in a total 
volume of 50 µl. The PCR reactions were amplified using the Perkin-Elmer 
GeneAmp PCR system 2400 (Perkin-Elmer, USA). The cDNA templates were first 
denatured at 95oC for 2 minutes, and the PCR cycles were initiated with denaturation 
of the cDNA template at 95oC for 30 seconds; the primers were annealed at the 
specific annealing temperatures for each specific gene (Table 3.2) for 30 seconds, 
followed by the extension step at 72oC for 1 minute. The final extension step was 
done at 72oC for 7 minutes. The PCR products were purified using QIAquick PCR 
Purification kit (Qiagen, UK).  
 
3.3.8.2 A+-tailing procedures 
Since PCR products amplified with proof-reading (Pfu) Taq polymerase are blunt-
ended, the A-tailing procedure was carried out in order to generate A-tailed overhang 
at both ends to facilitate TA-cloning. The reactions were prepared in a total volume 
of 10 µl, and reaction mixtures were as follows: 5 µl of purified cDNA template, 1 µl 
of 10 mM dATP (Promega, UK), 1 µl of GoTaq Buffer (Promega, UK), 1 µl of 
GoTaq Flexi DNA polymerase (Promega, UK) and 2 µl of nuclease-free water. The 
reactions were incubated at 70oC for 30 minutes using the Perkin-Elmer GeneAmp 
PCR system 2400 (Perkin-Elmer, USA).  
 
3.3.8.3 Ligation into pGEM-T Easy Vector 
A-tailed product was cloned into pGEM-T Easy Vector (Promega, UK). Ligation 
reactions contained: 5µl of 2x Rapid Ligation Buffer, 1 µl of pGEM-T Easy Vector, 
1µl of T4 DNA Ligase, 25 ng of A-tailed cDNA products, and 1 µl of nuclease-free 
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water to a total volume of 10 µl. The ligation reactions were incubated overnight at 
4oC in the Perkin-Elmer GeneAmp PCR system 2400 (Perkin-Elmer, USA) machine.  
 
3.3.8.4 Transformation into E.coli JM109 
The ligation mixtures were spun down and 2 µl of ligation reactions were transferred 
to the bottom of sterile 1.5 ml centrifuge tubes on ice. An E.coli JM109 High 
Efficiency Competent Cells (>108 cfu/µg DNA) (Promega, UK) were removed from   
-80oC storage and placed in an ice bath until just thawed (5 minutes). The cells were 
gently mixed by flicking the tubes. JM109 (25 µl) cells were transferred into the 
tubes containing the ligation reactions and placed on ice for 20 minutes. The 
reactions were heat shocked for 50 seconds in a 42oC water bath and immediately 
chilled on ice for another 2 minutes. 950 µl of SOC medium (Invitrogen, UK) was 
added and tubes were shaken at 150 rpm for 1.5 hours. After incubation, the 
reactions were spun at 3,000rpm for 10 minutes and re-suspended in 200 µl of SOC 
medium. 100 µl of cells were plated in duplicates on LB agar (Invitrogen, UK) 
containing ampicilin (100 µg/mL), IPTG (100 mM) and X-gal (50 mg/mL), and the 
plates were incubated overnight at 37oC. Control for DNA insert (provided by the 
manufacturer) was used and the same protocols performed, with the exception of the 
A-tailing procedure.  
 
3.3.8.5 Screening for positive clones 
The numbers of white/blue colonies were counted and recorded. Single white 
colonies from the sub culture plate were selected for screening by PCR (the same 
protocols used for original PCR amplification using GoTaq polymerase). PCR-
positive sub-cultures were selected for plasmid DNA extraction using Wizard® Plus 
DNA Purification System (Promega, USA) after overnight incubation in LB Broth 
(Invitrogen, UK), and the resulting recombinant plasmid DNAs were sent for 





3.4.1 Molecular cloning and sequence validation  
In the present study, PCR-based assays were developed in order to detect the 
expression of ovine beta-tubulin, beta-catenin, keratin 5, keratin 14 and FoxJ1 genes 
in samples derived from the ovine airway. In order to obtain and validate the 
sequence of amplified cDNA for all five genes, the PCR products were cloned into 
pGEM-T Easy vector and transformed into bacterial E. coli clone JM109. The results 
of the sequencing analysis for each gene are discussed below. 
 
The results for direct sequencing of PCR products prior to cloning demonstrated that 
the sequence for beta-catenin showed 98% similarity to bovine (NM_001076141.1) 
and 94% similarity to human (NM_001904.3) beta-catenin mRNA sequences. The 
sequence for beta-tubulin showed 99% similarity to bovine (NM_001046549.1) and 
89% similarity to human (NM_178014.2) beta-tubulin mRNA sequence. The 
sequence for keratin 5 showed 98% similarity to bovine (NM_001008663.1) and 
90% similarity to human (NM_000424.3) keratin 5 mRNA sequences and the 
sequence for FoxJ1 showed 99% similarity to bovine (XM_582255.3) and 92% 
similarity to human (NM_001454.3) FoxJ1 mRNA sequences. Lastly, the sequence 
for keratin 14 showed 82% similarity to human keratin 14 (NM_000526.4) and 91% 
similarity to bovine keratin 13 (NM_001130747.1) mRNA sequences.  
 
3.4.1.1 Screen for positive clones 
PCR products amplified from two different RNA samples were used for cloning in 
duplicate. PCR products amplified for beta-catenin were successfully cloned. (Figure 
3.3A) shows the PCR products derived from screening the positive clones. Clones A, 
C, D and E were complete 407bp sequences. Of the 29 clones analyzed, only 16 gave 
a PCR product of the expected 503bp size for beta-tubulin. Five clones were sent for 
DNA sequencing (Figure 3.3B) and 3 clones (clones E, C and M) had a complete 
503bp sequence for the beta-tubulin gene with correct 5’ to 3’ orientation. The PCR 
products for keratin 5 were amplified using normal Taq polymerase (GoTaq 
polymerase) since proof-reading Taq polymerase (Pfu) gave no product despite 
attempts to optimise the assay. The PCR products were amplified from two different 
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sources of airway tissue (LC and RVD1), and the A+-tailing procedure was not 
required. These PCR products were successfully cloned and, of the 40 white colonies 
observed, 39 were shown to have a positive clone for the KRT14 gene when 
screened by PCR using specific primers (Figure 3.3C). Three clones contained the 
complete 493bp length of sequence (clones A, B and C). PCR products for the 
keratin 14 gene were successfully amplified and cloned (Figure 3.3D). Out of 6 
clones sent for sequencing, only 2 clones produced a satisfactory result but were 
cloned in the wrong orientation (clones J and Q). The PCR products of this gene 
were amplified using normal Taq polymerase (GoTaq polymerase) since proof-
reading Taq polymerase (Pfu) gave no product despite attempts to optimise the assay. 
The PCR products for FoxJ1 were successfully cloned and, out of four plates of 
colonies, only seven white colonies were observed. Among those, 6 were positive 
when screened by PCR using specific primers (Figure 3.3E), and these were sent for 
DNA sequencing analysis. Only 2 clones were successfully sequenced as having the 
complete 210bp in length (clones C and D). Low quality of sequencing data was the 
primary factor in leading to rejection of clones.  
 
3.4.1.2 Sequence analyses  
The sequencing results generated from both primers (T7 and SP6) were used to 
perform a blast 2-Sequence alignment to get full sequences of the genes of interest. 
For beta-catenin, although all samples had a complete target sequence (407bp) only 
four clones were cloned in 5’ to 3’ orientation. Sequence alignment of those four 
clones (ClustalW) demonstrated that they were identical. When this sequence was 
blasted through the EMBL-EBI (www.ebi.ac.uk) database, the results demonstrated 
100% similarity with unpublished ovine EST sequences (EE756183, EE754439, 
FE022986, FE032823 and EE782646), and 98% similarity with bovine beta-catenin 
gene sequences (BC119949 and BT030683). Figure 3.4A shows the sequence 
alignment between clones which was performed using ClustalW on the EMBL-EBI 
database.   
   
For beta-tubulin, sequence alignment (ClustalW) analysis of the 3 clones showed that 
these clones share a 100% similarity (Figure 3.4B). Blast analysis was performed 
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using EMBL-EBI and NCBI databases, and the results revealed that the cloned 
sequences are 99% homologous with the unclassified ovine ESTs (EE798210, 
EE765525, EE747478, DY496913, EE774297) and 98% similar to bovine beta-
tubulin (TUBB) mRNA (BT030522 and NM_001046549.1 (NCBI)) and bovine 
beta-tubulin 2A mRNA (BC105401).  Furthermore, these sequences are 90% similar 
to that of a human beta-tubulin mRNA sequence (NM_178014.2). 
  
For keratin 5, seven clones were selected for full-length DNA sequencing and a blast 
2-Sequence analysis was performed. Three clones had sequence of the anticipated 
493bp size with the primer sequences at either end (Figure 3.4C) and cloned in 
correct orientation. When the sequence of all three clones were blasted through the 
NCBI database, the sequence was found to be 98% similar to that of the bovine 
keratin 5 mRNA sequence (NM_001008663.1) and 91% similar to the keratin 5 
mRNA sequence for humans (NM_000424.3) and mice (NM_027011.2). When this 
ovine sequence was blasted through the EMBL-EBI database, a sequence was 
identified with a 100% similarity with unclassified Ovis aries (EE838877) EST 
sequence generated from wool follicle mRNA. Analysis using the NCBI database 
demonstrated that this EST sequence produced the same results as the 493bp clone. 
Therefore, it is likely that cloned sequence is the ovine keratin 5 mRNA sequence. 
 
For keratin 14, the clones were not identical (79% identity) and both clones were 
403bp rather than the 405bp predicted from the bovine sequence (TC3860) - (Figure 
3.4D - clone J). Since the primers were designed based on the bovine EST sequence 
for the KRT14 gene (TC3860), this sequence might possibly reflect a species 
difference. The blast result for the clone KRT14-J, using the NCBI database revealed 
that this sequence demonstrated 98% similarity with bovine and human keratin 17 
mRNA (NM_001105322.1 and NM_000422.2 respectively), 92% similarity with 
human keratin 14 mRNA (NM_000526.4) and 90% similarity with mouse keratin 14 
mRNA sequence (NM_016958.1). In addition, when the result of this sequence was 
blasted through the DFCI sheep EST database, these results showed that 98% of this 
sequence was similar to bovine EST for keratin 17 gene sequence (TC2398 and 
 
 116
TC2943), 95% similar to bovine EST keratin 14 gene sequence (TC3860) and 81% 
similar to an ovine EST Keratin 15 gene sequence (TC6677). 
 
However, analysis of the KRT14-Q clone sequence through the NCBI database 
revealed that this sequence demonstrated 100% similarity with K13 of Pan 
troglodytes (XM_511487), 91% similarity with bovine K15 (NM_001130747.1) and 
only 82% similarity with that of human KRT14 (NM_000526.4). Analysis using the 
DFCI database revealed that this sequence demonstrated 91% similarity with ovine 
K15 (TC6677), 80% similarity with bovine K17 (TC2398) and 80% similarity with 
bovine KRT14 (TC3860). It was therefore considered unlikely that the clone 
KRT14-Q encoded the KRT14 gene. Further analysis is required to confirm if clone 
KRT14-J genuinely codes for the keratin 14 gene. 
 
For FoxJ1, sequence analysis showed that the two clones (both 210bp in length) were 
identical. A blast 2 Sequence analysis indicated that these clones shared similar 
sequence to the expected FoxJ1 gene (Figure 3.4E). In order to confirm that the 
sequences of these two clones belong to the FoxJ1 gene, a Blast analysis using the 
NCBI and EMBL-EBI databases was performed. Analysis of these sequences 
demonstrated a similarity of 99% with bovine Forkhead box protein J1 (Forkhead-
related protein FKHL13) (Hepatocyte nuclear factor 3 forkhead homolog 4) (HNFH-
4) (FoxJ1), mRNA sequence (XM_582255.3), and 92% similarity with human 








 Figure 3.3: A screening for positive clones by PCR 
The PCR products of the expected positive clones for the beta-catenin, beta-tubulin, KRT14, 
KRT14 and FoxJ1 genes were screened by PCR using specific primers. The white colonies 
were used as PCR template and different sizes of the PCR products observed indicate that 
some of the clones might represent the full sequence of the genes of interest. (the lane 
characters indicate the samples selected for DNA sequencing); A) beta-catenin, B) beta-









CloneD      GCTGCAGGGGTCCTCTGTGAACTTGCTCAGGACAAGGAAGCTGCAGAAGCTATTGAAGCC 60 
CloneE      GCTGCAGGGGTCCTCTGTGAACTTGCTCAGGACAAGGAAGCTGCAGAAGCTATTGAAGCC 60 
CloneC      GCTGCAGGGGTCCTCTGTGAACTTGCTCAGGACAAGGAAGCTGCAGAAGCTATTGAAGCC 60 
CloneA      GCTGCAGGGGTCCTCTGTGAACTTGCTCAGGACAAGGAAGCTGCAGAAGCTATTGAAGCC 60 
            ************************************************************ 
CloneD      GAGGGAGCCACAGCTCCTCTGACAGAACTACTTCATTCTAGGAATGAGGGTGTGGCAACA 120 
CloneE      GAGGGAGCCACAGCTCCTCTGACAGAACTACTTCATTCTAGGAATGAGGGTGTGGCAACA 120 
CloneC      GAGGGAGCCACAGCTCCTCTGACAGAACTACTTCATTCTAGGAATGAGGGTGTGGCAACA 120 
CloneA      GAGGGAGCCACAGCTCCTCTGACAGAACTACTTCATTCTAGGAATGAGGGTGTGGCAACA 120 
            ************************************************************ 
CloneD      TATGCAGCTGCTGTTTTGTTCCGAATGTCTGAGGACAAGCCACAGGATTATAAGAAACGG 180 
CloneE      TATGCAGCTGCTGTTTTGTTCCGAATGTCTGAGGACAAGCCACAGGATTATAAGAAACGG 180 
CloneC      TATGCAGCTGCTGTTTTGTTCCGAATGTCTGAGGACAAGCCACAGGATTATAAGAAACGG 180 
CloneA      TATGCAGCTGCTGTTTTGTTCCGAATGTCTGAGGACAAGCCACAGGATTATAAGAAACGG 180 
            ************************************************************ 
CloneD      CTTTCAGTTGAGCTGACCAGTTCTCTCTTCAGAACGGAGCCAATGGCTTGGAATGAGACT 240 
CloneE      CTTTCAGTTGAGCTGACCAGTTCTCTCTTCAGAACGGAGCCAATGGCTTGGAATGAGACT 240 
CloneC      CTTTCAGTTGAGCTGACCAGTTCTCTCTTCAGAACGGAGCCAATGGCTTGGAATGAGACT 240 
CloneA      CTTTCAGTTGAGCTGACCAGTTCTCTCTTCAGAACGGAGCCAATGGCTTGGAATGAGACT 240 
            ************************************************************ 
CloneD      GCTGATCTTGGACTTGATATTGGTGCCCAGGGAGAACCTCTTGGATATCGCCAGGATGAT 300 
CloneE      GCTGATCTTGGACTTGATATTGGTGCCCAGGGAGAACCTCTTGGATATCGCCAGGATGAT 300 
CloneC      GCTGATCTTGGACTTGATATTGGTGCCCAGGGAGAACCTCTTGGATATCGCCAGGATGAT 300 
CloneA      GCTGATCTTGGACTTGATATTGGTGCCCAGGGAGAACCTCTTGGATATCGCCAGGATGAT 300 
            ************************************************************ 
CloneD      CCCAGCTATCGTTCTTTTCACTCCGGTGGGTACGGCCAGGACGCCTTGGGGATGGACCCC 360 
CloneE      CCCAGCTATCGTTCTTTTCACTCCGGTGGGTACGGCCAGGACGCCTTGGGGATGGACCCC 360 
CloneC      CCCAGCTATCGTTCTTTTCACTCCGGTGGGTACGGCCAGGACGCCTTGGGGATGGACCCC 360 
CloneA      CCCAGCTATCGTTCTTTTCACTCCGGTGGGTACGGCCAGGACGCCTTGGGGATGGACCCC 360 
            ************************************************************ 
CloneD      ATGATGGAGCATGAGATGGGCGGCCACCACCCCGGTGCTGACTATCC 407 
CloneE      ATGATGGAGCATGAGATGGGCGGCCACCACCCCGGTGCTGACTATCC 407 
CloneC      ATGATGGAGCATGAGATGGGCGGCCACCACCCCGGTGCTGACTATCC 407 
CloneA      ATGATGGAGCATGAGATGGGCGGCCACCACCCCGGTGCTGACTATCC 407 


















CloneM      GTGGCAAATATGTCCCTCGTGCTATCTTGGTGGATCTAGAACCCGGAACCATGGACTCTG 60 
CloneC      GTGGCAAATATGTCCCTCGTGCTATCTTGGTGGATCTAGAACCCGGAACCATGGACTCTG 60 
CloneE      GTGGCAAATATGTCCCTCGTGCTATCTTGGTGGATCTAGAACCCGGAACCATGGACTCTG 60 
            ************************************************************ 
 
CloneM      TTCGCTCAGGTCCTTTTGGTCAGATCTTCAGACCAGACAACTTTGTTTTTGGTCAGTCCG 120 
CloneC      TTCGCTCAGGTCCTTTTGGTCAGATCTTCAGACCAGACAACTTTGTTTTTGGTCAGTCCG 120 
CloneE      TTCGCTCAGGTCCTTTTGGTCAGATCTTCAGACCAGACAACTTTGTTTTTGGTCAGTCCG 120 
            ************************************************************ 
 
CloneM      GGGCAGGCAACAACTGGGCCAAGGGCCACTATACAGAGGGAGCCGAGCTGGTTGACTCGG 180 
CloneC      GGGCAGGCAACAACTGGGCCAAGGGCCACTATACAGAGGGAGCCGAGCTGGTTGACTCGG 180 
CloneE      GGGCAGGCAACAACTGGGCCAAGGGCCACTATACAGAGGGAGCCGAGCTGGTTGACTCGG 180 
            ************************************************************ 
 
CloneM      TCCTGGATGTGGTTCGGAAGGAGGCCGAGAGCTGTGACTGCCTGCAGGGCTTCCAGCTGA 240 
CloneC      TCCTGGATGTGGTTCGGAAGGAGGCCGAGAGCTGTGACTGCCTGCAGGGCTTCCAGCTGA 240 
CloneE      TCCTGGATGTGGTTCGGAAGGAGGCCGAGAGCTGTGACTGCCTGCAGGGCTTCCAGCTGA 240 
            ************************************************************ 
 
CloneM      CCCACTCACTGGGTGGGGGTACTGGCTCCGGAATGGGCACCTTGCTCATTAGCAAGATCC 300 
CloneC      CCCACTCACTGGGTGGGGGTACTGGCTCCGGAATGGGCACCTTGCTCATTAGCAAGATCC 300 
CloneE      CCCACTCACTGGGTGGGGGTACTGGCTCCGGAATGGGCACCTTGCTCATTAGCAAGATCC 300 
            ************************************************************ 
 
CloneM      GTGAAGAGTATCCTGACCGAATCATGAACACCTTCAGCGTGGTGCCCTCACCCAAAGTGT 360 
CloneC      GTGAAGAGTATCCTGACCGAATCATGAACACCTTCAGCGTGGTGCCCTCACCCAAAGTGT 360 
CloneE      GTGAAGAGTATCCTGACCGAATCATGAACACCTTCAGCGTGGTGCCCTCACCCAAAGTGT 360 
            ************************************************************ 
 
CloneM      CCGACACTGTGGTTGAGCCCTACAATGCCACCCTCTCCGTCCATCAGCTGGTGGAGAACA 420 
CloneC      CCGACACTGTGGTTGAGCCCTACAATGCCACCCTCTCCGTCCATCAGCTGGTGGAGAACA 420 
CloneE      CCGACACTGTGGTTGAGCCCTACAATGCCACCCTCTCCGTCCATCAGCTGGTGGAGAACA 420 
            ************************************************************ 
 
CloneM      CTGATGAAACCTACTGCATTGACAACGAGGCCCTTTACGACATATGTTTCCGCACCCTCA 480 
CloneC      CTGATGAAACCTACTGCATTGACAACGAGGCCCTTTACGACATATGTTTCCGCACCCTCA 480 
CloneE      CTGATGAAACCTACTGCATTGACAACGAGGCCCTTTACGACATATGTTTCCGCACCCTCA 480 
            ************************************************************ 
 
CloneM      AGCTGACCACACCAACCTATGGA 503 
CloneC      AGCTGACCACACCAACCTATGGA 503 
CloneE      AGCTGACCACACCAACCTATGGA 503 






















CloneA          CACCAAGACTGTGAGGCAGAACCTGGAGCCTTTGTTCGAGCAGTACATCAACAACCTCAG 60 
CloneC          CACCAAGACTGTGAGGCAGAACCTGGAGCCTTTGTTCGAGCAGTACATCAACAACCTCAG 60 
CloneB          CACCAAGACTGTGAGGCAGAACCTGGAGCCTTTGTTCGAGCAGTACATCAACAACCTCAG 60 
                ************************************************************ 
 
CloneA          GAGACAGCTGGATGGTATCCTTGGGGAGAGAGGCCGCCTGGACTCGGAGCTCAGGAACAT 120 
CloneC          GAGACAGCTGGATGGTATCCTTGGGGAGAGAGGCCGCCTGGACTCGGAGCTCAGGAACAT 120 
CloneB          GAGACAGCTGGATGGTATCCTTGGGGAGAGAGGCCGCCTGGACTCGGAGCTCAGGAACAT 120 
                ************************************************************ 
 
CloneA          GCAGGACTTGGTGGAGGACTTCAAGAACAAGTATGAAGATGAAATCAACAAGCGTACCAC 180 
CloneC          GCAGGACTTGGTGGAGGACTTCAAGAACAAGTATGAAGATGAAATCAACAAGCGTACCAC 180 
CloneB          GCAGGACTTGGTGGAGGACTTCAAGAACAAGTATGAAGATGAAATCAACAAGCGTACCAC 180 
                ************************************************************ 
 
CloneA          TGCCGAGAATGAGTTTGTGATGCTGAAGAAGGATGTGGACGCTGCCTACATGAACAAAGT 240 
CloneC          TGCCGAGAATGAGTTTGTGATGCTGAAGAAGGATGTGGACGCTGCCTACATGAACAAAGT 240 
CloneB          TGCCGAGAATGAGTTTGTGATGCTGAAGAAGGATGTGGACGCTGCCTACATGAACAAAGT 240 
                ************************************************************ 
 
CloneA          GGAACTAGAGGCCAAGGTCGATGCACTGATGGACGAGATCAACTTCATGAAGATGTTCTT 300 
CloneC          GGAACTAGAGGCCAAGGTCGATGCACTGATGGACGAGATCAACTTCATGAAGATGTTCTT 300 
CloneB          GGAACTAGAGGCCAAGGTCGATGCACTGATGGACGAGATCAACTTCATGAAGATGTTCTT 300 
                ************************************************************ 
 
CloneA          CGATGCGGAGCTGTCCCAGATGCAGACACATGTCTCAGACACATCCGTGGTCCTGTCCAT 360 
CloneC          CGATGCGGAGCTGTCCCAGATGCAGACACATGTCTCAGACACATCCGTGGTCCTGTCCAT 360 
CloneB          CGATGCGGAGCTGTCCCAGATGCAGACACATGTCTCAGACACATCCGTGGTCCTGTCCAT 360 
                ************************************************************ 
 
CloneA          GGACAACAACCGCAGCCTGGACTTGGACAGCATCATTGCTGAGGTCAAGGCCCAGTATGA 420 
CloneC          GGACAACAACCGCAGCCTGGACTTGGACAGCATCATTGCTGAGGTCAAGGCCCAGTATGA 420 
CloneB          GGACAACAACCGCAGCCTGGACTTGGACAGCATCATTGCTGAGGTCAAGGCCCAGTATGA 420 
                ************************************************************ 
 
CloneA          AGACATTGCCAACCGCAGCCGCACAGAAGCTGAGTCCTGGTACCAGACCAAGTATGAGGA 480 
CloneC          AGACATTGCCAACCGCAGCCGCACAGAAGCTGAGTCCTGGTACCAGACCAAGTATGAGGA 480 
CloneB          AGACATTGCCAACCGCAGCCGCACAGAAGCTGAGTCCTGGTACCAGACCAAGTATGAGGA 480 
                ************************************************************ 
 
CloneA          GCTGCAGCAGACT 493 
CloneC          GCTGCAGCAGACT 493 
CloneB          GCTGCAGCAGACT 493 


















CloneJ          TGCTGAGCTGGGACTGCAGCTCGATCTCCAGGGCCTGCAAGGTGCGCCGGAGCTCCGAGA 60 
CloneQ          TGCTGAGCTGGGACTGCAGCTCGATCTCCAGGCCCTGGAGCGTGCGCCTGAGCTCGGTGA 60 
                ******************************** **** *  ******* ****** * ** 
 
CloneJ          TCTCGCTCTTGCCGCTCTGCACCAGCTCGCTGTTGGTGGCCACCTCGCGGTTCAGTTCCT 120 
CloneQ          TCTCTGTCTTGCTGGTCTGGATCATGGCTGTGCTGGAAGACACCTCCTTGTTCAGCTCGG 120 
                ****  ****** * **** * **   *  ** ***  * ******   ****** **   
 
CloneJ          CCGTCTTGCTGAAGAACCAGTCCTCGGCATCCTTGCGGTTCTTCTCTGCCATCTTCTCAT 180 
CloneQ          CGCTCTTGCTGTGGAACCATTCCTCGGCATCCCGGCGGTTCTTCTCTGCCATGGCCTCGT 180 
                *  ********  ****** ************  ******************   *** * 
 
CloneJ          ACTGGTCGCGCATCTCGTTCAGGATGCGGCTCAGGTCCACGCCGGGGGCGGCGTCCATCT 240 
CloneQ          ACTGCTCCCTCATCTCTGCCAGCACGCGGGTCAGGTCAATGCCTGGTGCTGCGTCCATCT 240 
                **** ** * ******   *** * **** ******* * *** ** ** ********** 
 
CloneJ          CCACGTTGATCTCGCCACCCACCTGGCCTCGAAGGGCTTTCATCTCCTCCTCGTGGTTCT 300 
CloneQ          CCACGTTGACCTGGCCAGCCAGCTGGTTGCTGAACTCCTTCATCTCCTCCTCGTGGTTCT 300 
                ********* ** **** *** ****   *  *   * ********************** 
 
CloneJ          TGCGGAGGTAGGCCAGCTCCTCCTTGAGGTTCTCGATCTGCATCTCCAGGTCAGCTCTGG 360 
CloneQ          TCTTCAGGTAGGCCAGCTCCTCGTTCAGGCTCTCAATCTGCATCTCCAGATCAGTCTTGG 360 
                *    ***************** ** *** **** ************** ****   *** 
 
CloneJ          CCAGGGTCAGCTCGTCCAGCACCCTGCGCAGGCCGTTGATGTC 403 
CloneQ          TCAGGGTCAGCTCGTCCAGCACCCTGCGCAGGCCGTTGATGTC 403 





cloneC          CCGCGGGCGTCAGCGGGCCAGAGAGCTCGGCCGGCCACCCTCGGCTCGGCTCGTGGATGT 60 
cloneD          CCGCGGGCGTCAGCGGGCCAGAGAGCTCGGCCGGCCACCCTCGGCTCGGCTCGTGGATGT 60 
                ************************************************************ 
 
cloneC          TGACCGCCCCCTCGGAGAGTCCCCGCAGATATGGCGGAGAGCTGGCTACGCCTCTCGGGG 120 
cloneD          TGACCGCCCCCTCGGAGAGTCCCCGCAGATATGGCGGAGAGCTGGCTACGCCTCTCGGGG 120 
                ************************************************************ 
 
cloneC          GTAGGGGCGGCGGAGGAGCCCGGGCCGGAGGGCGGCCTGGAGGAGCCCGACGCTCTGGAT 180 
cloneD          GTAGGGGCGGCGGAGGAGCCCGGGCCGGAGGGCGGCCTGGAGGAGCCCGACGCTCTGGAT 180 
                ************************************************************ 
 
cloneC          GACAGCCTGACCAGCCTGCAGTGGCTGCAG 210 
cloneD          GACAGCCTGACCAGCCTGCAGTGGCTGCAG 210 
                ****************************** 
 
Figure 3.4: The sequence alignment analyses performed for beta-catenin, beta-tubulin, keratin 
5, keratin 14 and FoxJ1 genes using ClustalW 
The results show the results of sequence alignment analyses performed for the beta-catenin (A), beta-
tubulin (B), keratin 5 (C), keratin 14 (D) and FoxJ1 (E) genes using ClustalW (EMBL-EBI). The 
comparisons were made between clones for each gene and showed 100% similarity over the complete 
sequence of the targeted genes except for keratin 14. In the latter instance the two clones only shared 
80% identity. The underlined sequences show the sequences for the forward and reverse primers. 
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3.4.2 RT-PCR analysis of gene expression studies 
The limited number of sheep used in the present study predicted an approach based 
on qualitative appraisal of the nature and extent of change in gene expression as a 
function of time after injury. Data are presented both in relation to individual values 
at each time point (wherein samples were derived from different segments), for each 
sheep, and also where the mean of the values at each time point was calculated – 
involving averaging of values derived from different segments and from different 
animals. Fold changes were calculated relating expression values in treated segments 
(from both brushed and unbrushed sites) to those obtained in naive segments (time 
point 0) for each individual sheep. Graphs were therefore plotted 1) based on the fold 
changes for brushed and unbrushed segments relative to the naive airways (left 
panel) and 2) based on the mean values (±SD) of absolute densitometry of genes of 
interest relative to absolute densitometry of ATPase gene for each time point (right 
panel) so as to compare overall expression patterns between brushed and unbrushed 
areas. Plotting the individual values (fold change) for each sample was deemed 
useful in assessing the extent of variation in expression between different sheep and 
duplicate segments within sheep. 
 
Figure 3.5(a), Figure 3.6(a), Figure 3.7(a), Figure 3.8(a) and Figure 3.9(a) show the 
PCR products for the brushed, unbrushed and naive samples for the expression of the 
studied genes relative to ATPase. Figure 3.5(b), Figure 3.6(b), Figure 3.7(b), Figure 
3.8(b) and Figure 3.9(b) show the expression values based on relative comparison 
between samples and ATPase gene plotted according to their fold change (left panel) 
and the mean values (right panel). 
 
The graph (Figure 3.5(b); right panel) depicting the means and standard deviations of 
the expression relative to ATPase for brushed and unbrushed sites indicates that 
initially elevated levels of gene expression for beta-catenin on days 1 and 3 
subsequently declined to broadly consistent levels of expression from day 7 onwards. 
Expression of beta-catenin within the brushed sites remained marginally more 
elevated than unbrushed sites at days 7, 14 and 28 post injury. Assessment of the 
individual fold-changes (Figure 3.5(b); left panel) contributing to these observations 
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Figure 3.5(a): Agarose gel for a semi quantitative RT-PCR analysis for beta-catenin  
Duplex RT-PCR products of beta-catenin and ATPase genes amplified from brushed (lanes 1-8) and 
unbrushed (lanes 9-16) samples at days 1 and 3 post injury, and a PCR negative control (lane 17).  
 
Lane 1 & 9: Ovine 2683, segment LVD1, day 1 
       
Lane 2 & 10: Ovine 2683, segment LCD, day 1 
  
Lane 3 & 11: Ovine 2676, segment LCD, day 1  
 
Lane 4 & 12: Ovine 2676, segment RVD1, day 1  
 
Lane 5 & 13: Ovine 2683, segment RVD2, day 3  
 
Lane 6 & 14: Ovine 2683, segment LC, day 3   
  
Lane 7 & 15: Ovine 2676, segment LC, day 3  
 
Lane 8 & 16: Ovine 2676, segment RVD2, day 3  
 
Lane 17 : PCR negative control 
 






(...cont) Agarose gel for a semi quantitative RT-PCR analysis for beta-catenin  
Duplex RT-PCR products of beta-catenin and ATPase genes amplified from brushed (lanes 1-6) and 
unbrushed (lanes 7-12) samples at days 1, 3 and 7 post injury, and a PCR negative control (lane 17). 
 
 
Lane 1 & 7: Ovine 8038, segment RC, day 1 
       
Lane 2 & 8: Ovine 8039, segment RVD1, day 1 
  
Lane 3 & 9: Ovine 8038, segment LC, day 3  
 
Lane 4 & 10: Ovine 8039, segment LC, day 3  
 
Lane 5 & 11: Ovine 8038, segment RVD2, day 7  
 
Lane 6 & 12: Ovine 8039, segment LVD1, day 7  
  
Lane 13 & 14: Ovine 8038, segment RVD1, naive (duplicate)  
 
Lane 15 & 16: Ovine 8039, segment RC, naive (duplicate)  
 
Lane 17 : PCR negative control 
 









(cont…) Duplex RT-PCR products of beta-catenin and ATPase genes amplified from brushed 
samples at days 7, 14, 21 and 28 post injuries 
 
Lane 1: Ovine 2683, segment LVD2, day 7   
 
Lane 2: Ovine 2683, segment RC, day 7 
 
Lane 3: Ovine 2683, segment LVD1, day 14 
 
Lane 4: Ovine 2683, segment RA, day 14 
 
Lane 5: Ovine 2676, segment LVD2, day 21 
 
Lane 6: Ovine 2676, segment RC, day 21 
 
Lane 7: Ovine 2676, segment LVD1, day 28 
 
Lane 8: Ovine 2676, segment RA, day 28 
 














(cont…) Duplex RT-PCR products of beta-catenin and ATPase genes amplified from unbrushed 
samples at days 7, 14, 21 and 28 post injuries 
 
Lane 1: Ovine 2683, segment LVD2, day 7   
 
Lane 2: Ovine 2683, segment RC, day 7 
 
Lane 3: Ovine 2683, segment LVD1, day 14 
 
Lane 4: Ovine 2683, segment RA, day 14 
 
Lane 5: Ovine 2676, segment LVD2, day 21 
 
Lane 6: Ovine 2676, segment RC, day 21 
 
Lane 7: Ovine 2676, segment LVD1, day 28 
 
Lane 8: Ovine 2676, segment RA, day 28 
 
Lane 9: Ovine 2683, segment RCD, naïve (d14) 
 
Lane 10: Ovine 2683, segment RCD, naïve (d28) 
 
Lane 11: 1kb DNA ladder 
 













Figure 3.5 (b): Graphs depicting the expression patterns of beta-catenin between 1 and 28 days after injury. Graphs were plotted based on the fold change of the 
treated airways (brushed and unbrushed) relative to their respective naive airway (left panel) and based on the mean values (±SD). Expression of beta-catenin within 
the brushed sites remained marginally more elevated than unbrushed sites especially at days 7 and 14 post injury (right panel) whilst the individual fold changes plots 






The expression profile of keratin 5 in the brushed, relative to the unbrushed, area was 
up-regulated throughout the initial time points (Figure 3.6(b); right panel). The 
highest expression values observed in the brushed samples for this gene were 30-fold 
in excess of naïve site expression levels (Figure 3.6(b); left panel). The graph 
depicting averaged values relative to ATPase indicates an initial upregulation (days 1 
and 3) of gene expression in the brushed sites (relative to unbrushed) that decreased 
through day 7 to levels broadly similar to those of ATPase by day 14 onwards for 
both brushed and unbrushed sites. However, as with beta-catenin there was evidence 
of variation within- and between-sheep (Figure 3.6(b); left panel). 
 
 
Figure 3.6 (a): Agarose gel for a semi quantitative of RT-PCR analysis for the keratin 5 gene 
Duplex RT-PCR products of KRT5 and ATPase genes amplified from brushed (lanes 1-8) and 
unbrushed (lanes 9-16) samples at days 1 and 3 post injuries, and a PCR negative control (lane 17). 
 
Lane 1 & 9: Ovine 2683, segment LVD1, day 1 
       
Lane 2 & 10: Ovine 2683, segment LCD, day 1 
  
Lane 3 & 11: Ovine 2676, segment LCD, day 1  
 
Lane 4 & 12: Ovine 2676, segment RVD1, day 1  
 
Lane 5 & 13: Ovine 2683, segment RVD2, day 3  
 
Lane 6 & 14: Ovine 2683, segment LC, day 3   
  
Lane 7 & 15: Ovine 2676, segment LC, day 3  
 
Lane 8 & 16: Ovine 2676, segment RVD2, day 3  
 
Lane 17 : PCR negative control 
 





(...cont) Agarose gel for a semi quantitative RT-PCR analysis for keratin 5  
Duplex RT-PCR products of KRT5 and ATPase genes amplified from brushed (lanes 1-6) and 
unbrushed (lanes 7-12) samples at days 1, 3 and 7 post injury, and a PCR negative control (lane 17). 
 
 
Lane 1 & 7: Ovine 8038, segment RC, day 1 
       
Lane 2 & 8: Ovine 8039, segment RVD1, day 1 
  
Lane 3 & 9: Ovine 8038, segment LC, day 3  
 
Lane 4 & 10: Ovine 8039, segment LC, day 3  
 
Lane 5 & 11: Ovine 8038, segment RVD2, day 7  
 
Lane 6 & 12: Ovine 8039, segment LVD1, day 7  
  
Lane 13 & 14: Ovine 8038, segment RVD1, naive (duplicate)  
 
Lane 15 & 16: Ovine 8039, segment RC, naive (duplicate)  
 
Lane 17 : PCR negative control 
 









(cont…) Duplex RT-PCR products of KRT5 and ATPase genes amplified from brushed samples 
at days 7, 14, 21 and 28 post injuries 
 
Lane 1: Ovine 2683, segment LVD2, day 7   
 
Lane 2: Ovine 2683, segment RC, day 7 
 
Lane 3: Ovine 2683, segment LVD1, day 14 
 
Lane 4: Ovine 2683, segment RA, day 14 
 
Lane 5: Ovine 2676, segment LVD2, day 21 
 
Lane 6: Ovine 2676, segment RC, day 21 
 
Lane 7: Ovine 2676, segment LVD1, day 28 
 
Lane 8: Ovine 2676, segment RA, day 28 
 














(cont…) Duplex RT-PCR products of KRT5 and ATPase genes amplified from unbrushed 
samples at days 7, 14, 21 and 28 post injuries 
 
Lane 1: Ovine 2683, segment LVD2, day 7   
 
Lane 2: Ovine 2683, segment RC, day 7 
 
Lane 3: Ovine 2683, segment LVD1, day 14 
 
Lane 4: Ovine 2683, segment RA, day 14 
 
Lane 5: Ovine 2676, segment LVD2, day 21 
 
Lane 6: Ovine 2676, segment RC, day 21 
 
Lane 7: Ovine 2676, segment LVD1, day 28 
 
Lane 8: Ovine 2676, segment RA, day 28 
 
Lane 9: Ovine 2683, segment RCD, naïve (d14) 
 
Lane 10: Ovine 2683, segment RCD, naïve (d28) 
 
Lane 11: 1kb DNA ladder 
 
















Figure 3.6(b): Graphs depicting the expression patterns of KRT5 between 1 and 28 days after injury. Graphs were plotted based on the fold change of the treated 
airways (brushed and unbrushed) relative to their respective naive airway (left panel) and based on the mean values (±SD). The expression profile observed indicates 
that KRT5 is up-regulated throughout the initial time points (right panel) whilst whilst the individual fold changes plots show a considerable variation in expression of 
this gene (left panel). 
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Changes in the expression of keratin 14 (where the underlining reflects the uncertainty 
regarding the true identity of the target in this instance) appeared to follow a similar 
pattern of initial (days 1 to 3) upregulation (relative to ATPase) followed by a 
decrease through day 7 to relatively consistent levels of expression by day 14 onwards 
(Figure 3.7(b); right panel). Although there was the suggestion of marginally 
increased levels of expression in brushed relative to unbrushed sites the individual 
value plots (Figure 3.7(b); left panel) indicated the considerable variability within and 
between sheep and cautioned against over-interpreting this data.  
 
 
Figure 3.7(a): Agarose gel for a semi quantitative RT-PCR analysis for the keratin 14 gene 
RT-PCR products of KRT14 and ATPase genes amplified from brushed (lanes 1-8) and unbrushed 
(lanes 9-16) samples at days 1 and 3 post injuries, and a PCR negative control (lane 17). 
 
Lane 1 & 9: Ovine 2683, segment LVD1, day 1 
       
Lane 2 & 10: Ovine 2683, segment LCD, day 1 
  
Lane 3 & 11: Ovine 2676, segment LCD, day 1  
 
Lane 4 & 12: Ovine 2676, segment RVD1, day 1  
 
Lane 5 & 13: Ovine 2683, segment RVD2, day 3  
 
Lane 6 & 14: Ovine 2683, segment LC, day 3   
  
Lane 7 & 15: Ovine 2676, segment LC, day 3  
 
Lane 8 & 16: Ovine 2676, segment RVD2, day 3  
 
Lane 17 : PCR negative control 
 







(...cont) Agarose gel for a semi quantitative RT-PCR analysis for keratin 14  
Duplex RT-PCR products of KRT14 and ATPase genes amplified from brushed (lanes 1-6) and 
unbrushed (lanes 7-12) samples at days 1, 3 and 7 post injury, and a PCR negative control (lane 17). 
 
 
Lane 1 & 7: Ovine 8038, segment RC, day 1 
       
Lane 2 & 8: Ovine 8039, segment RVD1, day 1 
  
Lane 3 & 9: Ovine 8038, segment LC, day 3  
 
Lane 4 & 10: Ovine 8039, segment LC, day 3  
 
Lane 5 & 11: Ovine 8038, segment RVD2, day 7  
 
Lane 6 & 12: Ovine 8039, segment LVD1, day 7  
  
Lane 13 & 14: Ovine 8038, segment RVD1, naive (duplicate)  
 
Lane 15 & 16: Ovine 8039, segment RC, naive (duplicate)  
 
Lane 17 : PCR negative control 
 








(cont…) RT-PCR products of KRT14 and ATPase genes amplified from brushed samples at days 
7, 14, 21 and 28 post injuries  
 
Lane 1: Ovine 2683, segment LVD2, day 7   
 
Lane 2: Ovine 2683, segment RC, day 7 
 
Lane 3: Ovine 2683, segment LVD1, day 14 
 
Lane 4: Ovine 2683, segment RA, day 14 
 
Lane 5: Ovine 2676, segment LVD2, day 21 
 
Lane 6: Ovine 2676, segment RC, day 21 
 
Lane 7: Ovine 2676, segment LVD1, day 28 
 
Lane 8: Ovine 2676, segment RA, day 28 
 














(cont…) RT-PCR products of KRT14 and ATPase genes amplified from unbrushed samples at 
days 7, 14, 21 and 28 post injuries 
 
Lane 1: Ovine 2683, segment LVD2, day 7   
 
Lane 2: Ovine 2683, segment RC, day 7 
 
Lane 3: Ovine 2683, segment LVD1, day 14 
 
Lane 4: Ovine 2683, segment RA, day 14 
 
Lane 5: Ovine 2676, segment LVD2, day 21 
 
Lane 6: Ovine 2676, segment RC, day 21 
 
Lane 7: Ovine 2676, segment LVD1, day 28 
 
Lane 8: Ovine 2676, segment RA, day 28 
 
Lane 9: Ovine 2683, segment RCD, naïve (d14) 
 
Lane 10: Ovine 2683, segment RCD, naïve (d28) 
 
Lane 11: 1kb DNA ladder 
 










    
Figure 3.7(b): Graphs depicting the expression patterns of KRT14 between 1 and 28 days after injury. Graphs were plotted based on the fold change of the treated 
airways (brushed and unbrushed) relative to their respective naive airway (left panel) and based on the mean values (±SD). There is a marginally increased levels of 




FoxJ1 gene expression appeared to vary according to the stage of repair, with the 
highest values being expressed initially followed by consistent levels at days 7 and 14 
(Figure 3.8; right panel). Thereafter (days 21 and 28), expression in unbrushed sites 
exceeded that in brushed sites. As with the other candidate genes there was 
considerable variation in the fold-changes relative to naïve both within- and between-
sheep (Figure 3.8(d); left panel).  
 
 
Figure 3.8(a): Agarose gel for a semi quantitative analysis of RT-PCR analysis for the FoxJ1 gene 
RT-PCR products of the FoxJ1 and ATPase genes amplified from brushed (lanes 1-8) and unbrushed 
(lanes 9-16) samples at days 1 and 3 post injuries, and a PCR negative control (lane 17) 
 
Lane 1 & 9: Ovine 2683, segment LVD1, day 1 
       
Lane 2 & 10: Ovine 2683, segment LCD, day 1 
  
Lane 3 & 11: Ovine 2676, segment LCD, day 1  
 
Lane 4 & 12: Ovine 2676, segment RVD1, day 1  
 
Lane 5 & 13: Ovine 2683, segment RVD2, day 3  
 
Lane 6 & 14: Ovine 2683, segment LC, day 3   
  
Lane 7 & 15: Ovine 2676, segment LC, day 3  
 
Lane 8 & 16: Ovine 2676, segment RVD2, day 3  
 
Lane 17 : PCR negative control 
 





(...cont) Agarose gel for a semi quantitative RT-PCR analysis for FoxJ1  
Duplex RT-PCR products of FoxJ1 and ATPase genes amplified from brushed (lanes 1-6) and 
unbrushed (lanes 7-12) samples at days 1, 3 and 7 post injury, and a PCR negative control (lane 17). 
 
 
Lane 1 & 7: Ovine 8038, segment RC, day 1 
       
Lane 2 & 8: Ovine 8039, segment RVD1, day 1 
  
Lane 3 & 9: Ovine 8038, segment LC, day 3  
 
Lane 4 & 10: Ovine 8039, segment LC, day 3  
 
Lane 5 & 11: Ovine 8038, segment RVD2, day 7  
 
Lane 6 & 12: Ovine 8039, segment LVD1, day 7  
  
Lane 13 & 14: Ovine 8038, segment RVD1, naive (duplicate)  
 
Lane 15 & 16: Ovine 8039, segment RC, naive (duplicate)  
 
Lane 17 : PCR negative control 
 








(cont…) RT-PCR products of the FoxJ1 and ATPase genes amplified from brushed samples at 
days 7, 14, 21 and 28 post injuries 
 
Lane 1: Ovine 2683, segment LVD2, day 7   
 
Lane 2: Ovine 2683, segment RC, day 7 
 
Lane 3: Ovine 2683, segment LVD1, day 14 
 
Lane 4: Ovine 2683, segment RA, day 14 
 
Lane 5: Ovine 2676, segment LVD2, day 21 
 
Lane 6: Ovine 2676, segment RC, day 21 
 
Lane 7: Ovine 2676, segment LVD1, day 28 
 
Lane 8: Ovine 2676, segment RA, day 28 
 














(cont…) RT-PCR products of the FoxJ1 and ATPase genes amplified from unbrushed samples at 
days 7, 14, 21 and 28 post injuries 
 
Lane 1: Ovine 2683, segment LVD2, day 7   
 
Lane 2: Ovine 2683, segment RC, day 7 
 
Lane 3: Ovine 2683, segment LVD1, day 14 
 
Lane 4: Ovine 2683, segment RA, day 14 
 
Lane 5: Ovine 2676, segment LVD2, day 21 
 
Lane 6: Ovine 2676, segment RC, day 21 
 
Lane 7: Ovine 2676, segment LVD1, day 28 
 
Lane 8: Ovine 2676, segment RA, day 28 
 
Lane 9: Ovine 2683, segment RCD, naïve (d14) 
 
Lane 10: Ovine 2683, segment RCD, naïve (d28) 
 
Lane 11: 1kb DNA ladder 
 












Figure 3.8(b): Graphs depicting the expression patterns of FoxJ1 between 1 and 28 days after injury. Graphs were plotted based on the fold change of the treated 
airways (brushed and unbrushed) relative to their respective naive airway (left panel) and based on the mean values (±SD). FoxJ1 gene expression appeared to vary 
according to the stage of repair especially on the earlier time points (right panel) whilst its a considerable variation in the fold-changes relative to naïve both within- 
and between-sheep (left panel). 
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For beta-tubulin, patterns of expression over time were similar to those already 
observed – namely elevated expression (relative to ATPase) initially (days 1 and 3), 
followed by a decrease in that expression through day 7 to broadly consistent levels 
of expression from days 14 to 28 (Figure 3.9(b); right panel). Levels of expression in 
brushed areas appeared to exceed those in unbrushed areas over the initial phase of 
repair, with this phenomenon being also reflected in the individual fold-change plots 
(Figure 3.9(b); left panel).  
 
 
Figure 3.9(a): Agarose gel for a semi quantitative RT-PCR analysis for the beta-tubulin gene 
Duplex RT-PCR products of beta-tubulin and ATPase genes amplified from brushed (lanes 1-8) and 
unbrushed (lanes 9-16) samples for days 1 and 3 post injuries, and a PCR negative control (lane 17).  
 
Lane 1 & 9: Ovine 2683, segment LVD1, day 1 
       
Lane 2 & 10: Ovine 2683, segment LCD, day 1 
  
Lane 3 & 11: Ovine 2676, segment LCD, day 1  
 
Lane 4 & 12: Ovine 2676, segment RVD1, day 1  
 
Lane 5 & 13: Ovine 2683, segment RVD2, day 3  
 
Lane 6 & 14: Ovine 2683, segment LC, day 3   
  
Lane 7 & 15: Ovine 2676, segment LC, day 3  
 
Lane 8 & 16: Ovine 2676, segment RVD2, day 3  
 
Lane 17 : PCR negative control 
 









(...cont) Agarose gel for a semi quantitative RT-PCR analysis for beta-tubulin  
Duplex RT-PCR products of TUBB and ATPase genes amplified from brushed (lanes 1-6) and 
unbrushed (lanes 7-12) samples at days 1, 3 and 7 post injury, and a PCR negative control (lane 17). 
 
 
Lane 1 & 7: Ovine 8038, segment RC, day 1 
       
Lane 2 & 8: Ovine 8039, segment RVD1, day 1 
  
Lane 3 & 9: Ovine 8038, segment LC, day 3  
 
Lane 4 & 10: Ovine 8039, segment LC, day 3  
 
Lane 5 & 11: Ovine 8038, segment RVD2, day 7  
 
Lane 6 & 12: Ovine 8039, segment LVD1, day 7  
  
Lane 13 & 14: Ovine 8038, segment RVD1, naive (duplicate)  
 
Lane 15 & 16: Ovine 8039, segment RC, naive (duplicate)  
 
Lane 17 : PCR negative control 
 













(cont…) Duplex RT-PCR products of beta-tubulin and ATPase genes amplified from brushed 
samples for days 7, 14, 21 and 28 post injuries.  
 
Lane 1: Ovine 2683, segment LVD2, day 7   
 
Lane 2: Ovine 2683, segment RC, day 7 
 
Lane 3: Ovine 2683, segment LVD1, day 14 
 
Lane 4: Ovine 2683, segment RA, day 14 
 
Lane 5: Ovine 2676, segment LVD2, day 21 
 
Lane 6: Ovine 2676, segment RC, day 21 
 
Lane 7: Ovine 2676, segment LVD1, day 28 
 
Lane 8: Ovine 2676, segment RA, day 28 
 















(cont…) Duplex RT-PCR products of beta-tubulin and ATPase genes amplified from unbrushed 
samples for days 7, 14, 21 and 28 post injuries, and a PCR negative control (lane 12). 
 
Lane 1: Ovine 2683, segment LVD2, day 7   
 
Lane 2: Ovine 2683, segment RC, day 7 
 
Lane 3: Ovine 2683, segment LVD1, day 14 
 
Lane 4: Ovine 2683, segment RA, day 14 
 
Lane 5: Ovine 2676, segment LVD2, day 21 
 
Lane 6: Ovine 2676, segment RC, day 21 
 
Lane 7: Ovine 2676, segment LVD1, day 28 
 
Lane 8: Ovine 2676, segment RA, day 28 
 
Lane 9: Ovine 2683, segment RCD, naïve (d14) 
 
Lane 10: Ovine 2683, segment RCD, naïve (d28) 
 
Lane 11: 1kb DNA ladder 
 










Figure 3.9(b): Graphs depicting the expression patterns of beta-tubulin between 1 and 28 days after injury. Graphs were plotted based on the fold change of the treated 
airways (brushed and unbrushed) relative to their respective naive airway (left panel) and based on the mean values (±SD). The expression level in brushed areas 
appeared to exceed those in unbrushed areas over the initial phase of repair (right panel) whilst and the individual value plots (right panel) indicated the considerable 
variability within and between sheep (left panel). 
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Considering the variation in expression patterns observed between samples, from 
different segments and/or sheep, but representing the same treatment condition, 
effort was directed towards establishing whether variable ATPase expression might 
contribute towards this phenomenon. The densitometry values for ATPase for each 
sample were plotted and (Figure 3.10) shows the expression profiles of ATPase gene 
for the beta-catenin and keratin 5 genes graphed according to the time points. 
Marked variation of ATPase expression levels were observed over the time course 
and these changes were not consistently reflected amongst samples deemed 
equivalent (Figure 3.10). Some of this variation may arise during PCR preparation. 
Indeed, with some of the genes being prepared using a singleplex PCR (in which 
ATPase and the genes of interest were prepared separately), variation might have 
occurred during preparation of the master mix i.e pipetting errors - especially in 
relation to the amount of template, primers and magnesium concentration. 
 
 
Figure 3.10: Scatter plots demonstrating the expression of ATPase throughout the time of injury 










3.5  DISCUSSION  
As discussed in the previous chapter a large animal model has been developed that 
allows us to investigate the mechanisms of repair and regeneration of the airway 
following bronchial brushing. The studies presented in the present chapter were 
designed to build on the preliminary studies (Chapter 2) in order to assess the 
changes in expression of certain candidate genes, the expression of which are 
acknowledged to relate to cellular regeneration (basal and ciliated cells in particular) 
in the early and late processes of tissue repair. As discussed in the previous chapter, 
one limitation of the model is the lack of specific antibodies to identify and localise 
specific cell types that respond to airway injury.  
 
This study adopted a molecular strategy to study the expression profiles associated 
with the regeneration and repair process following bronchial brushing. Although the 
ovine genome has not been completely sequenced, there is a substantial amount of 
ovine sequence information available in databases such as DFCI, EMBL-EBI and 
GenBank (although often as unclassified EST sequences). Therefore, the 
identification and classification of gene annotations rely on conventional 
bioinformatics analysis such as blasting through the databases with sequence from 
the other species (such as bovine, human and mouse). Thus, sequence alignment 
analysis was used to demonstrate the areas conserved between species. Resulting 
ovine sequences were checked for sequence similarity using GenBank.  
 
The designed primers for the genes of interest used in this study were thus based on 
sequences conserved between species. Therefore the amplified PCR products were 
cloned and sequenced to confirm that the target sequence showed similarity to the 
sequence from which the primers were designed. The ovine sequences of these genes 
have now been made available via the network data servers of GenBank which are 
also available to EMBL in Europe and the DNA Data Bank of Japan for wider 
reference. It is not surprising to note that these gene (except keratin 14) sequences 
most closely resemble the bovine equivalents with similarity as high as 98%. 
For keratin 14, the sequence analysis revealed that the PCR product demonstrated 
95% similarity with the bovine EST sequence for keratin 14, 92% similarity with 
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human mRNA KRT14 sequence and 90% similarity with mouse KRT14 mRNA 
sequence. However, as the sequence demonstrated greater similarity with bovine 
keratin 17 the question arose as to whether these primers did indeed amplify the 
keratin 14 gene. Initial analysis to check the specificity of the primers showed that, 
both forward and reverse primer sequences were 100% similar to many bovine 
keratin genes such as KRT42, KRT17, KRT15 and KRT13. However, whilst both 
primers (forward and reverse) showed 100% similarity to bovine (NM_001166575.1) 
keratin 14 and the reverse primer was 100% similar to human (NM_000526.4) 
keratin 14 gene, the forward primer was only 95% similar to the human gene. 
Therefore, the possibility exists that this amplified sequence belongs to other types of 
keratin genes. Indeed analysis suggests that the designed primers would be expected 
to amplify PCR products of the same size for other types of keratin genes – including 
keratins 10, 13, 15, 17 and 42. However, alignment analysis (Appendix 3.1 and 
Appendix 3.2) shows that the sequence for amplified “KRT14” gene was highly 
similar to 13, 15, 17 and 42 (except keratin 10 – repeat sequence alignment was 
performed with keratin 10 excluded) in terms of the similarity of both forward and 
reverse primers. It is appreciated that further analysis is required in order to confirm 
the reliability of this sequence in representing the keratin 14 gene and until such time 
it is not possible to comment on the expression of keratin 14 with any confidence in 
this model. 
 
Cytokeratin belongs to a group of protein known as intermediate filaments. Six 
groups of intermediate filaments exist based on their cellular origin and they form the 
cytoskeletal structure in all cells. These groups are acidic cytokeratins, basic 
cytokeratins, vimentin, neurofilaments (neurons), nuclear laminin (nuclear lamina) 
and nestin (stem cells). Cytokeratins are classified according to mass: low weight 
(acidic type 1 cytokeratins) and high weight (basic or neutral type II cytokeratins). In 
the context of possible alternative keratin genes amplified in our study, KRT10, 
KRT13 and KRT17 are considered low weight molecules which group with the 
KRT14 gene. In terms of epithelial cytokeratin expression: K10 is expressed in 
keratinized squamous epithelium, K13 is expressed in intermediate and superficial 
cells of non-keratinized mucosal stratified squamous epithelium, and KRT5, KRT14 
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and K17 are expressed in stratified epithelium. Therefore, although the identity of the 
amplified sequence in this study could not be accurately defined, the amplified 
product(s) still likely reflect genes that play a role in basal cell differentiation and 
may thus be relevant in the context of indicating potential involvement of basal cells 
in airway injury and repair. 
 
In the present study, semi-quantitative RT-PCR assays were developed to investigate 
the expression profiles of the beta-catenin, beta-tubulin, keratins 5 and 14, and FoxJ1 
genes in the airway wall following physical injury. Although limited numbers of 
sheep were used, qualitative appraisal suggested that the selected genes may be 
involved in regeneration and repair of the airway following bronchial brushing 
injury.  
 
In our study using BrdU to label proliferative cells we observed increased  
proliferative activity at day 1 which reached a peak at day 3 when compared to the 
naïve and unbrushed airways (Chapter 2, Section 2.4.2.1). Histopathologically, at 
these time points there were some areas where the mucosa was still denuded at the 
brushed sites. From a molecular point of view, of the genes examined, only keratin 5 
and beta tubulin showed a trend towards increased expression during the first 3 days 
post injury. Keratin 5 and keratin 14 are known as markers for basal cells (Boers JE 
et al., 1998, Voynow JA et al., 2005), and our finding of increased expression in 
brushed vs unbrushed sites suggests that these genes may play a role at a time when 
basal cells might be expected to contribute to the repair process. In cystic fibrosis 
airways cytokeratin 5/14 expression was found to be restricted to basal cells and to 
zones of hyperplasia (LeSimple P et al., 2007). 
 
A rapid migration of basal cells at the area of damage is thought to be an important 
aspect of airway regeneration and repair. The histopathological and molecular 
aspects of this study support the hypothesis that basal-like cells might be involved in 
early migration and proliferation and may ultimately give rise to new differentiated 
cells. While basal cells may give rise to the other cell types, such as the ciliated cell 
(Hong KU et al., 2004b, Hong KU et al., 2004a, Voynow JA et al., 2005), there is 
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also speculation that cells residing close to the sub mucosal glands (Engelhardt JF, 
2001), and cells from the blood (Abe S et al., 2004) may migrate and differentiate to 
become specialised epithelial cells.  
 
In addition, it has been shown that basal cells often remain in the injured region of 
the wounded airway (Lane BP and Gordon R, 1974, Rennard SI et al., 1991), and 
release fibronectin which can serve as a chemoattractant for other airway epithelial 
cells to migrate to the area of injury (Rennard SI et al., 1991). In a study by Hong 
KU et al., (2004b) which investigated the hypothesis that basal cells represent a 
multipotent progenitor cell type for renewal of the injured tracheal epithelium of 
mice exposed to naphthalene, it was demonstrated that the injury resulted in a rapid 
induction of cytokeratin 14 expression among the majority of Griffonia simplicifolia 
I (GS1)-B4-reactive cells. Restoration of depleted secretory cells occurred after 6 
days of recovery and was associated with regression of the basal cell hyperplasia, 
suggesting that these basal cells have the capacity for restoration of a fully 
differentiated epithelium (Hong KU et al., 2004b).  
 
Patterns of beta-catenin gene expression in the first 3 days post injury suggested that 
there was a trend towards a high expression of beta catenin in both brushed and 
unbrushed areas. This finding was in agreement with the finding reported in mice 
that were subjected to bronchiolar injury with naphthalene (Park KS et al., 2006). 
Both nuclear and cytoplasmic staining for beta-catenin was markedly increased as 
early as 24 to 48 hours post injury in the squamous and cuboidal cells lining the 
bronchioles (in the normal adult lung, beta-catenin is expressed on the cell membrane 
and is rarely observed in the nuclei of the airway epithelial cells) (Park KS et al., 
2006). Protein expression was decreased (below normal) at four days post injury, and 
thereafter restored to the pattern seen in the normal lung. This study demonstrated 
that beta-catenin gene was able to translocate to the nucleus, and suggested that it 
may be associated with the activation of the transcriptional genes that are required 





Previous studies have suggested that beta-catenin plays a major role during lung 
development (Mucenski ML et al., 2003, Mucenski ML et al., 2005, Li C et al., 
2002, De Langhe SP and Reynolds SD, 2008), however it is unclear whether this 
gene product plays a role in maintaining and regulating adult lung stem and/or 
progenitor cells (Stripp BR and Reynolds SD, 2008). It is likely that many signalling 
pathways interact to mediate normal regulation of the proliferative and 
differentiation responses of a tissue stem cell and roles for these signals in regulation 
of the reparative characteristics of different organs are likely to be highly tissue 
specific (Stripp BR and Reynolds SD, 2008). However, Reynolds SD et al., (2008) 
suggested that beta-catenin signalling functions primarily as a negative regulator of 
bronchiolar cell differentiation and attenuation of beta-catenin signalling during the 
late prenatal/early postnatal period promotes establishment of the bronchiolar stem 
cell hierarchy by promoting transit-amplifying cell (TAC) differentiation (Reynolds 
SD et al., 2008). 
 
The expression of beta-tubulin and FoxJ1 genes were reported to be associated with 
the regeneration of ciliated cells in lung development and repair (Park KS et al., 
2006). This is the first study to generate an ovine mRNA sequence for the FoxJ1 
gene. Preliminary findings presented here suggest that expression of this gene 
changed according to the stage of the repair process. An  in vitro study  by You Y et 
al., (2004)  with a primary air-liquid interface (ALI) culture model of wild-type 
mouse airway epithelial cells, indicated that FoxJ1 expression was present at day 2 of 
culture (in relatively undifferentiated cells) before the appearance of cilia and 
expression of beta-tubulin 1V on the cell surface. In contrast, apical beta-tubulin IV 
expression was not observed in the FoxJ1 null cells maintained under identical 
culture conditions, indicating a requirement for FoxJ1 for ciliogenesis (You Y et al., 
2004). 
 
Although there were similar patterns of expression between brushed and unbrushed 
areas, the expression of beta-tubulin at brushed sites exceeded that seen in unbrushed 
sites from days 1 to 14 following bronchial brushing. The pathophysiological 
changes observed on the tissue sections at days 7 and 14 post injury (Chapter 2) 
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suggest that the injury site is mostly covered with regenerated epithelial cells. 
However some areas of this epithelial layer were still not fully differentiated and a 
lack of ciliated cells was observed. Since the repair process involves migration and 
differentiation of the regenerated epithelium towards the central area of the injury, 
some areas (transitional areas) had partially or even fully differentiated epithelium at 
the earlier time points (days 1 to 3), thus it is possible that the expression of beta-
tubulin and FoxJ1 is associated with epithelial cell differentiation in giving rise to 
ciliated cells at these areas in the initial stages of repair. Therefore, it could be that 
the variation in terms of the expression profiles observed results from the lack of a 
coordinated change in expression across the entire injury site.  
 
The results of this study neither permit elucidation of the role of beta-tubulin and 
FoxJ1 during regeneration of the ciliated cells nor indicate how they cooperate. A 
study by Blatt EN et al., (1999) in embryonic mouse lung development revealed that 
HFH-4 (FoxJ1) protein expression is restricted to ciliated cells and temporally related 
to ciliogenesis. Characterization of the expression of this gene in developing organs 
suggests that FoxJ1 plays a role in regulation of the genes important for epithelial cell 
differentiation and ciliogenesis (Blatt EN et al., 1999 ). Taken together, it is likely 
that activated FoxJ1 is important in providing a foundation for the beta-tubulin gene 
to be expressed by fully differentiated, ciliated cells in a repaired epithelium.  
 
Although this preliminary study used a limited number of sheep, the expression 
profiles of those genes observed in this study provide hints on how those genes 
responded to the injury and repair. However, there are obvious limitations in using 
this type of semi-quantitative RT-PCR technique to quantify the expression of the 
candidate genes. The technique provides less accurate quantification when compared 
to the probe-based assays developed for real-time PCR techniques. In addition, the 
evaluation of changes at the molecular level does not allow the identification and 
location of cell types that express their protein products. The ability to identify the 
locations and types of cells expressing the specific protein-markers would be 




Another limitation in this study is the low RNA concentrations isolated from the 
cartilaginous airway tissue samples. The quality measurement of the RNA used in 
this study relied on spectrophotometric absorbance (A260/A280 ratios). We found that, 
although all of RNA samples used in this study generated acceptable A260/A280 and 
A260/A230 ratios, there was still variation observed in terms of the RNA 
concentrations. Although the initial amounts of RNA used in the cDNA synthesis 
and the amounts of cDNA used in the PCR amplification were kept as consistent as 
possible, the observed variation in the ATPase gene PCR products was still a concern 
since the expression level of the gene of interest was normalised according to the 
ATPase gene. The variation in the expression profiles of the studied genes observed 
in this study might be partly due to unexpected and unexplained variation in the 
expression of the housekeeping gene (Figure 3.10).  
 
In this preliminary study, the expression patterns of the genes seem to suggest that 
there are time dependent changes in expression of some of these genes following 
injury to the ovine airway epithelium. Limitation with respect to experimental design 
(n=4) preclude definitive statements in this regard and highlight the need to extend 
the scope of these investigations towards a more involved protocol wherein the 
















3.6  CONCLUSION OF THE CHAPTER  
Semi-quantitative RT-PCR assays were developed to evaluate the expression profiles 
of the ovine beta-catenin, beta-tubulin, keratins 5 and 14, and FoxJ1 genes in airway 
epithelium following bronchial brushing to assess whether some of the genes 
reported to be involved in the repair process in other species may also be involved in 
the sheep. Despite the limited number of sheep used this study, the information 
obtained in terms of the expression profiles of the studied genes suggests that these 
genes may be involved in the repair of the airway.  
 
The limitations of this study in terms of sheep numbers and the accuracy and 
reproducibility the PCR assays led us to the conclusion that candidate gene 
approaches in this context are naturally limited by the scope of selection, and as such 
benefit would accrue from taking advantage of a more comprehensive approach to 
transcriptional analysis in order to broaden our understanding of the fundamental 
mechanisms involved. The availability of an ovine array for microarray analysis 
[(ovine oligo array (15k), Agilent Technologies, UK)] gives the opportunity to screen 
the expression of 15000 probe targets in order to identify lists of the genes 
significantly regulated during the course of repair. The application of such 
technology requires high quality RNA samples for reproducibility and reliability of 
the data. As the RNA isolation technique is considered crucial to ensuring adequate 
RNA quality and integrity for such microarray analysis we considered it appropriate 
to give due regard to optimising this process in the context of samples derived from 





4. CHAPTER 4 
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4.1  INTRODUCTION 
The airway epithelium is a pseudostratified layer consisting of specialised cell types 
that play a key role in defence and protecting the respiratory tract by combating 
inhaled toxicants and pathogens. The ability of the airway to respond to injury varies 
depending on the type of injury. In the case of asthma and COPD, repeat exposure of 
the airway epithelium to injury leads to remodelling of the airway tissue with 
potential impact on its role as a unique barrier against external damaging agent. 
Following extensive injury resulting in epithelial denudation the repair process not 
only involves regeneration of a new epithelial cell layer to cover the denuded area 
but also involves subsequent proliferation and differentiation to reconstitute a fully 
differentiated epithelium.  
 
The process of cellular migration to cover the denuded area involves initial 
dedifferentiation of epithelial cells bordering the lesion. Such dedifferentiation 
reflects the need to revert to cell types with the capacity to migrate and form 
interactions or communication with other cells in order to progress airway repair 
(Evans MJ et al., 1990, Evans MJ et al., 1989, Evans MJ and Plopper CG, 1988). 
Such interaction and communication involves specific molecules which in turn 
controls the whole process of the repair. Effective and complete repair can thus be 
seen as a well coordinated and balanced series of events which likely show 
significant interdependence at several levels.  
 
Amongst these events, cellular proliferation and re-differentiation are critical aspects 
and reflect the need for cells to ‘sense’ their environment such that their fate is 
appropriate in the context of repair. Such fate may involve differentiation to 
specialised cell types, cell repair, or cell death. The mechanisms involved during 
repair following injury include interaction between aspects of the inflammatory 
response, activation of innate immunity, migration, apoptosis, activation of signal 





During the development of this thesis, preliminary studies had been carried out 
which involved studies directed towards understanding the pathophysiological and 
molecular aspects of airway repair (Chapters 2 and 3, respectively). Appreciating that 
conclusions derived from such initial experiments were necessarily limited as a 
consequence of the relatively few sheep involved and the pre-defined nature of the 
molecular analyses it was considered appropriate to direct attention towards 
designing a more robust experimental approach to realise the objective of 
characterising the cellular and molecular changes associated with airway 
regeneration and repair. With proliferation being a key aspect of repair and resolution 
following injury we sought to characterise this aspect of the response using Ki67 
labelling. The advantage of using Ki67 as a proliferative cell marker is that it can 
label cells at all of the cell cycle phases (other than resting phase (G0) and thus will 
potentially label all cells that are involved in proliferative activity. Additionally, with 
potential roles identified for mucus and/or secretory cells in contributing to the early 
steps of dedifferentiation and migration following injury (Keenan KP et al., 1982a, 
Keenan KP et al., 1982b, Keenan KP et al., 1982c, Lane BP and Gordon R, 1974, 
McDowell EM et al., 1979) and a stem cell niche described adjacent to the ducts of 
mucus-producing sub mucosal glands (Borthwick DW et al., 2001), we sought to 
determine whether there was any evidence for co-association between mucus-
producing cells and Ki67-positive cells in the sheep airway following injury. 
 
Therefore, in order to improve our understanding of the airway and cellular changes 
during epithelium repair as described in the Chapter 2, the study in this chapter was 
designed to give more comprehensive understanding of the pathophysiological 
changes of the airway during repair in response to bronchial brushing. More focus 
was directed towards the early processes of epithelial cell dedifferentiation, 
migration, proliferation and re-differentiation in order to confirm our preliminary 
findings as described in the Chapter 2. This would represent the first attempt to use 
bronchial brushing as a tool to induce airway epithelial perturbation in healthy sheep 
in order to understand the mechanisms involved in airway epithelial regeneration and 




4.2  OBJECTIVES 
The aims of this chapter are: 
1. To confirm histopathological changes associated with repair following 
bronchial brushing injury 
2. To investigate the time course of proliferation and repair activities following 
lung injury using Ki67 as a proliferative marker. 
3. To investigate the effect of bronchial brushing on the extent and distribution 
of airway wall tissue components and mucus-producing cells during the time 
course of the study and to relate any changes to concomitant cell proliferative 
activity using Ki67 as a marker. 
 
4.3  MATERIALS AND METHODS 
4.3.1 Experimental design 
Eight sheep (n=8) [(breed = Suffolk Cross), (sex; Male = 4, Female = 4), (Age; 
means = 14.75 ± 0.45 months old), (bodyweight; means = 54.5 ± 3.74 kg)] were 
involved. Lung health was ascribed on the basis of bronchoscopic examination 
undertaken approximately 2 weeks (14.8 ± 6.2 days) prior to entry into the described 
experimental protocol. Such visual examination, in determining the absence of 
airway disease, was later confirmed by necropsy examination at gross and light 
microscopic levels. Bronchial brushings were performed on anaesthetised sheep as 
previously reported (Chapter 2; Sections 2.3.3, 2.3.4 (exclude BrdU administration) 
and 2.3.5) at predefined sites (approximately 15mm x 4mm located on the ventral 
aspect of each airway) within the major airways at staged time-points 6 hours, 1 day, 
3 days and 7 days prior to euthanasia. Selection of these time points was based on 
our preliminary study (Chapter 2) which suggested that the major aspects of 
dedifferentiation, migration, proliferation and re-differentiation occur during this 
period. 
 
Each sheep was subjected to a protocol which involved bronchial brushing on three 
occasions and two separate sites on each occasion were brushed at each time point so 
that changes at the histology level could be correlated with associated gene 
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expression profiles. Four different protocols were used and identified as 316, 716, 
731 and 736 (Table 4.1) with two sheep assigned to each protocol. This number 
identifies the combination of time points for brushings in the respective sheep 
assigned to the protocol (i.e 316 corresponds to 3 days, 1 day and 6 hours). In this 
study, two naïve sites (from segments not subjected to any brushing procedure) were 
collected from each sheep for both histopathological analysis and subsequent RNA 
extraction for microarray profiling (n=8 of naive control). In addition to comparison 
with unbrushed naïve sites, the undamaged areas opposite the brushed sites were 




Protocol  731 316 736 716 731 316 736 716 
Sheep 8039 45 8064 7958 8038 8003 7954 8020 
Segment -7d -3d -1d -3d -1d -6h -7d -3d -6h -7d -1d -6h -7d -3d -1d -3d -1d -6h -7d -3d -6h -7d -1d -6h 
RC       BBr       BBr             BBr     BBr     BBr   BBr   
LC   BBr     BBr         BBr     BBr        BBr      BBr   
RVD1    BBr    BBr         BBr           BBr  BBr       BBr 
LVD1 BBr            BBr      BBr   BBr   BBr      BBr       
RVD2    BBr   BBr   BBr    BBr    BBr               BBr    
LVD2   BBr      BBr    BBr          BBr BBr         BBr    
RCD BBr          BBr       BBr BBr       BBr   BBr         
LCD       BBr         BBr   BBr           BBr    BBr       BBr 
 
Table 4.1: Table indicating the combination of brushing protocols applied in the present study.  
Each sheep was subjected to a protocol which involved BBr on three occasions with two separate sites being brushed on each occasion. Sheep were assigned to one of four different possible 
combinations of times used for BBr prior to necropsy. Such protocols were identified as 316, 716,  731 and 736 with two sheep assigned to each protocol. This number identifies the combination 
of time points for BBr in the respective sheep assigned to the protocol. Grey-coloured boxes on each sheep indicate which segments were used as naïve controls areas in each lung. (-) prior to post 
mortem, d = day, h = hour 
* BBr = collected for histology and BBr = collected for microarray; grey-boxed with lines indicate the naive segment allocated for histology experiment
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4.3.2 Tissue samples and processing 
At post mortem, the lung segments were carefully mapped and dissected out to 
identify the injured sites, and the segments allocated for microarray and 
histopathology experiments were separated. The tissues used for histological analysis 
were fixed with 10% neutral buffered formalin for 12 hours before being dehydrated 
in alcohol and embedded in paraffin.  
 
4.3.3 Analysis of pathophysiological changes of the airways and IHC 
Individual airway sections from each location were subjected to the following: 1) 
Standard HE staining; 2) IHC for Ki67 followed the procedure described for BrdU 
incorporation (Chapter 2; Section 2.3.6.2). Mouse monoclonal anti human Ki-67 
(clone MM1) (Novocastra, UK) was used at a dilution of 1:100. 3) Combined AB-
PAS stain as previously described (Chapter 2; Section 2.3.7). 
 
4.3.3.1 Morphometric analysis 
4.3.3.1.1 HE and Ki67 staining 
The protocol for morphometric analysis of the tissues stained with HE and anti-Ki67 
antibody was similar to that described for the group of sheep used in the study 
discussed in the Chapter 2 (Sections 2.3.8 and 2.3.8.1). However, additional 
components were added to the morphometric analysis of Ki67 staining. First, unlike 
morphometric analysis in the Chapter 2, in this study, submucosal gland tissue was 
also subjected to morphometric analyses on HE-stained section and IHC for Ki67 
staining.  Second, to compare the distribution of Ki67-positive cells on each tissue 
category, the number of positive cells residing in each tissue category was counted in 
addition to counting the number of points landing on each tissue type. Therefore, the 
proportion of Ki67-positive cells residing in each tissue category was measured.  
 
4.3.3.1.2 AB-PAS staining 
The principles underlying the morphometric analysis of AB-PAS staining was 
similar to that described for BrdU and Ki67 staining. The areas of interest were 
defined as before - damaged, transitional and undamaged. Only two tissue categories 
are associated with mucus producing cells – the epithelium contains goblet cells and 
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the glands contain serous cells. The number of AB-PAS positive cells on these 
tissues was estimated by counting the number of grid points landing on these cell 
types for each tissue category. In the mucosal compartment counts were obtained for 
epithelium and gland tissue whereas in the submucosal compartment only gland 
tissue was involved.  
 
4.3.3.1.3 Statistical analysis 
In these analyses (HE, AB-PAS and Ki67 staining), the sheep’s identity (SheepID) 
was used as a random effect in order to control for any pseudoreplication, and to 
minimise the noise associated with variation between observations and/or 
measurements on the same sheep (see Chapter 2; Section 2.3.8.2). In order to assess 
the distribution of Ki67-positive cells between compartments, areas of interest and 
time points, a model with Poisson error was used whilst to assess the proportion of 
positive cells on each tissue category, the proportion was estimated by dividing the 
number of positive cells on the tissue measured with the number of points falling on 
that particular tissue (binomial error). A similar approach of binomial data was used 
to estimate the AB-PAS stained cells. By using the number of grid points falling on 
the tissues measured on the morphometric analysis for Ki67 staining, one could 
estimate the effect of the brushing procedure on the proportion of epithelial, 
glandular, smooth muscle and vascular tissue.  
 
The data was analysed using the freely available statistical software environment R 
(The R Foundation, Software version 2.9.0, Vienna, Austria). In all cases, a p<0.05 
were considered statistically significant.  
 
4.4  RESULTS 
4.4.1 Analysis of the histopathology of the airway  
4.4.2 Model validation 
Generalised linear mixed model (family binomial) ANOVA was applied to 
quantitative morphometric data obtained from HE-stained sections of undamaged 
sites in order to determine that airways selected from different lung segments shared 
similar structural morphology (see Chapter 2; Section  2.4.1.1). The right cranial 
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(RC) segment was used as a reference level. The results of this analysis indicated that 
in this model, with sheep identity included as a random effect and segment RC as a 
reference level, airway tissues from different segments did not differ significantly in 
their structural morphology (p>0.05) – (Figure 4.1). The details of the R ouputs are 
shown in the Supplement 3 on CD. In order to correlate the original data points 
plotted for the graph in the Figure 4.1 in terms of how the segments been selected for 
BBr, the Table 4.2 shows the numbers of each segment subjected to BBr.  
 
 









Table 4.2: Table shows the segments and the numbers of times they have been selected for 




























































































































Figure 4.1: Box plots depicting the proportion of different tissue types found in the walls of 
undamaged airways derived from different lung segments  
Plots illustrate the proportions of each tissue type lying within mucosal and submucosal 
compartments. There are no significant differences between segments (p>0.05). Symbols represent 
proportion data number of points landing on tissues for each segment measured. The numbers of 
points for each segment indicate the number of that particular segment subjected to histology 
experiment from different sheep i.e for RC segment, there are 8 airway sections of RC subjected to 
histology including the naive airway (Table 4.2) whilst only one sample from each of LVD2 and RCD 
was used for histology. Upper and lower box plot margins represent the interquartile range; middle bar 




4.4.3 The effect of bronchial brushing on the relative proportion of airway 
tissues  
Analysis by time point (areas of interest combined) showed that in brushed regions 
there was a significant decrease in the proportion of epithelium in the airway at early 
time points following injury (6 hours (mean proportion=0.103); p=0.017), day 1 
(mean proportion= 0.110); p=0.029) but no significant difference at days 3 (p=0.939) 
and 7 (p=0.307) when compared to the naive (mean proportion=0.204) sites (mean 
proportion for both 0.2 and 0.2690, respectively) – (Figure 4.2; top left panel). If the 
analysis is done by area of interest (time points combined), then overall the damaged 
(mean proportion=0.053) sites have significantly less epithelium (p=0.000) than 
undamaged (mean proportion=0.224) but there was no significant difference between 
transitional (mean proportion=0.179) and undamaged (p=0.056).  
 
Analysis by time point (areas of interest combined) demonstrated no significant 
effect of the brushing on the proportion of blood vessels at any of the time points (6 
hours p=0.423 (mean proportion=0.089); day 1 p=0.671 (mean proportion=0.072); 
day 3 p=0.066 (mean proportion=0.105) and day 7 p=0.953 (mean proportion=0.077) 
as compared to time point 0 (mean proportion=0.078). If the analysis was completed 
according to area of interest (time points combined) the damaged area had 
significantly more blood vessels compared to the undamaged (p=0.0255) but not the 
transitional area (p=0.4737) – (Figure 4.2; top right panel) (mean proportion for 
damaged, transitional and undamaged were 0.097, 0.083 and 0.077, respectively). 
There was no effect of the brushing on the proportion of the gland structures in 
submucosal compartments (6 hour p =0.647 (mean proportion=0.089); day 1 
p=0.134 (mean proportion=0.155); day 3 p=0.164 (mean proportion=0.151) and day 
7 p=0.548 (mean proportion=0.122)) in all time points as compared to time point 0 
(mean proportion=0.102) and in all three areas of interest (damaged p=0.837 (means 
proportion=0.113) and transitional p=0.225 (mean proportion=0.142)) – (Figure 4.2; 
bottom left panel) as compared to undamaged (mean proportion=0.117). The 
brushing had a significant effect on the proportion of smooth muscle at all time 
points in which less smooth muscle tissues were found at 6 hours (p= 0.0060; mean 
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proportion=0.202), day 1 (p=0.0123; mean proportion=0.214) and day 3 (p= 0.0199; 
mean proportion=0.222) following injury other than day 7 (p= 0.9306; mean 
proportion=0.346) as compared to the time point 0 (mean proportion=0.352). There 
was a significant reduction in proportion of the smooth muscle tissues in damaged 
(p=0.0026; mean proportion=0.203) and transitional (p=0.02; mean 
proportion=0.234) areas when compared to the undamaged area (mean 
proportion=0.312) – (Figure 4.2; bottom right panel). The details of the R outputs are 







Figure 4.2: The effect of bronchial brushing on the airway tissues 
Boxplots illustrate the proportions of the individual tissue category measured either by time points or 
by areas of interest. Y-axis shows proportion of tissues, and X-axis shows the time points or areas of 
interest. Symbols represent proportion data number of points landing on tissues for each area 
measured. Upper and lower box plot margins represent the interquartile range; middle bar indicates 
the median. The points outside the ends of the whiskers are outliers. There is a significant loss 
(p<0.05) of epithelium structure affected by the brushing in 6 hours and day 1 following injury as 
compared to the time point 0 and there is a significant different (p<0.05) in the proportion of the 
epithelial tissue in damaged area compared to the undamaged (top and left panel). There is no 
significant effect on the proportion of the blood vessels in any times of injury as compared to the time 
point 0 (p>0.05) and the proportion of the blood vessels is higher in the damaged area as compared to 
the undamaged (p<0.05)  – top right panel. Brushing showed no significant effect on the submucosal 
gland structure at any time points following injury as well as to the areas of interest (p>0.05) – bottom 
left panel. There is less smooth muscle tissues at 6 hours, days 1 and 3 post injury as compared to the 
time point 0 as affected by the brushing as well as in the damaged and transitional areas as compared 
to the undamaged (p<0.05) – bottom right panel.  
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4.4.4 Morphology of the airway following a bronchial brushing 
One control site from a naïve segment and injured sites from three other segments 
per sheep (n=8 sheep) had been dissected out for analysis similar to that described in 
Chapter 2. The brushing procedure disrupted the morphology of the mucosal area 
including the basement membrane as previously described in the Chapter 2. 
Generally, the histopathological changes of the airways from 6 hours to day 7 
following bronchial brushing were similar to those described in Chapter 2 (Section 
2.4.1.2). Similarly, the injury extended to smooth muscle tissue in the submucosal 
compartment. However, the submucosal gland tissue was not affected by the 
brushing (see Section 4.4.3 in this chapter). At the damaged area at 6 hours post-
injury (Chapter 2; Figure 2.7), there was generally no epithelium remaining with the 
exception of a single layer of cells in places which may be the first signs of 
regeneration of the epithelial layer. In HE-stained sections from six hours post injury, 
the denuded area adjacent to the remaining epithelium was partially covered with 
squamous epithelial cells. This single layer of cells bordering the lesion is likely to 
be migrating de-differentiated cells derived from the epithelium bordering the lesion 
which are involved in the ongoing process of repair. This dedifferentiation process at 
the marginal areas of the damaged site was clearly seen on sections stained with the 
AB-PAS staining at this time point (see Section 4.4.6 of this chapter). The number 
and morphology of the goblet cells were changed dramatically following brushing as 
compared to the undamaged epithelium and in the very few remaining goblet cells, 
PAS staining was observed at the apex of the cells (see Section 4.4.6 of this chapter). 
 
At day 1 post injury (Chapter 2; Figure 2.8), the flattened cells were extending 
towards the centre of the damaged area. Some of the peripheral damaged areas were 
covered with new epithelium at the transitional area and some ciliated cells were 
occasionally observed. However, the basement membrane was still absent in central 
areas of the lesion. The lesion area became smaller compared to that seen at 6 hours 
post injury and the size continued to reduce over the time of injury. Whilst AB-PAS 
staining was evident at the transitional area, there was more evidence of 
dedifferentiation of goblet cells/ciliated cells at the transition areas compared to 6 
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hours post injury (see Section 4.4.6 of this chapter). At day 3 post injury (Chapter 2; 
Figure 2.9), the entire mucosal injury site was covered with a stratified squamous 
epithelial layer, and in some areas there was still evidence of mucosal haemorrhage. 
This undifferentiated epithelial cell layer was thickened in places suggesting an 
epithelial hyperplasia. Few ciliated cells could be seen and although in some areas 
the numbers of AB-PAS staining cells had begun to increase, the overall number was 
still reduced compared to normal (see Section 4.4.6 of this chapter). The damaged 
area was also overlaid with what appeared to be a mucin-rich layer with a dense and 
compact accumulation of neutrophils held within and below the mucin - a 
phenomenon previously described in Chapter 2.  
 
At seven days post injury (Chapter 2; Figure 2.10) the epithelium at the brushing site 
appeared intact however the submucosa was thickened with granulation tissue and 
fibrosis. At this time point, the morphology of the epithelium had still not fully 
differentiated. The number of goblet cells in the repairing epithelium had increased 
compared to the day 3 but were still not back to normal levels (see Section 4.4.6 of 
this chapter). 
  
4.4.5 Ki67 to label proliferative cells  
In this study mouse anti-human Ki67 antibody was used to label proliferating cells in 
response to injury. In the airway sections Ki67-labelled cells were identified by IHC 
at the site of injury at all time points. Only a few Ki67-positive cells were observed 
in the undamaged area and these tended to reside at the basal area of the epithelium, 
blood vessels and submucosal glands (Figure 4.3 (a)). Sparsely scattered Ki67-
labelled cells were identified as early as six hours post-injury; in both the mucosa 
and submucosa, not only in the damaged areas but also in transitional and 
undamaged areas (Figure 4.3 (b)). There was however no significant difference 
(Mucosa p=0.8953 and Submucosa p=0.4160) at 6 hours compared to time point 0 
(naïve). Thereafter, the specific location and number of proliferating cells varied with 




In general, the distribution patterns of the Ki67-positive cells were similar to that 
seen in the BrdU-stained airway sections (Chapter 2) especially on the airway tissues 
such as epithelium, glands and blood vessels. However, there were more proliferative 
cells observed when sections were stained with anti-Ki67 compared to the BrdU - 
even in the airway sections at the later time point (day 7). At day 1 (Figure 4.3 (c)), 
Ki67-labelled cells were visible within the airway epithelium in clusters on both 
sides of the injury. The distribution of Ki67-positive cells extended to the area 
underneath the damaged epithelium in the mucosal and submucosal compartments, 
and especially in the regions of the submucosal glands (SMGs). At day 3 (Figure 4.3 
(d)), more Ki67-labelled cells were observed in the epithelium and SMGs compared 
to day 1 of injury. Although the extent of proliferation was higher compared to the 
undamaged, the number of positive cells at day 7 was reduced relative to day 3 post 
injury (Figure 4.3 (e)). Overall, with the exception of the 6 hours time point 
(p=0.455; means=7.193), in all time points (with areas of interest and compartments 
combined), there were significantly increased numbers of Ki67-positive cells present 
(day 1; p=0.000 (means=42.573), day 3; p=0.000 (means=42.137) and day 7; 
p=0.000 (means=48.550)) as compared to the time point 0 (means=4.635) (Figure 
4.4).   
 
The Table 4.3 shows the details of p-values generated for the distribution of Ki67-
positive cells on each areas of interest over the time of injury. When the distribution 
of Ki67-positive cells was compared between compartments (data for the areas of 
interest and the time points combined), the submucosal (geometric means=55.962) 
compartment had significantly less (p=0.0322) Ki67-positive cells as compared to 
the mucosal (geometric means=52.831) compartment (data not shown). To assess the 
distribution of Ki67-positive cells between the areas of interest (with the time points 
and compartments combined), significantly more Ki67-positive cells were found in 
the damaged (p=0.000; geometric means=94.148) and transitional (p=0.000; 
geometric means=81.014) areas as compared to the undamaged (geometric 
means=19.470) area (data not shown). The distributions of Ki67-positive cells were 
then compared between areas of interest and the time points for each compartment 
(Figure 4.5). As compared to the naïve airway (time point 0), there were significant 
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differences (p<0.05) in the Ki67-positive cell distribution at days 1, 3 and 7 (except 
day 1 in mucosal compartment) post injury (Table 4.3). In the transitional area, the 
distributions of Ki67-positive cells differed significantly (p<0.05) at days 1, 3 and 7 
post injury as compared to the naïve airway (Table 4.3). For the undamaged area 
there were significantly more Ki67-positive cells at days 1, 3 and 7 (p<0.05) in the 
mucosa whilst only at day 1 and 3 in the submucosal compartment (Table 4.3). In 
order to get better overview of the statistical analysis outputs generated for these 
morphometric analyses, the details of the geometric mean values are shown in the 
appendix.  
 
As described in the morphometric analysis section of the Methods, the numbers of 
Ki67-positive cells within different tissue categories were also counted involving the 
epithelium, glands, blood vessels and smooth muscle. For this analysis, a statistical 
model was created by using the number of Ki67-positive cells as the response 
variable, the time points and areas of interest (damaged, transitional and undamaged) 
used as factors and the total number of grids on each tissue category used as a 
covariate – by taking into account the effect of the size of the tissues on the number 
of Ki67-positive cells observed. For blood vessels, the data for both mucosal and 
submucosal compartments were combined whilst for the gland tissues only the 
glands in the submucosal compartment were involved in the analysis due to the fact 
that only a few glands were observed within the mucosal compartment. The analysis 
for the epithelium and smooth muscle was performed on the mucosal and 
submucosal compartments, respectively. In all tissue studied, there were significantly 
increased in the numbers of Ki67-positive cells within the tissue category for both 
damaged and transitional areas (p<0.05) as compared to the undamaged areas (with 
the time points combined). The details of p-values generated from the statistical 
analysis for the distribution of Ki67-positive cells over the time points on the tissues 
of interest are shown in the Table 4.4 and the details of their geometric means are 
shown in the appendix. The analyses were investigated further for each area of 




In the epithelium (Figure 4.6(A)), the number of Ki67-positive cells were increased 
significantly at days 1, 3 and 7 (p<0.05) compared to naïve, in both damaged and 
transitional areas. There was a small increase in the number of proliferating cells 
observed at day 1 in the undamaged area (p<0.05).   
 
Similarly, the number of Ki67-positive cells on gland tissues was increased (p<0.05) 
at days 1, 3 and 7 in the damaged area compared to the time point 0 (naïve) whilst in 
the transitional area, the number was significantly increased (p<0.05) only at days 1 
and 3. There was no significant different observed in the undamaged area at all time 
points (p>0.05) – (Figure 4.6(B)). 
 
In the blood vessels (Figure 4.6(C)), Ki67-positive cells were significantly increased 
(p<0.05) at days 1, 3 and 7 post injury compared to naïve not only in damaged and 
transitional areas but also in undamaged areas. At 6 hours, there was a significant 
increase in Ki67-positive cells in the transitional areas compared to time point 0 
(naive).   
 
In the smooth muscle (Figure 4.6(D)), the number of Ki67 positive cells was 
increased in the damaged area at days 3 and 7 post injury (p<0.05) but only at day 7 
(p<0.05) in the transitional area. There was no significant different in terms of the 
number of Ki67-positive cells between the time points in the undamaged area 
(p>0.05).  
 





Figure 4.3(a): Undamaged airway tissue section stained with Ki67 antibody 
A few numbers of Ki67-positive cells were observed in undamaged airway tissue sections. These cells 
were sparsely scattered along the basal area of the epithelium, and in association with glands and 




Figure 4.3 (b): Airway tissue section at 6 hours post injury stained with Ki67 antibody 
At this time point, the positive stained cells were sparsely scattered within the transitional area and 
also underneath the damaged area. The distribution of these cells at this time point was not 
significantly different (p>0.05) to that found in the undamaged area. The arrows head show the Ki67-





Figure 4.3(c): Airway tissue section at day 1 post injury stained with Ki67 antibody 
Whilst the damaged site showed a clear mucosal disruption, the proliferative activity of the cells at 
this time point was increased significantly in response to injury. These cells accumulated at both 
edges of the lesion as well as in the submucosal glands. Different intensities of Ki67 staining reflect 
different stages of the cell cycle phase.  
 
 
Figure 4.3(d): Airway tissue section at day 3 post injury stained with Ki67 antibody  
The number of Ki67-positive cells observed at this time point was increased relative to day 1 with 
similar features observed at both edges of the lesion. In some sections, the damaged area was covered 
with new epithelium and stained cells accumulated at this area. Proliferative activity is still active in 




Figure 4.3(e): Airway tissue section at day 7 post injury stained with Ki67 antibody  
Whilst most of the damaged site was covered with a new epithelial layer by day 7 proliferative 
activity could still be discerned, centred mainly underneath the new epithelial layer and on the smooth 
muscle in the submucosal compartment. The number of Ki67-positive cells was decreased relative to 
day 3 post injury especially on the epithelium and the submucosal glands.  











Figure 4.4: The number of Ki67-positive cells between time points with the data for areas of 
interest and compartments combined. 
Although there were proliferative cells observed as early as 6 hours post injury, these cells were not 
significantly different in number relative to the naïve airway (time point 0). Other time points showed 
a significant increase relative to numbers observed in naïve airways following injury. Upper and lower 
box plot margins represent the interquartile range; middle bar indicates the median. The graph was 
plotted based on the absolute number of cells stained with Ki67 antibody on each area measured. The 
















































































































   
  Table 4.3: Table shows the details of p-values generated for the distribution of Ki67-positive cells on each areas of interest over the time 






Figure 4.5: Boxplots of Ki67-positive cell distribution arranged to illustrate relationships between compartments (mucosal and submucosal), areas of interest 
(damaged, transitional and undamaged) and the times of injury.  
Upper and lower box plot margins represent the interquartile range; middle bar indicates the median. The graph was plotted based on the absolute number of cells 
stained with Ki67 antibody on each area measured. The points outside the ends of the whiskers are outliers. 
With the exception of the proliferative activity evident in the mucosa underlying the damaged area on day 1 and in the submucosa underlying the undamaged area on 
day 7, the number of proliferating cells increased significantly relative to numbers found in naïve airways from day 1 onwards. The details of the geometric mean 






DAMAGED TRANSITIONAL UNDAMAGED 
Time points (days) Time points (days) Time points (days) 
0.25 1 3 7 0.25 1 3 7 0.25 1 3 7 
EPITHELIUM 0.999 0.001 0.000 0.006 0.861 0.000 0.004 0.005 0.482 0.001 0.725 0.225 
BLOOD VESSELS 0.066 0.000 0.000 0.000 0.004 0.000 0.000 0.000 0.428 0.000 0.000 0.002 
GLANDS 0.625 0.000 0.001 0.004 0.835 0.004 0.009 0.071 0.659 0.084 0.135 0.256 
SMOOTH MUSCLE 0.925 0.464 0.042 0.000 0.968 0.552 0.055 0.025 0.830 0.195 0.683 0.797 
 
Table 4.4: Table shows the p-values for the statistical analysis for the number of Ki67-positive cells counted on epithelium, blood vessels, glands and smooth muscle 
for each areas of interest (damaged, transitional and undamaged) at the various time points following injury as compared to the time point 0. The details of its graph is 




















Figure 4.6: The distribution of the Ki67-positive cells on the tissue category.  
In all tissues, the number of proliferative cells was increased following injury with significantly higher 
proliferative activity at the damaged and transitional areas compared to the undamaged areas. Less 
proliferative activity was observed in the undamaged areas in all tissue types except the epithelium 
(A), submucosal gland (B), blood vessels (C) and smooth muscle (D). In a smooth muscle tissue 
shows the proliferative activity is taken place at later time points (day 3 onwards) whilst the 
epithelium and blood vessels show the numbers of proliferating cells increased significantly (p<0.05) 
in both damaged and transitional areas. In the submucosal glands tissue, cells are significantly active 
proliferate in both damaged and transitional areas. Upper and lower box plot margins represent the 
interquartile range; middle bar indicates the median. The graph was plotted based on the absolute 
number of cells stained with Ki67 antibody on each area measured. The points outside the ends of the 
whiskers are outliers. The details of the geometric mean values are shown in the Supplement 5 on CD.
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4.4.6 AB-PAS staining 
The effect of the brushing on the mucus-producing cells within the epithelium was 
similar to that described in the Chapter 2; Section 2.4.2.3. Two tissue categories 
contain mucus-producing cells, the epithelium (goblet cells) and the submucosal 
gland (serous cells). AB-PAS-positive cells were easily identified on the epithelium 
and glands of the normal airway (Figure 4.7 (a)). The number of PAS-positive cells 
in total was decreased in damaged and transitional areas as compared to the 
undamaged areas (p<0.05) in both tissues. The morphology of the mucus-producing 
cells (particularly the goblet cells (GC)) on the epithelium at the transitional area, 
changes significantly over the time of injury [(Figure 4.7 (b)) to (Figure 4.7(c))]. 
This cell was generally absent on the damaged epithelium and gradually began to 
reappear by 3 days post injury (Figure 4.7(d)). At day 7 post injury, greater numbers 
of GCs were observed at the damaged site although the morphology of these cells 
was dissimilar to that seen on the epithelium of the undamaged area (Figure 4.7 (e)) 
compared to the normal morpholopgy of the GCs as shown in the Figure 4.7(a).  
 
Table 4.5 shows the details of p-values generated from statistical analysis to measure 
the distribution of AB-PAS positive cells on the tissues of interest (epithelium and 
submucosal gland) over the various times following injury as compared to the time 
point 0. In the epithelium (Figure 4.8(A), as compared to the naive airway (time 
point 0), in the damaged and transitional areas, the number of PAS-positive stained 
cells was significantly reduced at all time points (p<0.05) following injury (except at 
days 3 and 7 in the transitional area) whilst in the undamaged area, the number of 
PAS-positive cells was significantly reduced at day 3 post injury (p<0.05). In the 
submucosal gland tissues (Figure 4.8(B), the number of cells stained with AB-PAS 
staining in both damaged and transitional areas was significantly less at 6 hours and 
day 1 post injury compared to naïve (time point 0). In the undamaged area, there was 
no significant difference observed in any time points as compared to naïve sites. The 





Figure 4.7(a): AB-PAS staining of an undamaged airway   
The figure illustrates the normal morphology of the goblet cells in the epithelium and serous cells in 
the SMGs (AB-PAS staining). (* SMG = submucosal gland; SM = smooth muscle) 
 
 
Figure 4.7(b): AB-PAS staining of an airway section at 6 hours post injury 
The figure illustrates the absence of GCs at the lesion site and the morphology of this cell at the 
transitional area is changed (picture insert) where PAS staining was found at the apex of the epithelial 







Figure 4.7(c): AB-PAS staining of an airway section at day 1 post injury  
At this time point a clearer dedifferentiation of the GCs at the transitional area can be observed 
(arrows) and intense PAS staining can be discerned at the submucosal glands (picture insert). At the 
damaged site, there was still evidence of mucosal loss at this time point and centrally within the 




Figure 4.7(d): AB-PAS staining of an airway section at day 3 post injury 
At the brushed site (right panel), there were some thickened areas of epithelial hyperplasia (insert) and 
the AB-PAS staining indicated that the goblet cell numbers increased compared to day 1 especially at 











Figure 4.7(e): AB-PAS staining of an airway section at day 7 post injury 
At this time point, the epithelium at the brushing site was intact and some areas were lined with 
stratified squamous epithelium (not depicted). The number of the goblet cells had increased at the 
damaged (A) area at this point in time and the majority of these newly regenerated PAS-positive 
stained epithelial cells showed morphology inconsistent with GCs (B – higher magnification of the 
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Table 4.5: Table shows the p-values for the statistical analysis for the number of AB-PAS -positive cells counted on epithelium and submucosal glands for each areas 
of interest (damaged, transitional and undamaged) at the various time points following injury as compared to the time point 0. The details of its graph is illustrated in 









Figure 4.8: The number of the PAS-positive stained cells within the epithelium and submucosal 
gland structures of the airway wall.  
The number of positive-stained cells on the epithelium in the damaged area was significantly reduced at 
all time points relative to numbers seen in naïve airways. A similar phenomenon was apparent in the 
transitional area (with the exception of the reduction at day 7 which was not significant), whilst only at 
day 1 was there a significant reduction in the numbers of PAS-positive cells within the undamaged area 
relative to naïve airways. In the submucosal gland tissue, the number of PAS-positive cells was 
significantly reduced in the damaged area relative to naïve airways at days 1 and 3 post injury. 
Significantly reduced numbers of PAS-positive cells relative to naïve airways were also identified within 
the transitional area at 6 hours and day 1 post injury. Upper and lower box plot margins represent the 
interquartile range; middle bar indicates the median. The graph was plotted based on the absolute number 
grid points landing on each cell stained with AB-PAS staining on each area measured. The points outside 
the ends of the whiskers are outliers. The details of the geometric mean values are shown in the 




4.5  DISCUSSION 
The main goal of this study was to confirm the characteristic histopathological changes 
that are found in the airway epithelium in response to bronchial brushing injury. This 
study followed on from our pilot studies using in vivo BrdU labelling of airway 
epithelial cells (Chapter 2).  
 
This study was designed such that two sheep were subjected to brushing at three time 
points in each of four different combinations of time points (protocols). Two segments 
were subjected to brushing at each time point (Table 4.1). One site per time point was 
harvested for subsequent microarray analysis and the other for analysis of the 
histopathological changes of the airway following injury. As a consequence the 
comparison of molecular and histopathological changes at each time point was made 
between different segments of the lung. As in the previous chapter (Chapter 2) effort 
was directed towards confirming that airway structure (in terms of the proportion of 
epithelium, glands, smooth muscle, blood vessels and cartilage) was consistent between 
separate lung segments. The study confirmed that there was no segment effect on the 
proportion of these airway tissues within the airway wall regardless of their position 
within the tracheolbronchial tree and suggests that injury sites within different segments 
are structurally comparable.   
 
 The experimental design was adapted from the previous preliminary experimental 
approach involving two different protocols (Chapter 2; Protocols A and B). The 
proliferative response of the BrdU-positive cells observed in Chapter 2 suggested no 
difference in terms of histological changes and cellular (proliferative) activity in both 
protocols, at least at the histological level. Therefore, this study was adapted from one of 
these protocols (Protocol A) and brushing employed as described in Chapter 2. Tissue 
from a naïve segment was collected from each sheep (n=8) as a control based on the 
assumption that minimal cellular and molecular responses would occur at such naïve 
sites. This approach was based on our observations in Chapter 2 where there was scant 
evidence of histological changes or BrdU incorporation in undamaged sites. Similarly, in 
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this study, from the histopathological point of view (HE, AB-PAS, Ki67), there were no 
obvious changes in terms of airway morphology, goblet cell morphology or proliferation 
in the naïve regions in agreement with the previous study.  
 
At 6 hours post injury, there was disruption of the airway mucosa including the 
basement membrane similar to that observed in the Chapter 2. The single layer of 
squamous epithelial cells migrating from the border of the lesion is thought to be an 
early stage of the airway repair. The histopathological features of the airways at day 1 
differed to those observed at day 3 post injury. At day 1, the damaged regions were 
clearly visible and the transitional area comprised single- to multiple layers of epithelial 
cells. At day 3, although within some areas of damage there was still evidence of 
mucosal haemorrhage, at the transitional area there was evident of thickened epithelium 
comprising multiple layers of undifferentiated cells.  
 
In general, based on the histopathological changes observed in the airway sections, the 
surface of the injured site was fully covered, with at least a partially differentiated 
airway epithelium by 7 days post injury. This finding was similar to that previously 
described in study of bronchial brushing in healthy human volunteers (Heguy A et al., 
2007) which revealed that at day 7 post injury, the damaged airway was completely 
covered by epithelial cells, the majority of which appeared to be undifferentiated. At day 
7 post injury, peripheral areas of the injured epithelium had regained a normal 
morphology likely due to the fact that the airway repair process was initiated from the 
transition region around the lesion and progressed towards the central area. Therefore 
the epithelium at the central area of damage was still only partially differentiated by day 
7. In the transition region, the proportion of the airway epithelium was not different at 
day 7 to that seen in the undamaged (day 0) area thus indicating that the airway 
epithelium at the transitional area had been fully covered (most areas had begun to 
differentiate) with the new epithelium following injury. This finding was supported by 
the analysis of the AB-PAS staining on the epithelium where the total number of PAS-
positive cells had returned to the level of the naive airway (time point 0). The number of 
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PAS-positive stained cells in the damaged region was also increased at day 7 compared 
to the earlier time points ie it had still not returned to normal. This finding supports the 
concept that at this time point the newly regenerated epithelial cells had begun to 
differentiate into specialised epithelial cells (goblet cells in particular). Although the 
number of PAS-stained cells was increasing towards normal at this time point (day 7), 
many of them had an unusual morphology (Figure 4.7 (e)). The preliminary study 
(Chapter 2) suggested that the central part of the damaged area had still not regained a 
fully differentiated epithelium even at day 14 post injury and numbers of AB-PAS 
stained cells were similar to that seen in day 7 post injury.  
 
In relation to assess the proliferative activity of the airway epithelial cells in response to 
bronchial brushing, this study used Ki67 marker instead of in vivo labelling using BrdU. 
The advantage of Ki67 over BrdU in functioning as a proliferative marker is that the 
Ki67 labels all proliferating cells at all stages of the cell cycle except during the resting 
phase (G0). Variation in staining intensity likely reflects staining during different cell 
cycle phases (Gerdes J et al., 1984). The increase in proliferative activity within the 
mucosal compartment may reflect the process of replacing the damaged epithelium. 
Increased proliferative activity in the mucosal compartment was not only observed at the 
damaged site but also at the transitional areas bordering the lesion. The submucosal 
gland ducts have previously been described as the location of stem cell niches from 
which epithelial cells migrate to cover the denuded areas (Borthwick DW et al., 2001). 
In the present study, the proliferative activity in the submucosal gland was not only 
increased in the damaged region, but also in the transitional region bordering the lesion. 
This finding supports the initial hypothesis that submucosal gland as a source of 
progenitor cells (stem cell niche). The number of Ki67 positive cells peaked at days 1 
and 3 post injury within the transitional area (Figure 4.6(A); epithelium). This finding 





The delay in the peak of proliferation observed in this study (as compared to the small 
animal model system described in Chapter 2) might be related to the severity of the 
brushing protocol. In our case the airway mucosal epithelium was completely removed 
(including the basement membrane and elements of the smooth muscle layer) as 
discussed in the Chapter 2 (Chapter 2: Section 2.5; Discussion). Indeed, when the 
analysis was performed in order to assess the effect of the brushing on the tissues in 
mucosal and submucosal compartments, it was revealed that not only was the proportion 
of the epithelium significantly different to naïve (p<0.05) with no epithelium at the 
damaged site at the earlier time points (6 hours and day 1) but the proportion of the 
smooth muscle was reduced at the earlier time points. By day 7 post injury the 
proportion of the smooth muscle tissue had returned to that of naïve airways. This 
regeneration of the smooth muscle appeared to be happening between 3 and 7 days post 
injury. A corresponding increase in the number of Ki67-positive cells in the smooth 
muscle tissue at the damaged and transition regions at days 3 and 7 was observed 
(Figure 4.2; smooth muscle). Although the brushing had no significant (p>0.05) effect 
on the proportion of the submucosal gland tissues, the distribution of the Ki67-positive 
cells on this tissue especially underneath the damaged region might contribute to the 
overall proliferative activity observed on the damaged area at the mucosal compartment 
as to compensate for brushing-induced epithelium loss. 
 
Overall the proportion of blood vessels did not significantly alter following the brushing 
procedure at any of the time points, however there was a significant increase in the 
proportion of the blood vessels in the damaged region compared to undamaged at day 3 
post injury which was likely due to the visible angiogenesis, a normal feature of injury 
and repair processes. The increased number of proliferating cells on the blood vessels in 
all areas of interest as compared to naive airway suggests that some of the proliferative 
activity observed in this study might have its origins in blood-derived cells. This finding 
contrasts with our initial assumption in the Chapter 2 in which proliferative activity was 
not necessarily adjudged to be of blood cells origin. Dual staining would help to confirm 
this fact. However, the lack of appropriate reagents constrains attempts to follow this 
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through. There is no doubt that blood-derived cells contribute to airway epithelial 
regeneration and repair (Abe S et al., 2004, Asakura A and Rudnicki MA, 2002) by 
migrating towards the damaged site but whether or not these cells directly proliferate 
and differentiate to become specialised epithelial cells could not be ascertained in this 
study.  
 
Consistent with the pathophysiological changes observed at day 7 post injury (with 
evidence of undifferentiated airway epithelial cells within the central area of the 
damaged site), a proliferative activity measured by the distribution of Ki67-positive cells 
was highly significant compared to the undamaged area. Although the total numbers of 
Ki67-positive cells were found to be lower compared to day 3 post injury this finding 
might suggest that the majority of the proliferating cells were involved in the late stage 
of the cell cycle (G2 and M) with relatively few still at the early stage of the cell cycle 
phase. This observation is based on the various intensities of the Ki67 staining on 
proliferating cells with dense staining indicate cells at the late stage of the cell cycle and 
faint staining indicating cells at an earlier cell cycle phase (Figure 4.3). In a study of 
airway repair in healthy volunteers, Heguy et al., (2007) showed that most of the genes 
up-regulated on microarray analysis at day 7 post injury were those involved in the late 
stage of the cell cycle, including those governing signal transduction and metabolism 
(Heguy A et al., 2007).  
 
Mucus producing cells were involved in the early process of dedifferentiation involving 
the airway epithelial cells bordering the lesion either by changing their shapes and 
morphology to migrate to the denuded area or through the intermediate cells (basal or 
para-basal cells) migrating towards the denuded area to become squamous epithelial 
cells that would eventually cover the brushed area. The AB-PAS staining revealed that 
there was a significant reduction of AB-PAS-positive cells at 6 hours, days 1 and 3 post 
injury with consistent loss of epithelium at the earlier time points (6 hours and day 1) 
following bronchial brushing (Figure 4.7(b) and (c)). The morphology of the mucus-
producing cells at the transitional areas changed remarkably compared to the staining on 
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these cells within undamaged areas. Although there was an evidence of regeneration of 
epithelial cells or mucus-producing cells (goblet cells in particular) at day 3 post injury 
(Figure 4.7(d)), the total number of cells stained for AB-PAS was still less than seen in 
undamaged areas.  
 
A finding consistent with that demonstrated in Chapter 2 was the intact mucus ‘scaffold’ 
overlying the damaged area at day 3 post injury. The AB-PAS staining was arranged in a 
thin covering over the top of the injured epithelial surface, and this layer was packed 
with neutrophils. Whether this consistent finding suggests a key step in the process of 
epithelial repair and regeneration remains to be seen.  
 
 
4.6  CONCLUSION OF THE CHAPTER 
In conclusion, this study demonstrates a novel model for the study of airway injury and 
repair via bronchial brushing in large animal lung. The study confirmed the findings 
described in the Chapter 2 in terms of the pathophysiological changes of the airways 
over time from injury involving dedifferentiation, proliferation and re-differentiation to 
restore almost completely regenerated airway wall morphology by seven days. Indeed, 
although the brushing technique used in this study perturbed both mucosal and 
submucosal morphology, the ability of the airway to regenerate a new epithelium and 
other airway components such as smooth muscle and glands as early as 3 to 7 days post 
injury was remarkable. Consistent with the findings in the Chapter 2, the physical lung 
injury model carried out in this study appears to show similar features to the mechanical 
injury techniques previously described in small animal model systems. It is anticipated 
that subsequent high throughput molecular analysis will provide opportunities to 
associate the histopathological findings observed in this chapter with the molecular 
changes in response to bronchial brushing. Thus this approach will lead to new insight 
into the functional genomics of sheep airway injury and could provide information 





5. CHAPTER 5 
 
TRANSCRIPTIONAL PROFILING OF OVINE AIRWAY 




















5.1  INTRODUCTION    
A microarray study is a high throughput expression profiling method which requires 
high quality and integrity of RNA samples to ensure reliability, accuracy and 
reproducibility of the microarray results. Expression profiling studies have been widely 
reported since the advent of this technology in the early 1990’s and such use has 
extended to studies of lung development (Mariani TJ et al., 2002), lung disease 
pathogenesis (Hansel NN and Diette GB, 2007, Wang IM et al., 2008, Raman T et al., 
2009), and lung repair following either chemical or physical injury (Brass DM et al., 
2008, Heguy A et al., 2007, Jeyaseelan S et al., 2004, Shultz MA et al., 2004, Yoneda K 
et al., 2003). Naturally these, and other, studies have encompassed a wide range of 
complex experimental design to meet defined objectives and obtain a better 
understanding of the complex molecular structure that underlies lung biology.  
 
During the development of this thesis, preliminary studies had been carried out 
involving studies of the pathophysiological (Chapter 2) and molecular aspects (Chapter 
3) of airway repair. Realising the fact that both these studies are limited in terms of the 
numbers of sheep used and the low number of genes studied, a more robust study was 
designed to achieve a clearer understanding of cellular and molecular changes during 
airway regeneration and repair and how these changes might relate to the 
pathophysiological changes described in Chapter 4. An advantage of high-throughput 
microarray technologies is that they can offer an opportunity to gain insight into the 
global gene expression profiles of disease processes such as asthma, leading to the 
identification of new asthma-associated genes and pathways (Tölgyesi G et al., 2009).  
 
Microarrays have provided novel insight into many complex human diseases and 
microarray-based discovery can be classified into three components, biomarker 
detection, disease (sub) classification and identification of causal mechanisms 
(Bhattacharya S and Mariani TJ, 2009). The application of transcriptomic analysis of 
genes involved in airway epithelial repair has mostly been performed in samples taken 
from patients with lung-related diseases such as asthma and COPD. The use of lung 
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tissue is ideal for the investigation of asthma pathogenesis, and several recent studies 
have analyzed global gene expression in bronchial biopsy specimens (Hansel NN and 
Diette GB, 2007). In COPD, studies have mapped comparative gene expression profiles 
of lung tissues from patients with different stages of COPD relative to healthy smokers 
or non-smokers. Such studies have revealed a number of differentially-regulated genes 
associated with COPD progression, which include genes involved in the regulation of 
inflammation, extracellular matrix, cytokines, chemokines, apoptosis, and stress 
responses (Chen ZH et al., 2008). Endoscopic bronchial brushing procedures for airway 
epithelial cell sampling are more effective in sampling specific target areas within the 
lung. 
 
However, in the context of understanding the mechanisms involved in airway epithelium 
regeneration and repair in the normal condition (healthy individual with no lung-related 
disease), to the best of our knowledge, only one study has applied  this combination of 
bronchoscopy and mechanical brushing of small regions of the airway epithelium of 
normal individuals, to force the epithelium to undergo regeneration in vivo (Heguy A et 
al., 2007). A limitation of this study was that the expression profiles at brushed sites 
were compared to the unbrushed airways at only two time points (Days 7 and 14 post-
injury). Therefore, this study provides no insight into the early molecular changes 
following injury. However, at day 7 compared with resting epithelium, there were 
substantial differences in gene expression pattern, with a distinctive airway epithelial 
"repair transcriptome" of actively proliferating cells in the process of re-differentiation 
(Heguy A et al., 2007). 
 
This study was designed to build on the observations from Chapters 2 to 4 and provides 
a more comprehensive knowledge of the genes and pathways involved in airway 
epithelial repair. The recent availability of an ovine microarray chip (Agilent 
Technology) provided an opportunity to investigate a time-course of molecular changes 
in our sheep model of bronchial brushing induced airway injury from 6 hours to 7 days, 
and compare those expression profiles with uninjured (naive) airways.   
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As reviewed by Murphy D, (2002), the basic concept of microarray analysis involves 
labelling the RNA extracted from the tissue of interest to generate the target—the free 
nucleic acid sample whose identity or abundance is being detected. This is hybridized to 
the tethered probe DNA sequences corresponding to specific genes that have been 
affixed, in a known configuration, onto a solid matrix. Hybridization, based on Watson 
and Crick base pairing, between probe and target provides a quantitative measure of the 
abundance of a particular sequence in the target population. This information is captured 
digitally and subjected to various analyses to extract biological information. Comparison 
of hybridization patterns enables the identification of mRNAs that differ in abundance in 
two or more target samples (Murphy D, 2002).  
 
There are two common approaches to microarray studies, depending on the objective of 
the designed study. A one-colour (intensity-based) approach can be used  to compare 
treated and untreated animals exposed to certain chemicals (Brass DM et al., 2008, 
Yoneda K et al., 2003) whereas a two-colour (ratio-based) approach can be used to 
assess the expression differences between mRNA isolated from two types of tissues such 
as parenchyma and airway (Shultz MA et al., 2004). The addition of a one-colour 
platform to the Agilent gene expression portfolio gives the ability to take advantage of 
the enhanced performance and sensitivity of Agilent's 60-mer oligonucleotide 
microarrays (Xiao J et al., 2006). When an intensity-based microarray platform is used 
for gene expression analysis, each sample is hybridized on a single microarray therefore, 
a one-colour solution provides the ability to compare the measured gene expression 
output of a microarray directly across other microarrays to generate new and multiple 
ratiometric measurements (Xiao J et al., 2006). This differs from a two-colour approach 
where all gene expression ratios are generated only from two samples compared on the 
same microarray. Two-colour microarray experiments typically use cyanine 3 and 
cyanine 5 dyes. In one-colour experiments, the cyanine 3 dye is used because it is less 
susceptible to degradation by environmental factors such as ozone, pH, and organic 




The nature of such high-throughput platforms places considerable technological 
demands that, if compromised, can confound the fidelity of the results. Such demands 
range from the precision and reproducibility of the print heads in spotting the arrays to 
the uniformity of the hybridisation process and the stringency and consistency of the 
slide washing process. The effects of compromise in such technology are usually 
manifest in systematic bias that appears irrespective of the underlying biological 
variation present within and between arrays on slides. One type of problem is regional 
bias, in which one region of a chip shows artifactually high or low intensities (or ratios 
in a two-channel array) relative to the majority of the chip (Reimers M and Weinstein 
JN, 2005). Factors such as temperature, liquid flow rate or RNA diffusion rate may 
differ among different regions on the array. Higher local off-spot background near the 
edges is normally due to less thorough washing near the edge of the slides which push 
up the spot measures, although not always predictably. Another problem is due to a 
bubble which remains after filling an Affymetrix cassette. This bubble will not travel 
uniformly over the chip during hybridization mixing and may get stuck or move in an 
irregular circuit. Scratches and other manufacturing imperfections can make a difference 
(Reimers M and Weinstein JN, 2005). 
 
The presence of such bias can be detected, and quantified by various quality-control 
assessments that are applied to the scanned images from each array and area feature of 
the output from commercial platforms such as from Agilent arrays.  
 
To counteract and allow for the effects of such bias array experiments will often include 
some process of normalization. Common methods of normalization applied to two-
colour arrays include global normalization (where a measure of distribution (eg mean, 
median or percentile) of different arrays is adjusted to a constant, and locally weighted 
scatterplot smoothing (LOWESS), where a locally weighted polynomial regression of 
the intensity scatterplot is used in order to obtain the a calibration factor. Similar global 
normalization strategies such as percentile normalization, dividing the expression of 
measured genes by the intensity of pre-selected housekeeping genes, dividing expression 
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values of genes of interest by the sum of all signals or finding the most probable 
consistent pairwise scaling based on central tendency of expression ratios can be applied 
to single-colour arrays. Importantly however, as remarked by Kreil and Russell (2005), 
“there is no silver bullet – no single ‘catchall’ method solves the problem of appropriate 
microarray data analysis” and, importantly, the normalisation method used should be 
justifiable in the particular biological context of the experiment and not just performed 
"as standard". Normalization should not be performed for the sake of normalization, but 
in response to demonstrable systematic bias attributable to the process itself (Kreil DP 
and Russell RR, 2005).  
 
Protocols for collection and storage of lung tissue samples for subsequent extraction of 
RNA with the required high quality and integrity for microarray analysis have been 
reported (Chomczynski P, 1992, Keating DT et al., 2008). RNAlater, a proprietary tissue 
storage reagent that rapidly permeates tissue to stabilize and protect cellular RNA in situ 
in unfrozen specimens, is a popular medium to preserve samples for subsequent 
molecular analysis such as microarray studies. A study by Keating DT et al., (2008) 
suggested that storage in RNAlater preserved RNA quality to a level appropriate for 
gene expression studies (Keating DT et al., 2008). This study contrasted with the 
experience of Micke P et al., (2006) who suggested that preserving the tissue samples in 
RNAlater introduced variability in measured gene expression levels. As an alternative 
approach, flash freezing in liquid nitrogen is quick and effective in preserving tissue. 
Indeed a recent study demonstrated that RNA is relatively well preserved when fresh 
tissue is rapidly frozen for tissue bio-banking with expression levels of selected genes 
remaining stable in such non-fixed tissue specimens for a long period of time (Micke P 
et al., 2006). 
 
We have established that the semi-quantitative RT-PCR analysis in Chapter 3 revealed 
substantial variation in terms of the observed expression profiles of the selected genes. 
Whilst the cause of this variation is unknown, RNA quality and integrity may be 
contributing factors. Expression profiling the time course of corresponding molecular 
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changes during the repair process requires the preparation of high quality RNA from the 
injury sites. These airway tissue samples are relatively small and cartilaginous which, at 
least on an anecdotal level (R Talbot, personal communication), can lead to problems in 
preparing RNA of the concentration and quality required for microarray analysis. A 
related concern was that the tissues under study may contain an increased proportion of 
apoptotic cells containing degraded RNA which could contribute to problems with 
quality (Aigner T and Kim HA, 2002 ). Regarding the amount of RNA required for 
microarray analysis, Wang S et al., (2003) suggested that 5µg of total RNA is the 
minimum that should be used for direct labelling procedure. While lower amounts of 
RNA input may be sufficient to yield detectable and accurate log ratios for some 
transcripts, less than 2 µg total RNA may result in lowered detection of less abundant 
transcripts and ultimately yield reduced amounts of data (Wang S et al., 2003). 
 
There are various fundamental aspects of the RNA assessment that can be used as 
indicators for the quality and purity of the extracted RNA. Ultra violet (UV) 
spectrophotometry at the following wave lengths can inform on a number of parameters; 
240 nm (background absorption and possible contamination), 260 nm (specific for 
nucleic acids), 280 nm (specific for proteins), and 320 nm (background absorption and 
possible contamination) (Fleige S and Pfaffl MW, 2006). Sambrook J et al., (1989) 
suggested that for DNA or RNA quantification, the readings should be taken at 
wavelengths of 260 nm and 280 nm. The ratio between the reading at 260 nm and 280 
nm (A260/A280) provides an estimate of the purity of the nucleic acid in which pure 
preparation of DNA and RNA have A260/A280 values of 1.8 and 2.0, respectively 
(Sambrook J et al., 1989). A review by Fleige S and Pfaffl MW, (2006)  suggested that 
pure RNA should be 1) free of protein (absorbance 260 nm/280 nm), 2) free of genomic 
DNA, 3) non-degraded (28S:18S ratio should be roughly between 1.8 and 2.0, with low 
proportion of short fragments), 4) free of enzymatic inhibitors, 5) free of any substances 
which complex essential reaction co-factors, like Mg2+ or Mn2+, and 6) free of nucleases 
for extended storage. Pure RNA will have A260/A230 equal to A260/A280 and >1.8 




A new tool for RNA quality assessment is the RNA Integrity Number (RIN) generated 
by the  Bioanalyzer 2100 (Mueller O et al., 2004) (Agilent Technologies). This Lab-on-
a-Chip capillary gel-electrophoresis system separates and detects RNA samples via laser 
induced fluorescence detection. The bioanalyzer software generates an electropherogram 
which provides a detailed visual assessment of the quality of an RNA sample (Mueller O 
et al., 2004). Integrity of the RNA may be assessed by visualization of the 18S and 28S 
ribosomal RNA bands (Fleige S and Pfaffl MW, 2006, Mueller O et al., 2004). The RIN 
was developed to remove individual interpretation in RNA quality control (Mueller O et 
al., 2004). It takes the entire electrophoretic trace into account. The RIN software 
algorithm allows for the classification of riboeukaryotic total RNA, based on a 
numbering system from 1 to 10, with 1 being the most degraded profile and 10 being the 
most intact (Mueller O et al., 2004).  
 
Although use of the Bioanalyzer has become accepted in the standardization of RNA 
integrity assessment, the interpretation of the electropherograms requires some expertise 
(Imbeaud S et al., 2005, Raman T et al., 2009). Therefore, a common practice is to set 
up a standard baseline in order for consistent application of the RIN score to ensure 
reproducibility and reliability of the data. Fleige S and Pfaffl MW., (2006) suggested 
that a RIN higher than five indicates a good total RNA quality whilst the RIN higher 
than eight indicates a perfect total RNA for downstream application (Fleige S and Pfaffl 
MW, 2006). Indeed, a minimum cut-off for RIN score of  ≥7.0 has been adopted in 
standard operating procedures at Ark Genomics (Roslin Institute, UK) to ensure 
reproducibility and reliability of the microarray data for downstream application (R 
Talbot, personal communication). 
 
In a study by Raman T et al., (2009) samples with RIN ≥ 7.0  generally performed well 
(failure rate of 2.8%) in microarray assessment of gene expression in human airway 
epithelium and a consistent application of RIN ≥ 7.0 as a cut-off was useful for 
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obtaining high quality gene expression microarray data (Raman T et al., 2009). The 
effect of sample type on RIN was examined in a variety of calf tissues, white blood cells 
and four cell lines (Fleige S et al., 2006). For solid tissues the average RIN was between 
6 and 8. Tissues or organs with high connective tissue content, e.g. rumen, omasum and 
jejunum in the gastrointestinal tract, showed increased RIN variation (Fleige S and Pfaffl 
MW, 2006, Fleige S et al., 2006) likely due to RNA degradation through the sampling 
and extraction procedures. This may relate to the solid and tough structure of the 
connective tissues, presence of fatty tissue, the RNase enzymatic activity and/or 
problems during tissue sampling and storage (Fleige S and Pfaffl MW, 2006). In the 
context of lung tissue, the average RIN score obtained was 6.55 (Fleige S and Pfaffl 
MW, 2006, Fleige S et al., 2006).  
 
The RNA samples used in the previous chapter (Chapter 3) came from cartilaginous- 
tissue samples and little is known about RNA integrity since the quality of the isolated 
RNA relied only on conventional spectrophotometric absorbance readings (A260/A280 and 
A260/A230). Therefore, this study was designed to determine whether the yield and 
quality of RNA obtained from these bronchial samples was sufficient for microarray 
analysis and if not, to investigate whether modifications to our standard extraction 
protocol could sufficiently enhance the quality of the RNA for this purpose. 
 
A challenging task in microarray-based studies is to extract the valuable information 
from thousands of genes available in the array. Murphy D, (2002) described two levels 
involved in microarray data analysis once the primary image data has been collected. 
The aims of the first level of analysis, so-called low-level analysis, are background 
elimination, filtration, and normalization, all of which should contribute to the removal 
of systematic variation between chips, enabling group comparisons. Microarray data 
normalization involves comparing different microarrays relative to some standard 
intensity value. Data are often then subjected to log transformation to improve the 
characteristics of the distribution of the expression values (Murphy D, 2002). High-level 
microarray analysis, often called "data mining," is the uncovering of relevant patterns of 
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interest in data and typically, will involve data processing using various statistical 
techniques to identify the patterns (Murphy D, 2002). 
 
In the present study, the large-scale assessment of gene expression aims to use 
expression profiling to allow the macro-dissection of molecular events and potentially 
identify novel pathways and regulators involved in airway regeneration and repair. An 
improved understanding of the temporal gene expression profiles could be important in 
understanding the primary mechanisms of cellular dedifferentiation, migration, 
proliferation, re-differentiation, checkpoint control and repair occurring after airway 
epithelium perturbation. These findings should open new approaches for determining the 
possible mechanisms of pathology and repair after lung injury.   
 
 
5.2  OBJECTIVES 
The aims of the study presented in this chapter are divided into two components: 
A) Optimising RNA isolation from cartilaginous airway samples 
1) To optimize homogenization techniques for isolating mRNA from lung tissue 
samples 
2) To identify the amount of the lung tissue required to generate sufficient RNA 
of the required quality and integrity for microarray analysis 
 
B) Transcriptional profiling of airway epithelial regeneration and repair using 
microarray   
1) To use single-colour ovine microarray technology to explore the alterations 
in the transcriptional programme of the airway in this model of airway 
regeneration and repair.  
2) To identify genes and/or pathways associated with the different stages of the 





5.3  MATERIALS AND METHODS 
5.3.1 Optimising RNA isolation  
5.3.1.1 Experimental design  
A total of 28 tissue samples were obtained from six sheep. These consisted of three 
different types of lung tissue – cartilaginous airways (n=20), lung parenchyma (n=4) and 
bronchial brushings (n=4). The amount of cartilaginous airway or parenchyma tissue 
used as starting material was either 30mg or 100mg. The cartilaginous airway tissues 
samples were lysed by one of two methods, either by addition of lysis buffer alone 
(RLT-Buffer; Qiagen, UK) for 30 minutes, or in combination with a homogenisation 
step using a FastPrep System (MP Biomedicals, UK) and FastRNA ProGreen matrix 
tube. In the latter regard four different speed/time settings were employed: S4T20 - Speed 
Setting 4 for 20 seconds, S6T20 Speed Setting 6 for 20 seconds, S4T40 Speed Setting 4 for 
40 seconds and S6T40 Speed Setting 6 for 40 seconds. 30mg starting material was used 
for optimising the FastPrep protocols at different speed (S) and time (T) settings (S4T20, 
S6T20, S4T40, and S6T40).  For the parenchyma tissue samples, homogenisation followed 
the protocol suggested by the manufacturer (S6T40) whilst no homogenisation was 
required for bronchial brushing samples. RNA was extracted from lysates using RNeasy 
Mini kits (Qiagen, UK). 
 
5.3.1.2 Isolation of mRNA   
Two preservation methods were used: 1) RNAlater: Cartilaginous airway (n=2) and 
parenchyma (n=4), and 2) Snap frozen: Cartilaginous airway (n=18) and bronchial 
brushing (n=4). Samples (cartilaginous airways and lung parenchyma) were weighed 
into a FastRNA ProGreen matrix tube containing 0.7 ml RLT buffer and β-
mercaptoethanol (1ml RLT buffer: 10µl β-mercaptoethanol). Samples from bronchial 
brushings were extracted directly from the cell pellet with RNeasy kit (Qiagen, UK). 
The tissue samples that were treated only in lysis buffer alone were incubated for 30 




The upper phase from each FastPrep tube was transferred to a Qiashredder column 
(Qiagen, UK). For the sample treated only with lysis buffer, the whole 0.7ml buffer was 
transferred into the Qiashredder column. Samples were centrifuged at 13,000 rpm for 2 
minutes and the supernatant transferred into RNeasy columns (Qiagen, UK). The 
extraction protocol was completed as suggested by the manufacturer. The RNA was 
eluted using 40µl of RNAse free water (Qiagen, UK). 
 
5.3.1.3 RNA quality check 
Measures of RNA quality (purity and integrity) and abundance were determined for each 
sample using a NanoDrop Spectrophotometer (Thermo Fisher Scientific Inc, UK) to 
determine the A260/A280 ratio and RNA concentration, and the Agilent Bioanalyzer 2100 
(Agilent Technologies, UK) to generate an electropherogram and an RNA Integrity 
Number (RIN).    
 
5.3.1.4 Statistical analysis 
To assess the correlations between RIN score, RNA concentration and OD readings, the 
data for all samples (n=28) were pooled. The mean and standard deviations of RIN 
score, RNA concentration and A260/A280 reading for each tissue type (parenchyma, 
bronchial brushing and cartilaginous airways) were calculated. The degree of association 
between the RNA concentration, the A260/A280 ratio and the RNA integrity number 
obtained by the Agilent Bioanalyzer 2100® were analyzed by Pearson correlation 
coefficient test. A p<0.05 was considered statistically significant.  
 
5.3.2 Microarray experiment  
5.3.2.1 Experimental design 
The design of the experiment carried out for microarray analysis was described in the 




5.3.2.2 Tissue samples and processing 
At post mortem, the lung segments were carefully mapped and dissected out to identify 
the injured sites, and each injured airway site was immediately cut into 4 or 5 pieces, 
frozen in the dry-ice/isopropanol and stored at -80oC. Later the tissues were transferred 
to the RNAlater and kept at -80oC. 
 
5.3.2.3 Total RNA isolation 
Total RNA was isolated as described above but using 100mg of cartilaginous airway 
tissue a FastPrep setting of T40S6. The rest of the RNA isolation procedure was 
performed using RNeasy Mini kits (Qiagen, UK) following the manufacturer’s 
instructions. The RNA was eluted using 40µl of RNAse free water (Qiagen, UK). 
 
5.3.2.4 RNA quality control assessment 
The quality and yield of the extracted RNA was initially measured with a NanoDrop 
ND-100 Spectrophotometer (Thermo Fisher Scientific Inc, UK) to determine the RNA 
concentration and A260/A280 ratio. Samples were subsequently sent to the Ark Genomics 
(Roslin Institute, UK) for analysis using an Agilent Bioanalyzer 2100 to generate 
electropherogram profiles and to assess the RIN score.  
 
All the procedures used in this protocol were followed the techniques as recommended 
by the manufacturer. The Agilent 2100 Bioanalyzer with the RNA 6000 LabChip kit 
(Agilent, UK) was used as a more stringent assessment of mRNA quantity, integrity and 
purity. This system uses fluorescence detection, monitoring the fluorescence between 
the wavelength of 670 and 700nm for RNA. RNA samples are normally considered 
good quality and integrity if the RIN produced is greater than 7.0 and two distinct peaks 
for 18S and 28S ribosomal RNA are clearly observed.  
 
5.3.2.5 Designing of oligonucletide probes  
In our preliminary study (Chapter 3) a semi-quantitative RT-PCR approach was used to 
look at expression of selected genes in a limited number of sheep. The microarray study 
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gave us the possibility of looking at the same genes (except keratin 14 gene) in a more 
quantitative manner in a larger number of animals. However, of these genes, the array 
only contained a probe for the beta-catenin gene; catenin beta-like 1 (CTNNBL1); 
Probe: A_70_P068021 (Accession No: DQ152928). Additional probes were designed by 
Ark Genomics, Roslin Institute UK. To design probes for beta-tubulin, keratin 5, and 
FoxJ1 the sequences generated in Chapter 3 were used to Blast through the GenBank 
and DFCI databases to find similarities with ovine and/or bovine sequences. Since there 
was no available ovine sequence for FoxJ1 gene, both the ovine sequence generated in 
Chapter 3 for FoxJ1 gene and  the bovine sequence for FoxJ1 gene 






























Table 5.1: Lists of probe sequences added to the array 
These probes were designed based on similarity between sequences generated in the previous preliminary study (Chapter 3) and bovine and/or ovine sequences 
available on the DFCI website. For beta tubulin, when the probes were designed, blast analysis of the sequence generated in the Chapter 3 was similar to this EST 
sequence (TC2191). Similarly, there was no ovine FoxJ1 mRNA sequence available when the probes were designed; therefore both FoxJ1 sequences generated in the 





5.3.2.6 RNA Amplification, cDNA synthesis, labelling, hybridization and 
scanning 
For the microarray experiment, all the procedures including RNA amplification, 
cDNA synthesis, labelling and hybridization, were carried out by the professional 
technician at Ark Genomics, Roslin Institute, UK following Ark Genomics Standard 
Operation Procedures (SOP) – please see Supplement 7a for the details (on the CD). 
 
Four slides containing eight arrays (n=8) each were used for the microarray study. As 
described previously, there were six replicates (n=6) for each of the four time points 
which were all taken from different sheep (Table 4.1). One segment from each of the 
treated sheep was used as a naive control (n=8 naive controls). Sheep were allocated 
at random to Agilent slides and samples were allocated at random to arrays within 
slides so that any variation between slides or arrays caused by the measurement 
process should not bias the comparison of treatments. The allocated positions of each 
of the samples within the slides are shown in Figure 5.1. 
 
The glass slides containing the RNA samples were scanned using the auto photo 
multiplier tube (PMT) Axon 4200AL scanner following the manufacturer's standard 
operation procedures. The microarray expression data was extracted using the 
Agilent Feature Extraction (FE) software version 9.5.3.   
 
When the Agilent microarray file generated by the scanner is loaded into a project, 
the software assigns a grid template based on the bar code (AMADID), and a 
protocol. The protocol uses the grid template to automatically locate the spots. After 
the software positions the grid and finds spots, it uses the remaining default FE 
algorithm parameters contained in the FE protocol to carry out data analysis. See 
supplement 7b on the CD for the FE parameters table. Feature Extraction removes 
outlier pixels and does statistics on inlier pixels of features and local backgrounds 
(FE Software Manual, Agilent version 9.5.3 for one colour). The gMeanSignal used 
in this anlysis is one of the basic values generated by the FE software. Raw signal is 
calculated, based only on the "inliers" pixels, meaning all the pixels in a spot retained 
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after removing saturated, or not "well above background" pixels. The CookieCutter 
method was used to select all the pixels used in the calculation. 
 
Quality control checks were performed on the microarray data output generated from 
FE software. The quality control parameters followed were as recommended by the 





Array 1_4          7958_7         1      7954_0.25        5 Array 2_4   Array 1_4         8039_0          9           45_0          13 Array 2_4 
              
Array 1_3       7958_0.25       2         7954_7          6 Array 2_3   Array 1_3          8039_1       10          45_1           14 Array 2_3 
              
Array 1_2          7958_1         3         7954_0          7 Array 2_2   Array 1_2          8039_7       11          45_3           15 Array 2_2 
              
Array 1_1          7958_0         4         7954_3          8 Array 2_1   Array 1_1          8039_3       12       45_0.25         16 Array 2_1 
              
                  
  barcode        barcode    
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Array 1_4       8003_0.25      17         8020_1         21 Array 2_4   Array 1_4      8064_0.25       25         8038_3         29 Array 2_4 
              
Array 1_3          8003_3        18         8020_7         22 Array 2_3   Array 1_3          8064_3        26         8038_0         30 Array 2_3 
              
Array 1_2          8003_1        19         8020_0         23 Array 2_2   Array 1_2         8064_0         27         8038_1         31 Array 2_2 
              
Array 1_1          8003_0        20      8020_0.25       24 Array 2_1   Array 1_1         8038_7         28          8064_7        32 Array 2_1 
              
                  
  barcode        barcode    
                  
 
Figure 5.1: The allocated array positions for the samples on each of the slides.  
Sheep were allocated at random to Agilent slides and samples were allocated at random to arrays within slides. The numbers in each box indicate sheep ID, time point 
and, on the right hand side, the numbering system (slides position) given to the arrays.
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5.3.2.7 Microarray statistical analysis 
The study investigated 5 different time points following injury (Control (uninjured), 
6 hours, 1 day, 3 days and 7 days as described in Chapter 4; Section 4.3.1.) from four 
combinations of time points (protocols) at which each sheep was injured (Table 4.1). 
Therefore, in order to assess the effect of the brushing on the gene expression 
profiles over the time of injury, the effects were estimated by comparing each of the 
four time points between control (naïve) samples. To compensate for an interaction 
between the time of the brushing (Time point) and the protocol (combination of time 
points), brushed sites were compared to naive control airway from animals subjected 
to the same protocol. For instance, for protocol 731, there were two sheep which 
were subjected to brushing at 7, 3 and 1 days prior to harvest. In order to assess the 
effect of the brushing on the gene expression profiles, the data generated from the 
microarray from each time point (day 1, day 3 and day 7) were only compared with 
the microarray data generated from control samples of the same two sheep (n=2) 
 
Analysis of microarray data was performed using a linear mixed model fitted by 
residual maximum likelihood (REML) (Patterson and Thompson, 1971). For this 
analysis, the gMeanSignal (raw means signal of feature in green channel) from 
microarray raw data extracted from Agilent Feature Extraction software was used 
and gMeanSignal intensity was transformed to logarithms base 2 (logBase2) for each 
probe separately using GenStat commands and procedures (Payne et al., 2008).  
 
5.3.2.8 Microarray validation study 
Semi-quantitative RT-PCR was performed on selected genes from the microarray 
experiment in order to validate the observed changes. Four samples for each time 
point (total n=20 samples) were selected and used in this validation. The selection of 
these genes was based on the gMeanSignal values with less variation whilst values 
with large variation were excluded. In addition, the genes selected for the assay were 
based on 1) a significant change in expression (up or down) at one or more time 
points at p<0.001 (highly significantly changed), 2) either high or low fold change at 
one or more time points, 3) genes thought to be have a relevant biological function 
such in cell cycle, immune response, cell communication, cell adhesion and cellular 
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differentiation, and 4) genes described in Chapter 3. The full list of genes used for 
RT-PCR assay is listed in Table 5.2. The semi-quantitative RT-PCR protocols used 
were similar to those described in Chapter 3. Data for these genes were normalised to 
ATPase gene expression.  
 
The gene annotations for the probes on the sheep array were obtained by blasting the 
mRNA sequences of these genes through the nucleotide mRNA database using the 
NCBI programme available at http://blast.ncbi.nlm.nih.gov/Blast.cgi. The selection 
criteria for selecting the annotations for the sequences of interest were based on a 
sequence similarity of more than 90% with bovine mRNA sequence database. The 
mRNA sequences for these genes were used for primers design using 
http://biotools.umassmed.edu/bioapps/primer3_www.cgi. The list of the primers and 
the PCR conditions are shown in (Table 5.2). 
 
In order to assess the correlation between expression data obtained from the array 
and semi-quantitative RT-PCR, a Pearson correlation coefficient test was carried out 
using R program with p<0.05 considered significant. The array data for some of the 
genes were log-transformed due to the fact that they were not normally distributed. 
Expression profiles of the array and semi-quantitative data of the selected samples 

























CCNB2 Forw: CTGTGTCCAGTCCGAGTCCT 
Rev: GCACTGGTTTCACAGAAGCA 
304 59 
CCNB1 Forw: ACCTCTGGAAAAGGCTCCTG 
Rev: GGTTGACTGCTTGCTCTTCC 
303 59 
CDC2 Forw: CTCCACAGGGACCTAAAACC 
Rev: AGTGCCCAAAGCTCTGAAAA 
294 59 
KRT6A Forw: TACACCACCACCTCCTCCTC 
Rev: GCCAGTGGAAAGCAAGTAGG 
299 60 




Table 5.2: The list of the genes for a microarray validation study using a semi-quantitative RT-
PCR assay.  




5.4  RESULTS  
5.4.1 Optimizing RNA quality and integrity 
5.4.1.1 Preliminary observations 
Our preliminary data for quality control assessment of the RNA samples for 
microarray analysis indicated that of the 12 samples screened for RNA integrity 
using Agilent Bioanalyzer 2100, only 1 had passed the RIN cut-off (≥7.0). Although 
similar techniques for RNA isolation and QC assessment were repeated several times 
using the same and/or different samples all with high RNA concentration, there was 
no improvement observed in terms of the RIN score. To preserve the remainder of 
these samples for the microarray study, a set of normal cartilaginous airways tissues 
were obtained to optimize the RNA extraction procedures. 
 
5.4.1.2 RNA quality from airway samples 
Initial RNA was extracted from 30mg of cartilaginous airway samples as 
recommended in the RNeasy Mini Kit Protocol. For these samples, the average ratios 
for A260/A280 were ≥1.8 – (Table 5.3). However, the RNA concentrations obtained 
from these tissues were considered suboptimal in the sense that the Agilent 
Bioanalyzer (Mueller O et al., 2004) specifies a minimum RNA yield of 25ng/µl for 
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a quality control (QC) check and approximately 10µg - 20µg of RNA is required for 
microarray (Wang S et al., 2003). From 30mg tissue, the average RIN score obtained 
was very low (RIN <4.0) as compared to the cut-off (≥7.0). The electropherograms 
(Figure 5.2; left panel) did not have the desired flat baseline with distinct 18S and 
28S ribosomal RNA peaks expected from good quality RNA (Figure 5.2; right 
panel). Figure 5.3 shows the different of 18S and 28S ribosomal RNA peaks profiles 
from the various RNA integrity (RIN) scores screened on the cartilaginous airway 
tissue samples.  
 
Increasing the amount of starting material to 100mg improved the RNA yield. The 
average ratios for A260/A280 were ≥ 1.8 – (Table 5.3), even though the amount of the 
tissue exceeds that recommended by the RNeasy Mini Kit Protocol. The average RIN 




30mg (n=7) 100mg (n=7) 
Mean ±SD Mean ±SD 
Yield (ng/µl) 7.93 6.65 57.61 1.41 
A260A280 (nm) 2.13 0.64 2.02 0.07 
RIN 2.77 3.08 6.0 1.41 
 
Table 5.3: Mean values for samples types and the amount of tissues used 
There was an effect of the amount of starting material for isolating the RNA from cartilaginous airway 





Figure 5.2: Electropherograms demonstrating profiles associated with both low and high RNA integrity number. 
Quality and integrity of RNA assessed by the Agilent 2100 Bioanalyzer. For the sample with high RIN a flat baseline and distinct peaks of both 18S and 28S of 
ribosomal RNA are clearly seen (left panel) while the sample that had low RIN score (right panel) has a noisy baseline that appeared early before the appearance of the 
18S rRNA and is indicative of degraded RNA. In the cartilaginous RNA sample, the RNA concentration is low (Y-axis) and makes the background degradation appear 





Figure 5.3: The differences of 18S and 28S ribosomal RNA peaks profiles from the various RNA integrity (RIN) scores screened by the 
Agilent Bioanalyzer 2100 
Although additional peaks reflecting RNA degradation can be appreciated clear 18S and 28S ribosomal peaks could still be discerned in these 




5.4.1.3 Homogenisation parameters 
Variations in the speed and time settings for the FastPrep system were compared to 
address the concern that our standard settings were resulting in RNA degradation. 
Within the 30mg samples of cartilaginous airway tissue samples assessed, there was 
no improvement in the RIN score achieved for the samples prepared at any of the 
settings tested (Table 5.4). 
 
 
Table 5.4: The effects of different processing protocols on the quality and integrity of the RNA 
from the cartilaginous airway samples 
The results indicate that the small amount of the initial tissue samples used in RNA extraction rather 
than the Fastprep conditions had contributed to the low RIN score. Different homogenising settings 
for the cartilaginous airway samples failed to make an impact on the overall yield of the extracted 
RNA (possibly due to low cellular density in this tissue type).   
 
5.4.1.4 Lung specific or sample type specific?  
To test the hypothesis that this problem was specific to the cartilaginous airway 
samples, RNA was extracted from other lung-derived samples, namely bronchial 
brushings and lung parenchymal tissue. The A260/A280 ratios from both these sample 
types were consistent and generally equivalent and indicated acceptable RNA purity. 
RNA from these samples generated improved RIN values (Table 5.5), indeed all of 


















Cartilaginous airways lysis buffer 30 6.05 2.01 0 
Cartilaginous airways lysis buffer 30 8.42 2.03 0 
Cartilaginous airways S4/T20 30 1.79 2.65 0 
Cartilaginous airways S4/T20 30 2.17 2.06 2.4 
Cartilaginous airways S4/T40 30 9.73 1.69 2.5 
Cartilaginous airways S4/T40 30 5.4 2 2.5 















and distinct peaks for both 18S and 28S ribosomal RNA (exemplified by the right 
































Table 5.5: A summary of the RNA concentration, A260/A280 ratios and the RIN scores for the 
parenchyma and bronchial brushing samples 
Mean (+/- SD) values for parenchyma and bronchial bushing samples. RNA concentration, A260/A280 
ratios and, the RIN score obtained 
 
 
5.4.1.5 Is RNA integrity dependent on RNA yield and purity? 
To assess the individual tissue type effect on RNA concentration and RIN score, data 
was plotted based on the initial tissue weight (30mg vs 100mg for both parenchyma 
and cartilaginous airway tissue types), RNA concentration and RIN scores (Figure 
5.4). This figure shows that although the RNA concentration isolated from bronchial 
brushing and parenchyma tissue samples were low, the majority of RIN scores for 
these samples were greater than 7. In order to assess a correlation between RNA 
yield and purity of the samples, the data of each variable (yield and purity) for all 
samples were combined. There was a positive correlation (Figure 5.5; left panel) 
observed between the RNA concentration and the RIN score for the same samples 
(Spearman rs=0.64, p<0.001). There was no correlation observed (Figure 5.5; right 
panel) between the A260/A280 ratio and the RIN score for the same samples 




Figure 5.4: The effect of different tissue types on the RNA quality and integrity. 
There were low RNA concentrations obtained from the 30mg samples of all lung tissue types. Despite the low RNA concentrations obtained for the 





Figure 5.5: The relationship between RNA concentration and A260/A280 ratio. 
The scatter plots show the relationship between RNA concentration (left panel) and A260/A280 ratio (right panel) with RNA integrity number obtained. The 
data of each variable (yield and purity) for all samples (n=28) were combined. Overall, there was evidence of a significant association between the yield of 
the RNA and the RIN number (Spearman rs=0.64, p<0.001) whilst no such association could be demonstrated between the A260/A280 ratios and RIN score 
(Spearman, rs=0.23, p>0.05).  
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5.4.2 Analysis of gene expression study 
5.4.2.1 RNA quality control check 
In total, there were 32 samples were subjected to microarray experiment consists of 8 
naive controls and 24 treated samples that were subjected to brushing at various time 
points. The details of the samples and their RIN scores, initial RNA concentration, 
aRNA volumes for hybridization process are shown in the Supplement 8 on CD. The 
first quality control check for the RNA samples was carried out immediately after 
isolation using the conventional spectrophotometric method of RNA quantification. The 
A260/A280 ratios for all samples were within the “very good” range of RNA purity 
between of 1.9 to 2.15 while the average RNA concentration was 109.2±77.67 ng/µl. 
The second quality control check was performed using the Agilent 2100 Bioanalyzer to 
assess the RNA integrity and quality. An average RIN score of 7.42 ± 0.63 was 
achieved. For a number of samples, the Agilent recommended threshold for microarray 
analysis (RIN>7.0, Talbot R, personal communication) could not be achieved, even after 
several optimisation steps, therefore the  minimum RIN score accepted for subsequent 
microarray analysis was lowered to 6.0. The appearances of the 18S and 28S ribosomal 
peaks were also taken into consideration. During the quality control check, overall, 4/6 
samples belonging to the day 1, 2/6 from day 3 and 1/6 samples each for days 0 and 7 
post injury groups had a RIN score < 7. Two of these had RIN score <6.5 (RIN 6.0 for 
6-hour sample and RIN 6.2 for day 1 sample). Overall 94% (n=30) of the samples had a 
RIN score more than 6.5. A Pearson correlation coefficient test demonstrated that 
neither RNA concentration nor A260/A280 ratios were predictive of the RIN for the RNA 
samples (p>0.05) – (Figure 5.6). Similarly, there was no correlation (p>0.05) between 
the time from injury and the RIN number obtained for RNA samples – data not shown.  
 
The third quality control check was at the amplification stage where the sizes of the 
amplified RNAs (aRNA) were measured. The required size distribution range for 
reproducibility and optimal microarray performance is between 300 to 4000 nucleotides 
(Talbot R, personal communication). At this stage, eight of the amplified samples (Table 
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5.6) had unacceptable size ranges of approximately 500-1000 nucleotides. This failure 
did not appear to be dependent on the RNA integrity and RNA concentration (the means 
of the concentrations of these samples were 49.07±17.81ng/µl). However, increasing 
both the annealing time and the amount of the Transcriptase enzyme for the cDNA 
synthesis for these eight samples gave improved average sizes of around 2000 
nucleotides which are in line with the manufacturer’s minimum expectations (Ambion, 
Applied Biosystems). The average peak sizes for the majority of samples were around 
3000 nucleotides.  
 
Samples ID Time points 
(days) 
RIN 
8039-8B 0 7.7 
45-3B 1 7.5 
8003-8B 1 6.3 
8020-4B 0 8.1 
8003-3B 0 6.2 
8038-8B 0 7.8 
7958-8B 1 7.5 
8020-8B 0.25 6.3 
 
Table 5.6: Samples which generated oligonucleotides with lower average sizes.   
Table shows the RIN for samples which performed poorly in the amplification process and the time points 












Figure 5.6: An association between the effect of the RNA concentration and RNA purity measured by spectrophotometer with the RNA integrity 
numbers (RIN) measured by Agilent Bioanalyzer.  




5.4.2.2 Quality control of the microarray output 
In order to ensure their reproducibility and reliability, the outputs generated from the 
Agilent Feature Extraction (FE) software were analysed. The QC reports from the FE 
software output for all 32 arrays are provided in the Supplement 9 on CD. The raw data 
files for each array (32 arrays in total) are provided in the Supplement 10 on CD. JPEG 
(Joint Photographic Experts Group standard) images for all 8 slides which contain 32 
arrays are shown in the Supplement 9 on CD. The standard QC metrics for one colour 
arrays include spot finding of the four corners of each array, spatial distribution of the 
outliers and the histogram of the signals across all non-control probes. The FE output 
profiles of the arrays used in this study indicated that the microarray data generated were 
reliable and of good quality. In this regard the quality control reports from the feature 
extraction showed that there were no spatial abnormalities and the spike in control 
profiles in both the feature extraction and other analysis programs (i.e GeneSpring) 
showed that the arrays were performing normally and no array(s) were performing 
exceptionally in this regard. Indeed the chip spike-in control signal profiles behaved 
similarly and that there were no obvious outliers. The presence of outliers might have 
raised questions regarding RNA quality and prompted further analysis to relate RNA 
quality metrics to array QC metrics. Further data analysis using GeneSpring identified 
that samples with small fragment sizes tended to cluster separately to the bulk cluster on 
the principal component analysis (PCA) plot. However QC metrics from those samples 
were, as previously indicated, considered normal and it was adjudged that those samples 
did not differ to such an extent that excluding them from further analysis would be 
warranted (data not shown). Figure 5.7 shows a representative image of the overall 
distribution of the outliers of the array in which the distribution of the fluorescence 
signals across the microarray indicated that the hybridization process was achieved in an 
even and unbiased manner  (the rest of the images are shown in Supplement 9 on CD for 





Figure 5.7: A representative image of the spatial distribution of the outliers which extracted from 
the feature extraction software. This image taken from the slide 1, Array_1_3 and the sheep 7958 (6 
hours time point). For one colour platform, only green colour appears. This view is a way to 
visualize in the spots rejected (background or non uniform) are organized in a certain way. The 





In this study, examination of the spatial distribution of all outliers on the arrays 
demonstrated no systematic bias within arrays. In terms of between-array and between-
slide normalization, a plot of the log2gMean signals across the four slides, organised 
according to column and row position on the slide indicates that there is no systematic 























Boxplot of Log2GMean vs Slide, Column, Row
 
Figure 5.8: A normalization between-array and between-slide. A plot of the log2gMean signals 
across the four slides, organised according to column and row position on the slide indicates that 
there is no systematic (ie shared between all slides) bias detectable 
 
The spread of the intensity log ratios is largely similar across slides and importantly 
there is no evidence of spatial bias. These observations, in conjunction with the 
additional knowledge that the time points were randomly allocated between rows within 
columns (sheep), indicate that any detected significant differences in gene expression 
between time points are more likely to be a true reflection of biological variation and not 




5.4.2.3 Changes in airway gene expression induced by bronchial brushing  
The gene expression changes at the brushed sites were evaluated by comparing the 
gMeanSignal expression values for each of 15015 probes at each of the time points (n=6 
samples per time point) with those of the corresponding paired naïve samples (day 0). 
The expression level of a gene derives from the number of bound mRNA molecules as 
measured by the green fluorescence intensity in the microarray experiment.  
 
A linear mixed model was fitted by REML to intensity observations transformed to 
logarithms base 2 for each probe separately using Genstat commands and procedures. In 
the first analysis, the model included random variation from three sources: between 
Agilent slides, between sheep within slides and between samples within sheep, and 
treatment effects, ignoring any interaction between Time points and Protocol. However, 
there was evidence of an interaction between Time points and Protocol in many probes. 
The shape of the Time point profile showed variation with Protocol over and above that 
expected by chance. This is indicated by the backward J-shaped frequency histogram of 
the significance probabilities (Figure 5.9) associated with the Time point x Protocol 
interaction for each probe, as described by F statistics derived from Wald statistics 
(analogous to variance ratios in analysis of variance). Significance probabilities would 
be expected to follow a uniform distribution (level across the range 0-1) if interaction 
was zero in all probes. 
 
This interaction could be due to a systematic effect of the timing of injury on the 
expression profiles over time, which would require further investigation. It could also be 
a chaotic interaction (i.e. with no coherent pattern) caused by factors involved in the 
management and treatment of sheep and the collection and processing of samples prior 
to the microarray process.   
 
Assuming the latter, an additional linear mixed model was fitted which included the 
Time points x Protocol interaction as a further source of random variation. Estimates of 
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effect sizes and fold changes remained unaltered by this but standard errors and 
significance probabilities generally increased in the model with no interaction        
(Table 5.7). The significant changes observed from the statistical analysis of microarray 
data are considered up- or down-regulated based on the values of fold changes in which 
fold change <0.5 (expression down-regulated), >2.0 (expression up-regulated) and 
0.5>FC<2.0 (unchanged).   
 


















Figure 5.9: Figure shows the backward J-shaped frequency histogram of the significance 
probabilities of interaction between the time points and the protocols. 
Frequency histogram of the significance probabilities associated with the Time point x Protocol 
interaction for each probe, as described by F statistics derived from Wald statistics (analogous to variance 
ratios in analysis of variance). Significance probabilities would be expected to follow a uniform 



















Number of probes 
achieving statistical significance 2: 
  >2 <1/2 p<0.05 p<0.01 p<0.001 
       
6 hrs vs 
Naive 
46 301 801 4236 2133 668 
1 day vs 
Naive 
27 463 240 2340 1031 395 
3 days vs 
Naive 
39 475 413 3040 1345 457 
7 days vs 
Naive 
47 292 173 2317 796 206 
        
gMeanSignal : Random interaction Time points x Protocol 
 
6 hrs vs 
Naive 
37 301 801 2659 842 96 
1 day vs 
Naive 
15 463 240 1325 435 91 
3 days vs 
Naive 
28 475 413 1797 552 77 
7 days vs 
Naive 
38 292 173 1175 243 20 
 
Table 5.7: Output of two different statistical models 
Two different statistical models were tested in order to compare between probes in treated samples for 
each time points with naive control samples (time point 0) in which models were fitted with first, with no 
interaction between Time points and second, with a random interaction. There was a lower percentage of 
probes differentially expressed when model was fitted with Time points and Protocol as random 
interaction. However, no difference was found in terms of the number of probes with fold changes either 
>2 and/or <1.5. There were also lower numbers of probes achieving statistical significance with a random 
interaction.  
 
1 estimated using a uniform-beta mixture distribution of significance probabilities (Allison et al., 2002)  







A further analysis of the data was performed assuming a fixed interaction between Time 
point and Protocol. For the most part, significance probabilities of effects determined via 
the random interaction model are conservative at lower values of probability compared 
with those of the average effects in the presence of a fixed interaction. We chose to 
move forward with the output from the analysis with the fixed interaction. The reasons 
for considering the time point and protocol interaction in microarray statistical analysis 
was due to the complexity of the experimental design for this study. The complexity of 
the experimental design includes multiple brushing given to the same sheep at different 
time points and each of the sheep was subjected to the different combination of the time 
points.  Introduction of these two components (timepoints and protocols) during the 
experiment, has indirectly introduced another sources of variation which might be 
contributed to the changes in expression profiles observed. Therefore, these two sources 
of variation cannot be ignored in which preliminary analysis revealed that protocols and 
time points contributed to the expression of the probes. This was also supported by the 
morphometric analysis and also preliminary experimental design for Protocols A and B 
in which even though the proliferative response in both protocols were pretty much 
similar, at specific time points (days 1 and 3) some variations (differences) were 
observed. Significance probabilities (for all probes at different time points following 
injury vs naive airway (time point 0)) were calculated approximately using an F 
distribution with degrees of freedom 2 and 12.  The proportion of probes with such 
interactions was estimated by a Bonferroni method. 
 
In this analysis, the numbers of probes with significant changes in expression at the 
given p-values were determined (Table 5.8). Across all time points there was a total of 
13,495 probes that were significantly changed at the p<0.05 level. The highest number 
of changes was at 6 hours and the lowest at day 7. Amongst the 13,495 probes, there are 
6,420 probes been annotated (details of the annotation process will be discussed in the 
Chapter 6). These 6,420 annotated probes were used for downstream application for the 
gene functional and pathway analyses. The list of 6,420 probes and the details of 
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Table 5.8: Statistical analysis of microarray data using a linear mixed model with a fixed interaction 
between the time points and protocols. 
Table illustrates the numbers of probes that are differentially expressed at each time point either by fold 












5.4.2.4 Validation of microarray study  
5.4.2.4.1 Ki67 vs PCNA 
Further molecular analysis was performed to validate the array data for the proliferating 
cell nuclear antigen (PCNA) gene expression with Ki67 staining data – both of which 
are involved in proliferative activity. In the array experiment, the PCNA gene was 
highly significantly change at day 3 post injury (p=0.002) with fold change of 3.23 
whilst no change at day 1 (p<0.001; FC=1.0) when compared to the naïve airway (time 
point 0). This compares favourably with the morphometric analysis of Ki67-stained cells 
where proliferative activity was also significantly increased (p<0.05) from day 1 to day 
7 post injury when compared to naive.  
 
In order to compare these two datasets, the Ki67 counts for damaged and transition areas 
from treated airways were combined since this is the equivalent region harvested for the 
gene expression study. The dataset for naïve control airways (time point 0) were 
included. Statistical analysis was performed to assess the correlation between PCNA 
array data and positive Ki67 cell counts (equivalent bronchial brushing sites from the 
same sheep at same time point). A correlation coefficient test was performed using 
Pearson with p<0.05 considered significant. The data shows a correlation between 





Figure 5.10: A comparison of the two indicators of cell proliferation   
Figure illustrates a) the profiles of PCNA expression (p<0.05 compared to naive at days 1 and 3) and Ki67 positive cell counts (p<0.05 at all time points 
except 6 hours) over time and b) Correlation between paired Ki67 counts and PCNA expression levels (r = 0.45, p = 0.008). Box plots on the left panels 
for PCNA were plotted based on the mean values of green signal density (gMeanSignal) whilst the Ki67 was plotted based on the absolute numbers Ki67-
positive cells counted during morphometric analysis (Chapter 4; Section 4.4.5 –damaged and transitional areas). To generate the correlation between Ki67 
vs PCNA, the count data for Ki67 staining for damaged and transitional areas (Chapter 4; Section 4.4.5) corresponding to the areas used for microarray 
experiment were used. Upper and lower box plot margins represent the interquartile range; middle bar indicates the median. Scatter plot on the right panel 
was plotted based on the data from the left panels which were logged-transformed.   
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5.4.2.4.2 AB-PAS staining vs mucus-related genes 
This analysis was performed to validate the array data for genes related to mucus-
production with the AB-PAS positive cell staining data. Although there are many genes 
associate with the mucus production in the airway, for the purpose of this study, we only 
selected genes from the array data for interleukin 4 (IL4) and interleukin 13 (IL13) 
based on the fact that these genes play a role in mucus production in response to injury 
and repair (Dabbagh K et al., 1999, Shim JJ et al., 2001 ). Expression of these genes was 
unchanged throughout the times following brushing (Table 5.9). The expression patterns 
for both genes can be seen in the (Figure 5.11). From the array experiment, it shows that 
the IL4 gene was significantly unchanged at day 1 and day 7 post injury (FC at 0.94 and 
0.93, respectively). The IL13 gene was also significantly unchanged at day 3 post injury 
(FC at 1.16). Expression of other genes that relate to the mucus production such as 
EGFR and TNF-alpha were not significantly altered.  
 
In order to assess whether the distribution of AB-PAS positive stained cells correlated 
with the expression of these genes, the AB-PAS positive cell count data from treated 
airways were adjusted to include only the data for damaged and transition areas for each 
segment since this is the equivalent region harvested for the gene expression study.  
However, only the undamaged data for naïve control segments were included. The 
absolute numbers of AB-PAS positive cells count and gMeanSignal were both normally 
distributed. As described for the Ki67 staining dataset, the data were transcribed 
according to the sheep ID, time points and the number of AB-PAS stained counted. 
Statistical analysis was performed by using a Pearson correlation coefficient test with 
p<0.05 was considered significant. Neither the expression of these genes had significant 
correlation with the number of goblet cells on the correspond areas of measured 









Table 5.9: The significant probabilities and fold changes of the IL4 and IL13 genes over the time of injury 
The IL4 gene was significant changed (p<0.05) at day 1 and day 7 post injury whilst IL13 gene was only significantly changed (p<0.05) 
at day 3 post injury.  
 
 
Figure 5.11: The expression patterns of the IL4 and 13 genes based on the fold changes across the time of injuries. A similar data 
 was taken from (Table 5.9). 
  The significance changes observed from statistical analysis of microarray data are considered up- and/or down-regulated based on the  
  values of fold changes between <0.5 (down-regulated), >2.0 (up-regulated) and 0.5>FC<2.0 (unchanged). 
Time points (days) 0.25 1 3 7 
Genes IL4 IL13 IL4 IL13 IL4 IL13 IL4 IL13 
FC 0.93 1.1 0.92 1.1 0.97 1.1 0.93 1.0 




Figure 5.12: An association between interleukin genes IL4 and IL13 plotted against number of AB-PAS stained cells. 









5.4.2.4.3 Semi-quantitative RT-PCR analysis  
Semi-quantitative RT-PCR assay was performed to validate 9 genes including IL6, 
keratin 19 (KRT19), keratin 6A (KRT6A), cell division cycle 2 (CDC2), cyclin B1 
(CCNB1), Cyclin B2 (CCNB2), keratin 5 (KRT5), tubulin beta (TUBB) and catenin 
beta-like 1 (CTNNBL1) – (Table 5.10). All the PCR conditions (cycles and temperature) 
for both genes of interest and internal control (ATPase) were successfully optimised. 
The RT-PCR assays were developed and the genes of interest successfully amplified. 
The amplified signals were quantified from agarose gels relative to the expression of the 
ATPase gene. The expression values detected by RT-PCR assay for these genes were 
compared with the gMeanSignal expression values detected by the array. Majority of the 
samples (for array dataset) were Log-transformed to the LoggMeanSignal since the data 
were not normally distributed. The expression profiles were plotted as a mean value 
(±SD) for each array (n=4 for each time point – data equivalent to the dataset for RT-
PCR) and semi-quantitative RT-PCR (n=4 for each time point) data – (Figure 5.13). 
Pearson correlation coefficient tests showed that the expression values detected by the 
semi-quantitative RT-PCR assay had significant correlation with the expression values 




































KRT6A 24.30 55.51 75.87 43.47 p<0.001 p<0.001 p<0.001 p<0.001 
 
IL6 54.40 54.72 23.65 4.39 p<0.001 p<0.001 p<0.001 0.028909 
 
KRT19 7.33 16.99 20.43 13.50 p<0.001 p<0.001 p<0.001 p<0.001 
 
CDC2 0.73 5.29 7.39 2.47 0.218 p<0.001 p<0.001 0.002193 
 
CCNB1 0.82 7.78 7.78 2.87 0.254 p<0.001 p<0.001 p<0.001 
 
CCNB2 1.05 3.77 4.56 2.21 0.815 p<0.001 p<0.001 0.002 
 
KRT5 1.50 2.40 2.50 1.79 0.059 p<0.001 p<0.001 0.011 
 
TUBB 1.15 2.14 1.48 1.56 0.148 p<0.001 0.001 p<0.001 
 
CTNNBL1 0.90 1.14 0.92 0.73 0.557 0.426 0.639 0.091 
   
  Table 5.10: A list of genes subjected for a validation study using a semi-quantitative RT-PCR assay 
A significant probability and fold changes observed for each time point (n=32 samples in total) calculated using a linear mixed model 




















Figure 5.13: Semi-quantitative RT-PCR expression profiles compared to Microarray data for selected genes. 
RT-PCR analysis for genes of interest (left panels). A 100bp marker was used to estimate the DNA sizes. The PCR products at the bottoms are the product 
for ATPase whilst at the upper lines are the products for the genes of interest. The mean values for both data – RT-PCR (semi-Q) and gMeanSignal 
(Array) were plotted across the time of injuries. Most of the gMeanSignal for array dataset were Log transformed since not normally distributed. X-axis 
shows the time points of where the samples were collected following brushing and time point 0 refers to the samples taken from naive control segments, 
and the Y-axis shows the mean values of four samples for each time point, for both RT-PCR assay (relative to the ATPase) and array (intensity of green 





Figure 5.14: A correlation coefficient test between the data from microarray (gMeanSignal) and a semi-quantitative RT-PCR assay (relative to 
the ATPase) for the genes subjected for validation study. 
The X-axis shows the log transformed array data and the Y-axis shows the semi-quantitative RT-PCR for each sample (n=4 for each time point – relative 
to the ATPase). All genes show a positive correlation (p<0.05) between microarray data and a semi-quantitative RT-PCR assay for the selected samples 
except for the CTNNBL1 gene. (* Semi-Q = semi-quantitative RT-PCR)
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In order to understand the patterns of genes expression regulation in all annotated probes 
which significantly expressed at p<0.05, the average effects were plotted according to 
the time points (Figure 5.15). This figure shows that the numbers of probes been up-
regulated were increased over the time following injury in which most of the 














6 hours Day 1 Day 3 Day 7
 
Figure 5.15: The profiles of the significantly regulated probes following bronchial brushing  
This figure was plotted based on the average effect values obtained from the statistical analysis for all 
annotated probes that significantly expressed following injury. The x-axis shows the list of the probes and 
y-axis shows the average effect of the probes which are listed from highest to lowest values in each time 
points. The average effect values plotted in this graph is taken from the data presented in the Appendix 6.1 
(on CD) of “effect” in the coumn H. Since the values for the average effect reflects the fold changes of the 
probes, by looking at this figure one could expect to have the high fold changes with the increase of 
average effect values. The chages of the probes considered up-regulated if the average effect >1, down-
regulated < -1 whilst no changed if -1 > average effect <1. The 6 hours time point shows a massive 
numbers of genes been regulated following a bronchial brushing, however majority of the regulated genes 
at this time point are down-regulated and unchanged. The numbers of up-regulated genes are gradually 





Due to the massive numbers of genes that being significantly altered following bronchial 
brushing, it is impossible to highlight all these genes in this chapter. One way of 
presenting this dataset is to extract the genes with most robust changes in both up- and 
down-regulated. A number of genes that exhibited greater than 10-fold increases in 
expression were identified (Table 5.11). Most of the genes that were highly up-regulated 
are involved in cytokine activity, immune and inflammatory responses and response to 
wound such as metallothionein 1E (MT1E), chemokine (CXC motif) ligand 5 (CXCL5), 
lipopolysaccharide binding protein (LBP), pentraxin 3 (PTX3), interleukin 6 (IL6), 
selectin P (SELP) and interleukin 8 (IL8), cellular proliferation and differentiation 
[keratin 6A (KRT6A), keratin 19 (KRT19), ADAM metallopeptidase domain 12 
(ADAM-12)], and cellular migration and adhesion [thrombospondin-2 (THBS2), 
olfactomedin 4 (OLFM4), SELP, ADAM12 and IL8). Amongst those down-regulated 
changes were pulmonary surfactant-associated protein A2B (SFTPA2B), surfactant 
protein C (SFTPC), CD5 molecule-like (CD5L), complement component (3d/Epstein 
Barr virus) receptor 2 (CR2), macrophage receptor with collagenous structure 
















0.25 1 3 7 
A_70_P021596 DY511316 ADAM12  ADAM metallopeptidase domain 12 2.26 3.77 11.08 16.36 
A_70_P054711 EE770225 AGP Alpha-1 acid glycoprotein  1.16 1.93 8.20 13.60 
A_70_P030361 NM_001009366 BLG Beta-lactoglobulin 6.76 15.17 15.64 3.46 
A_70_P002816 AY392761 CHI3L1 Signal processing protein 5.00 11.04 5.40 3.53 
A_70_P001891 EE774505 COL1A1 Collagen, type I, alpha 1 1.17 1.96 10.81 8.25 
A_70_P059886 DY496997 COL1A1 Collagen, type I, alpha 1 1.24 1.44 9.38 13.35 
A_70_P030126 NM_001009733 CP Ceruloplasmin 6.17 24.16 13.97 3.76 
A_70_P030127 NM_001009733 CP Ceruloplasmin 8.34 32.22 19.14 4.86 
A_70_P058706 FE033277 CXCL5 Chemokine (C-X-C motif) ligand 5 (CXCL5) 11.25 14.56 18.55 6.17 
A_70_P038041 EE791827 HP Haptoglobin (HP) 19.55 32.51 12.05 5.54 
A_70_P039706 NM_001009392 IL6 Interleukin 6 54.40 54.72 23.65 4.39 
A_70_P039661 NM_001009401 IL8 Interleukin 8 10.74 6.06 27.23 8.40 
A_70_P039662 NM_001009401 IL8 Interleukin 8 9.16 5.30 25.35 7.50 
A_70_P002596 EE860756 KRT19 Keratin 19 (KRT19) 7.33 16.99 20.43 13.50 
A_70_P068966 EE837811 KRT6A Keratin 6A (KRT6A) 24.30 55.51 75.87 43.47 
A_70_P045231 EE787299 LBP Lipopolysaccharide binding protein (LBP) 44.82 49.20 13.41 4.52 
A_70_P026536 AF267156 MMP-1 Interstitial collagenase 3.50 3.67 20.74 3.20 
A_70_P026761 DY513601 MMP-13 Matrix metalloproteinase 13 1.40 1.35 15.37 10.84 
A_70_P037411 EE798177 MT1E Metallothionein 1E (MT1E) 110.22 59.84 15.15 2.27 
A_70_P009666 EE765361 MT-2 Metallothionein 2A  13.99 14.71 11.74 2.56 
A_70_P064826 EE851232 OLFM4 Olfactomedin 4 (OLFM4) 14.21 22.43 4.82 1.39 
A_70_P010836 EE829599 PTX3 Pentraxin-related gene, rapidly induced by IL-1 beta 10.79 6.92 2.75 1.85 
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A_70_P004271 EE804747 RRM2 
Ribonucleotide reductase M2 polypeptide transcript variant 3 
(RRM2) 0.60 13.80 9.23 4.82 
A_70_P019681 EE866720 SAA3 Serum amyloid A 3 (SAA3) 14.96 20.68 14.74 9.67 
A_70_P039517 NM_001009295 SELP Selectin P (granule membrane protein 140kDa, antigen CD62) 10.97 12.06 4.47 2.09 
A_70_P060116 EE772499 THBS2 Thrombospondin 2 1.81 2.03 5.09 10.53 
A_70_P038291 EE830791   2.02 2.82 7.77 10.09 
 
Table 5.11: The list of significantly up-regulated genes with the FC more than 10 at any given time of injury (in bold) 




























Table 5.12: List of significantly down-regulated genes with the FC more than 10 at any given time of injury (in bold) 
Majority of these genes are involved in regulation of liquid surface tension, respiratory gaseous exchange, homeostasis process and defence response. 
There are more than one probes encode for the same genes. 
Probenames TargetID GeneSymbols GeneName 
 Fold change  
6 hours Day 1 Day 3 Day 7 
A_70_P051201 NM_001009721 GHRL ghrelin/obestatin prepropeptide 0.451277 0.338967 0.231581 0.07697 
A_70_P051202 NM_001009721 GHRL ghrelin/obestatin prepropeptide 0.390526 0.317788 0.193863 0.062363 
A_70_P045486 EE862425 CYP2B cytochrome P450 subfamily 2B  0.191148 0.217368 0.074232 0.42846 
A_70_P019746 EE788235 HSD17B11 hydroxysteroid (17-beta) dehydrogenase 11 0.121486 0.216232 0.092625 0.612878 
A_70_P019656 EE789897 ADH1C alcohol dehydrogenase 1C (class I), gamma polypeptide 0.103437 0.10427 0.072873 0.346057 
A_70_P030377 NM_001009189 SHEUGT1A07 UDP-glucuronosyltransferase 0.097427 0.133277 0.100579 0.452924 
A_70_P045421 EE790996 BSP30C common salivary protein BSP30 form C 0.097156 0.162488 0.111051 0.342399 
A_70_P045421 EE790996 BSP30C common salivary protein BSP30 form C 0.097156 0.162488 0.111051 0.342399 
A_70_P003891 FE033669 CLDN18 claudin 18 0.084601 0.126006 0.08729 0.410856 
A_70_P041841 S79795 CYP1A1 cytochrome P4501A1 0.074732 0.110169 0.059738 0.300586 
A_70_P020236 EE786153 BSP30C common salivary protein BSP30 form C 0.071274 0.132524 0.086807 0.34502 
A_70_P039392 NM_001009724 CR2 complement component (3d/Epstein Barr virus) receptor 2 0.064773 0.13942 0.183443 0.579722 
A_70_P045261 EE825133 MARCO macrophage receptor with collagenous structure 0.051556 0.092943 0.043158 0.427027 
A_70_P039391 NM_001009724 CR2 complement component (3d/Epstein Barr virus) receptor 2 0.04813 0.118102 0.17051 0.429781 
A_70_P014851 CN821988 CD5L CD5 molecule-like 0.043726 0.089881 0.057625 0.431331 
A_70_P039301 NM_001009729 SFTPC surfactant protein C 0.041848 0.0998 0.128709 0.260685 
A_70_P051276 NM_001009728 SFTPA2B pulmonary surfactant-associated protein A 0.030921 0.125114 0.079272 0.215829 
A_70_P039302 NM_001009729 SFTPC surfactant protein C 0.030805 0.081981 0.09456 0.225396 




5.5  DISCUSSION 
The main objectives of the study presented in this chapter were to optimise the integrity 
and quality of the RNA samples isolated from the cartilaginous airway tissues for the 
microarray study, and to investigate the expression profiles involved in airway 
regeneration and repair. RNA yield as well as quality and integrity are crucial elements 
for success and reliability of microarray-based expression profiling for thousands of 
genes in a single assay. However, a lower RNA yield is expected in the lung tissue 
compared to other solid organs (Fleige S et al., 2006) due to the presence of cartilage 
tissue in the airway. Cartilage in airway samples presents potential problems in RNA 
isolation as cartilage has low cell content and contains an extracellular matrix rich in 
proteoglycans, which tend to co-purify with the RNA (Fleige S et al., 2006). 
 
In the present study, quality of the isolated RNA was initially assessed by conventional 
UV spectrophotometric absorbance. The A260/A280 and A260/A230 ratios reflected RNA
 
purity, but were not informative regarding the integrity of the RNA (Imbeaud S et al., 
2005). Low A260/A280 ratios are indicative of protein
 contamination, whereas low 
A260/A230 ratios serve to indicate the absence of residual contamination by organic 
compounds such as phenol, sugar or alcohol, which could be highly detrimental to 
downstream applications (Imbeaud S et al., 2005). Sambrook and colleagues (1989) 
suggested that a A260/A280 ratio of greater than 1.8 indicates a good quality of the RNA 
(Sambrook J et al., 1989). However, it was reported that samples with A260/A230 ratios 
<1.8 did not exhibit any inhibition during downstream applications such as cDNA 
synthesis and labelling or in vitro transcription (Imbeaud S et al., 2005).  
 
The current accepted standard for expressing information pertaining to RNA quality and 
integrity is the RNA integrity number (RIN). The RIN score is generated as part of the 
Agilent 2100 bioanalyzer platform and represents the results of an algorithm applied to 
the electropherograms (Schroeder A et al., 2006 ). Thus the quality and integrity of the 
samples assessed in this study was not determined simply by the ratio of the ribosomal 




RIN therefore takes into consideration the ratio of the 28S:18S ribosomal RNA 
peaks,.the appearance of additional peaks and elevation of the baseline in the region 
between ribosomal peaks (Copois V et al., 2007). Indeed, in relation to the 28S:18S 
rRNA ratios, a study by Imbeaud S et al., (2005) cast doubt on their value as a gold 
standard for assessing RNA integrity. Whilst these authors found that there was no 
correlation between 28S:18S ratios and RNA integrity, RNAs with 28S:18S >2.0 were 
usually of high quality and 28S:18S ratios >1.0 were reported to be of good quality 
(Imbeaud S et al., 2005).  
 
In the context of our preliminary study of optimising the RNA preparation for the 
microarray experiment, the integrity of the RNA was assessed using the RIN score. 
Initial RNA samples from 30mg cartilaginous airway tissue failed to generate good RIN 
values although the average of the A260/A280 ratio for all samples was greater than 1.8 
(Table 5.3 and Figure 5.4). This study demonstrated that there was no association 
between A260/A280 ratio and RIN score (Figure 5.5; right panel). Increasing the amount 
of airway tissue used in RNA preparation to 100mg generated acceptable RIN values for 
the majority of samples although some of the RIN scores were still below the Agilent 
quality control standard (RIN ≥7). Whilst the profiles of the two ribosomal bands can be 
seen very clearly in those samples with RIN below 7 (particularly those with RIN 
between 6 and 7), the profiles also reflect the appearance of additional peaks before the 
18S peak – which may be due to the presence of short fragments of degraded RNA – 
(Figure 5.3). The height of the 28S peak contributes additional information about the 
state of the degradation process since the 28S band disappears faster than the 18S band 
thus allowing early detection of the degradation process (Schroeder A et al., 2006 ). As 
we were unable to consistently achieve a RIN ≥7 with the cartilaginous airway tissue, an 
internal compromise on this target was forced, and RINs in excess of 6.0 were 
considered acceptable as long as both ribosomal peaks were clearly observed and their 
presence not obscured by additional peaks before and between these ribosomal bands. 
The low RIN score may be a feature of dealing with RNA from lung tissue samples. 




reported that the average RIN score for lung tissue was 6.55±0.67 (Fleige S et al., 2006, 
Fleige S and Pfaffl MW, 2006) whilst RIN scores as high as 9.62±0.32 were obtained 
from Corpus luteum (Fleige S and Pfaffl MW, 2006).      
 
Low RIN scores normally associate with degraded RNA samples and such degradation 
can often cause a problem when handling RNA samples extracted from formalin-fixed, 
paraffin-embedded (FFPE) tissue (Farragher SM et al., 2008). However, a study by 
(Roberts L et al., 2009) reported that microarray data generated from FFPE samples 
from lung and colon tissues were comparable with data from frozen samples. Whilst the 
RIN scores in the former instance were relatively low (RIN> 4) distinct peaks of 18S 
and 28S rRNA were observed. This study demonstrated that such samples (clear 18S 
and 28S ribosomal RNA peaks and RIN>4) can reliably generate microarray data with 
greater than 35% of the probe sets detected as present and indeed would usually generate 
sets with greater than 50% detected. Conversely significantly degraded and modified 
samples, those without distinct 18S and 28S peaks, had less than 35% probe sets 
detected as present on the microarray (Roberts L et al., 2009).  
 
The present study revealed that a larger amount of starting material of the airway 
samples gave an increased concentration of RNA and generally resulted in improved 
RNA integrity. However, a more robust analysis involving the samples for the 
microarray study showed that there was no correlation (p>0.05) between RNA 
concentration or A260:A280 ratio and RIN score. After several optimization strategies 
failed to consistently achieve improved quality and integrity of RNA, concerns were 
raised that  this might be an issue specific to extraction of RNA from cartilaginous 
airway tissues and hence could negatively impact on our strategy of following molecular 
changes in the airway wall using such samples. To assess this issue we compared the 
RNA quality obtained from different lung tissue types (cartilaginous airway vs 
parenchyma vs bronchial brushing). We observed that the quality of RNA extracted 
from cartilaginous airways was consistently poorer than that obtained from other lung-




parenchymal samples were of optimal quality (>7). Notably, despite the relatively poor 
yields of RNA obtained from the small bronchial brushing samples used in this study, 
the quality of RNA isolated from such samples was considered excellent. This concurs 
with reports describing the transcriptomic analyses of bronchial brushing samples 
obtained from lung transplant patients where such samples, which contain a relatively 
pure cell population of >90% bronchial epithelial cells (Skawran B et al., 2009), 
generated high quality RNA for microarray analysis (Raman T et al., 2009, Skawran B 
et al., 2009). However, in the context of studying changes in the cellular and molecular 
aspects of airway repair, such samples will potentially not reflect the contribution of 
non-epithelial compartments (such as glands and smooth muscle) which may be 
important in the process of airway repair. 
 
The findings from this preliminary study were used as a baseline for the microarray 
study in relation to obtaining optimal RNA integrity from the cartilaginous airways 
samples. Although the majority (> 90%) of the samples have good RNA quality and 
integrity scores, some of the RNA samples with a high RIN (≥7.5) failed to generate the 
optimal sizes of the amplified RNA (aRNA) during the amplification process. The 
presence of short fragment sizes might be due to the presence of an inhibitor in the RNA 
samples that blocked the whole amplification process. The bottle-neck appeared to be at 
the reverse transcription stage since a combination of increased amount of enzyme and 
incubation time was sufficient to overcome the problem. There are several types of 
inhibitors that could have been present in our samples. One of the ‘classics’ is lithium 
chloride which is commonly used as a co-precipitant for RNA precipitations and is 
known to inhibit RT enzymes. However, this was not the case in our samples since we 
used a linear acrylamide to deal with the low amounts of RNA for precipitation step. 
Although we had to compromise on the acceptable RIN limit for a small number of 
RNA samples (RIN > 6 compared to the Agilent suggested RIN ≥7), the actual 
microarray data output suggested that the data generated from these samples were 





In relation to the microarray data analysis, it should be recognised that there are 
alternative approaches to the method of analysis described here. We chose to perform 
tha analysis on the gMean signal dataset on the advice of our experienced statistician 
however there is some debate over whether the gMean or gProcessed signal datasets are 
the most correct for downstream application in statistical analysis of the microarray data. 
 
In relation to the output measures from the feature extraction protocol the gMeanSignal 
is considered one of the basic values. This “raw” signal is calculated from the pixel 
intensities contained within an “inlier” region of the spot and thus does not consider 
intensities relating to saturated, or not "well above background" pixels. Selection of the 
inlier region is often likened to the use of a “cookie cutter” (American terminology) 
where the best (middle) part of the dough is kept for baking and the rest discarded. 
 
To get the gProcessed value the BG subtracted gMean signal is divided by the 
gMultDetrendSig value. Multiplicative detrending is used to perform an error 
compensation to compensate the heterogeneity of signal across the array (the "dome 
effect", which is due to the hybridization dynamic in the hybridization chamber). This 
adjustment is often more useful when intensities are higher. Whenever the BG 
subtracted gMean signal falls below a certain threshold (that appears to be close to the 
BG estimate (gLocalBGInlierAve)), a surrogate value is used. Feature Extraction 
calculates this surrogate signal from the standard deviation (SD) of the background used 
for that feature. When the “No Background” option is chosen, the SD is the pixel level 
SD of the local background. These SDs are reported in the Feature Extraction output 
columns, “gBGSDUsed” 
 
Although the overall analysis carried in this thesis was based on the gMeanSignal 
generated from the Agilent FE software rather the gProcessedSignal, the same approach 
for statistical analysis was carried out for the gProcessed signal dataset using a fixed 
interaction between the time points and the protocol. The statistical analysis output 




in some cases) with fold change <1/2 or >2 the numbers of probes statistically 
significant at the 5% level are lower by 3% to7% across time points. Both statistical and 
biological significance should be used to indicate differential expression. If a fold 
change of <1/2 or >2 is regarded as biologically significant then gProcessedSignal gives 
higher numbers of probes which are both statistically significant at 5% and have fold 
change <1/2 or >2 in all time effects considered. With this criterion it seems unlikely 
that the use of gMeanSignal rather than gProcessedSignal has over-estimated the number 
of differentially expressed probes. In addition to this it is however useful to consider 
how many probes selected via gMeanSignal would also have been selected using 
gProcessedSignal. If a subset of probes is selected for further investigation or discussion 
using the criterion of statistical significance and fold change mentioned above then 
nearly all probes (in excess of 98%) selected using gMeanSignal would also be selected 
using gProcessed signal. The details of the statistical analysis outputs are shown in the 
Supplement 11 on the CD. 
 
The rationale for subtracting a measure of background from the signal intensity is the 
assumption that the fluorescence of a spot is the sum of signal intensity and some 
background noise which is due to a variety of technical factors such as non-specific 
hybridization and fluorescence emitted from other chemicals on the glass. If background 
is included in the estimate of the signal for a spot, then the result is a biased estimate of 
the true hybridization. This is particularly prominent at low signal intensities, resulting 
in an underestimate of the fold changes. On the other hand, subtraction of background 
involves an additional estimate which will increase the variability of the signal log 
ratios. 
 
Background correction was not selected for in our protocols. This is consistent with a 
recent study of pre-processing methods appropriate for Agilent array data in which the 
authors stipulated a preference for no background subtraction arguing the case from a 
primary philosophy of avoiding unnecessary data processing but also presenting data 




variability, especially at the low intensity end (Zahurak M et al., 2007). The ability to 
detect differentially expressed genes suffers as a result. 
 
Part of the Agilent pre-processing involves the use of a surrogate intensity value when 
the measured intensity of an array feature is not significantly different from background 
levels. This may contribute to the variability at the low threshold end. 
 
Zahurak et al., (2007) also demonstrated that the largest portion of mean squared error 
for low intensity genes was due to random background estimation error rather than the 
systematic shrinkage of fold changes. It was found that this was true unless there was 
clear correlation between background and foreground, indicating that local background 
is an important component of foreground intensities. 
 
In terms of the normalization process for microarray data, the purpose of normalization 
is to adjust for any bias which arises from variation in the microarray technology rather 
than from biological differences between the RNA samples or the printed probes. Most 
common is red-green bias due to differences between the labelling efficiencies and 
scanning properties of the two fluors complicated perhaps by the use of different scanner 
settings. Where only one colour of fluor is used this source of bias is irrelevant. 
 
Other biases may arise from variation between spatial positions on a slide or between 
slides. Positions on a slide may vary because of differences between the print-tips on the 
array printer, variation over the course of the print-run or non-uniformity in the 
hybridization. Differences between arrays may arise from differences in print quality or 
from differences in ambient conditions when the plates were processed. It is necessary to 
normalize the intensities before any subsequent analysis is carried out. In our situation 
both within-array, between-array and between-slide normalization could be applied. 
 
On the basis that we observed no systematic procedural bias (Figure 5.8), and in line 




as slightly as possible in order to conserve biologically relevant information, but as 
much as necessary to remove systematic biases, the decision was made not to apply any 
further normalization as any potential benefit of such data processing could not be 
clearly identified a priori. 
 
Whilst the rationale for not applying normalization in this instance has been clearly 
stated it should also be acknowledged that such an approach is not immune to criticism 
and that the subject of normalization, or at least the most appropriate normalization 
strategy for such one-channel arrays, remains controversial. Indeed, Fundel et al., (2008) 
illustrated that all normalization strategies make underlying assumptions of the data and 
their implementation can change the results of a particular experiment.  
 
Another important issue with microarray studies is the requirement for some form of 
validation of the data. Ideally this would include a demonstration of coordinate changes 
at the protein level for gene(s) with significantly altered expression but it is also 
common practice to show similar changes in expression at the molecular level with a 
different assay system such as RT-PCR. In this study, antibody detection of Ki67 has 
already been used to illustrate proliferative changes. The microarray contained a probe 
for the proliferating cell nuclear antigen (PCNA), therefore it could be demonstrated that 
the molecular data for PCNA gene expression from the array showed significant 
correlation with the presence of Ki67 at the protein level.  
 
The previous chapter also demonstrated significant changes in goblet cell number in the 
damaged and transitional areas. IL-4 and IL-13 were identified as genes present on the 
array that have been implicated in changes in goblet cell numbers and/or mucus 
production (Dabbagh K et al., 1999, Shim JJ et al., 2001 ). However no correlation 
between expression of these genes and GC numbers was observed.  This is unlikely to 
be the sole or main function of these genes therefore it is by no means certain that such a 






To further assess the reliability and reproducibility of the microarray data presented in 
this study, semi-quantitative RT-PCR assays were carried out on a selection of genes 
which demonstrated highly significant changes (p<0.001) in expression in injury sites. 
The selection of these genes were based on one of the following; 1) a distinct change in 
expression level at various time points as determined by high and low fold changes 2) 
different functional categories known to be modified during airway injury and repair, 
and 3) genes previously reported as critical mediators in airway inflammation. This 
study revealed that for all selected genes there is a significant correlation (p<0.05) 
between the array and the semi-quantitative RT-PCR data in terms of the expression 
profiles except the gene for beta-catenin (p>0.05). The significant correlation between 
array and semi-quantitative RT-PCR assay gives us confidence that the microarray data 
is reliable and reproducible even by using a non-probe based technique (semi-
quantitative RT-PCR) for validation study.  
 
The selected genes for validation study are thought to be involved in various functions in 
response to airway damage and repair. Interleukin 6 (IL6) was one of the most 
significantly up-regulated genes from the microarray analysis and can act either as a pro-
inflammatory or anti-inflammatory cytokine. It is produced by the T cells and 
macrophages to stimulate an inflammatory immune response to tissue damage. IL6 
expression was also reported to be down-regulated during airway epithelial cell 
apoptosis in vitro (Hodge S et al., 2002) and increased IL6 expression was important for 
mucus hypersecretion by airway epithelial cells in response to inhaled Aspergillus 
fumigatus (Neveu WA et al., 2009). The up-regulation of this gene from 6 hours to day 3 
post injury observed in the microarray study was confirmed by the PCR data and 
indicates that this gene may play a role in the early response of the sheep airway to 
injury.  
 
The KRT6A and KRT19 genes are known as markers of basal cells (Liu HW et al., 




the number of poorly differentiated cells expressing basal cell markers has been 
associated with the early cellular response during the de-differentiation and migration 
processes (Evans MJ et al., 1989, Evans MJ and Plopper CG, 1988, Lane BP and 
Gordon R, 1974). The regulation of these genes might be consistent with a potential role 
for cells with basal cell-like properties as “progenitor” cells (Rock JR et al., 2009, Hong 
KU et al., 2004a, Voynow JA et al., 2005) during airway regeneration, particularly in 
migration and proliferation processes. Although there is a lack of studies describing the 
role of keratin 6A (KRT6A) and keratin 19 (KRT19) in airway repair following injury, 
these genes have been extensively studied in the injured skin (Takahashi K and 
Coulombe PA, 1997, Wojcik SM et al., 2000, Liu HW et al., 2009). It was suggested 
that the KRT6A was expressed by the basal cell and plays a role in activation of 
follicular keratinocytes after wounding (Wojcik SM et al., 2000). Mouse endogenous 
KRT6A is also reported to be expressed by the basal layer in epidermal tissue at the 
edge of the wound (Takahashi K and Coulombe PA, 1997). A study by Liu HW et al., 
(2009) using skin samples from aborted fetuses at different gestational ages and from 
healthy individuals, showed that the expression of KRT19 was mainly confined to the 
basal layer (Liu HW et al., 2009). Although at the time the primer was designed to 
amplify keratin 19, it was difficult to ensure that the designed primer was specific for the 
target gene especially in relation to the keratin genes. As clearly discussed in the Chapter 
3 for the keratin 14 gene, majority of the keratin genes share highly similar mRNA 
sequence, therefore the chances that the designed primers could amplify other types of 
keratin genes are high. In addition to this, the limitation of the microarray and the semi-
quantitative RT-PCR techniques may not have been able to distinguish between different 
keratins.  
 
The up-regulation of these genes following injury in the microarray study was again 
confirmed by conventional PCR. This finding supports our initial hypothesis that basal-
like cells are the first cells to repopulate the denuded areas following injury to form a 
single layer of squamous epithelial cells. It is possible that these have originated through 




towards the centre of the lesion. The up-regulation of these genes with a peak at day 3 
post injury suggest that these cells, with basal cell-like properties, play a major role 
during airway regeneration and repair. The histopathological changes of the airway at 
this time point showed that most of the lesion had repopulated with epithelial cells with 
evidence of some thickened areas of epithelial hyperplasia. We suggest that at this point 
in time, these basal-like cells may play a major role by giving rise to other types of 
epithelial cells (Hong KU et al., 2004a, Rock JR et al., 2009) (goblet and ciliated cells). 
The involvement of the basal cell in epithelial differentiation has been described 
previously (Boers JE et al., 1998, Evans MJ et al., 1989, Evans MJ and Plopper CG, 
1988, Hong KU et al., 2004a, Voynow JA et al., 2005) as this cell was reported to play a 
role as stem or progenitor cell of the mouse trachea and human airway epithelium (Rock 
JR et al., 2009).  
 
Other genes described in this validation study were genes involved in the cell cycle 
[cyclin B1 (CCNB1), cyclin B2 (CCNB2) and cell division cycle 2 (CDC2)] and the 
activation of genes involved in cell cycle was previously reported by Heguy et al. 
(Heguy A et al., 2007) in human airway epithelial repair following bronchial brushing. 
Transition from G2 to mitosis is basically controlled by B-type cyclins in which cyclin 
B1 appears during S phase and is primarily cytoplasmic and moves into the nucleus just 
at the start of mitosis and associates with condensed chromosomes and the mitotic 
spindle (Pines J and Hunter T, 1992). In a study by (Heguy A et al., 2007) reported that 
most of the genes were highly expressed at day 7 post injury, predominantly at G2 and M 
phases of the cell cycle phase (Heguy A et al., 2007). In the context of the present study, 
the activation of these cell cycle genes (CCNB1, CCNB2 and CDC2) from day 1 up to 
day 7 post injury with fold changes peaked at day 3, might suggest the active regulation 
of the cell cycle activity in response to repair process of the airway (Chapter 6_ 
Appendix 6.1 on CD) involving the transition from the S-phase to M-phase of the cell 
cycle activities. This finding is consistent with the Ki67 staining (Chapter 4) in which 




compared to naive airway (time point 0) with various staining density of the Ki67-
positive cells which indicate different stages of the cell cycle phase. 
 
In regards to the beta-catenin gene (CTNNB), the expression profiles observed both in 
array and semi-quantitative analyses showed no significant correlation (p>0.05).  
However, consistent with our preliminary finding as described in Chapter 3, the 
expression of this gene detected by the semi-quantitative RT-PCR assay was showed to 
be up-regulated from the day 1 to day 7 post injury as compared to naive. This 
observation was in agreement with the expression of its known co-expressed gene, 
WNT5A which was significantly unchanged at day 3 whilst significantly increased 7 
days post injury with the fold changes 1.9 and 2.1, respectively. Based on the array data, 
it appears that the expression of the CTNNBL1 gene was not affected following 
brushing. 
 
As described in Chapter 4 for the 6 hour time point, the histopathological changes were 
characterised by disruption of the airway mucosal including the basement membrane. 
The single layer of squamous epithelial cells migrating from the border of the lesion is 
thought to be an early stage of the airway repair. At this time point, only few 
proliferative cells were observed as compared to other time points. At this time point the 
number of probes with significantly altered (both up- and down-regulated) expression 
compared to control was greater than other time points (4749 probes) at p<0.05 - (Table 
5.8). However, it is noticeable that the majority of the altered expression was down-
regulation whilst only 387 probes found to be up-regulated. An increased number of 
genes were significantly altered at day 3 compared to days 1 and 7 and was consistent 
with the histopathological finding in terms of proliferative activity and histopathological 
changes (epithelium hyperplasia/metaplasia and fibroplasias – (Chapter 2; Figure 2.9)) 
of the airway at this time point. This finding suggests that around day 3 may be a critical 
and important time for the airway to get to the stage where the repair machinery is being 
activated at both cellular and molecular levels. However, the proportion of up-regulated 




and down regulated genes were relatively equal. Additional analysis to investigate 
functional classification and pathways for both up- and down-regulated genes will open 
a new window to better understand the biological function of these genes in regulating 
airway regeneration and repair.  
 
In terms of the genes that have robust gene expression changes, our array data showed 
that the biggest fold change with up-regulation was of the MT1E gene (fold change of 
110 at 6 hours) which gradually decreased down to 2.2-fold at day 7. This suggests that 
MT1E may play an important role in the early response to injury since it is so rapidly 
activated following injury. A study of endotoxin inhalation (Hur T et al., 1999) in the rat 
showed that the induction of this gene was greater (FC=4) after 3 hours exposure to the 
endotoxin and decreased to the basal level at 24 hour later. This gene was found to be 
largely increased in epithelial cells of the conducting airways, surrounding airway tissue, 
and in the nearby gas exchange region (Hur T et al., 1999). The function of this gene in 
the early response of the airway to bronchial brushing is still unknown, however it has 
been suggested that the metallothionein mRNA was inducted in the rodent liver 
(Andrews GK, 2000) to protect the cell from free radicals as the process of limiting free 
radical damage is a high priority for the cell survival. The major functions of the down-
regulated genes with fold change more than 10 are involved in regulation of liquid 
surface tension, respiratory gaseous exchange, homeostasis process and defence 
response. Amongst those down-regulated genes, the expression of surfactant proteins 
(SP-A and SP-C) were significantly down-regulated from 6 hours up to day 3 post 
injury. Lung surfactant is a complex mixture of phospholipids and four surfactant-
associated proteins (SP-A, SP-B, SP-C and SP-D). Its major function in the lung 
alveolus is to reduce surface tension at the air-water interface in the terminal airways by 
the formation of a surface-active film enriched in surfactant lipids, hence preventing 
cellular collapse during respiration (Walther FJ et al., 2007). Decreased levels of the 
main component of surfactant--phospholipids--have been implicated in atrophic rhinitis 
(Schlosser RJ, 2006). The lamellar body arrangement of phospholipids has now been 




these structures may play a crucial role in mucociliary clearance against inhaled 
pathogens, as well as in the regulation of mucous viscosity (Schlosser RJ, 2006). 
 
Since the advent of microarray technology it has become apparent that difficulties exist 
in reproducing results between, and often within, laboratories. Much of this difficulty 
may arise out of the inordinate number of non-biological variables that can influence 
results. Such variables range from the aforementioned technological issues surrounding 
printing, hybridisation, washing and scanning of slides to the various data processing 
steps that can be applied to correct for any inherent bias arising out of the technology. In 
recognition of this issue there has seen the inception of proposed standards that apply to 
the running and reporting of microarray experiments. In this regard Brazma et al., (2001) 
proposed such standards under the acronym “MIAME” in order to ensure that 
microarray data can be easily interpreted and that results derived from its analysis can be 
independently verified (Brazma A et al., 2001). 
 
5.6  CONCLUSION OF THE CHAPTER 
The microarray study has generated expression profiles for each of the time points 
following injury and provides information on which genes are up or down-regulated and 
by how much.  The volume of data is such that it is impossible to comment on all the 
changes in expression observed and the challenge therefore is knowing how best to 
interpret and present it. Rather than trawling through these lists selecting genes either on 
the basis of the most significant fold-changes in expression or using a candidate-gene 
approach to select those which we think might be biologically relevant to the system 
under study, an alternative approach is to use the data to try and identify what pathways 
or networks might be involved through a process that applies state-of-the-art functional 
genomics and network analysis tools to link the experimental findings into functional 
gene networks with a much wider significance. The outcome of this alternative approach 





6. CHAPTER 6 
 
ANALYSIS OF THE BIOLOGICAL FUNCTIONS OF SIGNIFICANTLY 
EXPRESSED GENES DURING SHEEP AIRWAY EPITHELIAL 























Gene expression profiling through high throughput microarray analysis presents 
researchers with the considerable challenge of interpreting the biological relevance of 
any measured ‘interesting’ change in individual gene expression in the context of the 
system under study. Since the dawn of the genomic era the challenge of interpreting 
large lists of such interesting genes has been compounded by the masses of information 
that has found its way into many different database platforms. Whilst, in most instances, 
such information has been freely available – the manner in which such data was initially 
categorised in the process of recording created obstacles to researchers keen to 
assimilate and understand the information relating to specific biological processes. The 
lack of initial standardisation of terms used to describe gene products lay at the root of 
the problem – thus challenging attempts to assimilate data in a particular area where 
subtlety different terms could be used to describe essentially similar gene products. In 
recognition of this growing problem the Gene Ontology Consortium (founded in 1998) 
initiated the Gene Ontology (GO) project to seek the collaboration of databases in 
arriving at a consensus over the use of a shared vocabulary (GO terms) to be used to 
annotate gene products in the respective databases. Many tools have now been 
developed in order to facilitate the identification of relevant GO terms for lists of genes 
(Ashburner M et al., 2000). The Gene Ontology Consortium defines such GO terms 
using a controlled vocabulary that can be applied to all eukaryotic gene and protein 
functions. There are three main categories of GO terms – 1) the biological process (BP) - 
which refers to the biological objective to which the gene and gene product contributes, 
2) the molecular function (MF) - which is defined as the biochemical activity of a gene 
product, and 3) the cellular component (CC) - which refers to the place in the cell that a 
gene product is active (Ashburner M et al., 2000). 
 
By such unifying process it is possible to cluster genes based on their biological and 
biochemical functions. Further, it is possible to systematically dissect large ‘interesting’ 




The foundation of such enrichment is that if a biological process is more or less 
prominent in a given study, the co-functioning genes should have a greater potential for 
selection as a relevant group by the chosen screening technology. The significance of 
any enrichment can be assessed by common statistical methods, including Fisher's exact 
test, Chi-square, Binomial probability and Hypergeometric distribution. Moreover, the 
software tools required to facilitate this process have become increasingly available 
through open-access websites devoted to this aim. Current popular examples include 
GOstat (Beissbarth T and Speed TP, 2004), Fatigo (Al-Shahrour F et al., 2004), 
GenMAPP(Doniger SW et al., 2003) and DAVID (database for annotation, visualisation 
and integrated discovery) (Dennis G Jr et al., 2003). These programmes provide tools 
that can increasingly deal with requests originating from different species and can 
accommodate query inputs (the list of genes for which functional annotation is 
requested) formatted according to the identifiers used in the originating databases 
(including GenBank ID, Unigene, ENSEMBL, EntrezGene ID and GeneSymbols). 
These programmes also provide links that can direct the users to more specific pathway 
information (Beissbarth T and Speed TP, 2004, Huang da W et al., 2009, Huang da W et 
al., 2008), other GO terms that one single gene belongs to and also to the hierarchical 
pathway within which each specific given GO term exists. In the latter context it should 
be appreciated that the GO database is structured in a hierarchical form, where if a child 
term describes a gene product, then all of its (less specific) parent terms must also apply 
to that gene product. The level at which a gene is annotated in the GO hierarchy depends 
on the detail of knowledge about its biological behaviour the annotator had.  
 
Traditional enrichment strategies take the users’ genes of interest (selected on the basis 
of p-value and fold change) and then iteratively test the enrichment of each annotation 
term one-by-one in a linear mode. By predefinition of a p-value threshold the 
significantly enriched annotation terms can then be reported in a tabular format. Clearly 
the level at which the p-value threshold is set will have a major impact on the number of 
significantly enriched terms. As indicated by (Huang da W et al., 2008) the criteria 




any particular method nor opinion is widely accepted and appropriate for all situations. 
Rather, that in the context of enrichment analysis output, the results should be viewed in 
an advisory sense and that it is up to the user to interpret the results in the context of 
their biological ‘sense’. Further potential error in interpretation can arise as a 
consequence of the effect of making so many individual tests at the same time. Standard 
statistical principles state that the more annotations tested, the greater the chance of an 
increase in the family-wide false-positive, or false-discovery rate (FDR). The FDR of a 
test is defined as the expected proportion of false positives among the given significant 
results (Benjamini and Hochberg, 1995). To control for such effects it is necessary to 
correct for such errors through application of methods such as Bonferroni or Benjamini–
Hochberg (Shaffer, 1995).  
 
In order to extend our ability to interpret the list of ‘interesting’ genes identified in 
Chapter 5 we sought to employ functional annotation and enrichment analysis 
techniques through application of the software tools that comprise the online DAVID 
resource (http://david.abcc.ncifcrf.gov/). The reasons for selecting this particular 
resource included the following: 1) DAVID is a freely available web-based programme, 
2) DAVID provides user friendly tools that ease access to all relevant information 
relating to the terms that associate with the single genes, and provides the functional 
hierarchy within which genes are placed, 3) DAVID’s methods are applicable for 
smaller gene lists, and 4) DAVID provides for different species of interest to be used as 
reference backgrounds. However, the analysis of biological function using DAVID 
programme is only a theoretical analysis of what the DAVID software is capable of and 
that is demonstrate the way in which microarray data can be interpreted. The valid 
conclusion of this theoretical analysis can only be done on the laboratory test. However, 
it is to note that the dataset used to understand the biological function and pathways 
analyses was from the gMeanSignal (raw data) files obtained from the microarray 







6.2  OBJECTIVES 
The aims of this chapter were: 
1. To cluster the significantly expressed genes detected by the microarray 
experiment undertaken in Chapter 5 based on their biological function using 
DAVID (http://david.abcc.ncifcrf.gov/) 
2. To analyse the biological functions of the significantly expressed genes based on 
their GO terms relating to biological process, cellular component and molecular 
function and relate these functions to the staging of the repair process. 
3. To determine the pathways associated with the list of significantly expressed 
genes 
 
6.3  METHODS 
6.3.1 Genes selection 
Thirteen thousand four hundred and ninety-five probes were significantly regulated 
(either up or down) at p<0.05. Amongst those, 6,420 probes were annotated and these 
probes were used for downstream application of biological function and pathway 
analyses. The appendix (Chapter 6_ Appendix 6.1_Significant at p less than 
0.05_annotated on CD) contains the list of significantly expressed probes (annotated) at 
p<0.05.  
 
6.3.2 Curating ontologies through cross-species analogy  
In order to identify human refseq RNA sequences highly homologous with the probe 
targets on the Agilent 15K ovine array a strategy of using a locally installed Basic Local 




batch queries to the NCBI BLAST servers that power the NCBI web BLAST service 
(www.ncbi.nlm.nih.gov/BLAST/). 
 
The client, named blastcl3, bypasses the web browser and is capable of performing the 
batch search with multiple sequences by taking one query sequence at a time from the 
input file, formulating the search according to the settings of the command line 
parameters, and sending the search through the internet connection to NCBI BLAST 
server for processing. The program receives the search results from the BLAST server, 
in the format set in the search command line, and saves it to a local file specified. The 
program loops through all the queries in the input file until all are searched. 
 
Because the only query format blastcl3 accepts is FASTA it was necessary in the first 
instance to use entrez batch (http://www.ncbi.nlm.nih.gov/sites/) to upload, in batches, 
the list of accession numbers and output the respective FASTA sequences to text files – 
with a separate file for each consecutive 500 sequences (FASTA 1_500.txt, FASTA 
501_1000.txt, FASTA 1001_1500.txt, et seq.).  
 
Because the blastcl3 program has no graphic user interface (GUI) and must be executed 
from command line under a terminal window it was necessary to programmatically 
create a command line executable that would automatically read a specified number of 
FASTA entries at a time from each file and submit these as a query to NCBI BLAST 
using the blastcl3 client. The program, “DDSC Blastcl3 recaller.vi” kindly made 
available by Dr D Collie, was created to meet these needs using LabView (National 
Instruments, USA). The specific command line submitted at each call was as follows: 
 
blastcl3 -p blastn -i FASTA_input.txt -p blastn -d refseq_rna -o n_refm.txt -e 2e-20 -m 8 





The various parameters included in the command reflect the options available to define 




blastcl3 The name of the client .exe file located on the host computer 
-p A mandatory default parameter which simply specifies which 
program to run – in this case – the following “Blastn” 
Blastn Specifies that the Blastn search algorithm is to be used – ie a 
nucleotide blast on nucleotide databases 
-I Specifies that the accession number, GI, should be shown in the 
definition line 
FASTA_input.txt The name of the text file containing the FASTA sequences for 
BLAST submission 
-d Specifies the target database(s) to search against – in this case – 
the following “Refseq_rna” 
Refseq_rna The target database to be searched – in this case the Reference 
Sequence RNA collection. 
-o Specifies the output file – in this case – the following 
“N_refm.txt” 
N_refm.txt The output text file 
-e Specifies the Expect value cutoff 
2e-20 The expect value used in this instance ie 2x10-20 
-m 8 Specifies the alignment view option – in this case in a tabular 
format 
T Specifies whether to produce HTML output (defaults to false) 
-u Restricts the search of the database to the subset satisfying the 
query 
"human[organism]" Specifies the human subset in the refseq_rna database 
 
For each file of FASTA sequences a corresponding file listing the identities of entries in 
the RefSeq_RNA database that met the search criteria was created (FASTA 
1_500_hits.txt, FASTA 501_1000_hits.txt, FASTA 1001_1500_hits.txt, et seq.). These 
separate files were collated into one file “Collated FASTA hits.txt” containing over 
30,000 entries and these entries entered in a database file within Microsoft Access 





It was then possible to reduce the burden of non-essential entries by creating a query 
within Microsoft Access to pick out, for each unique query sequence identity, the 
FASTA hit with the lowest expect value where the homologous refseq entry is prefixed 
by “NM” – for manually curated information. This created a list comprising 8901 
entries. Limiting the query to select only the manually curated information for mature 
mRNA transcripts filtered out reference to non-coding transcripts (NR) and coding and 
non-coding transcripts (XM and XR) identified on the basis of automated procedures.  
 
The NM identifier could then be used as input into IDconverter, the online tool available 
for conversion and annotation of gene and protein IDs 
(http://idconverter.bioinfo.cnio.es/), to yield the Gene Name (taken from UniGene), 
Ensembl transcript ID, UniGene ID, EntrezGene ID, the relevant GenBank Accession 
numbers and Clone IDs and information relating to chromosomal position.  
 
This information could then be paired with the originating query sequence identities to 
provide the means by which the ascribed annotations could be linked to the results of the 
array hybridizations and, following addition of any manually curated annotations, 




















































Matching sequence identityQuery Sequence IdentityID
NM_001077493NM_001077493.1|gi|117320539|ref|NM_001077493.1|31E-73AF283892gi|10086318|gb|AF283892.1|AF283892
NM_171825NM_171825.2|gi|212549565|ref|NM_171825.2|216E-117AF283510gi|10086316|gb|AF283510.1|AF283510














BC007927 NM_000178 CR602068 U34683 
CR596201 CR617218 CR620374 
CR611077 BQ952755 BI757536 BF690367 
BM557033 BQ649135 BQ940490 
BQ897884 BE882644 BU507992 BQ067914 
BU539684 AL563039 BE561366 BG033543 

































































































Pair best matching seq with FASTA hit identity info: Query
etc
Results aveffect plus all annotation: Query
Combined 
annotation
Human homolog Probe names ProbeID TargetID Gene Symbol Gene Name Accessions Description aveffect_1
ADA A_70_P000001 9080 EE850561 ADA adenosine deaminase ug|EE850561 020829OSI1005015HT OSI Ovis aries cDNA, mRNA 
sequence [EE850561]
0.314693031
A_70_P000011 8399 EE751926 ug|EE751926 020314OCSI1001069HT OCS1 Ovis aries cDNA, mRNA 
sequence [EE751926]
-0.725248451
ZW10 ZW10 A_70_P015006 893 DY494304 ug|DY494304 sh2P0012F21_F.ab1 adult sheep fracture callus 7d Ovis 
aries cDNA, mRNA sequence [DY494304]
-0.192484002
 




6.3.3 Identification of GO terms and gene functions of significantly 
expressed genes 
Gene functional enrichment analysis was performed using a free web-based 
programme, DAVID version 2008 (http://david.abcc.ncifcrf.gov/), as previously 
described (Dennis G Jr et al., 2003, Huang da W et al., 2009, Huang da W et al., 
2007, Huang da W et al., 2008). Two lists of genes are specified in setting up the 
analysis using this programme, the first being the genes of interest represented on the 
microarray, and the second being a background set of genes. The latter is required in 
order to assign the associated GO terms relating to the list of significant genes. The 
complete GO gene-associations database for the human genome is used as a 
reference in this regard. Whilst the preferred background is the entire genome-wide 
genes of the species concerned, and prebuilt backgrounds, such as the genes 
represented on Affymetrix chips, are available for the user's choice (particularly for 
well-studied model organisms such as human, mouse, rat and Arabidopsis), the 
relatively poor annotation of the Agilent sheep array conspired against using sheep 
genes as the background of choice in this study. A presumption was therefore made 
that human biological pathways are sufficiently similar to those of the sheep and 
effort was directed towards identifying the nearest human homologs to the 
significantly expressed genes in order that the human genomic database could be 
used as the population background. Selecting a larger set of background genes tends 
to give smaller p-values for each set of the given functional classification (Huang da 
W et al., 2009). In the analysis, DAVID determines all the annotated GO terms that 
exist both in the background gene list and those associated with our genes of interest. 
The number of appearances of each GO term will be counted and compared between 
the groups of interest and for the reference genes. A modified Fisher exact test was 
calculated for all analyses and the Benjamini-Hochberg method (Benjamini and 
Hochberg, 1995) was used to control the false discovery rate for the enrichment p-
values for the given individual term members.  
 
Two approaches were adopted in order to analyse our lists of genes. The first 
‘general analysis’ involved screening for significant GO terms associated with our 




‘specific analysis’ was performed in two ways, the first involved considering the 
significantly regulated genes at each time point separately, and the second involved 
separating the significantly regulated genes at each time point into lists according to 
whether they were up-, or down-regulated. For the latter analysis, largely prompted 
by the disproportionate distribution of down-regulated genes at the 6 hour time point 
(Chapter 5; Figure 5.12), up- and down-regulated genes were considered separately 
and inference gained as to the major processes involved as a consequence. However, 
the “general analysis” was done only to get overview of the general GO terms 
involved in our list of significantly annotated genes whilst “specific analysis” for 
both types of genes regulation (up- and/or down-regulated) was used to get more 
specific and relevant biological functions of the annotated probes when probes were 
separated by the time points especially for the pathway analysis.  
 
An important consequence of the latter approach was a reduction in the number of 
genes presented for forward analysis, and whilst such gene lists could still be 
clustered according to function, the associated significance of such groupings 
suffered some erosion and this was generally reflected in increased p-values for each 
given term.  
 
Using this tool, the relationship between the given lists of the annotation terms were 
measured on the basis of their co-association with the genes expressed at the 
particular time points and clustered based on their similar function. DAVID default 
settings were used. Such default settings are recognised to increase the specificity 
and tightness of the analysis and reduce the overall number of clusters (Huang da W 
et al., 2009). As an initial guideline for selecting an appropriate degree of clustering 
to identify time-dependent shifts in biological process, molecular function and 
cellular components during repair, the significance of gene-term probabilities was set 
at p<0.05. However, attention was also directed towards the appraisal of non-






6.3.4 Pathway analysis 
The DAVID programme was also used to consider the relevant pathways that could 
be involved in the given sets of genes. Particular interest in this regard was directed 
towards identifying and graphically summarizing the distribution of the associated 
genes among functional domains and pathways in KEGG metabolic and regulatory 
pathways (Dennis G Jr et al., 2003). Similar to the strategy adopted in identifying the 
associated GO terms (Section 6.3.3 in this chapter), an initial “general analysis” was 
undertaken, followed by time point of “specific analyses”. As previously noted the 
strength of relationship between likely pathways and gene lists was influenced by the 
numbers of gene involved, with larger gene sets producing smaller significant 
probabilities (p-values).  
 
6.4  RESULTS 
6.4.1 Analysis of the biological functions of differentially expressed 
genes 
Initial analysis was performed by combining all significantly expressed genes from 
all the time points. This analysis was performed in order to construct an overview of 
1) the major biological functions associated with the gene list, 2) to discover the 
enriched functionally related genes and 3) to explore genes-terms relationship in the 
list of significantly expressed genes. In order to make the resulting group specific 
GO terms more interpretable the results were clustered. Following identification and 
association of available homologous human gene symbols to the combined 6420 
significantly regulated probe targets and input of this information to the DAVID 
functional analysis tool, 2550 unique genes could be identified - the reduction in 
number reflecting both probe redundancy and a failure of the DAVID human 
database programme to recognise the annotated gene symbols. In the latter context it 
should be appreciated that in some instances, the given gene annotations were only 
available as the locus names e.g. LOC514296, or species-specific forms, such as 
“C11H9orf16” for the manually curated bovine chromosome 9 open reading frame 
16 ortholog gene, which were not recognised by the DAVID programme. The 
advantage of using DAVID is that the programme converts the given gene symbols 




for downstream analysis using DAVID. The list of genes converted by the DAVID 
programme is shown in the (Chapter 6_ Appendix 6.2_DAVID conversion on CD). 
This set of genes was clustered according to their respective GO terms. The lists of 
significant terms (BP, CC and MF) are shown in the appendix (Chapter 6_ Appendix 
6.3(a) to (c) on CD).  
 
The most significant functions represented in the gene list were those relating to  
cellular component organization and biogenesis, positive regulation of biological 
process, response to stress, developmental process and cellular process. Other highly 
represented functions included cell proliferation, cell cycle, cell differentiation, 
mitotic cell cycle, inflammatory response, blood vessel development, response to 
wounding, vasculature development, apoptosis and cell development. Some terms 
such as cell activation, transcription from RNA polymerase II promoter, cell 
migration, regulation of B cell activation, lymphocyte differentiation, cell-matrix 
adhesion, cytokine metabolic process, cytokine production, embryonic development, 
T cell proliferation and regulation of cell differentiation were amongst the less 
significant clusters.  
 
The list of pathways and component gene counts are shown in the (Table 6.1) and the 
list of genes that fall in each pathway are shown in the appendix (Chapter 6_ 
Appendix 6.3(d) on CD). Twelve pathways identified by DAVID commonly 
associate with our gene list – the most significant being those involved in cell cycle 
and ECM-receptor interaction. The genes were grouped in these pathways based on 




Term Count % p-value Benjamini 
Cell cycle 46 1.8 6.40E-07 1.30E-04 
ECM-receptor interaction 38 1.5 1.10E-06 1.10E-04 
Focal adhesion 63 2.5 5.70E-05 3.80E-03 
Small cell lung cancer 30 1.2 1.80E-03 8.50E-02 
Leukocyte transendothelial migration 37 1.4 2.60E-03 9.90E-02 
Cell communication 40 1.6 6.80E-03 2.10E-01 
p53 signalling pathway 23 0.9 9.00E-03 2.30E-01 
TGF-beta signalling pathway 28 1.1 1.20E-02 2.70E-01 
Hematopoietic cell lineage 26 1 2.00E-02 3.60E-01 
Toll-like receptor signalling pathway 28 1.1 5.70E-02 6.60E-01 
Complement and coagulation cascades 20 0.8 7.20E-02 7.10E-01 
Cytokine-cytokine receptor interaction 61 2.4 7.40E-02 7.00E-01 
 
Table 6.1: The list of pathways associated with the complete list of significantly regulated list of 
genes (combined analysis).  
The most highly significantly associated pathways are listed at the top of the list. Although the p-
values for the toll-like receptor signalling, complement and coagulation cascades and cytokine-
cytokine receptor interaction pathways are not significant, these pathways are considered biologically 






Relevance KEGG pathways associated to the given genes analysed using        
DAVID database. The most significant terms are listed on top of the list. 
 
Count:  
The number of genes clustered in the given pathways  
   
%:  
The percentage of the genes clustered in the given terms relative to the number of analysed genes i.e 
46 genes clustered in the cell cycle pathways / 2550 of total unique genes analysed X 100 = 1.8%. 
 
P-value:  
Modified Fisher Exact p-value, EASE score - calculated by DAVID. DAVID determined all pathways 
associated with the list of genes analyzed. It will then count the number of appearances of each 
pathway for the genes inside the group and for the reference genes (human genomic database). 
Fisher's Exact Test is performed to judge whether the observed difference is significant or not. The 
smaller, the more enriched. 
 
Benjamini:  
A false discovery rate; the values presented have been multiplied by 100 (range from 0 to 100%). 







The analysis was repeated for each time point separately.  
6.4.1.1 GO terms 
6 hours 
One thousand, six hundreds and sixteen unique genes were significantly 
differentially expressed at this time point. Among these, 1286 genes (79%) were 
clustered in the GO term of biological process, 1339 genes (82%) were clustered in 
the GO term of cellular component and 1370 genes (84%) were clustered in the GO 
term of molecular function. The lists of significant terms associated with genes 
expressed at 6 hours time point are shown in the appendix with the most significant 
GO terms are listed on top of the list [(Chapter 6_ Appendix 6.4a_Biological 
process_6 hours), (Chapter 6_ Appendix 6.5a_Molecular function_6 hours), and 
(Chapter 6_ Appendix 6.6a_Cellular component_6 hours) on CD]. The most 
significant GO terms for the biological process are positive regulation of biological 
process, positive regulation of cellular process, developmental process, cellular 
component organization and biogenesis and response to stress. A further analysis 
was completed to classify the functions of the genes separated based on whether they 
were significantly up- or down-regulated after injury. Separation according to these 
criteria established that 281 unique genes were up-regulated whilst 1338 unique 
genes were down-regulated at the 6-hour time point. Amongst those up-regulated 
were genes significantly involved in response to stress, response to wounding, 
response to external stimulus, inflammatory response and amine metabolic process 
[(Chapter 6_ Appendix 6.7a) on CD]. The down-regulated genes[(Chapter 6_ 
Appendix 6.7b) on CD] at this time point were most significantly involved in 
positive regulation of biological process, positive regulation of cellular process, 
developmental process, biological regulation and cellular component organization 
and biogenesis (Table 6.2).  
 
Day 1 
One thousand and ninety eight unique genes were significantly expressed at this time 
point with 919 genes (83%) clustered in the GO term of biological process, 949 




clustered in the GO term of molecular function. The lists of significant terms 
associated with genes expressed at day 1 time point are shown in the appendix with 
the most significant GO terms listed at the top of the list [(Chapter 6_ Appendix 
6.4b_Biological process_ Day 1), (Chapter 6_ Appendix 6.5b_Molecular function_ 
Day 1), and (Chapter 6_ Appendix 6.6b_Cellular component_ Day 1) on CD]. The 
most significant GO terms for biological process included cell cycle process, cell 
cycle, response to stress, mitotic cell cycle and regulation of progression through cell 
cycle. Implementing a further analysis with gene lists separated according to whether 
significantly up- (642 genes) or down- (459 genes) regulated indicated that the most 
significant GO terms for the biological process for up-regulated genes [(Chapter 6_ 
Appendix 6.8a) on CD] were cell cycle, cell cycle process, mitotic cell cycle, mitosis 
and M phase of mitotic cell cycle whilst the most significant GO terms for the 
biological process of down-regulated genes [(Chapter 6_ Appendix 6.8b) on CD] 
were those concerned with developmental process, anatomical structure 
development, cell differentiation, cellular developmental process and multi-cellular 
organismal development (Table 6.2).  
 
Day 3 
One thousand, two hundred and forty nine unique genes were significantly expressed 
at this time point with 1030 (82%) clustered in the GO term of biological process, 
1068 (85%) clustered in cellular component and 1050 (84%) clustered within 
molecular function. The lists of significant terms associated with genes expressed at 
day 3 time point are shown in the appendix with the most significant GO terms  
listed at the top of the list [(Chapter 6_ Appendix 6.4c_Biological process_ Day 3), 
(Chapter 6_ Appendix 6.5c_Molecular function_ Day 3), and (Chapter 6_ Appendix 
6.6c_Cellular component_ Day 3) on CD]. The most significant GO terms for 
biological process associated with the list of significant genes at this time point were 
response to stress, mitosis, mitotic cell cycle, M phase of mitotic cell cycle and M 
phase. At this time point, there were 646 up-regulated genes whilst 610 genes were 
down-regulated. In considering these gene lists separately, the most significant GO 
terms amongst the up-regulated genes [(Chapter 6_ Appendix 6.9a) on CD] were 




phase, whilst the most significant GO terms amongst the down-regulated genes 
[(Chapter 6_ Appendix 6.9b) on CD] were biological regulation, cellular process, 




Eight hundred and thirty eight unique genes were significantly expressed at this time 
point with 691 (82%) clustered in the GO term of biological process, 700 (83%) 
clustered in cellular component and 713 (85%) clustered in molecular function. The 
lists of significant terms associated with genes expressed at day 7 are shown in the 
appendix with the most significant GO terms listed at the top of the list [(Chapter 6_ 
Appendix 6.4d_Biological process_ Day 7), (Chapter 6_ Appendix 6.5d_Molecular 
function_ Day 7), and (Chapter 6_ Appendix 6.6d_Cellular component_ Day 7) on 
CD]. The most popular GO terms for biological process were mitosis, M phase of 
mitotic cell cycle, developmental process, organ development and M phase. Amongst 
those genes significantly expressed at this time point were 372 up-regulated genes 
and 470 down-regulated genes. The most significant GO term for biological process 
in up-regulated genes (Chapter 6_ Appendix 6.10a) were those involved in M phase, 
mitosis, M phase of mitotic cell cycle, mitotic cell cycle and phosphate transport 
while those for down-regulated genes (Chapter 6_ Appendix 6.10b) were involved in 
metabolic process, cellular metabolic process, muscle system process, muscle 

















Biological process Cellular component Molecular function 
6 hours response to stress extracellular region protein binding 
day 1 cell cycle organelle part protein binding 
day 3 mitotic cell cycle extracellular region part protein binding 






Biological process Cellular component Molecular function 
6 hours positive regulation of biological process Cytoplasm protein binding 
day 1 developmental process integral to plasma membrane protein binding 
day 3 biological regulation Cytoplasm protein binding 
day 7 metabolic process intracellular part protein binding 
 
Table 6.2: Lists of the most significant GO terms for biological process, molecular function and cellular component associated with the up- or down-










Five hundred and twenty-two (32%) out of the 1616 significantly expressed unique 
genes were associated with KEGG pathways. The most significantly highly 
associated pathways involved at this time point were small cell lung cancer and TGF-
beta signalling pathways. The details for the pathways associated with the genes 
regulated at 6-hour time point and genes clustered in each pathway are shown 
(Chapter 6_ Appendix 6.11(a)_Pathways_ 6 hours on CD).   
 
Day 1 
Three hundred and ninety-six (36%) out of the 1098 unique genes at this time point 
were associated with KEGG pathways. The most significantly highly associated 
pathways involved at this time point were the cell cycle and p53 signalling pathways. 
The details for the pathways associated with the genes regulated at day 1 time point 
and genes clustered in each pathway are shown (Chapter 6_ Appendix 6.11(b) 
_Pathways_ Day 1 on CD).  
 
Day 3 
At this time point, 421 (33%) out of the 1249 unique genes were shown to be 
associated with KEGG pathways. The ECM-receptor interaction and focal adhesion 
pathways were amongst the most significantly highly associated pathways involved 
at this time point. The details for the pathways associated with the genes regulated at 
day 3 time point and genes clustered in each pathway are shown (Chapter 6_ 
Appendix 6.11(c) _Pathways_ Day 3 on CD). 
 
Day 7 
Three hundred and seven (36%) of the 838 unique genes were associated with KEGG 
pathways. The ECM-receptor interaction and cell communication pathways were the 
most significantly associated pathways involved at this time point. The details for the 
pathways associated with the genes regulated at day 7 time point and genes clustered 





A summary of the pathways involved in each time points is shown in the (Table 6.3). 
 
(Chapter 6_Appendix 6.12(a-k) – as attached) shows a schematic of the relationship 
between the pathways that are associated with the significant genes lists (combined 



















Small cell lung cancer Cell cycle ECM-receptor interaction ECM-receptor interaction 
TGF-beta signalling pathway p53-signalling Focal adhesion Cell communication 
Hematopoietic cell  lineage Complement & coagulation cascade Cell cycle Focal adhesion 
Cell cycle Small cell lung cancer Cell communication Cell cycle 
Leukocyte transendothelial 
migration ECM-receptor interaction 
Complement & coagulation 
cascade 




p53-signalling Leukocyte transendothelial migration 
Toll-like receptor signalling  Toll-like receptor signalling  Adherens junction 
 
Small cell lung cancer Cell-adhesion molecules (CAMs) 
 
Hematopoietic cell  lineage 
p53-signalling 
 
Table 6.3: A summary of the time-dependent changes in pathways associated with the repair process 





6.5  DISCUSSION 
Conventional microarray data analysis often yields comprehensive lists of genes that 
are associated with experimental intervention in some way. The burden that is placed 
on scientists is the interpretation of what, amongst this unwieldy listing, is actually 
biologically significant. As biological effect normally relates to the coordinate 
interplay of multiple genes acting along complex pathways it pushes the scientist to 
consider microarray data in the context of both the roles that the gene products are 
perceived to have in biology, and also in relation to how such underlying biology can 
be pieced together from studying the coordinate expression of genes of similar 
function. This chapter is constructed with this in mind.  
 
One important issue that deserves some discussion concerns the selection of the 
background for the functional analysis of the gene expression data. Based on the 
current, relatively poor annotation of the sheep genomic database, the classification 
of sheep gene functions was determined by analogy with similar genes characterised 
in the human genomic database. The assumption would be that underlying 
mechanisms are indeed relatively consistent between these species. As previously 
noted (Chapter 1; Section 1.10) sheep are generally well regarded as animal models 
for human disease – reflecting the similarities in structure, function and biology in 
health and disease. As an example in relation to the lung, a combined burn and smoke 
inhalation injury in sheep model has been reported to mimic human acute respiratory 
distress syndrome (ARDS) secondary to multiple trauma and airway damage (Westphal 
M et al., 2006) and the sheep is also considered an ideal potential model for cystic 
fibrosis (CF) study (Broackes-Carter FC et al., 2002 , Tebbutt SJ et al., 1996, Tebbutt 
SJ et al., 1995). The sheep lung has been well studied from both electrophysiological 
and developmental aspects and shows close similarities to the human lung, 
particularly with respect to the function of the respiratory epithelium (Davies LA et 
al., 2008, Olver RE and Robinson EJ, 1986). It has also been shown that spatial and 
developmental expression of CFTR in the sheep is similar to that seen in the human 
and thus the sheep lung may provide a useful system in which to reproduce CF lung 
disease (Tebbutt SJ et al., 1995). In this context sheep are currently being used in 




In the present study, a set of significantly (p<0.05) altered annotated probes were 
clustered based on their shared and similar GO terms. The use of gene symbols for 
downstream DAVID analysis imposed limits in that some genes were assigned 
synonyms or aliases which were not recognised by the programme or for other genes 
only locus positions were available. Amongst 2550 unique probes/genes, only around 
2389 genes matched with human database which recognised by DAVID were used.  
 
DAVID was first introduced by (Dennis G Jr et al., 2003). This programme translates 
the list of significantly expressed genes into a functional profile which provides 
insight into the cellular mechanisms relevant, in the context of the present study, to 
airway regeneration and repair. Many tools are now available to undertake functional 
analysis of microarray gene expression data. These include GeneSpring (Agilent 
Technologies Inc), GoStat (Beissbarth T and Speed TP, 2004), Fatigo (Al-Shahrour 
F et al., 2004), Blast2GO (Conesa A et al., 2005), GenMAPP (Doniger SW et al., 
2003), KEGG (http://www.genome.jp/kegg/) and Ingenuity 
(http://www.ingenuity.com). Most of the tools are freely available web-based 
programmes and some require a licence (GeneSpring and Ingenuity software). 
Although these tools use the same core strategy to systematically map a large number 
of interesting genes to the list of associated biological annotation, they differ greatly 
in many aspects that influence both the utility and outcome of the analysis (Khatri P 
and Drăghici S, 2005). In the former regard the degree to which tools offer utilities 
ranging from pathway analysis to ID conversion varies and this can influence the 
nature and extent of analysis undertaken. In the latter regard it is worthwhile 
considering the different methodologies that underlay the core strategy.  
 
Huang da W et al., (2008) describes three major classes of enrichment algorithms: 1) 
singular enrichment analysis (SEA), 2) gene set enrichment analysis (GSEA), and 3) 
modular enrichment analysis (MEA). In the SEA class, the enrichment p-value is 
calculated on each term from the pre-selected interesting gene list (e.g. differentially 
expressed genes selected between experimental versus control samples which were 
filtered based on p-value and fold changes). This strategy is commonly employed, 




linear output of terms can be very large and overwhelming, potentially diluting focus 
and obscuring relevant interrelationships (Huang da W et al., 2008). The GSEA 
approach involves a ‘no cut-off’ strategy and uses expression data relating to all the 
genes from a microarray experiment – regardless of any associated significance. The 
benefits of using this technique are that it reduces the arbitrary factors involved in 
traditional enrichment analysis and ensures that all genes contribute by taking every 
gene-specific experimental value (e.g. fold change) into the calculation for each 
annotation term (Huang da W et al., 2008). The ‘no cut-off’ strategy is the key 
advantage of GSEA, but is also becoming its major limitation in many biological 
studies. Indeed whilst the GSEA method requires a summarized biological value 
(e.g. fold change) for each of the genome-wide genes as an input, the relevance 
(whether statistical or biological) of any given fold-change is unknown. The 
technique relies on mapping patterns of association between groups of genes 
behaving in a similar way (Huang da W et al., 2008). The MEA strategy inherits the 
basic enrichment calculation found in SEA and incorporates extra network discovery 
algorithms by considering the term-to-term relationships in which joint terms may 
contain unique biological meaning for a given study and building such relationships 
is one step closer to the true nature of biology during data mining. Similar to the SEA 
approach, the use of a pre-selected gene list impacts on the analytic results (Huang da 
W et al., 2008).  
 
In the context of the present study, we used the DAVID programme as it is based on 
the SEA and MEA strategies. The relatively poor annotation of the sheep array was a 
factor in not considering the GSEA technique a realistic option in the current study. 
DAVID takes into account the redundant and networked nature of biological 
annotation content in order to concentrate on building the larger biological picture 
rather than focusing on individual terms or genes – and as a consequence moves us a 
step closer to understanding the nature of biological process (Huang da W et al., 
2008). 
 
In relation to the process of identifying which programmes to use for functional 




DAVID programmes were considered user friendly and both offered a minimum 
limit on the number of genes to be considered. Another particular advantage of these 
two programmes pertains to their accommodation of analyses involving relatively 
few annotated probes. However one perceived limitation of using GOstat in this 
context was that this programme would only provide lists of significant GO terms 
and their associated genes but did not provide the necessary tools to embark on 
further analysis e.g into pathway representation. In addition, DAVID provides some 
unique features and capabilities, such as an integrated and expanded back-end 
annotation database – the DAVID Knowledgebase - involving a single- linkage 
method to agglomerate tens of millions of gene/protein identifiers and associated 
annotation from dozens of well-known bio-databases, advanced modular enrichment 
algorithms and powerful exploratory ability in an integrated data-mining 
environment (Huang da W et al., 2009).   
 
Regardless of the specific methodology employed in the analysis, data interpretation 
is ultimately critical in the sense that the data generated merely reflects the input to 
the various algorithms employed, and making sense of the output must rely on 
biological plausibility and hence demands grounding in biological science. Indeed, 
although the DAVID programme provides significant p-values for given GO terms 
and FDR in order to increase confidence in output, these values are just guidelines 
and should not be used as the sole arbiter of the decision-making process (Dennis G 
Jr et al., 2003, Huang da W et al., 2008). Although some of the suggested pathways 
were not shown to have significant p-values their ranked importance appears to be 
biologically plausible when considered in the context of the associated phenotypic 
changes underway in the brushed airway wall.  
 
In the present study, the classification and analysis of the genes based on their 
regulation following injury (either up- or down-regulated) at each time point 
provided valuable information in relation to how genes and pathways inter-connected 
with each other during airway injury and repair. The biological functions of the 
genes which were up-regulated early after injury were those involved in the early 




activation of innate immune mechanisms (6 hours). Later on the most significant 
functions were those associated with cell cycle regulation. These findings are in the 
agreement with the concomitant histopathological changes highlighted in Chapter 4. 
Whilst some of the up-regulated genes were involved in cell cycle activities and 
mitosis and those genes defined as down-regulated were mostly involved in control 
of airway homeostasis which associate with developmental process, anatomical 
structure and development, metabolic process, cellular regulation and cellular 
differentiation – (Table 6.4). The control of airway homeostasis with the activation 
of the front line of defence mechanism in the early airway response to injury and cell 
cycle activities at later time points might have an association with the induction of 
rapid mechanism of repair of the airway in order to quickly regenerate a new 
epithelium layer. The down-play of such activities is in agreement with the 
morphological changes of the airway epithelium at this time point in which the 
airway sections showed evidence of mucosal haemorrhage at the damaged sites and 
flattened dedifferentiated cells within the transitional sites. Reduced cellular 
differentiation at this time point might in turn relate to the increase in proliferative 

























 GO:0006950~response to stress GO:0048518~positive regulation of biological process 
 GO:0009611~response to wounding GO:0048522~positive regulation of cellular process 
6 hours GO:0009605~response to external stimulus GO:0032502~developmental process 
 GO:0006954~inflammatory response GO:0065007~biological regulation 
 GO:0009308~amine metabolic process GO:0016043~cellular component organization and biogenesis 
 GO:0007049~cell cycle GO:0032502~developmental process 
 GO:0022402~cell cycle process GO:0048856~anatomical structure development 
Day 1 GO:0000278~mitotic cell cycle GO:0030154~cell differentiation 
 GO:0007067~mitosis GO:0048869~cellular developmental process 
 GO:0000087~M phase of mitotic cell cycle GO:0007275~multicellular organismal development 
 GO:0000278~mitotic cell cycle GO:0065007~biological regulation 
 GO:0007067~mitosis GO:0009987~cellular process 
Day 3 GO:0000087~M phase of mitotic cell cycle GO:0006950~response to stress 
 GO:0000279~M phase GO:0050789~regulation of biological process 
 GO:0022403~cell cycle phase GO:0032502~developmental process 
 GO:0000279~M phase GO:0008152~metabolic process 
 GO:0007067~mitosis GO:0044237~cellular metabolic process 
Day 7 GO:0000087~M phase of mitotic cell cycle GO:0003012~muscle system process 
 GO:0000278~mitotic cell cycle GO:0006936~muscle contraction 
 GO:0006817~phosphate transport GO:0044249~cellular biosynthetic process 
 
Table 6.4: The list of GO term of biological process associate with the genes either up- or down-regulated following injury in each time point.  
These genes are amongst the most significantly highly associated with the both set of genes in which at each time point, the most significant BP terms are listed at 




In relation to the present study, twelve pathways associating with our list of genes 
were identified. These were cell cycle, ECM-receptor interaction, focal adhesion, 
small cell lung cancer, leukocyte transendothelial migration, cell communication, 
p53 signalling, TGF-beta signalling, hematopoietic cell lineage, toll-like receptor, 
complement and coagulation cascades and cytokine-cytokine receptor interaction 
pathways (Table 6.1). Of these only the TGF-beta signalling pathway was suggested 
to be involved early in the response to physical injury (6 hours) – (Table 6.3). Most 
of the pathways involved at this time point (6 hours) were those with a potential role 
in defence mechanisms and cellular migration. A wide spectrum of cellular functions 
such as proliferation, apoptosis, differentiation and migration are regulated by TGF-
beta family members (Erjefalt JS et al., 1995). As all the genes involved in these 
activities or functions were down-regulated (as shown by GO term for BP) at this 
time point, it is conceivable that this represents a crucial transition point between the 
immediate needs of the site with respect to defence and damage limitation, and the 
activation of mechanisms geared towards subsequent repair. The involvement of 
hematopoietic cell lineage and leukocyte transendothelial migration at this time point 
suggest the early involvement of hematopoietic- and blood-derived cells in early 
cellular migration and induction of innate immunity. These cells undergoing 
differentiation process express a stage- and lineage-specific set of surface markers 
(Erjefalt JS et al., 1995). Therefore cellular stages are identified by the specific 
expression patterns of these genes. Small cell lung carcinoma (SCLC) is a highly 
aggressive neoplasm, and molecular mechanisms altered in SCLC include induced 
expression of oncogene, myelocytomatosis (MYC), and loss of tumorsuppressor 
genes, such as p53, phosphatase and tensin homolog (PTEN), retinoblastoma (RB), 
and fragile histidine triad (FHIT) (Erjefalt JS et al., 1995). The overexpression of 
MYC proteins in SCLC is largely a result of gene amplification (Erjefalt JS et al., 
1995). Such over-expression leads to more rapid proliferation and loss of terminal 
differentiation (Erjefalt JS et al., 1995). The involvement of this pathway (SCLC) 
was only observed from 6 hours up to day 3 post injury.  
 
Cell cycle and ECM-receptor interaction pathways were the only pathways that were 




pathways especially for ECM-receptor interaction during the course of injury can be 
seen by the increasing significance associated with their involvement from 6 hours to 
day 7 post injury. ECM-receptor interaction pathways generally involve a complex 
mixture of structural and functional macromolecules and serves an important role in 
tissue and organ morphogenesis and in the maintenance of cell and tissue structure 
and function (Erjefalt JS et al., 1995). These interactions lead to a direct or indirect 
control of cellular activities such as adhesion, migration, differentiation, 
proliferation, and apoptosis – all clearly important in the repair of the injured airway 
wall.  
 
The pathway analysis suggested that at days 3 and 7 post injury, most of the 
pathways associated with the genes regulated at these time points were involved in 
cells communication and re-structure of the damaged airway morphology. It is worth 
examining the potential interactions between pathways at this time. In this regard 
cell-matrix adhesions play essential roles in important biological processes including 
cell motility, cell proliferation, cell differentiation, regulation of gene expression and 
cell survival. At the cell-extracellular matrix contact points, specialized structures are 
formed and termed focal adhesions, where bundles of actin filaments are anchored to 
transmembrane receptors of the integrin family through a multi-molecular complex 
of junctional plaque proteins (Erjefalt JS et al., 1995). Whilst the cell-cell adherens 
junctions (AJs), the most common type of intercellular adhesions, are important for 
maintaining tissue architecture and cell polarity and can limit cell movement and 
proliferation (Erjefalt JS et al., 1995). At AJs, E-cadherin serves as an essential cell 
adhesion molecules (CAMs) (Erjefalt JS et al., 1995).  
 
ECM-receptor and focal adhesion pathways shared similar gene groupings and thus 
were likely involved in similar mechanisms in response to airway injury and repair. 
Genes involved within these clusters included the families of laminin, collagen, 
integrin and thrombospondin genes. The involvement of the integrin gene family is 
reported in epithelial cell migration and adhesion to the basement membrane 
(Quaranta V, 1990) which also plays an important role in cell-cell and cell-




the roles of the integrin gene family in the interaction of the cell with the 
extracellular matrix in order to create and maintain tissue architecture. Integrins are 
expressed by epithelial cells on the basement membrane (Pilewski JM et al., 1997). 
In the context of the present study, following a bronchial brushing, there was 
evidence of loss of the basement membrane at the earlier time points at the site of the 
damaged epithelium (6 hours and day 1 post injury) and this loss presumably 
influenced the subsequent production of integrin and laminin. However, this study 
revealed that several of the integrin gene families presented on the array were 
significantly regulated at various time points after injury (Table 6.5). However only 
ITGA5 was significantly upregulated (fold change >2.0 on days 1, 3 and 7 post 
injury) whereas ITGA4 was marginally no changed (fold change ~0.8-0.85 at 6-hour 
and day 3 respectively) and ITGA8 was down-regulated (fold changes 0.27-0.49 
through days 1-3 after injury). For the laminin gene, only laminin beta 1 (LAMB1) 
was found to be significantly upregulated from days 1-3 after injury (Chapter 
6_Appendix 6.1_Significant at p less than 0.05_annotated on CD). This finding 
suggests that up-regulation of the laminin and both up-regulation of ITGA5 and 
down-regulation of ITGA8 genes are associated with regenerating a layer of 
epithelial cells at the damaged sites. These expression patterns may also relate to 
roles played by the regenerating epithelial cells themselves in regulating interactions 
with the extracellular matrix in order to maintain epithelial architecture (Bosman FT, 
1993). The contrasting regulation of different integrins probably reflects the 
complexity of basement membrane structure and the fact that such structure may, in 
itself, show dynamic change during the course of repair.  The various regulations of 
the integrin molecules in the earlier time points might associate with the production 
of this molecule by the migrating epithelial cells bordering the lesion or 
inflammatory response-related cells. The former assumption is based on the fact that 
the RNA isolated from the damaged epithelium tissue might also have contained 
elements from the transitional areas at both edges of the damaged site (Chapter 2; 




Probenames TargetID GeneSymbols Timepoints p-values Fold Changes 
Regulation 
(effect) FDR 
A_70_P026032 AF349458 ITGA4 0.25 0.010875 0.805598 No changed 0.036839 
A_70_P026032 AF349458 ITGA4 3 0.048155 0.853837 No changed 0.11793 
A_70_P029596 FE031898 ITGA5 1 0.013926 2.169972 Up-regulation 0.094726 
A_70_P029596 FE031898 ITGA5 3 0.002357 2.812312 Up-regulation 0.026707 
A_70_P029596 FE031898 ITGA5 7 0.0139 2.170562 Up-regulation 0.118498 
A_70_P026036 DY499111 ITGA5 7 0.014525 1.209778 No changed 0.120687 
A_70_P058166 FE032203 ITGA8 0.25 0.007551 0.374059 Down-regulation 0.030483 
A_70_P058166 FE032203 ITGA8 1 0.005183 0.351454 Down-regulation 0.057167 
A_70_P058166 FE032203 ITGA8 3 0.001063 0.268788 Down-regulation 0.017937 
A_70_P058166 FE032203 ITGA8 7 0.038252 0.489729 Down-regulation 0.179046 
A_70_P028307 DQ239659 LAMB1 1 3.33E-05 3.176645 Up-regulation 0.003823 
A_70_P028306 DQ239659 LAMB1 1 1.04E-05 3.113726 Up-regulation 0.002025 
A_70_P028307 DQ239659 LAMB1 3 0.000633 2.282111 Up-regulation 0.013828 
A_70_P028306 DQ239659 LAMB1 3 0.00035 2.167268 Up-regulation 0.010254 
A_70_P028307 DQ239659 LAMB1 7 0.018051 1.63732 No changed 0.132048 
A_70_P028306 DQ239659 LAMB1 7 0.013052 1.579405 No changed 0.115428 
 
Table 6.5: Expression of integrin and laminin genes during airway regeneration and repair following bronchial brushing.  
Duplicates listed for specific time points reflect the fact that in some instances more than one gene-specific probe was present on the array and was therefore 
available to amplify the same gene. The listed time points represent those at which genes were found to be significantly expressed at p<0.05 as compared to the 
naive airway (day 0). The fold changes observed are relative to day 0 (naive). The significance changes observed from statistical analysis of microarray data are 




The consistent expression of the ITGA8 in the present study throughout the time 
course of injury might be associated with the involvement of basal cells in migration 
and cellular communication processes due to the fact that the expression of the beta 
ITGA8 was restricted to basal cells (Pilewski JM et al., 1997). A study by Pilewski 
JM et al., (1997) examined the effects of mechanical injury in an in vivo xenograft 
model of human bronchial epithelium. These authors reported that collagen-alpha 2 
and 6 were produced by the supra-basal epithelial layer at the later phase of repair 
thus suggesting a role for these genes in airway migration (Pilewski JM et al., 1997). 
White SR et al., (1999) subsequently demonstrated that inhibition of these genes 
(collagen, integrin and laminin) led to impaired wound closure due to the lack of 
cellular interaction and communication (White SR et al., 1999). The up-regulation of 
the fibronectin gene (FN1) as early as 6 hours, and then at day 3 and day 7 post 
injury (Chapter 6_Appendix 6.1_Significant at p less than 0.05_annotated on CD) 
may suggest a role for this gene in this model system. A study by Han SW and 
Roman J, (2006) demonstrated that the fibronectin gene played a role in stimulating 
human airway epithelial cell growth and inhibiting apoptosis through activation of 
the NF-(kappa)B pathway (Han SW and Roman J, 2006). 
 
The significant involvement of the cell cycle pathway from the day 1 up to day 7 
post injury agreed with previous histopathological findings in which significant 
proliferative activity was appreciated at days 1, 3 and 7 in which at these time points 
(days 1 up to day 7), the most significant terms associated with the list of genes in 
these time points are involved in cell cycle regulation process, cell cycle phase and 
mitosis [refers to the (Table 6.4) for a summary of the up-regulated genes at the time 
points of days 1, 3 and 7]. As previously alluded the different density of the Ki67 
staining seen on the histology sections supports the hypothesis that at any point in 
time cells were involved in different phases of the cell cycle. The involvement of 
complement and coagulation cascades pathway coincides with the evidence of 
mucosal haemorrhage (including fibrin, blood etc) at these time points (days 1, 3 and 




Clearly the process of regeneration and repair following injury involves different 
pathways with their respective involvement determined by the time point relative to 
injury. Respecting the diverse nature of the pathways concerned it is nonetheless 
clear that at any given time an equilibrium exists during this process that presumably 
reflects crosstalk and interaction both within, but presumably also between, 
pathways. 
 
The existence of the specific pathways at each time point of injury and its progress 
towards repair is consistent with the histopathological finding. For instance, 6 hours 
after injury whilst there was evidence of mucosal loss and airway structure 
perturbation, neither an inflammatory response nor proliferative activity were 
prominent features. Most of changes observed at this time point were thought to be 
related to dedifferentiation and migration activities. In contrast, at the molecular 
level, more probes were significantly regulated (p<0.05) at this time point (4749 
probes) as compared to any other time point. Most of the significantly regulated 
probes at this time point were in fact down-regulated. Whilst amongst those up-
regulated were genes involved in inflammatory response, response to wounding and 
innate immunity and the majority of down-regulated genes were those involved in 
regulation of the biological process of the cells and function. The balance (between 
the proportions of up- and down-regulate genes) was re-dressed with time, 
presumably reflecting the activation of specific pathways and biological functions 
required in order to engineer the repair to the damaged epithelium.  
 
The involvement of the TGF-beta signalling pathway early after injury warrants 
further discussion. TGF-beta1 induces epithelial-mesenchymal transition (EMT; the 
process by which differentiated epithelial cells undergo a phenotypic transition to 
mesenchymal cells (Kalluri R and Neilson EG, 2003)) in a Smad3-dependent manner 
in primary airway epithelial cells (AECs) (Hackett TL et al., 2009). EMT is 
characterized by loss of cell adhesion, repression of E-cadherin expression, and 
increased cell mobility and is a characteristic feature of cells undergoing 
proliferation. Members of the TGF-beta family of growth factors can initiate and 
maintain EMT in a variety of biological systems and different pathophysiological 
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contexts by activating major signalling pathways and transcriptional regulators 
integrated in extensive signalling networks (Zavadil J and Böttinger EP, 2005). It is 
tempting to speculate that the early molecular signature represents a “preparation 
phase” in which the airway recognises the type and extent of injury and prompts the 
activation of the pathways relevant to avoiding further damage to the airway 
brushing site. These include the migration of hematopoietic cell lineages and 
leukocyte transendothelial migration, cell cycle and toll-like receptor pathway 
activations.  
 
A study of TGF-beta induced apoptosis in hepatocytes suggested that GADD45B 
functions as a critical upstream component in the apoptosis pathway induced by 
TGF-beta in the liver (Yoo J et al., 2003). This apoptosis process is required to 
eliminate the damaged or abnormal cells from normal tissue and thus the loss of the 
TGF-beta-induced apoptosis was associated with hepatocellular carcinoma (Sue SR 
et al., 1995). In the context of the present study, the TGF-beta (TGFB1) gene was 
significantly up-regulated at day 3 and day 7 post injury whilst GADD45 
(GADD45A) gene was up-regulated at the earlier time points (6 hours and day 1) - 
(Chapter 6_Appendix 6.1_ Significant at p less than 0.05_annotated on CD). One of 
the functions of the TGFB1 is to stimulate ECM protein production (Lee JM et al., 
2006). In the context of the present study, the down-regulation of the TGFB1 gene in 
the earlier time points 6 hours and day 1 post injury may reflect an early requirement 
to control or limit apoptosis. Indeed the expression of the genes within this TGF-beta 
pathway such as SMAD2, SMAD6 and SMAD7 genes were down-regulated at the 6-
hour time point (Chapter 6_Appendix 6.1_ Significant at p less than 0.05_annotated 
on CD). The down-regulation of these genes might reduce or inhibit the activity of 
the apoptosis and cell cycle process (Appendix 6.12b – as attached). In contrast 
SMAD1 gene was found to be up-regulated at this time point and the activation of 
this gene might associate with the development of the airway structure following 
injury. A study by Chen C et al., (2005) suggested that airway epithelial cell 
proliferation and differentiation were inhibited when endogenous SMAD1 
expression was knocked down. It was also been reported that SMAD1 expression 
was found in the smooth muscle and suggested that SMAD1-mediated signalling 
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may be required for smooth muscle cell growth or maintenance at a particular 
developmental stage (E16.5) (Chen C et al., 2005). Jeffery TK et al., (2005) reported 
that SMAD1-mediated bone morphogenetic protein 4 (BMP4) signalling is essential 
for myofibroblast differentiation into smooth muscle cells in vitro (Jeffery TK et al., 
2005).  
 
The down-regulation of TGF-beta at early time points contrasts with the observation 
that TGF-beta appears to stimulate the dedifferentiation process in which treating 
dedifferentiated rabbit renal proximal tubular cells (RPTC) with TGF-beta for 24-
hour enhanced spindle morphology and vimentin expression compared with 
dedifferentiated cells treated with diluent (Hallman MA et al., 2008). In this study 
several markers were used to assess dedifferentiation activity in RPTC primary 
cultures following exposure to H2O2 (Hallman MA et al., 2008). Dedifferentiation 
was characterized using multiple markers, including vimentin expression, cell 
elongation, and the loss of N-cadherin and apical-basal polarity (Hallman MA et al., 
2008). Epidermal growth factor receptor (EGFR) activation has been reported to be a 
critical step in dedifferentiation in vitro after oxidant injury and inhibition of EGFR 
expression stimulated a redifferentiation (Hallman MA et al., 2008). Zhuang S et al., 
(2005) similarly reported the use of molecular markers for dedifferentiation activity 
in RPTC primary cultures. In this latter study, it was revealed that p38 mediates 
epidermal growth factor (EGF) receptor activation after oxidant injury; that sarcoma 
(Src) activates Medicago MAP kinase gene 3 (MMK3), which, in turn, activates p38; 
and that the EGF receptor signalling pathway plays a critical role in RPTC 
dedifferentiation (Zhuang S et al., 2005).  
 
The roles of the apoptosis in airway inflammation are clearly described by 
Monteseirín J, (2009). The apoptosis activity involves in eliminating of neutrophils 
during the allergic resolution and suppression of the apoptosis leads to prolong 
survival of these cells. Increases IL-8 secretion and inhibits neutrophil apoptosis and 
subsequent release of IL-8 may contribute to neutrophil inflammation in patients 
with atopic asthma (Monteseirín J, 2009). Apoptosis also may play an important role 
in COPD pathogenesis (Park JW et al., 2007). Increased numbers of apoptotic cells 
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can be detected in lung tissue and airways of human subjects with COPD and 
increased apoptosis in COPD can also imply defects in the normal physiological 
clearance of apoptotic cells (Park JW et al., 2007). However, the detection of 
apoptotic cells population is also used as a sign for cellular and tissue replacement 
following injury (Henson PM et al., 2006) in which the balance process between cell 
loss affected by the injury and cellular replication in order to restore its normal 
morphology.  
 
The airway epithelium forms  an important protective barrier to injuries induced by 
external stimuli, whether through smoke inhalation or aspiration of acid stomach 
contents, or through exposure to pollutants or infectious moeities in the atmosphere 
we breathe. It is important that the airway mounts a rapid response to such insult. 
Any breakdown in the epithelial barrier exposes the underlying architecture to further 
injury, leads to fluid loss through the epithelial surface and ultimately perturbs the 
innate defence of the lung.  
 
Recently, it has been reported that the activation of TLRs by endogenous and 
exogenous ligands may play a central role in determining the balance between a state 
of “mucosal homeostasis,” as is required for optimal organ function, and “mucosal 
injury,” leading to mucosal inflammation and barrier breakdown (Sha Q et al., 2004, 
Gribar SC et al., 2008). It has also been suggested that the epithelial cells rapidly 
generate complement proteins for purposes of host defence when exposed to 
pathogens that express agonists for TLRs (Sha Q et al., 2004). 
 
As highlighted by Gribar SC et al., 2008  not only is the epithelium able to respond 
to potentially dangerous microbial products, it also may sense endogenous molecules 
that are released during conditions of stress, hypoxia, or injury — so-called danger 
molecules that may play a critical role in the development of mucosal inflammation 
(Gribar SC et al., 2008). It assumes this important role at least in part through TLRs 
sensing the so-called “danger signals”, also called damage-associated molecular 
patterns (DAMPs) and those ligands on the surface or interior of pathogen-associated 
molecular patterns (PAMPs). That these mechanisms are likely involved in the 
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normal process of epithelial repair following physical injury is evidenced by the 
early involvement of TLR pathways in the present study. Six TLR genes (TLR1, 
TLR5, TLR6, TLR8, TLR9 and TLR10) were significantly regulated (up, down or 
unchanged) - (Chapter 6_ Appendix 6.1_Significant at p less than 0.05_annotated on 
CD) and (Table 6.6). The array data suggested that TLR genes were significantly 
regulated at various stages of the injury and repair process. Only TLR 2 (at 6 hours) 
post injury was found to be up-regulated at any of the time point with majority of 
those genes were unchanged (Table 6.6). The majority of the TLRs demonstrated a 
time-dependent increase in expression from an initial low point at 6 hours (Chapter 







6 hours Day 1 Day 3 Day 7 
TLR1 0.53* 0.69 0.60* 0.85 
TLR2 2.02* 1.65 1.56 1.40 
TLR5 0.41* 0.55* 0.41* 0.68 
TLR6 0.45* 0.67 0.61* 0.76 
TLR7 0.71* 0.95 1.55* 1.87* 
TLR8 0.71* 0.86 1.17 1.35* 
TLR9 1.03 1.07 1.10* 1.04 
TLR10 0.29* 0.44* 0.57 0.87 
 
Table 6.6: Toll-like receptor genes with fold changes relative to naïve indicated over the 
time course of the study. * indicates the fold changes with significance p-values < 0.05 
 The observed changes are considered up- and/or down-regulated based on the values of fold 
 changes between <0.5 (down-regulated), >2.0 (up-regulated) and 0.5>FC<2.0 (unchanged). 
 
 
As shown in the appendix (Chapter 6_ Appendix 6.12d_Toll-like receptor signalling 
pathway – as attached) TLR2, TLR5 and TLR6 are involved in pathogen recognition 
and are capable of provoking rapid activation of innate immunity by inducing 
production of proinflammatory cytokines and up-regulation of costimulatory 
molecules via induction of myeloid differentiation factor-88 (MyD88),  MAPK 
signalling and activation of NF-(kappa)B and AP-1. The activation of TLR2 is 
necessary to sufficiently stimulate NF-(kappa)B and MAPK pro-inflammatory 
signalling to recruit and activate polymorphonuclear leukocytes in the airway 
(Martin FJ and Prince AS, 2008) and TLR2 is also involved in regulating gap 
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junction intercellular communication in airway cells (Martin FJ and Prince AS, 
2008). The quick activation of the NF-(kappa)B and MAPK signalling pathways 
within the TLR signalling pathway are important to provoke a rapid induction of 
innate immunity. The effect of such rapid induction is likely evidenced by the early 
up-regulation of IL6 and IL8 which in turn likely contributes to activating the 
cytokine-cytokine receptor interaction pathway. Up-regulation of IL6 is important to 
induce the acute-phase reaction which promotes the innate immune system and 
protects against tissue damage whilst the up-regulation of the IL8 gene is required for 
attracting the cells involved in defence mechanisms including neutrophils, 
macrophages and other leukocytes. An in vitro study involving an airway epithelial 
cell line and primary bronchial epithelial cell cultures demonstrated that IL8 
expression (along with the expression of other TLR genes) significantly impacted on 
airway innate immune responses to pathogens (Sha Q et al., 2004).  
 
There were interesting findings in terms of the regulation of the TLR genes observed 
in the array data as observed in the present study in which the contrasting roles of 
TLR2 compared to its component molecules (TLR1 and TLR6) during the early 
response to injury in which both TLR1 and TLR6 were significantly down-regulated 
whilst TLR2 been significantly up-regulated at 6 hours post injury as compared to 
naïve (time point 0). It is well-known that the activation of TLR2 requires homo- or 
heterodimerization with TLR1 or TLR6 (Chang S et al., 2007 ). By designing small 
interfering RNAs targeted to TLR2, TLR1, and TLR6, (Chang S et al., 2007 ) 
showed that knockdown of each of these receptors impaired pro- and anti-
inflammatory cytokine activation by TLR-specific ligands in human embryonic 
kidney-TLR2 cells and in primary human macrophages (Chang S et al., 2007 ). The 
(Chapter 6_Appendix 6.12d – as attached) shows unique ability of TLR2 to form 
heteromers with TLR1 or TLR6 to mediate intracellular signalling in turn involved in 
activation of chemotactic and pro-inflammatory effects and apoptosis activity of the 
cells in response to injury. A study by (Farhat K et al., 2008) concluded that 
heterodimerization of TLR2 with TLR1 or TLR6 is important to enable the innate 
immune system to recognize the numerous, different structures of bacterial 
lipopeptides (LP) present in various pathogens (Chang S et al., 2007 ). In the context 
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of the present study, the mechanism of how these genes interacting to each other is 
unknown but one could be speculated is that the perturbation of these TLR genes 
might has induced the innate immune and inflammatory responses for downstream 
application in repair activity which clearly observed at the later time points (mucosal 
haemorrhage and proliferative activity). 
 
In the present study, the early involvement of toll-like receptor pathways may play a 
role in regulating cells into the apoptosis stage. An in vitro model system of human 
first trimester trophoblasts revealed that the apoptosis induced by exposure to Gram-
positive bacterial peptidoglycan (PDG) was found to be mediated by both TLR1 and 
TLR2 genes. TLR6 blocked the apoptosis pathway, activated trophoblast (NF-
(kappa)B and triggered these cells to secrete the IL6 and IL8 necessary to regulate 
the inflammatory responses (Abrahams VM et al., 2008).  
 
The p53 tumour suppressor protein is a multi-functional transcription factor that 
regulates cellular processes affecting proliferation, cell cycle checkpoints, and 
apoptosis and the consistent involvement of genes in this pathway indicates the 
importance of these processes in the airway epithelial response to injury. Apoptosis 
is well recognised in situations where cells fail to quickly repair following exposure 
to damage - whether at the level of the DNA or at the whole cell level. In the context 
of the present study, the brushing caused damage to cellular morphology and likely 
precipitated cell death. In addition, the activation of the cellular proliferation and cell 
cycle activities led to the generation of cells involved in the repair and regeneration 
process. Incumbent in such process would be the need to fine-tune and regulate the 
proportions of each cell type according to both the stage of injury and in relation to 
the ultimate repaired epithelial phenotype – hence the need to drive certain cells to 
apoptosis to accommodate this end (Tesfaigzi Y, 2003). Whilst apoptosis of 
neutrophils may benefit the host by helping the resolution of inflammation, apoptosis 
of epithelial cells may lead to further disruption of the epithelial barrier and lengthen 
the healing process. The activation of the p53 signalling pathway at day 1 up to day 3 
post injury suggest the important roles of the apoptosis activity in regulating airway 
regeneration and repair. Clearly, an apoptotic balance may exist between the 
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different cell types involved and at the different stages of the repair process and it is 
probable that the derived information in this regard reflects the overall balance 
between the multitudes of cells involved. The genes involved in the p53 pathway 
clustered in two groups, one of which (CDKN1A, SFN and GADD45A) is involved 
in inhibiting cell cycle arrest whilst the second (PAI, TSP1 and GADD45A) is 
involved in the inhibition of angiogenesis and metastasis, DNA repair and damage 
prevention (Chapter 6_Appendix 6.9c_p53 signalling pathway – as attached). In this 
pathway, the involvement of the TGF-beta gene within this cluster is significant as 
this gene is known to be involved in controlling cellular proliferation and 
differentiation through inhibiting epithelial cell proliferation and induction of 
apoptosis (Yoo J et al., 2003).  
 
The expression of the cell cycle-related genes early on in the response to injury was 
found to be associated with the regulation of the p53 signalling pathway that inhibits 
cellular senescence and cell cycle arrest. The activation of the cell cycle pathway was 
consistent with the evidence of cell proliferation which peaked at day 3 post injury. 
Most of the genes involved in the cell cycle pathway at day 1 post injury were the 
genes activated in all phases of the cell cycle stage of DNA replication (S-phase) and 
mitosis (M). In the overall analysis incorporating data from all time points, the GO 
term for mitosis was the most significant term associated with our list of genes. In 
fact, at every time point, this activity was among the most significant term 
associating with these significantly expressed genes. It is probable that the mitotic 
activity is essential in generating new daughter cells to regenerate the epithelium.  
 
Most of the up-regulated cell cycle-related genes observed in this study were 
associated with the G2 and M phases of the cell cycle – the phases during which 
protein synthesis and mitosis take place. This was consistent with a transcriptomic 
analysis of the response of the healthy human airway to bronchial brushing in which, 
at day 7 post injury, there was increased levels of many late stage cell cycle genes 
(G2 and M phases). It was suggested that the involvement of these genes was 
consistent with the morphological assessment of the airway epithelium at day 7 post 
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injury when there was evidence of complete coverage of the brushed area (Heguy A 
et al., 2007).  
 
6.6  CONCLUSION OF THE CHAPTER 
By application of functional annotation and analysis tools contained within DAVID 
the biological functions of the groups of genes that were significantly regulated in 
our study were assessed. GO terms for the analogous human genes were established 
and used in the analysis to predict the biological process in the sheep model. The 
appearance of the significant GO terms identified in this study is dependent on the 
stages or epithelial repair involving inflammatory response, cellular migration, 
extracellular matrix activities, differentiation, proliferation, cellular development, 
cell cycle activities, cellular adhesion, apoptosis and mitosis. During the airway 
regeneration different KEGG pathways were demonstrated to be involved at specific 
times during the process of repair. Such data will provide a foundation upon which 
future studies can exploit the increasing availability of annotated genomic 
information pertaining to large animal model systems and will potentially prove 
useful in linking the processes seen during normal repair with those seen in 
conjunction with more complex models of airway epithelial damage such as those 
















7. CHAPTER 7 
GENERAL DISCUSSION 
 
7.1  Summary of the results 
The work presented in this thesis was aimed towards understanding the mechanisms 
involved in airway regeneration and repair in the sheep. This study demonstrates, for 
the first time, that bronchial brushing in anaesthetised animals provides a means of 
physical injury that is well tolerated and quickly repaired. Histopathology of brushed 
areas indicated that the injury completely denuded the brushed area of epithelium 
and indeed removed the underlying basement membrane and perturbed the deeper 
structures. Initial studies indicated that the major part of the repair process was 
complete within the first week after injury and further confirmed the utility of 
following changes over time involving multiple brush sites in the same animal.   
 
The general process of repair appeared to broadly agree with that previously 
characterised in small animal tracheal injury systems - such repair being 
characterised by dedifferentiation of marginal epithelium, migration, proliferation 
and re-differentiation. However this model extends the value of such basic research 
in examining the repair process in the bronchi themselves, the site where this 
technique is commonly applied in clinical and veterinary clinical respiratory 
medicine, in a species with bronchial airway wall architecture comparable to that of 
human. With proliferation being a key part of repair these studies provide, for the 
first time, information about the dynamics, location and extent of proliferative 
activity in the more distal airway epithelium in large animals. 
 
Certain limitations exist that confound the value of such large animal systems in 
agricultural species. Notably very few antibodies are available to label cells of 
interest in order to trace their function and roles during the repair process. As a 
consequence this study sought to define the molecular characteristics of the repair 
process. Towards this end semi-quantitative analysis of RT-PCR assays were 
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developed to probe expression profiles of genes that are believed to associate with 
specific cell types such as basal and ciliated cells. The genes that were considered in 
this way were beta-catenin, beta-tubulin, keratins 5 and 14, and FoxJ1. This analysis 
revealed that whilst the expression profiles of the studied genes did indeed vary over 
the course of the repair process the extent of within- and between-animal variability 
in this regard would likely erode the potential ability of this approach to glean clear 
and definitive statements regarding the likely pathways and mechanisms underlying 
the different stages of repair. Such ability would of course further be influenced by 
the nature and extent of gene selection – hinged as it was, and would be, on the 
available literature, but as a consequence biased, and less likely to pick up species-
specific differences. Thoughts turned to the potential utility of microarray expression 
profiling using sheep microarrays made recently commercially available as a means 
of characterising the mechanisms underlying the repair process.   
 
Microarray hybridisation generally requires a high quality RNA sample to meet 
quality standards for reproducibility and reliability of the microarray data and 
generally involves optimisation of sampling protocols. This reality was quickly 
appreciated in the context of samples derived from the airway wall and efforts were 
directed towards optimising the sampling protocols. 
 
The experimental protocol that was designed to evaluate the time-dependent changes 
in gene expression concordant with histopathological features involved eight sheep. 
In order to facilitate evaluation of airways at four time points after injury (6 hours, 
days 1, 3 and 7) sheep were allocated to one of four possible sampling schedules (6 
hours, days 1 and 3; 6 hours, days 1 and 7; 6 hours, days 3 and 7; days 1, 3 and 7) 
and data collected from the brushed areas at each time point was compared to 
spatially disparate unbrushed (naive) control airways within the same lung. The 
complexity of this experimental design reflected the need to optimise the data return 
to facilitate meaningful statistical appraisal whilst minimising ethical cost. This study 
identified more than 13,000 probes which were significantly expressed at various 
times during the repair process and amongst those were genes and pathways that 
appeared to correlate in a biologically plausible sense with the pathophysiology of 
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the wound repair process. One significant limitation to the use of such commercial 
microarrays was the relative lack of annotation associated with the arrayed ovine 
genes. With full-scale annotation beyond the scope of the present study a 
compromise was necessary in order to progress with the underlying objectives of this 
research – namely that a subset of genes would be annotated. To this end, the 
experimental analysis of microarray data identified for each gene and time point in 
expression with associated significance level. And decision was made to select only 
those annotated genes at a significance level less the 5% for further analysis. Out of 
13, 495 probes significantly regulated at p<0.05, 6420 probes managed to be 
annotated and were selected for downstream application of biological and pathway 
analyses.  
 
In order to better understand the biological function of the significantly expressed 
genes a further analysis based on their gene ontologies was completed. Gene 
ontology (GO) terms associate genes with relevant functions (biological process, 
cellular component and molecular function) and analysis seeks to use this 
information to piece together pathways and biology underlying complex expression 
patterns. The repair process observed at the histopathological level was consistent 
with the biological function proposed by the analysis tools and involved 
inflammatory and innate immunity responses, early phase (6 hours) migration, 
cellular proliferation, ECM function, and the activation of cell cycle processes, 
apoptosis and cellular re-differentiation at later time points. Several pathways were 
found to be associated with the phases of repair in our study. These were identified 
as cell cycle, ECM-receptor interaction, focal adhesion, small cell lung cancer, 
leukocyte transendothelial migration, cell communication, p53 signalling pathway, 
TGF-beta signalling pathway, hematopoietic cell lineage, toll-like receptor signalling 
pathway, complement and coagulation cascades and cytokine-cytokine receptor 
pathways. Such studies indicate the facility of this model system to dissect and 
understand the events that are associated with airway epithelial repair. Potential 
naturally exists to carry this forward and several avenues of further work and 




7.2  Future works  
Two major limitations were identified in the context of this large animal system. The 
first concerns the availability of immunological markers to follow the involvement of 
specific cell types throughout the repair process and the second concerns the lack of 
annotation available for the currently available sheep commercial microarray. In the 
first regard it is fortunate that initiatives are underway (The Immunological Toolbox  
at http://www.immunologicaltoolbox.com/ and (Entrican G et al., 2009)) to develop 
the tools necessary to complete this analysis and the resource of tissues and tissue 
sections archived during the course of the present study will facilitate the ongoing 
assessment of this work as more and more relevant antibody sets become available. 
Equally, the question of annotation will likely be addressed in the near future by the 
commercial interests concerned but in the meantime the process of searching probe 
targets against the human genomic databases in order to identify likely analogues 
will presumably lend itself to an automated approach that will facilitate iteration to 
continually update and/or allow re-specification of selection criteria. In the context of 
the methodologies employed in the current study such selection would build upon the 
list of human analogues with Human Gene Symbols that could be input into the 
DAVID functional analysis software and extend the power of this analysis tool.  
 
The wider relevance of this study extends to abnormal airway epithelial repair in the 
context of airway pathology such as is observed in asthma, COPD and cystic fibrosis. 
The nature of the pathogenesis associated with these diseases share a common theme 
in that repetitive insult is believed to occur. How such repetitive insult impacts on the 
normal repair process is currently unknown but is a question that would lend itself 
well to the model system developed in this thesis. In particular, it would be possible 
to re-brush epithelium at different phases of the repair process to examine the impact 
of such an approach on the underlying gene expression and evoked pathways. 
Perturbing the normal process of repair and regeneration by repeating (perhaps on 
several occasions) the brushing process on the repairing epithelium would facilitate 
the study of the way in which such repeated insult influences the normal 
transcriptional pattern of repair. Indeed it may be possible to identify the pathways 
that continue to operate (in time and extent) on the basis of the original injury, those 
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that emerge as unique to the chronic injury and those that deviate from their 
anticipated pattern or time course of regulation initiated on the basis of the original 
injury. Such a model has not hitherto been characterized at the molecular level - 
although the idea of repeated injury has, as previously discussed (Gordon RE and 
Lane BP, 1977), been followed through to investigate cell cycle in small animal 
models. Such studies would have real relevance to understanding fundamental 
processes in complex diseases and potentially provide therapeutic angles that could 
be exploited in the future.  
 
Another area of specific interest concerns the source of cells that are involved in the 
re-epithelialisation of the denuded area. In addition to the marginal epithelial de-
differentiation, migration and re-differentiation, cells from the sub mucosal gland 
regions may also play a role. It is tempting to speculate that continual re-brushing of 
the denuded area will prevent these, and the wound marginal, cells from achieving 
the network of cell contacts that may be necessary to provoke the re-differentiation 
process.  
 
Ordinarily, posing mechanistic questions about the roles of specific genes or 
pathways involves the strategic development of transgenic or knockout mouse 
models and observing the impact of such strategy on the system under study. 
Whether, in future, the potential exists to bring such mechanistic studies into the 
realms of large animal studies remains to be determined but it is conceivable that the 
very precision associated with achieving the brushing injury itself will also lend itself 
to the targeted application and or expression of small interfering molecules such as 
RNAi or specific peptides in the region of interest. Naturally such a strategy hinges 
on the detailed characterisation of the molecular response - perhaps even on an 
individual animal basis. Such studies would be prefaced and paralleled by analysis of 
in vitro systems. Indeed the basis for such studies is well established and could, for 
example, follow the techniques described by (Wesley UV et al., 2007) which was 
used the SiRNA technique to study the roles of dual oxidase 1 (Duox1) within the 
tracheobronchial epithelium in airway epithelial cell migration and repair following 
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injury in vitro culture using human primary tracheobronchial epithelium (HTBE) cell 
cultures. 
 
Further refinement on our established technique could incorporate analysis of the 
brushed cells themselves. The molecular aspects of the associated methodology are 
well characterised within the sheep model and application of such would afford a 
means of following progress in airway epithelial repair without sacrifice of the 
animal. In any case the comparison of gene expression changes in the harvested cell 
population as compared with the airway wall itself would afford useful insight into 
the contribution of the epithelial surface to the observed gene expression changes in 
the wall itself.  
 
Finally, and following on from the necessary groundwork involved in annotating the 
sheep array the potential exists to extend the analysis of our data through the 
application of new software tools as they become available. One such current 
example is a free programme called BioLayout Express3D (Theocharidis A et al., 
2009, Freeman TC et al., 2007). This programme capitalises on the remarkable visual 
processing capabilities of the human brain to analyze patterns and images and directs 
this capability towards assessing large scale bioinformatic data through representing 
the same in a highly visual context – in both 2- and 3-dimensional formats. Such 
approaches have proven useful to study gene expression data and networks within a 
wide variety of biological relationship systems (Freeman TC et al., 2007) and would 
lend themselves well to the further analysis of the datasets accumulated in the 
context of the present study. The networks consist of nodes representing transcripts 
or genes connected by virtue of their expression profile similarity across multiple 
conditions (this includes the individual sheep ID and the time points). The similarity 
between individual expression profiles may be determined by one of a number of 
possible statistical techniques, including Pearson and Spearman correlation 
coefficients. Thus networks can be constructed by connecting transcripts (nodes) by 
edges that infer varying degrees of co-expression based on an arbitrary correlation 
threshold thus establishing relationships between genes based on correlation of 
expression (Freeman TC et al., 2007, Theocharidis A et al., 2009). By being able to 
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assess the sheep-specific expression patterns of those genes at the various time 
points, both the fundamental aspects of the process conserved between sheep could 
potentially be identified, as well as the processes that contribute to the variation seen 
between sheep. We hypothesize that by using this type of approach it may be 
possible to broaden the scope of the microarray dataset by mapping the molecular 
networks and pathways that exist between genes and as such could establish the 
intra-relationship between genes within clusters and also the inter-relationship of the 
genes lying in separate clusters in order to improve our understanding of the 
behaviour of the complex networks that underlay the repair mechanism in the airway 
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Sheep ID Age (d) Sheep Breed Gender Bodyweight (kg) 
11934 435 Suff x MN 49 
11784 443 Suff x MN 57 
12223 456 Suff x MN 56 
7458 457 Suff x F 50 
11907 512 Suff x MN 65 
12171 517 Suff x MN 52 
10908 520 Suff x MN 66 
10639 526 Suff x MN 75 
77 530 Suff x MN 65 
 
Appendix 2.7.1: Details of the animals used in this study 






































11784 √ √ √ √ √ √ √ - 
12223 - √ √ √ √ √ √ √ 
7458 √ √ √ √ √ √ √ - 
B) 
  TIMEPOINTS 
SHEEP -14 -7 -3 -1 -6 0 
  days Days days day hours hour 







10908 - - - √ - 
77 - - √ - - 
12171 - √ - - - 
10639 √ - - - - 
 
Appendix 2.7.2: Experimental protocols employed in this study  
Appendix 2.7.2A depicts the sampling schedule employed in Protocol A and Appendix 
2.7.2B, the sampling schedule employed in protocol B. In Protocol A, only one sheep (one 
segment) was evaluated 6 hours after injury (Sheep 12223) 
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SeqA Name     Len(nt)  SeqB Name     Len(nt)  Score 
1    CloneJ   403      2    TC3860   1654     94    
1    CloneJ   403      3    CloneQ   403      79    
1    CloneJ   403      4    42       1388     90    
1    CloneJ   403      5    17       1568     96    
1    CloneJ   403      6    13       1741     79    
1    CloneJ   403      7    14       1771     92    
1    CloneJ   403      8    15       1841     79    
2    TC3860   1654     3    CloneQ   403      79    
2    TC3860   1654     4    42       1388     69    
2    TC3860   1654     5    17       1568     69    
2    TC3860   1654     6    13       1741     50    
2    TC3860   1654     7    14       1771     97    
2    TC3860   1654     8    15       1841     50    
3    CloneQ   403      4    42       1388     80    
3    CloneQ   403      5    17       1568     78    
3    CloneQ   403      6    13       1741     91    
3    CloneQ   403      7    14       1771     78    
3    CloneQ   403      8    15       1841     91    
4    42       1388     5    17       1568     77    
4    42       1388     6    13       1741     62    
4    42       1388     7    14       1771     69    
4    42       1388     8    15       1841     62    
5    17       1568     6    13       1741     59    
 
Appendix 3.1: A summary of the alignment analysis result between clones and other types of bovine 
keratin genes. Highlighted (bolded) are the clones J and Q. The data shows that the sequence for 
Clone J is highly likely similar to bovine keratin 17, keratin 14 and EST sequence (TC3860) which is 
also has 97% similar to bovine keratin 14 (not shown). The sequence for Clone Q is likely to suggest 
that this sequence either belongs to bovine keratin 15 or 13. 
 
SeqA : Numbering system assigned by the programme for the studied sequences 
Name : The names given to the sequences  
Len(nt) : The length of the analysed sequences  
SeqB : Numbering system taken from SeqA 
Name : The names given to the sequences 
Len(nt) : The length of the analysed sequences 










TC3860          GGCCGACATCAACGGCCTGCGCAGGGTGCTGGACGAGCTGACCCTGGCCAGAGCCGACCT 771 
14              GGCCGACATCAACGGCCTGCGTAGGGTGCTGGACGAGCTGACCCTGGCCAGAGCCGACCT 891 
CloneJ          ----GACATCAACGGCCTGCGCAGGGTGCTGGACGAGCTGACCCTGGCCAGAGCTGACCT 56 
17              GGCCGACATCAACGGCCTGCGCAGGGTGCTGGACGAGCTGACCCTGGCCAGAGCCGACCT 699 
42              GGCCGACATCAACGGCCTGCGCAGGGTGCTGGACGAGCTGACCCTGGCCAGAGCCGACCT 670 
13              GGCCGACATCAACGGCCTGCGCAGGGTGCTGGATGAGCTGACCCTGACCAAGACTGACCT 735 
15              GGCCGACATCAACGGCCTGCGCAGGGTGCTGGATGAGCTGACCCTGACCAAGACTGACCT 865 
CloneQ          ----GACATCAACGGCCTGCGCAGGGTGCTGGACGAGCTGACCCTGACCAAGACTGATCT 56 
                    ***************** *********** ************ ***   * ** ** 
 
TC3860          GGAGATGCAGATCGAGAGCCTCAAGGAGGAGCTGGCCTACCTCCGGAAGAACCACGAGGA 831 
14              GGAGATGCAGATCGAGAGCCTCAAGGAGGAGCTGGCCTACCTCCGGAAGAACCACGAGGA 951 
CloneJ          GGAGATGCAGATCGAGAACCACTTGGAGGAGCTGGCCTACCTCCGCAAGAACCACGAGGA 116 
17              GGAGATGCAGATCGAGAACCTCAAGGAGGAGCTGGCCTACCTCCGCAAGAATCACGAGGA 759 
42              GGAGATGCAGATCGAGAACCTCAAGGAGGAGCTGGCCTACCTCCGGAAGAACCACGAGGA 730 
13              GGAGATGCAGATCGAGAGCCTGAATGAGGAGCTGGCCTACCTGAAGAAGAACCACGAGGA 795 
15              GGAGATGCAGATCGAGAGCCTGAATGAGGAGCTGGCCTACCTGAAGAAGAACCACGAGGA 925 
CloneQ          GGAGATGCAGATTGAGAGCCTGAACGAGGAGCTGGCCTACCTGAAGAAGAACCACGAGGA 116 
                ************ **** **     *****************    ***** ******** 
 
TC3860          GGAAATGAACTCCCTGAGAGGCCAGGTGGGCGGAGACGTCAACGTGGAGATGGACGCCGC 891 
14              GGAAATGAACTCCCTGAGAGGCCAGGTGGGCGGAGACGTCAACGTGGAGATGGACGCCGC 1011 
CloneJ          GGAGATGAAAGCCCTTCGAGGCCAGGTGGGTGGCGAGATCAACGTGGAGATGGACGCCGC 176 
17              GGAGATGAAAGCCCTGCGAGGCCAGGTGGGCGGCGAGATCAACGTGGAGATGGACGCTGC 819 
42              GGAGATGAATGCTCTGCGAGGCCAGGTGGGCGGGGACGTCAACGTGGAGATGGACGCCGC 790 
13              GGAGATGAAGGAGTTCAGCAACCAGCTGGCTGGCCAGGTCAATGTGGAGATGGATGCAGC 855 
15              GGAGATGAAGGAGTTCAGCAACCAGCTGGCTGGCCAGGTCAATGTGGAGATGGATGCAGC 985 
CloneQ          GGAGATGAAGGAGTTCAGCAACCAGCTGGCTGGCCAGGTCAACGTGGAGATGGACGCAGC 176 










TC3860          CCCCGGCGTGGACCTGAGCCGCATCCTGAACGAGATGCGCGACCAGTACGAGAAGATGGC 951 
14              CCCCGGCGTGGACCTGAGCAGAATCCTGAACGAGATGCGCGACCAGTACGAGAAGATGGC 1071 
CloneJ          CCCCGGCGTGGACCTGAGCCGCATCCTGAACGAGATGCGCGACCAGTATGAGAAGATGGC 236 
17              CCCCGGCGTGGACCTGAGCCGCATCCTGAACGAGATGCGCGACCAGTATGAGAAGATGGC 879 
42              CCCTGGCGTGGACCTGAGCCGCATCCTGAACGAGATGCGCGACCAGTATGAGAAGATGGC 850 
13              ACCAGCCGTGGACCTGACCCGCGTGCTGTCAGAAATGAGGGAGCAGTACGAGGCCATGGC 915 
15              ACCAGCCGTGGACCTGACCCGCGTGCTGTCAGAAATGAGGGAGCAGTACGAGGCCATGGC 1045 
CloneQ          ACCAGGCATTGACCTGACCCGCGTGCTGGCAGAGATGAGGGAGCAGTACGAGGCCATGGC 236 
                 ** * * * ******* * *  * ***   ** *** * ** ***** ***   ***** 
 
TC3860          AGAGAAGAACCGCAAGGATGCCGAGGACTGGTTCTTCAGCAAGACAGAGGAACTGAACCG 1011 
14              GGAGAAGAACCGCAAGGATGCCGAAGACTGGTTCTTTAGCAAGACAGAGGAACTGAACCG 1131 
CloneJ          AGAGAAGAACCGCAAGGATGCCGAGGACTGGTTCTTCAGCAAGACGGAGGAACTGAACCG 296 
17              GGAGAAGAACCGCAAGGATGCCGAGGACTGGTTCTTTAGCAAGACGGAGGAACTGAACCG 939 
42              GGAGAAGAACCGCAAGGATGCCGAGGACTGGTTCTTCAGCAAGACGGAGGAGCTGAACCG 910 
13              GGAGAAGAACCGCCGGGATGCCGAGGCCTGGTTCTTTAGCAAGACAGAGGAGCTGAATAA 975 
15              GGAGAAGAACCGCCGGGATGCCGAGGCCTGGTTCTTTAGCAAGACAGAGGAGCTGAATAA 1105 
CloneQ          AGAGAAGAACCGCCGGGATGCCGAGGAATGGTTCCACAGCAAGAGCGCCGAGCTGAACAA 296 
                 ************  ********* *  ******   *******  *  ** *****    
 
TC3860          CGAGGTGGCTACCAACAGCGAGCTGGTGCAGAGCGGCAAGAGCGAGATCTCGGAGCTCCG 1071 
14              CGAGGTGGCTACCAACAGCGAGCTGGTGCAGAGCGGCAAGAGCGAAATCTCGGAGCTCCG 1191 
CloneJ          CGAGGTGGCCACCAACAGCGAGCTGGAGCAGAGCGGCAAGAGCGAGATCTCGGAGCTCCG 356 
17              CGAGGTGGCCACCAACAGCGAGCTGGTGCAGAGCGGCAAGAGCGAGATCTCGGAGCTCCG 999 
42              CGAGGTGGCCACCAACACCGAAGCCCTGCAGAGCAGCCGGACGGAGATCACGGAGCTGCG 970 
13              GGAGGTGGCCTCCAACACAGAGATGATCCAGACCAGCAAGACGGAGATCACAGACCTGAG 1035 
15              GGAGGTGGCCTCCAACACAGAGATGATCCAGACCAGCAAGACGGAGATCACAGACCTGAG 1165 
CloneQ          GGAGGTGTCTTCCAGCACAGCCATGATCCAGACCAGCAAGACAGAGATCACCGAGCTCAG 356 










TC3860          GCGCACCATGCAAAACCTGGAGATCGAGCTGCAGTCCCAGCTCAGCATGAAAGCATCTCT 1131 
14              GCGCACCTTGCAAAACCTGGAGATCGAGCTGCAGTCCCAGCTCAGCATGAAAGCATCTCT 1251 
CloneJ          GCGCACCTTGCAGGCCCTGGAGATCGTGCTGCAGTCCCAGCTCAGCA------------- 403 
17              GCGCACCTTGCAGGCCCTGGAGATCGAACTGCAGTCCCAGCTCAGCATGAAAGCATCCCT 1059 
42              CCGCACGGTCCAGAACCTGGAGATTGAGCTGCAGTCCCAGCTCAGCATGAAAGCGTCGCT 1030 
13              ACGCACGATACAGGGGCTGGAGATTGAGCTGCAGTCCCAGCTCAGCATGAAAGCCGGGCT 1095 
15              ACGCACGATACAGGGGCTGGAGATTGAGCTGCAGTCCCAGCTCAGCATGAAAGCCGGGCT 1225 
CloneQ          GCGCACGCTCCAGGGCCTGGAGATCGAGCTGCAGTCCCAGCTCAGCA------------- 403 
                 *****  * **    ******** *  *******************              
 
Appendix 3.2: Sequences alignment between the sequences generated from the Clones J and Q and other types of keratin genes. The analysis was performed in order 
to find a similarity of the sequences between clones and other types of keratin genes. Highlighted (bolded) sequences are the forward and reverse primers. The 
sequences from both forward and reverse primers are conserved between majorities of keratin genes. (*) shows the areas of conserved between studied sequences.   
 
 
 
 
 
 
 
 
